data_2lz6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lz6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.877 0.37 . . . . 16.5 111.011 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -79.24 149.03 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.837 -0.62 . . . . 13.859999999999999 110.544 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.0 pt -142.94 147.88 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 12.19 110.678 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -97.55 137.24 36.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 11.640000000000001 110.597 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.41 91.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.573 -0.529 . . . . 9.0399999999999991 109.573 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' A' ' 7' ' ' THR . 61.7 tttm -77.03 164.29 25.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.916 -0.584 . . . . 9.0399999999999991 111.425 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.411 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.8 m -143.57 159.43 42.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.427 -0.806 . . . . 9.0399999999999991 110.041 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 pp -62.31 -22.37 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 9.0399999999999991 111.37 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -81.75 -13.7 57.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.369 . . . . 9.0399999999999991 111.272 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.98 47.63 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.057 -0.592 . . . . 9.0399999999999991 112.468 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -93.59 111.31 22.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 9.0399999999999991 111.492 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.03 125.0 44.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.759 -0.655 . . . . 9.0399999999999991 110.134 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -117.01 142.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.384 . . . . 9.0399999999999991 111.215 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.9 p -97.79 139.12 34.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 9.0399999999999991 110.704 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD11 ' H ' ' A' ' 16' ' ' GLU . 59.3 tp -139.89 150.77 45.0 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.548 -0.296 . . . . 10.02 110.524 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.406 ' H ' HD11 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -111.92 106.31 14.97 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.569 -0.287 . . . . 12.19 111.373 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.65 113.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.216 -0.447 . . . . 14.73 111.299 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 14.6 mp0 -60.78 172.15 0.91 Allowed Pre-proline 0 N--CA 1.467 0.408 0 N-CA-C 112.89 0.7 . . . . 18.57 112.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 41.2 Cg_exo -59.45 -39.74 73.33 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.32 2.68 . . . . 19.890000000000001 113.251 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.9 p -61.61 -26.2 67.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.38 -0.373 . . . . 21.489999999999998 111.759 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.04 151.26 9.23 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.921 0.391 . . . . 18.559999999999999 111.646 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -95.24 149.46 21.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.837 -0.62 . . . . 20.149999999999999 110.841 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.6 mm -58.62 -37.66 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 17.16 111.1 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.63 -40.48 92.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.902 0.382 . . . . 19.989999999999998 109.995 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.99 -41.8 95.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.935 -0.575 . . . . 16.559999999999999 110.013 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.65 -47.22 82.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.994 -0.548 . . . . 14.390000000000001 110.464 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -60.55 -36.37 78.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.922 -0.581 . . . . 14.57 110.541 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.86 84.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.03 -0.532 . . . . 14.550000000000001 110.375 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -65.44 -49.81 67.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.926 -0.579 . . . . 14.15 110.028 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -57.55 -40.5 75.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.959 -0.564 . . . . 10.06 110.457 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -63.76 -30.09 71.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.037 -0.529 . . . . 15.880000000000001 111.025 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.59 -38.51 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 12.470000000000001 111.235 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.13 -59.93 2.06 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.087 0.403 . . . . 9.2300000000000004 112.087 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.8 -11.93 60.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.022 0.749 . . . . 9.5999999999999996 113.022 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.0 -17.71 4.51 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.537 -0.84 . . . . 12.199999999999999 114.213 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.5 pt -59.43 132.0 88.12 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 117.337 0.569 . . . . 11.27 112.043 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.79 144.38 38.94 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 14.23 112.231 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.88 -22.26 63.35 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.745 2.297 . . . . 14.34 112.374 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.59 -25.49 66.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 16.960000000000001 111.176 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -106.25 -13.11 15.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.358 -0.383 . . . . 14.449999999999999 111.42 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -73.59 132.8 43.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.12 0.486 . . . . 11.609999999999999 111.954 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.424 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 61.7 mtp180 -127.73 114.5 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.356 -0.838 . . . . 9.6099999999999994 109.156 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -101.3 122.16 43.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.836 0.351 . . . . 10.56 110.907 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -113.3 133.17 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.899 -0.591 . . . . 9.75 110.442 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -151.06 124.28 8.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 15.27 110.578 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.77 19.35 11.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 14.76 111.967 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.57 80.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.566 -0.826 . . . . 12.99 112.97 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.21 147.92 42.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.745 0.307 . . . . 17.59 110.729 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -81.88 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 14.970000000000001 110.3 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.4 133.23 48.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 14.81 111.183 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.87 126.75 35.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 21.0 110.515 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.34 -35.03 25.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.921 -0.581 . . . . 18.5 112.351 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.7 1.87 88.02 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.954 -0.641 . . . . 21.789999999999999 114.273 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.78 177.64 4.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.172 0.486 . . . . 24.890000000000001 110.977 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -122.4 158.7 29.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.333 -0.394 . . . . 21.530000000000001 110.952 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.6 mm? -52.24 -24.29 7.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 18.41 111.744 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 m -75.04 -25.56 58.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.629 0.252 . . . . 21.809999999999999 111.515 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.18 -41.8 96.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 23.140000000000001 111.123 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -94.75 10.43 35.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.304 -0.407 . . . . 19.370000000000001 111.665 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 56.37 42.91 27.06 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.062 0.458 . . . . 22.789999999999999 111.207 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.9 mt -85.49 104.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 18.120000000000001 111.198 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -91.56 178.03 6.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.14 -0.482 . . . . 21.52 111.313 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -60.5 155.29 18.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.987 -0.552 . . . . 19.190000000000001 111.585 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 60.51 33.46 20.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.843 -0.617 . . . . 16.920000000000002 111.364 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 p -92.04 157.61 16.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 15.09 110.649 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 t -113.74 124.4 52.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 11.93 110.712 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -115.89 119.41 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 10.94 110.4 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -77.99 120.87 23.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.381 -0.372 . . . . 9.0399999999999991 111.148 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.51 109.75 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 9.0399999999999991 111.273 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 19.4 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 9.0399999999999991 109.962 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 C--O 1.232 0.164 0 N-CA-C 109.734 -0.469 . . . . 9.0399999999999991 109.734 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . 0.429 ' H ' ' HB2' ' B' ' 64' ' ' SER . 20.0 m-85 -124.05 172.08 9.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 9.0399999999999991 110.745 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 35.1 m -142.27 149.09 39.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 9.0399999999999991 111.027 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -99.51 138.0 37.21 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.519 -0.309 . . . . 9.0399999999999991 110.456 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -78.54 123.46 27.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.497 -0.32 . . . . 9.0399999999999991 110.856 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.54 -21.31 19.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.331 0.493 . . . . 9.0399999999999991 112.331 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -145.84 155.01 52.11 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 117.954 0.343 . . . . 9.0399999999999991 111.409 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.11 136.42 26.99 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.518 2.145 . . . . 9.0399999999999991 112.728 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -137.96 127.68 25.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.889 -1.05 . . . . 9.0399999999999991 109.539 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.2 m -112.06 121.67 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 9.0399999999999991 111.322 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.85 143.71 48.74 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.744 -0.741 . . . . 9.0399999999999991 111.926 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.1 p -107.17 -18.63 13.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.519 . . . . 9.0399999999999991 110.825 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -119.49 159.11 24.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 9.0399999999999991 110.222 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.51 -30.65 71.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 9.0399999999999991 111.357 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.31 -5.88 59.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 9.0399999999999991 111.012 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -81.76 157.65 24.44 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.146 -0.479 . . . . 9.0399999999999991 110.988 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.539 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 2.7 mt -110.59 151.61 27.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.626 -0.509 . . . . 9.0399999999999991 109.626 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -115.72 129.23 56.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.328 -0.396 . . . . 9.0399999999999991 110.468 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.539 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 29.9 m-85 -130.6 133.8 46.46 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.263 0.468 . . . . 9.0399999999999991 112.263 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.458 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 97.7 mtt180 -104.04 175.24 5.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.763 -0.458 . . . . 9.0399999999999991 109.763 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -81.5 134.44 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 9.0399999999999991 110.006 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.17 50.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.925 -0.87 . . . . 9.0399999999999991 110.925 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.2 mm-40 -98.42 179.42 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.423 0.898 . . . . 9.0399999999999991 113.423 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -131.34 113.55 23.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.76 -1.564 . . . . 9.0399999999999991 111.233 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.472 HG12 ' CD1' ' B' ' 25' ' ' PHE . 42.6 mt -106.89 129.41 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 9.0399999999999991 110.677 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -89.96 127.27 36.0 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.894 -0.41 . . . . 9.0399999999999991 109.894 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.28 128.04 34.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.044 0.45 . . . . 9.0399999999999991 110.923 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.41 -48.97 6.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 9.0399999999999991 110.785 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 79.3 p -167.06 113.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 9.0399999999999991 111.983 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -69.32 5.11 1.39 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.907 -0.588 . . . . 9.0399999999999991 111.32 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -121.85 101.89 7.85 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 116.63 -0.259 . . . . 9.0399999999999991 110.305 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 30.5 p -112.33 -2.96 14.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.454 -0.339 . . . . 9.0399999999999991 111.752 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.03 -5.14 78.68 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.685 . . . . 9.0399999999999991 112.014 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -125.99 119.7 28.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 9.0399999999999991 110.39 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.56 132.46 53.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 9.0399999999999991 111.302 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.32 -0.46 85.53 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.9 -0.591 . . . . 9.0399999999999991 112.704 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -122.92 123.74 41.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.454 0.627 . . . . 9.0399999999999991 112.016 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' TRP . . . . . 0.539 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 19.4 m0 -109.66 165.15 11.9 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.477 -0.783 . . . . 9.0399999999999991 109.428 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -115.91 131.72 56.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.021 0.439 . . . . 9.0399999999999991 110.965 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.7 174.82 21.86 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.411 -0.813 . . . . 9.0399999999999991 111.717 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.05 133.36 52.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.291 0.567 . . . . 9.0399999999999991 110.364 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' B' ' 50' ' ' GLY . 11.8 tp -130.06 170.99 13.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.929 -1.032 . . . . 9.0399999999999991 109.675 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.478 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 60.3 m-20 -17.69 64.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.424 1.638 . . . . 9.0399999999999991 115.424 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 82.97 -10.4 57.87 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 114.732 0.653 . . . . 9.0399999999999991 114.732 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -118.93 143.39 47.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.544 0.672 . . . . 9.0399999999999991 111.099 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.05 142.85 46.08 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.055 -0.52 . . . . 9.0399999999999991 110.585 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.34 -179.19 41.1 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.943 -0.646 . . . . 9.0399999999999991 112.481 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 33.7 m -113.44 163.36 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 112.441 0.534 . . . . 9.0399999999999991 112.441 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 3.3 p90 -124.57 152.92 69.53 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.602 -0.726 . . . . 9.0399999999999991 110.92 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.45 122.88 4.69 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.93 2.42 . . . . 9.0399999999999991 115.683 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 50.95 44.51 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.983 1.105 . . . . 9.0399999999999991 113.983 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 60.0 92.92 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.125 1.157 . . . . 9.0399999999999991 114.125 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -103.38 15.97 27.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.723 -0.843 . . . . 9.0399999999999991 108.723 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.09 138.58 29.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.977 0.362 . . . . 9.0399999999999991 111.977 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.59 119.43 59.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.366 -0.379 . . . . 9.0399999999999991 111.445 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.571 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 63.5 tt0 -54.47 105.62 0.16 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.847 0.356 . . . . 9.0399999999999991 110.611 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 33.0 pt -86.61 -30.12 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 9.0399999999999991 110.733 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' SER . . . . . 0.429 ' HB2' ' H ' ' B' ' 8' ' ' TYR . 48.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.251 -0.88 . . . . 9.0399999999999991 110.696 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 66.2 mtm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.716 0.293 . . . . 16.5 110.775 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.08 147.02 28.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 13.859999999999999 110.863 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.2 pt -146.53 156.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 12.19 110.765 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -108.74 147.13 32.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.854 -0.612 . . . . 11.640000000000001 110.424 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.25 103.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.009 -0.542 . . . . 9.0399999999999991 110.587 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 7' ' ' THR . 85.6 tttt -78.33 164.51 24.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 9.0399999999999991 111.077 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.442 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 8.4 m -139.91 147.09 40.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 9.0399999999999991 109.823 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 9' ' ' THR . 4.4 pp -60.67 -18.42 53.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.801 0.334 . . . . 9.0399999999999991 111.401 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.428 ' N ' HD13 ' A' ' 8' ' ' LEU . 69.4 p -73.89 -35.7 64.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 9.0399999999999991 110.531 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.43 -15.28 5.78 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.987 -0.552 . . . . 9.0399999999999991 112.607 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -83.16 136.62 34.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.388 0.514 . . . . 9.0399999999999991 112.388 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -115.68 124.53 51.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.283 -0.871 . . . . 9.0399999999999991 109.332 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.13 144.01 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.02 0.438 . . . . 9.0399999999999991 111.854 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -100.14 136.2 40.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.493 -0.776 . . . . 9.0399999999999991 110.737 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.3 153.14 52.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.841 0.353 . . . . 10.02 110.84 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -120.5 102.91 8.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.009 -0.541 . . . . 12.19 111.391 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -153.89 116.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 14.73 110.711 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 167.21 1.19 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.753 1.02 . . . . 18.57 113.753 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 21' ' ' ASP . 31.7 Cg_exo -60.12 -32.3 94.45 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.831 3.021 . . . . 19.890000000000001 114.08 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -77.87 31.18 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.762 0.315 . . . . 21.489999999999998 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 19' ' ' PRO . 9.5 t70 -115.23 129.89 56.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.317 -0.401 . . . . 18.559999999999999 110.942 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 70.6 p -68.89 145.95 53.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 20.149999999999999 111.278 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.454 HG12 ' HB3' ' A' ' 50' ' ' LEU . 1.1 mp -56.41 -35.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 17.16 110.755 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.48 -43.11 98.25 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 19.989999999999998 109.899 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -64.26 -39.63 94.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.973 -0.558 . . . . 16.559999999999999 109.931 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.105 -0.498 . . . . 14.390000000000001 110.036 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.94 -33.18 74.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.905 -0.588 . . . . 14.57 110.526 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.36 -34.1 76.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.066 -0.516 . . . . 14.550000000000001 110.217 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -71.36 -42.3 68.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 14.15 109.571 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.42 -47.97 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 115.866 -0.606 . . . . 10.06 109.741 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -58.42 -33.91 70.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 15.880000000000001 110.494 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.21 -33.71 76.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 12.470000000000001 110.931 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.11 -62.04 1.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 9.2300000000000004 112.165 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.7 -13.74 59.66 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.449 0.907 . . . . 9.5999999999999996 113.449 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 15.75 75.24 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.387 -0.911 . . . . 12.199999999999999 113.871 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -90.53 123.45 65.28 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 117.255 0.527 . . . . 11.27 110.932 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.9 138.82 87.52 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.723 2.282 . . . . 14.23 112.348 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.11 -30.29 88.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.521 2.147 . . . . 14.34 112.156 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.14 -20.61 66.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.779 -0.646 . . . . 16.960000000000001 111.074 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.61 -35.11 13.03 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.265 -0.425 . . . . 14.449999999999999 110.835 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -61.21 146.4 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 11.609999999999999 110.904 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 3.0 tpp180 -142.77 38.04 1.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 9.6099999999999994 111.296 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 42' ' ' ARG . 69.5 mt -20.83 127.59 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.727 1.01 . . . . 10.56 113.727 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 mm -114.95 136.33 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.183 -0.917 . . . . 9.75 109.734 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 81.7 t80 -138.7 123.75 19.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 15.27 111.276 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 13.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.545 0.572 . . . . 14.76 112.545 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.5 -29.34 9.16 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.829 -0.701 . . . . 12.99 113.191 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 49' ' ' GLN . 14.6 ptpt -70.27 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.941 0.37 . . . . 17.59 111.02 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.504 ' N ' ' HG3' ' A' ' 48' ' ' LYS . 30.3 tt0 -148.53 107.65 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.93 -0.767 . . . . 14.970000000000001 108.93 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.454 ' HB3' HG12 ' A' ' 23' ' ' ILE . 51.3 mt -57.75 127.22 30.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.875 0.695 . . . . 14.81 112.875 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.61 123.62 36.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.392 -0.822 . . . . 21.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -34.54 -61.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.713 -0.676 . . . . 18.5 112.168 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -47.96 -73.5 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 21.789999999999999 112.524 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 53' ' ' GLY . 31.0 mmt180 -34.24 163.2 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.366 0.876 . . . . 24.890000000000001 113.366 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.549 ' HG1' ' H ' ' A' ' 56' ' ' LEU . 8.8 t -115.1 165.28 13.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.211 -0.904 . . . . 21.530000000000001 111.278 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.549 ' H ' ' HG1' ' A' ' 55' ' ' THR . 91.0 mt -55.69 -38.46 69.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 18.41 111.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.0 -26.57 68.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.366 . . . . 21.809999999999999 111.383 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.59 -29.07 69.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 23.140000000000001 110.992 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.11 16.57 24.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 19.370000000000001 111.125 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.55 39.62 31.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.083 -0.508 . . . . 22.789999999999999 111.306 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -87.74 113.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 18.120000000000001 111.094 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -105.47 -165.42 1.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 21.52 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 22.5 pttp -68.16 162.72 24.21 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 19.190000000000001 111.255 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 55.99 32.37 19.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.933 -0.576 . . . . 16.920000000000002 111.252 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -91.56 138.48 31.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 15.09 110.712 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -98.99 122.46 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 11.93 111.146 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.1 mt -116.71 117.95 31.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 10.94 110.173 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -88.66 114.12 24.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 9.0399999999999991 111.831 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.419 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 45.8 mt -63.94 -172.13 0.06 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.958 -0.565 . . . . 9.0399999999999991 109.903 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 90.4 t . . . . . 0 C--N 1.33 -0.272 0 N-CA-C 109.763 -0.458 . . . . 9.0399999999999991 109.763 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 . . . . . 0 C--O 1.231 0.083 0 N-CA-C 109.498 -0.556 . . . . 9.0399999999999991 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -133.04 170.42 15.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.013 0.435 . . . . 9.0399999999999991 112.039 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.419 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 13.7 p -153.45 150.23 28.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.656 -0.702 . . . . 9.0399999999999991 111.036 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -102.5 138.2 39.73 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.384 -0.371 . . . . 9.0399999999999991 110.245 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 35.9 p -80.47 125.64 30.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 9.0399999999999991 111.825 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.1 -20.4 24.36 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.401 -0.363 . . . . 9.0399999999999991 111.448 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -149.26 158.0 38.87 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.739 0.304 . . . . 9.0399999999999991 111.468 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.21 140.34 24.77 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.736 2.291 . . . . 9.0399999999999991 112.88 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -136.0 130.97 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.377 -0.829 . . . . 9.0399999999999991 110.467 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 88.0 m -111.54 118.21 35.11 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.942 0.401 . . . . 9.0399999999999991 111.213 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.52 139.35 48.16 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.981 -0.628 . . . . 9.0399999999999991 112.127 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -107.19 -21.47 12.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.199 0.523 . . . . 9.0399999999999991 111.092 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -119.08 159.58 23.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.328 -0.851 . . . . 9.0399999999999991 110.011 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -64.41 -36.09 83.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 9.0399999999999991 111.505 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.75 -4.55 52.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 9.0399999999999991 110.817 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 150.58 29.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.038 -0.528 . . . . 9.0399999999999991 110.981 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.421 HD22 ' H ' ' B' ' 24' ' ' THR . 1.4 tt -100.07 137.48 38.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.526 -1.287 . . . . 9.0399999999999991 107.526 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' THR . . . . . 0.421 ' H ' HD22 ' B' ' 23' ' ' LEU . 89.5 m -114.55 123.9 50.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.745 -0.661 . . . . 9.0399999999999991 110.646 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -138.65 156.82 47.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.502 0.556 . . . . 9.0399999999999991 112.502 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -111.55 179.45 4.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.176 -0.305 . . . . 9.0399999999999991 110.176 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.93 143.55 31.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 9.0399999999999991 110.43 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.57 19.96 67.33 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.088 -0.805 . . . . 9.0399999999999991 111.088 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -98.15 179.11 4.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.517 0.932 . . . . 9.0399999999999991 113.517 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -132.37 116.6 29.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 113.557 -1.656 . . . . 9.0399999999999991 111.297 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.1 140.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 9.0399999999999991 111.152 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -91.38 127.55 36.86 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.397 -0.594 . . . . 9.0399999999999991 109.397 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tt -74.32 102.76 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 9.0399999999999991 110.636 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 31.9 mm -80.72 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 9.0399999999999991 111.243 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 89.1 p -157.86 120.28 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.098 0.777 . . . . 9.0399999999999991 113.098 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -65.18 -72.2 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.987 -0.552 . . . . 9.0399999999999991 109.911 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -44.8 100.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.099 -0.501 . . . . 9.0399999999999991 111.732 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 25.2 p -116.33 -3.69 11.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.964 -0.562 . . . . 9.0399999999999991 110.881 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.86 -7.6 76.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.978 -0.629 . . . . 9.0399999999999991 111.882 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -130.87 120.75 24.1 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.693 0.282 . . . . 9.0399999999999991 110.483 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.51 137.55 58.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 9.0399999999999991 110.878 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.808 -0.633 . . . . 9.0399999999999991 112.614 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.588 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 64.1 m95 -120.79 117.41 27.35 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.831 0.348 . . . . 9.0399999999999991 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -109.89 160.82 16.05 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.247 -0.649 . . . . 9.0399999999999991 109.247 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -116.09 129.56 56.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.894 0.378 . . . . 9.0399999999999991 110.389 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.37 175.63 22.24 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.731 -0.747 . . . . 9.0399999999999991 112.179 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -126.51 135.42 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.499 . . . . 9.0399999999999991 110.077 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.638 ' O ' ' N ' ' B' ' 50' ' ' GLY . 32.8 tp -128.53 170.16 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.31 -0.859 . . . . 9.0399999999999991 110.242 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.428 HD21 ' HG ' ' B' ' 48' ' ' LEU . 50.9 m-80 -18.3 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.403 1.631 . . . . 9.0399999999999991 115.403 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.69 -11.48 61.73 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 114.894 0.717 . . . . 9.0399999999999991 114.894 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -118.23 132.25 56.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.831 0.816 . . . . 9.0399999999999991 111.29 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.01 152.25 24.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.46 -0.57 . . . . 9.0399999999999991 109.46 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.11 -174.65 44.59 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.113 -1.041 . . . . 9.0399999999999991 113.353 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.24 149.75 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 110.398 -0.223 . . . . 9.0399999999999991 110.398 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -139.32 141.11 28.0 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.784 0.661 . . . . 9.0399999999999991 112.784 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.588 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.3 Cg_endo -95.19 175.17 1.06 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.444 3.429 . . . . 9.0399999999999991 111.511 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.408 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.1 m-20 79.57 -13.55 0.95 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.981 1.474 . . . . 9.0399999999999991 114.981 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.22 76.6 0.28 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.873 -0.788 . . . . 9.0399999999999991 108.873 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 13.1 m-85 -103.87 8.81 37.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.296 -0.865 . . . . 9.0399999999999991 112.268 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.419 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -133.84 138.98 45.95 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.292 0.478 . . . . 9.0399999999999991 112.292 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -113.53 136.16 50.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.882 -0.599 . . . . 9.0399999999999991 111.366 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.08 144.48 28.97 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 120.742 0.306 . . . . 9.0399999999999991 110.906 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 pt -137.9 -13.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.192 -0.458 . . . . 9.0399999999999991 111.087 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.272 -0.871 . . . . 9.0399999999999991 110.627 179.91 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.612 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 92.3 mtp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.853 0.359 . . . . 16.5 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -79.94 151.82 29.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 13.859999999999999 111.068 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.06 145.24 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.914 -0.585 . . . . 12.19 110.52 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -100.82 135.33 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 11.640000000000001 110.113 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.433 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 58.4 t -120.42 96.24 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.519 -0.549 . . . . 9.0399999999999991 109.519 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 7' ' ' THR . 86.5 tttt -76.3 164.02 26.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.816 -0.629 . . . . 9.0399999999999991 111.326 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.429 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 77.0 p -143.9 158.85 43.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 9.0399999999999991 110.268 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.529 ' HB3' ' HE1' ' B' ' 43' ' ' TRP . 4.0 pp -61.91 -24.59 67.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.535 . . . . 9.0399999999999991 111.219 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 p -78.59 -19.93 51.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.118 -0.492 . . . . 9.0399999999999991 111.205 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.37 13.39 33.19 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.089 -0.577 . . . . 9.0399999999999991 112.339 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.45 108.93 21.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.891 0.377 . . . . 9.0399999999999991 111.407 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.38 125.69 45.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 9.0399999999999991 110.128 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.433 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 31.2 pt -118.3 145.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.861 0.362 . . . . 9.0399999999999991 111.027 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 m -98.36 134.26 41.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 9.0399999999999991 111.213 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.44 149.75 49.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.098 -0.501 . . . . 10.02 110.369 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.47 98.88 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.31 -0.405 . . . . 12.19 110.701 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.88 -172.74 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.099 0.476 . . . . 14.73 111.816 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -143.14 159.25 56.53 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 18.57 110.276 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.612 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 Cg_endo -59.93 -31.72 94.08 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.584 2.189 . . . . 19.890000000000001 112.212 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.3 t -82.36 -21.36 35.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 21.489999999999998 111.504 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.91 150.92 9.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.7 0.286 . . . . 18.559999999999999 111.125 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.3 p -97.35 141.7 30.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 20.149999999999999 111.073 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mt -53.73 -32.02 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 17.16 111.466 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.91 -42.47 99.8 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.615 -0.513 . . . . 19.989999999999998 109.615 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -67.06 -36.16 81.43 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.752 -0.658 . . . . 16.559999999999999 110.133 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.2 t -57.59 -46.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.378 -0.374 . . . . 14.390000000000001 110.197 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.39 -37.76 84.6 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.039 -0.528 . . . . 14.57 110.451 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.05 86.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 14.550000000000001 110.432 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -64.68 -49.2 71.86 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.033 -0.531 . . . . 14.15 109.956 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.69 -40.75 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 10.06 110.368 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -61.4 -34.78 75.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.018 -0.537 . . . . 15.880000000000001 110.816 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.96 -36.26 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 12.470000000000001 111.329 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.23 -63.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.234 -0.439 . . . . 9.2300000000000004 112.025 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -78.4 -12.58 60.01 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.386 0.884 . . . . 9.5999999999999996 113.386 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.14 -12.5 12.26 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.294 -0.955 . . . . 12.199999999999999 113.38 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 tp -60.52 128.07 87.68 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.856 0.328 . . . . 11.27 111.565 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.06 137.2 26.04 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.623 2.215 . . . . 14.23 112.622 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.13 -29.0 73.15 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.026 2.484 . . . . 14.34 112.782 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.96 -24.85 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 16.960000000000001 111.271 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -108.54 -6.64 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 14.449999999999999 111.467 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -81.17 127.19 32.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.066 0.46 . . . . 11.609999999999999 111.984 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -121.24 112.53 18.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.466 -0.788 . . . . 9.6099999999999994 109.275 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.32 122.63 43.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.42 -0.355 . . . . 10.56 110.951 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mm -116.55 137.05 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.526 . . . . 9.75 110.983 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -155.86 127.57 7.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.772 -0.649 . . . . 15.27 110.541 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.5 17.12 10.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.934 -0.575 . . . . 14.76 111.767 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.96 -2.41 79.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 12.99 112.964 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -117.82 148.56 41.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.749 0.309 . . . . 17.59 110.777 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -81.91 131.34 35.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 14.970000000000001 110.196 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.9 mt -69.74 130.13 41.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.95 0.405 . . . . 14.81 111.288 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.565 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -86.84 126.19 34.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.62 . . . . 21.0 110.174 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -48.58 -40.35 27.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.551 0.574 . . . . 18.5 112.551 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.28 3.52 71.91 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.971 -0.633 . . . . 21.789999999999999 114.194 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 6.0 mmp_? -103.5 173.79 6.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.115 0.457 . . . . 24.890000000000001 110.881 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -118.99 160.84 21.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.872 0.368 . . . . 21.530000000000001 111.576 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.78 -34.04 37.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.015 -0.538 . . . . 18.41 111.395 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -69.31 -24.97 64.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.485 -0.325 . . . . 21.809999999999999 111.303 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.412 . . . . 23.140000000000001 111.065 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.565 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 92.6 m-85 -101.09 11.45 39.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.233 -0.44 . . . . 19.370000000000001 111.288 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 56.32 49.47 15.11 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.851 0.358 . . . . 22.789999999999999 111.184 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -92.09 108.27 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 18.120000000000001 110.882 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -92.81 -177.98 4.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 21.52 110.899 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.97 158.88 24.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.337 -0.392 . . . . 19.190000000000001 111.125 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 59.46 29.05 18.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.946 -0.57 . . . . 16.920000000000002 111.509 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.5 t -89.1 153.19 21.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.308 -0.405 . . . . 15.09 110.843 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 t -110.9 126.02 54.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 11.93 111.124 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.29 125.72 53.63 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.923 -0.58 . . . . 10.94 110.395 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -85.39 115.47 23.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.401 . . . . 9.0399999999999991 111.589 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.7 tp -94.17 105.83 17.81 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.903 -0.59 . . . . 9.0399999999999991 110.6 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.13 -0.486 . . . . 9.0399999999999991 110.885 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 . . . . . 0 C--O 1.231 0.111 0 N-CA-C 109.045 -0.724 . . . . 9.0399999999999991 109.045 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.15 169.13 15.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.988 0.423 . . . . 9.0399999999999991 111.9 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.621 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 6.7 p -152.63 147.69 26.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 9.0399999999999991 110.478 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -100.19 141.3 33.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.434 -0.348 . . . . 9.0399999999999991 110.684 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 54.4 p -80.25 124.78 29.12 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.271 -0.422 . . . . 9.0399999999999991 111.743 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.24 -21.49 19.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.616 -0.265 . . . . 9.0399999999999991 111.05 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -151.3 156.61 35.08 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.607 0.241 . . . . 9.0399999999999991 110.83 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.68 140.58 29.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.549 2.166 . . . . 9.0399999999999991 113.112 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -136.59 128.7 29.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.085 -0.961 . . . . 9.0399999999999991 110.044 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 88.3 m -112.2 120.4 41.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.8 0.333 . . . . 9.0399999999999991 111.579 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.412 ' H ' ' HG1' ' B' ' 24' ' ' THR . . . -63.47 144.64 49.37 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.828 -0.701 . . . . 9.0399999999999991 111.93 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -107.56 -22.19 12.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.057 0.456 . . . . 9.0399999999999991 111.292 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.79 158.67 25.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.476 -0.784 . . . . 9.0399999999999991 109.941 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.82 -35.91 82.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 9.0399999999999991 111.438 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.3 -4.47 45.18 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.934 0.397 . . . . 9.0399999999999991 110.535 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.91 156.58 22.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.762 -0.653 . . . . 9.0399999999999991 110.44 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 tp -107.14 146.33 31.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.354 -0.98 . . . . 9.0399999999999991 108.354 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' THR . . . . . 0.412 ' HG1' ' H ' ' B' ' 17' ' ' GLY . 93.8 m -115.83 130.93 57.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.44 . . . . 9.0399999999999991 111.099 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.49 ' CD1' HG12 ' B' ' 31' ' ' ILE . 31.3 m-85 -131.56 139.02 49.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.169 0.433 . . . . 9.0399999999999991 112.169 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.499 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 8.3 mpt_? -108.32 176.85 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.873 -0.418 . . . . 9.0399999999999991 109.873 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -80.41 138.17 36.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 9.0399999999999991 110.163 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.79 20.38 58.09 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.027 -0.829 . . . . 9.0399999999999991 111.027 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 22.9 mm-40 -98.29 179.73 4.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.04 0.924 . . . . 9.0399999999999991 113.391 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 mm -134.64 119.64 29.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 113.563 -1.653 . . . . 9.0399999999999991 110.707 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.621 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 39.5 mt -114.18 133.73 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.007 -0.542 . . . . 9.0399999999999991 111.591 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -93.43 126.68 38.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.384 -0.599 . . . . 9.0399999999999991 109.384 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 tt -74.37 102.77 4.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 9.0399999999999991 110.528 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mm -81.56 -64.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.498 -0.774 . . . . 9.0399999999999991 111.197 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' B' ' 45' ' ' LYS . 69.1 m -154.47 112.3 3.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.683 0.623 . . . . 9.0399999999999991 112.683 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.32 -72.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.979 -0.748 . . . . 9.0399999999999991 108.979 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -45.04 96.05 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.096 -0.502 . . . . 9.0399999999999991 111.381 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 4.5 t -112.08 -2.67 14.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.063 -0.517 . . . . 9.0399999999999991 111.077 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.18 0.41 67.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.993 -0.622 . . . . 9.0399999999999991 113.211 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -134.24 124.26 25.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.761 0.315 . . . . 9.0399999999999991 111.205 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.11 131.9 50.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 9.0399999999999991 111.035 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.16 -1.31 84.56 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.006 -0.616 . . . . 9.0399999999999991 112.588 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.529 ' HE1' ' HB3' ' A' ' 8' ' ' LEU . 69.5 m95 -117.76 135.3 54.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.188 0.518 . . . . 9.0399999999999991 111.543 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -123.51 155.42 37.58 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.086 -0.961 . . . . 9.0399999999999991 109.033 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' B' ' 35' ' ' SER . 23.9 ttmm -113.45 130.35 56.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.908 0.385 . . . . 9.0399999999999991 110.644 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.36 176.47 21.36 Favored Glycine 0 N--CA 1.453 -0.18 0 CA-C-N 115.73 -0.668 . . . . 9.0399999999999991 112.056 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.39 135.02 51.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 9.0399999999999991 110.414 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 50' ' ' GLY . 21.2 tp -130.12 170.02 14.58 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.332 -0.849 . . . . 9.0399999999999991 110.109 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.542 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 55.9 m-80 -17.88 65.19 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.401 1.63 . . . . 9.0399999999999991 115.401 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.33 -12.95 57.3 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.776 0.67 . . . . 9.0399999999999991 114.776 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -116.31 135.5 53.82 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.767 0.784 . . . . 9.0399999999999991 111.19 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -108.81 152.95 24.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.117 -0.492 . . . . 9.0399999999999991 109.853 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.18 -176.15 46.7 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.416 -0.897 . . . . 9.0399999999999991 112.808 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.57 154.88 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.468 0.175 . . . . 9.0399999999999991 110.571 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 46.5 p90 -141.49 140.18 20.05 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 112.755 0.65 . . . . 9.0399999999999991 112.755 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 55' ' ' PHE . 96.7 Cg_endo -94.61 174.72 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.457 3.438 . . . . 9.0399999999999991 110.637 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.464 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 79.75 -14.14 0.88 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.913 1.449 . . . . 9.0399999999999991 114.913 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 57.3 76.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.016 -0.735 . . . . 9.0399999999999991 109.016 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 19.5 m-85 -101.66 6.46 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 9.0399999999999991 111.948 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.1 139.01 40.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.466 0.543 . . . . 9.0399999999999991 112.466 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.28 130.53 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 9.0399999999999991 111.32 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -55.43 128.99 36.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.887 0.375 . . . . 9.0399999999999991 111.092 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -88.4 -61.01 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.965 -0.561 . . . . 9.0399999999999991 110.373 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.428 -0.796 . . . . 9.0399999999999991 110.69 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' CA ' ' A' ' 63' ' ' LYS . 45.5 tpp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.829 0.347 . . . . 16.5 110.92 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -82.03 145.62 30.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 13.859999999999999 110.91 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -147.59 151.69 13.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 12.19 111.008 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.21 146.1 34.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 11.640000000000001 110.89 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 50.9 t -136.52 97.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 9.0399999999999991 110.306 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.37 133.37 36.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 9.0399999999999991 111.439 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.7 m -106.89 152.43 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 9.0399999999999991 110.374 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.403 HD13 ' CD1' ' B' ' 43' ' ' TRP . 40.7 tp -56.45 -36.64 69.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 9.0399999999999991 111.073 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -56.47 -36.11 68.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.056 -0.52 . . . . 9.0399999999999991 111.209 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.29 8.62 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.068 -0.515 . . . . 9.0399999999999991 112.351 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -100.16 124.79 45.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.942 0.401 . . . . 9.0399999999999991 112.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -101.37 134.33 44.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.756 -0.656 . . . . 9.0399999999999991 109.365 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.427 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 23.0 pt -119.72 143.67 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 9.0399999999999991 111.623 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.6 p -101.32 137.62 39.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.484 -0.78 . . . . 9.0399999999999991 110.952 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 mp -137.85 160.85 38.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.268 -0.423 . . . . 10.02 110.526 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.52 103.04 7.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 12.19 110.771 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.03 113.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.303 -0.408 . . . . 14.73 111.382 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 41.3 mt-10 -50.5 166.84 0.27 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.416 0.895 . . . . 18.57 113.416 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' CD ' ' HB3' ' A' ' 18' ' ' GLU . 28.7 Cg_exo -64.14 -33.62 60.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.442 2.761 . . . . 19.890000000000001 113.279 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -20.12 64.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.546 -0.297 . . . . 21.489999999999998 111.752 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.16 147.32 53.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 18.559999999999999 111.716 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.478 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 67.2 p -88.83 152.98 21.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.932 -0.576 . . . . 20.149999999999999 110.707 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.6 mm -57.07 -36.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.459 -0.337 . . . . 17.16 111.036 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -46.39 80.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 19.989999999999998 110.156 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.9 OUTLIER -58.71 -42.84 89.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.863 -0.608 . . . . 16.559999999999999 110.303 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.18 -41.64 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 14.390000000000001 110.524 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.52 -28.69 70.03 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.286 -0.415 . . . . 14.57 110.599 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.37 70.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 14.550000000000001 109.843 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -67.71 -46.24 72.78 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.831 -0.622 . . . . 14.15 109.48 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -61.49 -38.73 80.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.884 -0.598 . . . . 10.06 110.113 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -66.88 -32.28 73.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 15.880000000000001 110.697 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.99 -38.49 82.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 12.470000000000001 111.234 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -88.99 -51.18 5.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.265 0.469 . . . . 9.2300000000000004 112.265 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.53 -10.87 47.41 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.487 0.921 . . . . 9.5999999999999996 113.487 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.59 -37.39 2.06 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.533 -0.841 . . . . 12.199999999999999 114.3 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 pt -45.84 124.48 6.48 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 112.133 0.42 . . . . 11.27 112.133 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.68 144.48 89.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.969 2.446 . . . . 14.23 112.881 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.61 -28.31 82.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.84 2.36 . . . . 14.34 112.583 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.3 -27.51 68.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 16.960000000000001 111.359 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -100.3 -9.27 22.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.314 -0.403 . . . . 14.449999999999999 111.12 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -84.43 120.92 26.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 11.609999999999999 112.113 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -118.25 117.01 27.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.56 -0.746 . . . . 9.6099999999999994 109.101 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.58 122.61 46.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.961 0.41 . . . . 10.56 111.963 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.534 ' CG1' ' HB3' ' A' ' 68' ' ' HIS . 40.6 pt -111.03 127.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.639 -0.71 . . . . 9.75 110.439 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -129.48 120.52 25.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.489 -0.778 . . . . 15.27 110.795 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.35 19.69 9.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.615 . . . . 14.76 112.272 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.7 5.64 62.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.588 -0.815 . . . . 12.99 113.127 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 144.39 47.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.589 0.233 . . . . 17.59 110.491 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.14 140.46 37.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.235 -0.283 . . . . 14.970000000000001 110.235 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.27 133.57 34.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.456 -0.338 . . . . 14.81 110.684 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.56 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 38.0 mt-10 -90.1 127.13 36.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 21.0 111.336 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -40.39 -51.38 2.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.793 -0.639 . . . . 18.5 111.373 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.71 -78.23 0.14 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.487 -0.863 . . . . 21.789999999999999 111.237 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -26.77 152.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.558 0.947 . . . . 24.890000000000001 113.558 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.4 p -107.05 164.09 12.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.194 -0.912 . . . . 21.530000000000001 111.256 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -53.08 -39.19 63.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 18.41 111.241 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 m -61.63 -28.58 69.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 21.809999999999999 111.352 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.06 -38.31 90.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 23.140000000000001 111.055 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.56 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 68.9 m-85 -96.05 12.54 30.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.443 . . . . 19.370000000000001 111.672 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 57.97 43.2 21.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.998 0.428 . . . . 22.789999999999999 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.7 mt -92.79 119.6 40.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.136 -0.484 . . . . 18.120000000000001 111.19 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -113.55 -170.43 1.69 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.256 -0.429 . . . . 21.52 111.491 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' CA ' ' SD ' ' A' ' 1' ' ' MET . 83.1 tttt -62.78 157.74 20.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.09 -0.505 . . . . 19.190000000000001 111.454 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 59.88 28.72 18.26 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.782 -0.645 . . . . 16.920000000000002 111.784 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -89.77 143.86 26.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.447 -0.342 . . . . 15.09 110.827 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -99.39 134.8 41.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 11.93 111.205 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.33 113.55 13.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.019 -0.537 . . . . 10.94 111.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.534 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 38.9 t-80 -83.62 119.32 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.999 0.428 . . . . 9.0399999999999991 110.487 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.9 tp -95.25 121.3 36.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 9.0399999999999991 110.777 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.898 -0.592 . . . . 9.0399999999999991 110.527 -179.82 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 C--O 1.231 0.124 0 N-CA-C 109.105 -0.702 . . . . 9.0399999999999991 109.105 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -128.4 165.1 21.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.185 0.517 . . . . 9.0399999999999991 111.91 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 26.2 p -145.77 148.15 32.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.187 -0.915 . . . . 9.0399999999999991 110.762 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -99.13 143.12 29.76 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.391 -0.368 . . . . 9.0399999999999991 110.684 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -86.66 124.18 32.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.083 -0.508 . . . . 9.0399999999999991 111.33 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -94.73 -21.13 18.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.223 0.453 . . . . 9.0399999999999991 112.223 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' B' ' 14' ' ' PRO . 79.6 t80 -145.68 140.9 16.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.886 0.328 . . . . 9.0399999999999991 111.886 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 13' ' ' PHE . 36.7 Cg_exo -61.61 139.75 82.98 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.809 2.339 . . . . 9.0399999999999991 112.488 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.418 ' HH ' ' HG3' ' B' ' 56' ' ' PRO . 77.7 t80 -138.69 133.64 32.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.72 -0.673 . . . . 9.0399999999999991 111.288 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' THR . . . . . 0.479 ' HG1' HH12 ' B' ' 26' ' ' ARG . 68.9 m -111.65 119.13 37.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.426 . . . . 9.0399999999999991 110.754 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.82 139.08 48.61 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.887 -0.673 . . . . 9.0399999999999991 112.553 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 24.9 p -103.94 -23.46 13.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.181 0.515 . . . . 9.0399999999999991 110.705 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -120.38 154.6 34.87 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.197 -0.91 . . . . 9.0399999999999991 109.757 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.5 -39.66 92.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 9.0399999999999991 111.458 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.13 -4.8 34.97 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.908 0.385 . . . . 9.0399999999999991 110.589 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.2 158.82 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.973 -0.558 . . . . 9.0399999999999991 110.949 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.451 ' HB2' ' C ' ' B' ' 53' ' ' GLY . 3.6 tt -102.62 139.99 37.49 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.812 -0.811 . . . . 9.0399999999999991 108.812 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 98.6 m -112.38 123.88 51.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.531 -0.759 . . . . 9.0399999999999991 109.474 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -135.61 146.01 47.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.962 0.727 . . . . 9.0399999999999991 112.962 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.479 HH12 ' HG1' ' B' ' 16' ' ' THR . 31.9 mmt180 -109.56 178.29 4.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.116 -0.327 . . . . 9.0399999999999991 110.116 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -81.35 142.77 32.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 9.0399999999999991 110.328 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 20.23 61.72 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.878 -0.889 . . . . 9.0399999999999991 110.878 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.6 mm-40 -98.53 178.81 4.9 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.343 0.868 . . . . 9.0399999999999991 113.343 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 21.9 mm -136.05 116.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.648 -1.615 . . . . 9.0399999999999991 110.943 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.435 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 55.2 mt -112.35 137.84 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 9.0399999999999991 111.083 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' HIS . . . . . 0.466 ' O ' ' HA2' ' B' ' 46' ' ' GLY . 1.8 m-70 -92.51 128.19 38.27 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.326 -0.62 . . . . 9.0399999999999991 109.326 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 tt -73.81 102.26 3.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 9.0399999999999991 111.113 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.422 HD12 ' HB2' ' B' ' 47' ' ' GLU . 55.1 mt -81.1 -64.61 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.666 -0.697 . . . . 9.0399999999999991 111.098 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.0 t -154.12 116.7 4.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 9.0399999999999991 112.286 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.459 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 52.3 mtpt -69.52 6.22 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.984 -0.553 . . . . 9.0399999999999991 111.398 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -121.61 98.46 5.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.593 0.235 . . . . 9.0399999999999991 110.64 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.427 HG22 ' HB2' ' B' ' 45' ' ' LYS . 48.1 p -108.07 -1.4 20.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.544 -0.298 . . . . 9.0399999999999991 111.423 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.83 -4.2 75.09 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.782 -0.723 . . . . 9.0399999999999991 111.565 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -129.31 121.49 27.61 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.385 0.274 . . . . 9.0399999999999991 110.65 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.87 133.28 55.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 9.0399999999999991 110.507 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.25 82.11 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.927 -0.654 . . . . 9.0399999999999991 112.387 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' B' ' 56' ' ' PRO . 86.3 m95 -120.35 122.32 40.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.053 0.427 . . . . 9.0399999999999991 111.443 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' TRP . . . . . 0.459 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 30.7 m0 -111.56 162.73 14.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.103 -0.703 . . . . 9.0399999999999991 109.103 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.427 ' HB2' HG22 ' B' ' 38' ' ' THR . 63.6 tttm -115.58 129.98 56.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.795 0.331 . . . . 9.0399999999999991 110.405 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' B' ' 32' ' ' HIS . . . -142.82 177.43 21.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.654 -0.784 . . . . 9.0399999999999991 112.359 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.422 ' HB2' HD12 ' B' ' 34' ' ' ILE . 36.5 tt0 -125.13 133.55 52.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.294 0.568 . . . . 9.0399999999999991 110.778 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.675 ' O ' ' N ' ' B' ' 50' ' ' GLY . 42.5 tp -127.45 169.96 13.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.987 -1.006 . . . . 9.0399999999999991 109.269 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.436 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 58.2 m-20 -17.92 64.45 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.256 1.576 . . . . 9.0399999999999991 115.256 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.71 -10.84 63.52 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 114.937 0.735 . . . . 9.0399999999999991 114.937 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.45 152.62 24.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.162 0.981 . . . . 9.0399999999999991 110.988 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 1.2 pm0 -125.73 142.15 51.65 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.948 -0.76 . . . . 9.0399999999999991 108.948 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . 0.451 ' C ' ' HB2' ' B' ' 23' ' ' LEU . . . -179.84 -171.27 42.57 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 120.254 -0.974 . . . . 9.0399999999999991 113.101 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 33.4 m -111.77 151.11 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 120.704 0.288 . . . . 9.0399999999999991 111.055 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 38.4 p90 -131.34 139.52 35.68 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 112.219 0.451 . . . . 9.0399999999999991 112.219 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.426 ' HB3' ' CZ2' ' B' ' 43' ' ' TRP . 94.4 Cg_endo -97.95 174.26 0.57 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.297 3.332 . . . . 9.0399999999999991 111.546 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.491 ' HB2' ' CD2' ' B' ' 59' ' ' PHE . 16.6 m-20 78.78 -10.68 1.31 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.49 1.293 . . . . 9.0399999999999991 114.49 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' B' ' 60' ' ' ALA . 15.8 m120 58.15 26.68 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 118.43 0.559 . . . . 9.0399999999999991 110.201 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' B' ' 57' ' ' ASP . 9.3 m-85 -56.64 3.97 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.201 0.815 . . . . 9.0399999999999991 113.201 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' B' ' 58' ' ' ASN . . . -129.47 138.87 51.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.225 0.454 . . . . 9.0399999999999991 112.225 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 128.06 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 9.0399999999999991 111.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -53.72 156.64 2.61 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 120.932 0.396 . . . . 9.0399999999999991 110.746 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.46 -32.71 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 9.0399999999999991 110.45 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 74.5 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.369 -0.824 . . . . 9.0399999999999991 110.529 179.75 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 tpp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.678 0.275 . . . . 16.5 110.835 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -84.7 142.37 29.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 13.859999999999999 110.794 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -145.42 151.43 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 12.19 110.712 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -109.93 145.48 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 11.640000000000001 110.795 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 m -136.27 106.4 5.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.184 0.516 . . . . 9.0399999999999991 110.678 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' A' ' 7' ' ' THR . 81.5 tttt -75.94 163.14 27.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 9.0399999999999991 111.076 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.45 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.3 m -137.43 142.16 41.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.681 -0.69 . . . . 9.0399999999999991 109.895 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.31 -21.86 16.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.453 -0.34 . . . . 9.0399999999999991 111.65 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.431 ' H ' HG21 ' A' ' 7' ' ' THR . 31.5 m -71.18 -39.37 71.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.397 -0.365 . . . . 9.0399999999999991 110.575 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.78 -1.95 5.97 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.076 -0.583 . . . . 9.0399999999999991 112.872 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -98.99 129.4 45.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.011 0.434 . . . . 9.0399999999999991 112.073 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -104.57 136.15 44.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.577 -0.738 . . . . 9.0399999999999991 109.448 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.0 152.72 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 9.0399999999999991 111.471 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -108.89 135.07 50.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 9.0399999999999991 110.425 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.4 tp -135.53 154.14 51.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.491 -0.322 . . . . 10.02 110.728 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.64 99.74 6.71 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.306 -0.406 . . . . 12.19 111.278 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -149.95 111.81 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.532 -0.303 . . . . 14.73 111.54 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -52.14 166.18 0.43 Allowed Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 114.176 1.176 . . . . 18.57 114.176 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.9 Cg_exo -60.16 -30.66 91.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.715 2.943 . . . . 19.890000000000001 113.864 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 m -80.95 32.92 0.32 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 21.489999999999998 111.552 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -118.7 126.9 52.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 18.559999999999999 110.896 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 77.1 p -64.71 148.87 50.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 20.149999999999999 111.151 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 54' ' ' ARG . 41.0 mm -58.51 -37.68 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 17.16 110.88 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 11.0 pt-20 -61.77 -40.52 95.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 19.989999999999998 110.091 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -64.16 -43.8 94.05 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.883 -0.599 . . . . 16.559999999999999 109.785 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.28 -41.07 88.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.884 -0.598 . . . . 14.390000000000001 110.434 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.89 -29.22 70.6 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.228 -0.442 . . . . 14.57 110.415 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.62 74.73 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.106 -0.497 . . . . 14.550000000000001 109.691 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -64.34 -47.62 78.67 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.586 -0.733 . . . . 14.15 109.559 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.46 -40.61 86.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 115.856 -0.611 . . . . 10.06 110.134 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -63.38 -30.38 71.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 15.880000000000001 110.909 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.19 -35.94 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 12.470000000000001 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -88.89 -58.97 2.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.114 -0.494 . . . . 9.2300000000000004 112.003 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -82.5 -11.43 58.49 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.396 0.887 . . . . 9.5999999999999996 113.396 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.36 -29.99 1.93 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.498 -0.858 . . . . 12.199999999999999 114.056 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.8 mm -50.09 124.72 17.69 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.994 0.397 . . . . 11.27 111.917 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.86 151.97 60.99 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.774 2.316 . . . . 14.23 112.341 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.09 -32.82 16.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.688 2.259 . . . . 14.34 112.114 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.84 -22.98 67.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.061 -0.518 . . . . 16.960000000000001 111.077 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -97.2 -18.06 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 14.449999999999999 110.86 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -78.73 124.17 27.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.046 0.451 . . . . 11.609999999999999 112.036 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -121.23 118.89 30.74 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.459 -0.941 . . . . 9.6099999999999994 108.459 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.56 127.96 50.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.142 0.496 . . . . 10.56 112.046 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.5 mm -115.49 120.33 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.273 -0.876 . . . . 9.75 110.474 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -130.12 119.46 23.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.031 -0.531 . . . . 15.27 111.028 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.95 18.33 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 14.76 112.097 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.7 1.84 63.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.603 -0.808 . . . . 12.99 112.989 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -117.36 143.49 45.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 17.59 110.893 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.83 131.83 35.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 14.970000000000001 110.719 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.22 134.72 36.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.921 0.391 . . . . 14.81 111.403 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 130.29 35.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.837 -0.62 . . . . 21.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 4.0 p30 -44.28 -49.34 9.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 18.5 111.214 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -58.79 -76.11 0.23 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.62 -0.8 . . . . 21.789999999999999 111.573 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' GLY . 60.7 mtp180 -28.55 156.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.584 0.957 . . . . 24.890000000000001 113.584 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.548 ' HG1' ' H ' ' A' ' 56' ' ' LEU . 9.3 t -110.9 164.1 13.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.061 -0.972 . . . . 21.530000000000001 110.506 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.548 ' H ' ' HG1' ' A' ' 55' ' ' THR . 92.7 mt -53.73 -36.57 62.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 18.41 111.629 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.7 t -62.34 -29.69 70.64 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.749 0.278 . . . . 21.809999999999999 111.749 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.33 -34.83 79.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.677 0.275 . . . . 23.140000000000001 110.945 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -93.77 4.71 53.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.472 . . . . 19.370000000000001 111.275 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 64.03 33.02 12.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.001 0.429 . . . . 22.789999999999999 110.897 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.8 mt -80.93 116.93 26.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.53 . . . . 18.120000000000001 111.582 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -107.4 -170.82 1.76 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.72 -0.673 . . . . 21.52 110.46 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.38 160.7 21.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.467 -0.333 . . . . 19.190000000000001 111.01 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.6 26.8 15.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.172 -0.467 . . . . 16.920000000000002 111.744 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 t -87.47 139.13 30.86 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.761 0.315 . . . . 15.09 111.09 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -100.03 129.15 46.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 11.93 110.975 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -127.36 114.89 18.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.125 -0.489 . . . . 10.94 110.783 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.96 122.32 25.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 9.0399999999999991 110.937 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.47 116.27 28.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.912 -0.585 . . . . 9.0399999999999991 110.335 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 9.0399999999999991 111.735 -179.402 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 . . . . . 0 C--O 1.232 0.171 0 N-CA-C 109.712 -0.477 . . . . 9.0399999999999991 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.11 171.64 12.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.271 -0.422 . . . . 9.0399999999999991 111.558 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 36.6 m -148.03 151.17 35.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.865 -0.607 . . . . 9.0399999999999991 111.345 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -99.81 139.47 35.43 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.985 -0.376 . . . . 9.0399999999999991 109.985 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 60.3 p -83.28 121.81 27.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.42 -0.355 . . . . 9.0399999999999991 111.611 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.04 -20.85 23.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.552 -0.295 . . . . 9.0399999999999991 111.309 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -147.57 157.46 44.64 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 9.0399999999999991 111.13 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.76 140.77 26.57 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.665 2.243 . . . . 9.0399999999999991 112.71 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.419 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 66.9 t80 -136.71 129.91 31.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 9.0399999999999991 110.375 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -113.0 121.33 44.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 9.0399999999999991 111.52 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.43 ' H ' ' HG1' ' B' ' 24' ' ' THR . . . -64.29 145.61 49.73 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.822 -0.704 . . . . 9.0399999999999991 111.865 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -107.98 -21.75 12.69 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.038 0.447 . . . . 9.0399999999999991 111.255 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -118.61 162.35 18.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.539 -0.755 . . . . 9.0399999999999991 110.516 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.13 -27.94 66.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.897 -0.592 . . . . 9.0399999999999991 112.544 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.73 -53.28 6.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.553 -0.459 . . . . 9.0399999999999991 110.59 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -32.35 146.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.704 -0.68 . . . . 9.0399999999999991 112.167 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tt -98.27 141.41 31.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.288 -1.005 . . . . 9.0399999999999991 108.288 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' THR . . . . . 0.43 ' HG1' ' H ' ' B' ' 17' ' ' GLY . 95.9 m -113.96 122.9 48.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.84 -0.618 . . . . 9.0399999999999991 110.374 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.449 ' CG ' HD13 ' B' ' 31' ' ' ILE . 37.1 p90 -138.54 155.27 48.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.614 0.598 . . . . 9.0399999999999991 112.614 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.41 -179.86 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.222 -0.288 . . . . 9.0399999999999991 110.222 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.18 141.49 32.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 9.0399999999999991 110.177 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.87 58.94 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.736 -0.946 . . . . 9.0399999999999991 110.736 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' B' ' 30' ' ' ILE . 4.4 tt0 -99.29 179.28 4.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.23 0.826 . . . . 9.0399999999999991 113.23 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.564 ' H ' ' HG2' ' B' ' 29' ' ' GLU . 30.3 mm -135.86 115.33 16.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.877 -1.51 . . . . 9.0399999999999991 110.979 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.449 HD13 ' CG ' ' B' ' 25' ' ' PHE . 51.5 mt -114.49 145.88 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 9.0399999999999991 111.166 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -97.43 129.22 44.67 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.514 -0.55 . . . . 9.0399999999999991 109.514 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.11 110.62 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 9.0399999999999991 111.172 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -84.11 -58.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 9.0399999999999991 111.264 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 70.6 m -158.92 121.43 3.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.32 0.489 . . . . 9.0399999999999991 112.32 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.08 6.38 2.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.915 -0.584 . . . . 9.0399999999999991 111.435 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.9 105.82 10.69 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.767 -0.197 . . . . 9.0399999999999991 110.558 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.417 HG23 ' HB2' ' B' ' 45' ' ' LYS . 28.0 p -115.0 -3.3 12.65 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.806 0.299 . . . . 9.0399999999999991 111.806 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.8 -9.04 77.69 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.759 -0.734 . . . . 9.0399999999999991 112.233 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.73 118.69 30.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.698 0.285 . . . . 9.0399999999999991 110.513 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.2 130.55 46.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 9.0399999999999991 111.229 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 2.41 79.72 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.881 -0.599 . . . . 9.0399999999999991 112.461 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.429 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 68.3 m95 -120.39 126.39 50.35 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.052 0.453 . . . . 9.0399999999999991 112.023 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -110.85 165.08 12.14 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.589 -0.893 . . . . 9.0399999999999991 108.589 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.417 ' HB2' HG23 ' B' ' 38' ' ' THR . 36.5 ttpt -119.86 129.95 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.956 0.408 . . . . 9.0399999999999991 110.874 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.23 175.41 20.93 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.566 -0.743 . . . . 9.0399999999999991 112.126 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -134.55 134.34 41.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 9.0399999999999991 110.366 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 50' ' ' GLY . 52.5 tp -123.97 133.23 53.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 9.0399999999999991 109.029 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -22.03 80.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.143 1.164 . . . . 9.0399999999999991 114.143 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 125.24 -50.85 0.85 Allowed Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.57 -0.741 . . . . 9.0399999999999991 114.753 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -112.06 153.87 26.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.998 0.899 . . . . 9.0399999999999991 112.127 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.41 142.14 51.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.205 -0.907 . . . . 9.0399999999999991 108.591 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.78 -176.08 41.96 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.086 -1.054 . . . . 9.0399999999999991 113.245 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -112.85 152.91 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.576 0.227 . . . . 9.0399999999999991 111.047 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 51.7 p90 -135.68 140.36 33.56 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.612 0.597 . . . . 9.0399999999999991 112.612 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 64.6 Cg_endo -96.16 175.05 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.657 3.572 . . . . 9.0399999999999991 110.976 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.527 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 3.2 m-20 77.34 -12.45 1.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.184 1.55 . . . . 9.0399999999999991 115.184 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . 0.466 ' C ' HD21 ' B' ' 58' ' ' ASN . 0.2 OUTLIER 58.19 75.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.424 -0.954 . . . . 9.0399999999999991 108.424 -177.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 17.3 m-85 -102.96 6.62 39.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.276 -0.874 . . . . 9.0399999999999991 112.211 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.57 139.01 43.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.479 0.548 . . . . 9.0399999999999991 112.479 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.84 130.0 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.942 -0.572 . . . . 9.0399999999999991 111.561 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.463 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 8.9 tp-100 -54.19 112.68 1.02 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.738 0.304 . . . . 9.0399999999999991 110.527 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 pt -90.6 -31.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 9.0399999999999991 110.933 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.356 -0.83 . . . . 9.0399999999999991 110.586 -179.827 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.823 0.344 . . . . 16.5 110.822 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.63 141.94 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 13.859999999999999 110.583 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.02 149.81 15.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.414 -0.357 . . . . 12.19 110.975 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -103.98 152.37 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 11.640000000000001 111.156 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.76 101.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.772 -0.649 . . . . 9.0399999999999991 109.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -89.43 133.56 34.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.182 0.438 . . . . 9.0399999999999991 112.182 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -103.15 160.0 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 9.0399999999999991 111.158 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 9' ' ' THR . 3.8 pp -64.78 -24.72 67.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.047 -0.524 . . . . 9.0399999999999991 111.178 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.436 ' N ' HD12 ' A' ' 8' ' ' LEU . 77.1 p -67.79 -35.88 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.288 -0.415 . . . . 9.0399999999999991 110.985 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.69 3.64 7.68 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.109 -0.567 . . . . 9.0399999999999991 112.675 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -99.65 126.64 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.275 0.472 . . . . 9.0399999999999991 112.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -101.07 133.67 45.24 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.712 -0.676 . . . . 9.0399999999999991 109.467 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 13' ' ' ILE . 4.6 mp -117.59 142.03 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 9.0399999999999991 111.68 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.717 -0.674 . . . . 9.0399999999999991 110.029 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.9 mt -134.58 155.22 50.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.525 -0.307 . . . . 10.02 110.959 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -123.0 99.82 6.57 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.199 -0.455 . . . . 12.19 111.028 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -153.04 115.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.542 -0.299 . . . . 14.73 111.731 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 43.6 mt-10 -51.46 168.77 0.25 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 113.867 1.062 . . . . 18.57 113.867 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 18' ' ' GLU . 16.7 Cg_exo -69.39 -23.19 32.76 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.572 2.848 . . . . 19.890000000000001 113.344 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -84.12 28.96 0.58 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.673 0.273 . . . . 21.489999999999998 111.546 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -116.58 139.83 50.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.428 -0.351 . . . . 18.559999999999999 110.839 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 p -73.76 151.37 40.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 20.149999999999999 111.41 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.25 -36.54 69.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.352 -0.386 . . . . 17.16 110.384 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -43.15 99.53 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.4 -0.593 . . . . 19.989999999999998 109.4 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -60.62 -43.21 97.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.789 -0.641 . . . . 16.559999999999999 110.081 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.57 -42.5 96.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.937 -0.574 . . . . 14.390000000000001 110.4 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.01 -28.7 69.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.125 -0.489 . . . . 14.57 110.421 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.89 71.68 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.59 -0.522 . . . . 14.550000000000001 109.59 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -62.93 -48.47 78.77 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.598 -0.728 . . . . 14.15 109.367 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.7 mt -61.1 -42.67 94.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.518 -0.764 . . . . 10.06 109.904 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -60.38 -28.41 68.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.602 -0.727 . . . . 15.880000000000001 110.833 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -75.74 -36.57 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 12.470000000000001 110.936 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.45 -64.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.05 -0.523 . . . . 9.2300000000000004 112.035 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -78.49 -8.36 58.46 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.719 1.007 . . . . 9.5999999999999996 113.719 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.66 26.96 67.45 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.388 -0.911 . . . . 12.199999999999999 113.416 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -98.27 118.59 63.31 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.799 0.299 . . . . 11.27 110.559 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.99 135.97 51.95 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.583 2.188 . . . . 14.23 112.219 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.79 -29.32 76.74 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.219 . . . . 14.34 112.046 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.1 -24.63 66.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.886 -0.597 . . . . 16.960000000000001 111.036 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -99.28 -16.3 18.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.025 -0.534 . . . . 14.449999999999999 110.979 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.411 ' HB3' HE21 ' A' ' 41' ' ' GLN . 21.8 mt-30 -80.03 123.8 28.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.005 0.431 . . . . 11.609999999999999 111.769 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.476 ' HB3' HG11 ' A' ' 70' ' ' VAL . 47.8 ttp180 -122.21 121.99 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.337 -0.986 . . . . 9.6099999999999994 108.337 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -106.11 129.69 54.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.024 0.44 . . . . 10.56 112.031 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.403 HD13 ' HD1' ' A' ' 68' ' ' HIS . 24.3 mt -116.17 121.03 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 9.75 110.52 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' N ' HD23 ' A' ' 50' ' ' LEU . 72.2 t80 -128.05 117.29 21.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 15.27 110.57 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.58 22.14 10.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 14.76 111.392 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -10.25 67.47 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.01 -0.614 . . . . 12.99 112.767 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.07 -163.04 0.08 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.244 0.218 . . . . 17.59 111.124 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 -13.51 6.59 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.711 1.004 . . . . 14.970000000000001 113.711 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 45' ' ' PHE . 2.2 mm? 58.5 106.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.788 0.328 . . . . 14.81 111.421 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.532 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 12.5 tp10 -92.13 130.23 37.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.337 -0.392 . . . . 21.0 111.601 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -40.23 -60.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.82 -0.627 . . . . 18.5 111.35 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -50.75 -75.49 0.21 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.529 -0.843 . . . . 21.789999999999999 111.552 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' GLY . 32.4 mmt180 -27.53 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 24.890000000000001 113.479 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.3 t -111.72 164.04 13.47 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.154 -0.93 . . . . 21.530000000000001 111.093 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.3 mm? -51.72 -44.29 63.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.344 -0.389 . . . . 18.41 111.2 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 t -58.33 -29.37 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.14 -0.482 . . . . 21.809999999999999 111.602 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.85 -35.6 81.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 23.140000000000001 110.892 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.532 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 91.9 m-85 -98.68 11.84 37.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 19.370000000000001 111.327 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 58.11 38.26 26.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.907 0.384 . . . . 22.789999999999999 111.317 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.32 115.96 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 18.120000000000001 110.864 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -109.35 -168.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.849 -0.614 . . . . 21.52 110.948 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.84 160.71 11.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 19.190000000000001 111.338 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 57.99 29.81 18.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.853 -0.612 . . . . 16.920000000000002 111.701 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.0 p -89.79 138.1 31.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 15.09 111.299 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.0 p -99.94 127.25 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 11.93 110.797 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -122.46 121.26 36.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.406 . . . . 10.94 110.884 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.403 ' HD1' HD13 ' A' ' 44' ' ' ILE . 28.0 t-80 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 9.0399999999999991 110.941 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.9 113.89 25.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 9.0399999999999991 110.244 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 9.0399999999999991 110.993 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 . . . . . 0 C--O 1.232 0.165 0 N-CA-C 109.365 -0.606 . . . . 9.0399999999999991 109.365 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.05 173.02 12.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 9.0399999999999991 111.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.401 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 7.5 p -148.23 151.69 35.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.7 -0.682 . . . . 9.0399999999999991 111.527 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -99.6 141.33 32.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.29 -0.414 . . . . 9.0399999999999991 110.033 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.412 ' HG1' ' H ' ' B' ' 29' ' ' GLU . 46.2 p -84.56 123.69 30.59 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.373 -0.376 . . . . 9.0399999999999991 111.557 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.81 -21.03 23.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 9.0399999999999991 110.514 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -148.53 156.25 42.08 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 9.0399999999999991 110.703 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.04 143.62 36.51 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.608 2.205 . . . . 9.0399999999999991 113.027 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.526 ' O ' ' CG ' ' B' ' 15' ' ' TYR . 11.9 t80 -130.58 68.67 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 9.0399999999999991 110.377 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 90.1 m -53.92 115.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 9.0399999999999991 110.707 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.61 140.01 47.16 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.772 -0.649 . . . . 9.0399999999999991 112.181 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -102.68 -24.37 13.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.148 0.499 . . . . 9.0399999999999991 110.925 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -119.11 165.14 14.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.491 -0.777 . . . . 9.0399999999999991 110.324 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.33 -38.61 78.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 9.0399999999999991 111.781 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.57 -6.01 43.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.884 0.373 . . . . 9.0399999999999991 110.6 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.99 162.63 15.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.779 -0.646 . . . . 9.0399999999999991 110.868 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 36.3 mt -108.47 150.8 26.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.197 -0.668 . . . . 9.0399999999999991 109.197 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 32.1 m -114.15 127.41 55.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 9.0399999999999991 110.155 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.557 ' CE1' HG12 ' B' ' 31' ' ' ILE . 50.3 m-85 -133.28 144.97 50.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.037 0.754 . . . . 9.0399999999999991 113.037 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.449 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 11.1 ptp180 -109.42 176.49 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.698 -0.853 . . . . 9.0399999999999991 108.698 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.27 126.41 31.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.65 0.738 . . . . 9.0399999999999991 109.921 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 26.2 7.14 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.347 -1.297 . . . . 9.0399999999999991 110.734 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 23.3 mm-40 -98.53 178.9 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.773 1.027 . . . . 9.0399999999999991 113.773 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 mm -135.95 116.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.557 -1.656 . . . . 9.0399999999999991 110.826 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.557 HG12 ' CE1' ' B' ' 25' ' ' PHE . 53.7 mt -108.36 132.21 56.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.044 -0.525 . . . . 9.0399999999999991 111.446 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -91.67 125.53 36.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.029 -0.73 . . . . 9.0399999999999991 109.029 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.82 100.67 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 9.0399999999999991 110.966 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 45.4 mm -82.73 -58.31 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 9.0399999999999991 110.972 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' SER . . . . . 0.424 ' C ' ' H ' ' B' ' 37' ' ' GLU . 66.8 m -157.18 105.89 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 9.0399999999999991 111.656 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.437 ' HB2' ' NZ ' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -66.66 5.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 9.0399999999999991 111.896 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' B' ' 35' ' ' SER . 10.6 tp10 -121.19 102.03 8.04 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 120.562 0.22 . . . . 9.0399999999999991 110.459 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.402 HG23 ' HB2' ' B' ' 45' ' ' LYS . 42.9 p -110.71 -4.66 15.24 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.488 -0.323 . . . . 9.0399999999999991 111.713 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.54 -1.2 71.89 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.967 -0.635 . . . . 9.0399999999999991 112.446 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -129.45 120.54 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.189 -0.3 . . . . 9.0399999999999991 110.189 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.03 132.74 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 9.0399999999999991 111.108 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 1.57 81.79 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.688 -0.687 . . . . 9.0399999999999991 112.394 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.61 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 53.6 m95 -120.78 123.15 41.94 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.937 0.398 . . . . 9.0399999999999991 111.731 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -112.93 161.43 17.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.062 -0.718 . . . . 9.0399999999999991 109.062 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.402 ' HB2' HG23 ' B' ' 38' ' ' THR . 64.1 tttp -116.07 130.56 56.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.09 0.471 . . . . 9.0399999999999991 111.216 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.54 175.45 21.22 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.407 -0.815 . . . . 9.0399999999999991 111.562 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.1 132.66 53.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.223 0.535 . . . . 9.0399999999999991 110.32 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.627 ' O ' ' N ' ' B' ' 50' ' ' GLY . 60.0 tp -124.87 169.22 12.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.219 -0.901 . . . . 9.0399999999999991 110.224 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.498 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 62.5 m-20 -18.62 67.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.283 1.586 . . . . 9.0399999999999991 115.283 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.98 -10.22 63.64 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.981 0.753 . . . . 9.0399999999999991 114.981 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -110.38 155.11 22.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.92 0.86 . . . . 9.0399999999999991 111.045 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.58 140.29 52.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.909 -0.774 . . . . 9.0399999999999991 108.909 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.8 -175.46 40.71 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.041 -1.076 . . . . 9.0399999999999991 113.455 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.21 150.02 15.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.451 0.167 . . . . 9.0399999999999991 111.076 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 50.6 p90 -134.97 140.45 35.06 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.049 0.452 . . . . 9.0399999999999991 112.167 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.61 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.6 Cg_endo -95.09 174.61 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.458 3.439 . . . . 9.0399999999999991 111.641 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.558 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 78.09 -12.83 1.03 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.255 1.576 . . . . 9.0399999999999991 115.255 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 14.9 m120 56.27 77.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.832 0.742 . . . . 9.0399999999999991 109.103 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.9 m-85 -101.87 6.84 41.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.382 -0.826 . . . . 9.0399999999999991 111.694 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.78 138.22 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.575 0.583 . . . . 9.0399999999999991 112.575 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.69 130.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.866 -0.606 . . . . 9.0399999999999991 111.77 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.417 HE22 ' C ' ' B' ' 64' ' ' SER . 0.0 OUTLIER -59.85 132.2 53.23 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.749 -0.463 . . . . 9.0399999999999991 109.749 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 24.7 pt -139.31 37.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.924 0.392 . . . . 9.0399999999999991 111.626 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' SER . . . . . 0.417 ' C ' HE22 ' B' ' 62' ' ' GLN . 30.4 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.23 -0.89 . . . . 9.0399999999999991 110.85 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.604 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 95.2 mtp . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.836 0.35 . . . . 16.5 110.786 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -81.55 151.75 27.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.821 -0.627 . . . . 13.859999999999999 110.786 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -143.7 146.75 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 12.19 110.341 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -95.82 139.17 32.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 11.640000000000001 110.503 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.32 91.33 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.45 -0.574 . . . . 9.0399999999999991 109.45 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.14 153.29 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.843 -0.617 . . . . 9.0399999999999991 111.678 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -133.6 159.82 39.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 9.0399999999999991 109.398 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.518 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 2.0 mm? -58.67 -37.95 77.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.944 0.402 . . . . 9.0399999999999991 110.761 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.9 m -61.14 -22.35 64.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.812 -0.631 . . . . 9.0399999999999991 111.262 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.36 17.66 21.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.079 -0.582 . . . . 9.0399999999999991 112.141 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -99.38 110.37 22.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.299 . . . . 9.0399999999999991 111.189 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -98.64 129.67 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 9.0399999999999991 110.028 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.96 144.67 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.954 0.406 . . . . 9.0399999999999991 111.285 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 p -96.6 136.54 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 9.0399999999999991 110.867 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 tp -137.64 151.47 48.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.317 -0.401 . . . . 10.02 110.284 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.96 105.24 13.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.63 -0.259 . . . . 12.19 111.474 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -152.83 112.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.436 0.532 . . . . 14.73 112.436 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.432 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 1.5 mp0 -56.63 172.89 0.33 Allowed Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 112.881 0.696 . . . . 18.57 112.881 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.604 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 30.1 Cg_exo -63.99 -37.47 43.2 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.42 2.746 . . . . 19.890000000000001 112.73 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -63.67 -25.55 68.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 21.489999999999998 111.541 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.4 147.59 25.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.472 -0.331 . . . . 18.559999999999999 111.188 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -93.89 145.51 24.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.059 -0.519 . . . . 20.149999999999999 110.948 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 50' ' ' LEU . 24.8 mt -55.93 -31.8 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 17.16 111.505 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.28 -38.68 90.28 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.943 -0.391 . . . . 19.989999999999998 109.943 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -69.84 -40.72 75.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.966 -0.561 . . . . 16.559999999999999 109.95 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.28 -49.79 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 115.977 -0.556 . . . . 14.390000000000001 110.355 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.07 -37.5 77.22 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.079 -0.509 . . . . 14.57 110.975 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.18 -38.28 87.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.294 -0.412 . . . . 14.550000000000001 110.944 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.59 -43.29 80.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.122 -0.49 . . . . 14.15 110.192 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.88 -36.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.143 -0.48 . . . . 10.06 109.772 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.427 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 59.0 tt0 -67.07 -29.17 68.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.898 -0.592 . . . . 15.880000000000001 111.164 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.3 -37.62 74.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 12.470000000000001 111.119 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -89.82 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.12 0.415 . . . . 9.2300000000000004 112.12 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -83.15 -9.44 59.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.112 0.782 . . . . 9.5999999999999996 113.112 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 62.54 25.02 66.64 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.427 -0.892 . . . . 12.199999999999999 113.208 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.1 mt -97.39 116.62 65.92 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.792 0.296 . . . . 11.27 110.829 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.95 138.71 70.07 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.698 2.266 . . . . 14.23 112.438 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.97 -22.7 55.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.585 2.19 . . . . 14.34 112.191 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.58 -25.28 66.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.535 . . . . 16.960000000000001 111.311 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -106.9 -5.48 18.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.368 -0.378 . . . . 14.449999999999999 111.572 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -88.95 127.0 35.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.948 0.404 . . . . 11.609999999999999 111.923 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 17.0 tpt180 -125.12 121.78 35.25 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.852 -0.796 . . . . 9.6099999999999994 108.852 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.4 mp -102.8 126.55 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 10.56 111.186 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.468 ' N ' HD11 ' A' ' 44' ' ' ILE . 3.6 mp -112.65 129.76 67.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 9.75 110.406 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -147.36 124.41 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 15.27 110.421 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.8 17.51 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 14.76 111.454 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.52 -3.62 81.79 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.786 -0.721 . . . . 12.99 112.593 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.22 150.32 32.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.778 0.323 . . . . 17.59 110.982 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -83.24 124.94 31.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 14.970000000000001 110.506 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 48.9 mt -64.7 131.65 47.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 14.81 111.109 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -90.31 127.29 36.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.996 -0.547 . . . . 21.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -41.45 34.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.599 -0.728 . . . . 18.5 112.301 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -0.12 83.79 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.982 -0.628 . . . . 21.789999999999999 114.208 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -99.69 173.95 6.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.044 0.422 . . . . 24.890000000000001 110.961 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.2 p -119.19 158.21 26.43 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.22 -0.445 . . . . 21.530000000000001 111.04 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 8.4 mp -52.97 -28.91 26.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 18.41 111.826 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 p -72.78 -21.77 60.94 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.735 0.303 . . . . 21.809999999999999 111.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.58 -42.37 87.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.193 -0.458 . . . . 23.140000000000001 110.958 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.2 10.18 32.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.251 -0.431 . . . . 19.370000000000001 111.579 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.81 24.27 11.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.48 0.548 . . . . 22.789999999999999 112.48 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -57.56 155.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.721 -0.474 . . . . 18.120000000000001 109.721 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -149.59 165.63 31.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.737 -0.468 . . . . 21.52 109.737 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -52.4 146.98 8.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 19.190000000000001 111.506 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.56 30.04 10.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.869 -0.605 . . . . 16.920000000000002 111.776 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.1 p -86.72 160.9 18.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 15.09 110.898 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.6 m -115.48 124.74 51.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 11.93 110.635 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.39 122.45 47.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.23 -0.441 . . . . 10.94 110.294 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -85.94 112.82 21.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 9.0399999999999991 111.078 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.56 118.12 31.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.009 -0.541 . . . . 9.0399999999999991 110.737 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG13 ' CZ2' ' B' ' 43' ' ' TRP . 39.5 t . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 9.0399999999999991 110.881 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.231 0.107 0 N-CA-C 109.383 -0.599 . . . . 9.0399999999999991 109.383 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -130.44 169.36 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.978 0.418 . . . . 9.0399999999999991 111.622 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.57 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 9.5 p -149.02 151.86 35.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 9.0399999999999991 111.114 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -99.22 143.38 29.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.211 -0.45 . . . . 9.0399999999999991 110.835 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 41.7 p -84.7 125.23 32.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.165 -0.47 . . . . 9.0399999999999991 111.84 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.54 -21.85 20.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.327 -0.397 . . . . 9.0399999999999991 111.379 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.26 160.64 59.08 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 120.714 0.292 . . . . 9.0399999999999991 111.622 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 26' ' ' ARG . 92.6 Cg_endo -81.23 71.61 6.88 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.86 2.373 . . . . 9.0399999999999991 113.619 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -64.58 127.65 32.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.042 -0.526 . . . . 9.0399999999999991 111.309 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 30.1 m -112.97 120.19 40.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.505 -0.316 . . . . 9.0399999999999991 111.39 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.09 138.41 47.87 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.962 -0.637 . . . . 9.0399999999999991 111.932 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.437 HG22 ' ND2' ' B' ' 19' ' ' ASN . 13.4 t -104.26 -24.58 13.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.936 0.398 . . . . 9.0399999999999991 111.536 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.437 ' ND2' HG22 ' B' ' 18' ' ' THR . 40.8 m-80 -116.37 162.88 16.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.785 -0.643 . . . . 9.0399999999999991 110.052 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.14 -41.05 86.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.211 -0.449 . . . . 9.0399999999999991 111.044 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.48 -4.89 36.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.088 0.47 . . . . 9.0399999999999991 109.961 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -83.34 156.87 22.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.53 -0.759 . . . . 9.0399999999999991 110.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.478 HD13 ' H ' ' B' ' 24' ' ' THR . 0.4 OUTLIER -107.11 146.61 31.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.803 -1.184 . . . . 9.0399999999999991 107.803 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' THR . . . . . 0.478 ' H ' HD13 ' B' ' 23' ' ' LEU . 53.3 m -111.83 128.08 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 9.0399999999999991 110.352 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.51 ' CD1' HG12 ' B' ' 31' ' ' ILE . 73.3 m-85 -128.02 128.62 45.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.323 0.49 . . . . 9.0399999999999991 112.323 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' B' ' 14' ' ' PRO . 24.4 mmm180 -100.58 174.37 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.285 -0.635 . . . . 9.0399999999999991 109.285 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.71 137.7 35.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.169 0.509 . . . . 9.0399999999999991 110.229 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.24 21.65 51.21 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.704 -0.958 . . . . 9.0399999999999991 110.704 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 21.6 mm-40 -99.36 -179.81 4.34 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.393 0.886 . . . . 9.0399999999999991 113.393 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.2 mm -135.07 118.7 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.83 -1.532 . . . . 9.0399999999999991 110.748 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.57 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 17.3 mt -112.23 136.74 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.911 -0.586 . . . . 9.0399999999999991 112.1 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -95.06 125.8 39.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.901 -0.777 . . . . 9.0399999999999991 108.901 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 tt -74.34 105.89 5.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 9.0399999999999991 111.622 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' B' ' 47' ' ' GLU . 75.5 mt -80.8 -65.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.577 -0.738 . . . . 9.0399999999999991 110.793 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -153.08 129.65 10.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.86 -0.609 . . . . 9.0399999999999991 111.929 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.407 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 48.9 mtpt -84.04 6.44 22.08 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.901 -0.591 . . . . 9.0399999999999991 111.535 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 94.84 4.46 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.224 -0.287 . . . . 9.0399999999999991 110.224 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 76.2 p -104.81 -1.96 25.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.413 -0.358 . . . . 9.0399999999999991 111.706 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.3 -3.18 72.15 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.974 -0.632 . . . . 9.0399999999999991 112.452 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -135.41 124.42 24.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.767 0.318 . . . . 9.0399999999999991 110.49 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.07 57.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 9.0399999999999991 110.881 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.59 2.38 82.2 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.639 -0.709 . . . . 9.0399999999999991 112.404 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.443 ' HE1' ' HG ' ' A' ' 8' ' ' LEU . 69.5 m95 -119.12 121.64 40.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.901 0.381 . . . . 9.0399999999999991 111.443 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' TRP . . . . . 0.407 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 36.5 m0 -113.07 168.57 9.59 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.813 -0.81 . . . . 9.0399999999999991 108.813 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -125.11 129.65 50.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 9.0399999999999991 110.704 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.11 174.69 21.79 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.812 -0.709 . . . . 9.0399999999999991 112.316 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.446 ' HB2' HD11 ' B' ' 34' ' ' ILE . 34.0 tt0 -125.7 133.25 52.2 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.225 0.536 . . . . 9.0399999999999991 110.728 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 50' ' ' GLY . 28.6 tp -127.93 171.18 12.04 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.184 -0.916 . . . . 9.0399999999999991 109.889 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.469 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 14.2 m120 -17.81 67.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.43 1.641 . . . . 9.0399999999999991 115.43 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.6 -10.02 63.26 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 115.128 0.811 . . . . 9.0399999999999991 115.128 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -109.94 154.41 23.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.15 0.975 . . . . 9.0399999999999991 111.197 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.68 140.79 51.86 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.996 -0.742 . . . . 9.0399999999999991 108.996 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.33 -176.03 42.38 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.012 -1.089 . . . . 9.0399999999999991 113.358 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.416 HG23 ' CZ3' ' B' ' 43' ' ' TRP . 29.9 m -113.82 152.72 15.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.432 0.158 . . . . 9.0399999999999991 110.985 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 52.3 p90 -136.56 141.02 33.95 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.384 0.513 . . . . 9.0399999999999991 112.384 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 95.2 Cg_endo -94.99 174.73 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.498 3.465 . . . . 9.0399999999999991 111.275 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.557 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 24.2 m-20 75.43 -11.01 1.15 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.079 1.511 . . . . 9.0399999999999991 115.079 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 56.33 76.63 0.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.829 -0.804 . . . . 9.0399999999999991 108.829 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.557 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.1 m-85 -100.9 8.27 43.2 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.16 -0.927 . . . . 9.0399999999999991 111.553 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.89 138.63 40.9 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.664 0.616 . . . . 9.0399999999999991 112.664 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -113.42 127.17 70.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 9.0399999999999991 111.296 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -54.47 108.23 0.36 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.851 0.358 . . . . 9.0399999999999991 110.503 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.29 -36.37 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 9.0399999999999991 110.934 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.38 -0.819 . . . . 9.0399999999999991 110.746 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.01 0.433 . . . . 16.5 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -84.22 149.9 25.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.822 -0.626 . . . . 13.859999999999999 110.537 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -144.04 149.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 12.19 110.692 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.34 136.32 42.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 11.640000000000001 110.479 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 40.8 t -121.19 96.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.574 -0.528 . . . . 9.0399999999999991 109.574 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 7' ' ' THR . 52.5 tttm -77.34 162.99 26.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.672 -0.694 . . . . 9.0399999999999991 111.527 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.436 ' HG1' ' H ' ' A' ' 11' ' ' LYS . 56.8 p -142.16 160.99 39.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.467 -0.788 . . . . 9.0399999999999991 110.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -64.33 -22.76 67.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 9.0399999999999991 111.175 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -81.82 -12.37 58.54 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.263 -0.426 . . . . 9.0399999999999991 111.618 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 16.69 41.79 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.886 -0.673 . . . . 9.0399999999999991 112.547 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' H ' ' HG1' ' A' ' 7' ' ' THR . 58.0 tptt -97.86 108.31 20.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.899 0.38 . . . . 9.0399999999999991 111.354 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 p -100.06 126.01 46.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 9.0399999999999991 110.256 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.415 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 36.1 pt -120.83 146.55 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.39 . . . . 9.0399999999999991 111.253 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.5 p -97.06 140.46 31.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.87 -0.605 . . . . 9.0399999999999991 111.123 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.2 tp -138.4 149.7 45.79 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.247 -0.433 . . . . 10.02 110.258 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -109.46 103.79 12.75 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.872 0.323 . . . . 12.19 111.872 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -153.83 112.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.268 -0.424 . . . . 14.73 111.615 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.506 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 25.0 mt-10 -63.71 173.32 1.35 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.708 0.633 . . . . 18.57 112.708 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.506 ' CD ' ' HB3' ' A' ' 18' ' ' GLU . 50.7 Cg_exo -57.98 -42.35 59.08 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.333 2.688 . . . . 19.890000000000001 113.741 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.0 m -60.42 -23.99 64.83 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.039 0.385 . . . . 21.489999999999998 112.039 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.31 148.48 32.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.845 0.355 . . . . 18.559999999999999 111.276 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 82.7 p -92.74 145.87 24.08 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.107 -0.497 . . . . 20.149999999999999 111.14 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.409 HD11 ' O ' ' A' ' 54' ' ' ARG . 1.1 mp -55.82 -34.49 37.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 17.16 111.205 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.2 -41.07 98.02 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.894 -0.41 . . . . 19.989999999999998 109.894 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.443 ' H ' ' HG1' ' A' ' 22' ' ' THR . 5.3 m-20 -66.22 -37.49 85.68 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.825 -0.625 . . . . 16.559999999999999 110.035 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 CA-C-N 116.152 -0.476 . . . . 14.390000000000001 110.037 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -58.61 -34.71 71.45 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.888 -0.597 . . . . 14.57 110.628 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 31' ' ' GLN . . . -68.23 -34.64 76.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 14.550000000000001 111.102 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -73.71 -38.46 64.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 14.15 110.383 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -65.01 -40.11 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 10.06 110.742 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 21.1 pt20 -69.72 -19.39 63.55 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.61 -0.268 . . . . 15.880000000000001 111.226 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -75.27 -35.33 61.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 12.470000000000001 110.467 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -93.1 -53.81 3.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.992 -0.549 . . . . 9.2300000000000004 112.021 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.69 -11.62 55.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.842 0.682 . . . . 9.5999999999999996 112.842 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 5.08 52.09 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.556 -0.83 . . . . 12.199999999999999 114.015 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.2 pt -79.82 128.91 72.67 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 117.355 0.578 . . . . 11.27 111.02 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.56 142.66 59.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.572 2.181 . . . . 14.23 112.738 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -24.66 64.74 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.881 2.387 . . . . 14.34 112.109 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.59 -24.9 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.894 -0.594 . . . . 16.960000000000001 111.142 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -108.59 -7.03 15.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.302 -0.408 . . . . 14.449999999999999 111.469 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -80.95 126.48 31.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 11.609999999999999 111.547 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -124.29 112.07 16.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 9.6099999999999994 109.327 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.4 mp -98.06 124.59 42.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 10.56 111.16 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.71 131.52 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.833 -0.621 . . . . 9.75 110.646 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -147.53 119.22 8.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.616 . . . . 15.27 110.439 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.35 29.97 9.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.993 -0.549 . . . . 14.76 112.154 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.37 -3.69 76.48 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.426 -0.892 . . . . 12.99 113.239 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -114.84 146.84 40.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.803 0.335 . . . . 17.59 111.116 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -82.49 128.75 34.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 14.970000000000001 110.381 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.76 130.62 43.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 14.81 110.995 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.48 123.89 33.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.927 -0.578 . . . . 21.0 111.017 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -36.26 -57.18 0.74 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.992 -0.549 . . . . 18.5 111.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -52.93 -75.04 0.24 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.771 -0.728 . . . . 21.789999999999999 112.019 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.409 ' O ' HD11 ' A' ' 23' ' ' ILE . 29.5 mmt180 -29.17 158.11 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.911 1.078 . . . . 24.890000000000001 113.911 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -111.4 165.72 11.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.087 -0.96 . . . . 21.530000000000001 111.322 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.5 mm? -53.42 -32.48 49.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.189 -0.46 . . . . 18.41 111.86 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -70.05 -21.7 63.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.653 0.263 . . . . 21.809999999999999 111.5 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.97 -38.45 86.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 23.140000000000001 111.041 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -97.91 8.47 44.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 19.370000000000001 111.615 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 59.3 46.96 12.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.954 0.407 . . . . 22.789999999999999 111.137 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.03 107.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 18.120000000000001 110.912 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.66 -178.87 5.19 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.016 -0.538 . . . . 21.52 110.936 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.55 157.06 33.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.835 0.35 . . . . 19.190000000000001 111.124 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.2 24.95 14.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.809 -0.632 . . . . 16.920000000000002 111.684 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -85.78 161.18 19.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.712 0.292 . . . . 15.09 110.814 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 t -116.73 126.85 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 11.93 110.84 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -115.27 121.48 43.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 10.94 110.164 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -83.96 112.47 20.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.944 0.402 . . . . 9.0399999999999991 111.778 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.4 tp -91.8 119.71 31.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 9.0399999999999991 109.62 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 121.241 0.544 . . . . 9.0399999999999991 112.346 -178.846 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.233 0.213 0 N-CA-C 108.834 -0.802 . . . . 9.0399999999999991 108.834 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -124.76 159.92 29.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 9.0399999999999991 111.828 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 16.8 m -141.14 146.35 36.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.186 -0.915 . . . . 9.0399999999999991 110.569 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -100.47 133.23 45.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 9.0399999999999991 110.199 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.3 m -73.85 127.13 32.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 9.0399999999999991 110.913 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.8 mt -95.87 -22.1 17.66 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.144 0.424 . . . . 9.0399999999999991 112.144 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -142.66 154.51 62.99 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 117.981 0.355 . . . . 9.0399999999999991 111.614 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.01 136.25 20.12 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.525 2.15 . . . . 9.0399999999999991 112.913 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.421 ' HH ' ' HG2' ' B' ' 22' ' ' GLU . 54.5 t80 -139.16 129.12 25.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 9.0399999999999991 109.883 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 31.8 m -110.84 121.35 45.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.85 0.357 . . . . 9.0399999999999991 110.617 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.73 128.76 43.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.98 -0.629 . . . . 9.0399999999999991 112.586 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 5.3 t -103.16 -23.07 13.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.182 0.515 . . . . 9.0399999999999991 110.63 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -119.89 159.41 24.7 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.123 -0.944 . . . . 9.0399999999999991 109.853 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.5 -29.13 69.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.386 0.513 . . . . 9.0399999999999991 112.386 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -86.53 -2.64 58.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.945 -0.302 . . . . 9.0399999999999991 111.682 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.421 ' HG2' ' HH ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -89.55 160.17 16.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 9.0399999999999991 111.281 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -117.24 165.46 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.246 -0.65 . . . . 9.0399999999999991 109.246 178.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 61.7 m -115.42 128.65 56.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 9.0399999999999991 110.187 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 10.8 m-85 -131.92 133.43 44.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.301 0.482 . . . . 9.0399999999999991 112.301 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.53 176.26 5.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.826 -0.435 . . . . 9.0399999999999991 109.826 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.21 136.68 35.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 9.0399999999999991 110.323 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.79 55.42 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.571 -0.74 . . . . 9.0399999999999991 111.318 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -100.13 179.72 4.4 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.877 1.066 . . . . 9.0399999999999991 113.877 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.49 136.11 60.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.781 -1.554 . . . . 9.0399999999999991 111.129 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 35.8 mt -132.86 133.09 59.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 9.0399999999999991 111.207 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -90.21 126.49 35.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.58 -0.526 . . . . 9.0399999999999991 109.58 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.405 ' C ' ' CD2' ' B' ' 33' ' ' LEU . 4.3 tt -73.47 102.08 3.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.995 0.426 . . . . 9.0399999999999991 111.149 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 23.5 mm -84.08 -61.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.765 -0.652 . . . . 9.0399999999999991 111.418 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' SER . . . . . 0.43 ' C ' ' H ' ' B' ' 37' ' ' GLU . 48.2 t -155.17 108.5 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.194 0.442 . . . . 9.0399999999999991 112.194 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -65.95 5.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.598 . . . . 9.0399999999999991 111.722 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' B' ' 35' ' ' SER . 0.0 OUTLIER -121.44 101.07 7.39 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.535 0.207 . . . . 9.0399999999999991 110.678 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 68.8 p -111.11 -4.38 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.449 -0.341 . . . . 9.0399999999999991 111.184 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.18 -1.77 62.99 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.018 -0.611 . . . . 9.0399999999999991 112.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.77 120.89 27.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.811 0.338 . . . . 9.0399999999999991 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.79 56.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 9.0399999999999991 110.962 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.63 1.56 85.41 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.826 -0.625 . . . . 9.0399999999999991 112.421 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -123.31 120.39 32.95 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.289 0.544 . . . . 9.0399999999999991 111.751 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' TRP . . . . . 0.541 ' HB2' ' CZ ' ' B' ' 55' ' ' PHE . 37.4 m0 -108.43 166.33 10.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.515 -0.766 . . . . 9.0399999999999991 109.494 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.427 ' HZ2' ' HA2' ' B' ' 53' ' ' GLY . 45.4 tptt -117.28 131.64 56.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.959 0.409 . . . . 9.0399999999999991 110.98 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.56 175.33 21.53 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.454 -0.794 . . . . 9.0399999999999991 111.752 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.61 134.75 50.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.196 0.522 . . . . 9.0399999999999991 110.629 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 50' ' ' GLY . 2.6 mt -130.9 171.73 12.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.105 -0.952 . . . . 9.0399999999999991 110.159 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.425 ' ND2' HD23 ' B' ' 48' ' ' LEU . 11.8 m-80 -17.35 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.127 1.529 . . . . 9.0399999999999991 115.127 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.54 -12.79 50.3 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 114.319 0.488 . . . . 9.0399999999999991 114.319 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.404 ' C ' HD22 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -123.07 133.79 54.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.314 0.557 . . . . 9.0399999999999991 111.337 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -107.11 146.72 30.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.958 -0.565 . . . . 9.0399999999999991 110.344 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' HZ2' ' B' ' 45' ' ' LYS . . . -166.51 -177.85 38.73 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.663 -0.78 . . . . 9.0399999999999991 112.855 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.99 160.51 12.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.453 0.538 . . . . 9.0399999999999991 112.453 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' B' ' 44' ' ' TRP . 3.0 p90 -124.79 157.49 65.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.375 -0.83 . . . . 9.0399999999999991 110.807 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.03 123.02 2.65 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.69 2.26 . . . . 9.0399999999999991 115.865 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p30 51.02 45.02 28.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.638 1.347 . . . . 9.0399999999999991 114.638 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 m120 62.7 88.64 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.772 1.027 . . . . 9.0399999999999991 113.772 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.1 16.26 27.1 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.908 -0.775 . . . . 9.0399999999999991 108.908 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.64 138.49 30.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.81 0.3 . . . . 9.0399999999999991 111.81 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.5 p -110.17 120.77 61.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 116.352 -0.385 . . . . 9.0399999999999991 111.323 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.445 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 34.1 tt0 -51.51 150.86 3.43 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 121.023 0.44 . . . . 9.0399999999999991 111.062 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.98 -37.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.671 . . . . 9.0399999999999991 110.403 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.237 -0.887 . . . . 9.0399999999999991 110.55 179.668 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttt . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.92 0.391 . . . . 16.5 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -82.93 152.7 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.587 . . . . 13.859999999999999 109.916 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 pt -145.32 150.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 12.19 110.249 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -102.73 135.15 44.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.189 -0.46 . . . . 11.640000000000001 110.691 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.37 99.4 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.327 -0.62 . . . . 9.0399999999999991 109.327 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.413 ' HG2' ' CG2' ' A' ' 12' ' ' THR . 6.7 tmtt? -86.81 111.78 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 9.0399999999999991 111.663 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.2 p -84.83 -178.48 6.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 9.0399999999999991 110.699 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp -85.93 -10.65 54.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.546 -0.297 . . . . 9.0399999999999991 111.68 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -97.29 21.06 10.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.928 0.394 . . . . 9.0399999999999991 110.684 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.62 13.09 65.26 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.911 -0.662 . . . . 9.0399999999999991 112.377 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -96.1 112.05 23.9 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.054 0.454 . . . . 9.0399999999999991 111.933 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.413 ' CG2' ' HG2' ' A' ' 6' ' ' LYS . 31.4 p -104.28 122.39 45.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.647 -0.706 . . . . 9.0399999999999991 110.012 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.1 pt -114.75 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.382 . . . . 9.0399999999999991 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.5 p -87.72 135.31 33.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 9.0399999999999991 110.36 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tp -134.67 146.45 49.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 10.02 110.556 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -102.67 130.92 49.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 12.19 110.498 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.76 -174.21 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.167 0.508 . . . . 14.73 111.575 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -138.97 145.95 47.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 18.57 109.044 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.09 -23.18 12.07 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.332 2.021 . . . . 19.890000000000001 112.709 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -87.85 -23.85 23.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 21.489999999999998 111.753 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.33 150.92 4.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.875 0.369 . . . . 18.559999999999999 111.656 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -96.49 140.71 30.73 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.931 -0.577 . . . . 20.149999999999999 111.259 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.7 mm -49.55 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.091 -0.504 . . . . 17.16 111.164 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.08 -41.06 78.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.87 0.367 . . . . 19.989999999999998 110.153 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -69.29 -35.55 76.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 16.559999999999999 110.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.05 -45.36 98.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.153 -0.476 . . . . 14.390000000000001 110.573 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -59.84 -37.19 78.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 14.57 110.826 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.01 66.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 14.550000000000001 110.82 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.21 -41.13 83.38 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.174 -0.676 . . . . 14.15 109.174 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.25 -37.79 79.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.353 -0.84 . . . . 10.06 110.546 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 60.2 tt0 -61.63 -33.97 74.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.024 -0.535 . . . . 15.880000000000001 110.84 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -56.86 -27.11 59.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 12.470000000000001 110.074 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -99.85 -71.03 0.71 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.861 -0.609 . . . . 9.2300000000000004 112.608 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.68 -10.98 60.25 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.537 0.569 . . . . 9.5999999999999996 112.537 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 63.26 7.29 17.78 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.595 -0.812 . . . . 12.199999999999999 113.305 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.5 pt -71.9 122.22 86.69 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.798 0.299 . . . . 11.27 111.017 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.56 142.76 70.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.405 2.07 . . . . 14.23 111.873 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.15 -25.32 43.55 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.712 2.275 . . . . 14.34 112.837 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.71 -23.62 66.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.918 0.71 . . . . 16.960000000000001 112.918 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -107.92 -5.62 17.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.612 . . . . 14.449999999999999 109.349 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -83.14 100.93 10.85 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.247 -0.888 . . . . 11.609999999999999 110.888 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.459 ' HE ' ' N ' ' A' ' 43' ' ' LEU . 6.4 tpm_? -100.35 113.58 26.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.485 -0.932 . . . . 9.6099999999999994 108.485 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' N ' ' HE ' ' A' ' 42' ' ' ARG . 61.9 mt -98.8 120.11 38.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.901 0.381 . . . . 10.56 110.887 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -109.43 137.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.681 -0.69 . . . . 9.75 110.367 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.427 ' CE2' HG12 ' A' ' 61' ' ' ILE . 62.5 t80 -156.47 132.34 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 15.27 111.182 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.72 6.23 2.58 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.837 -0.62 . . . . 14.76 111.87 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.41 -4.02 40.32 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.903 -0.665 . . . . 12.99 112.995 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -122.01 152.16 40.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.747 0.308 . . . . 17.59 110.663 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -81.43 119.98 24.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 14.970000000000001 110.574 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.85 128.81 38.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.321 -0.4 . . . . 14.81 110.5 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -81.08 124.97 29.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.323 -0.398 . . . . 21.0 109.986 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.47 -33.05 13.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.826 -0.624 . . . . 18.5 112.603 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.98 5.99 84.07 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.997 0.759 . . . . 21.789999999999999 114.997 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.516 ' HE ' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -105.55 173.04 6.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.672 0.736 . . . . 24.890000000000001 111.463 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -109.59 155.57 21.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.128 -0.487 . . . . 21.530000000000001 110.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.7 mt -53.97 -16.32 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 18.41 111.795 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -78.93 -26.01 43.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.647 0.26 . . . . 21.809999999999999 111.531 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.8 -36.98 84.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.39 -0.368 . . . . 23.140000000000001 110.765 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -99.44 12.23 36.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.155 -0.475 . . . . 19.370000000000001 111.878 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 m120 57.07 27.45 13.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.846 0.355 . . . . 22.789999999999999 111.416 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.427 HG12 ' CE2' ' A' ' 45' ' ' PHE . 98.1 mt -68.61 108.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.294 -0.412 . . . . 18.120000000000001 111.541 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.37 -179.54 4.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.207 -0.451 . . . . 21.52 111.108 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.37 156.77 28.17 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.949 0.404 . . . . 19.190000000000001 111.51 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 58.33 28.88 17.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.765 -0.652 . . . . 16.920000000000002 111.461 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 p -88.14 150.86 23.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 15.09 110.686 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.5 t -101.83 121.48 42.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 11.93 110.849 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -110.82 117.17 32.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 10.94 109.864 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -79.3 109.3 13.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 9.0399999999999991 112.074 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -92.55 115.12 27.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.076 -0.511 . . . . 9.0399999999999991 110.399 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 9.0399999999999991 111.466 -179.347 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.232 0.177 0 N-CA-C 109.252 -0.648 . . . . 9.0399999999999991 109.252 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -127.42 158.58 36.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.302 0.572 . . . . 9.0399999999999991 112.063 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.439 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 24.0 p -145.22 145.78 31.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.023 -0.99 . . . . 9.0399999999999991 110.581 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -101.76 137.15 40.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.824 0.345 . . . . 9.0399999999999991 110.555 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -76.87 126.0 30.24 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.106 -0.497 . . . . 9.0399999999999991 111.467 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 39.0 mt -88.73 -20.87 24.24 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.86 0.319 . . . . 9.0399999999999991 111.86 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -147.37 156.73 45.97 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 121.052 -0.259 . . . . 9.0399999999999991 111.399 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 138.47 29.24 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.48 2.12 . . . . 9.0399999999999991 112.378 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -136.74 130.55 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.489 -0.778 . . . . 9.0399999999999991 110.801 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' THR . . . . . 0.497 ' HG1' HH12 ' B' ' 26' ' ' ARG . 34.2 m -111.83 119.56 38.99 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.884 0.373 . . . . 9.0399999999999991 111.034 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.72 142.28 48.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.816 -0.629 . . . . 9.0399999999999991 112.319 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -111.14 -22.24 11.53 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.95 0.405 . . . . 9.0399999999999991 111.534 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -117.45 160.56 20.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.698 -0.683 . . . . 9.0399999999999991 110.206 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -33.46 75.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 9.0399999999999991 111.652 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -84.77 -4.26 58.97 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.834 0.35 . . . . 9.0399999999999991 110.952 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -81.74 153.88 26.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.068 -0.515 . . . . 9.0399999999999991 110.557 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.459 HD23 ' HB3' ' B' ' 48' ' ' LEU . 0.5 OUTLIER -104.43 144.05 32.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.961 -0.755 . . . . 9.0399999999999991 108.961 178.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' THR . . . . . 0.457 HG22 ' HA ' ' B' ' 16' ' ' THR . 99.8 m -114.81 121.94 44.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.767 -0.651 . . . . 9.0399999999999991 110.172 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -138.57 153.41 48.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.833 0.679 . . . . 9.0399999999999991 112.833 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.497 HH12 ' HG1' ' B' ' 16' ' ' THR . 27.0 mmt180 -109.52 -179.59 3.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.839 -0.43 . . . . 9.0399999999999991 109.839 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.5 135.45 35.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.114 0.483 . . . . 9.0399999999999991 109.842 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.03 31.97 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.524 -1.03 . . . . 9.0399999999999991 110.524 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' B' ' 30' ' ' ILE . 1.9 tp10 -96.79 178.69 5.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.793 0.806 . . . . 9.0399999999999991 113.001 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.413 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 27.7 mm -135.76 114.16 15.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 113.763 -1.562 . . . . 9.0399999999999991 111.245 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.07 139.58 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 9.0399999999999991 110.861 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' HIS . . . . . 0.409 ' N ' ' CD2' ' B' ' 32' ' ' HIS . 7.2 m170 -91.68 128.81 37.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.456 -0.572 . . . . 9.0399999999999991 109.456 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.08 98.7 2.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 9.0399999999999991 110.58 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.3 mm -79.54 -63.11 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 9.0399999999999991 111.125 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -157.97 110.13 2.33 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.824 0.676 . . . . 9.0399999999999991 112.824 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.421 ' O ' HG21 ' B' ' 38' ' ' THR . 58.6 mtmt -56.29 -69.81 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.999 -0.741 . . . . 9.0399999999999991 108.999 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.51 98.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.426 -0.352 . . . . 9.0399999999999991 111.394 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.421 HG21 ' O ' ' B' ' 36' ' ' LYS . 23.7 p -111.37 -5.3 14.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.34 -0.391 . . . . 9.0399999999999991 111.104 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.27 -8.36 72.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.81 -0.71 . . . . 9.0399999999999991 111.649 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.24 120.43 31.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.812 0.339 . . . . 9.0399999999999991 110.656 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.31 55.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.496 . . . . 9.0399999999999991 111.35 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 -0.7 83.72 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.807 -0.633 . . . . 9.0399999999999991 112.675 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -121.63 127.37 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.333 0.566 . . . . 9.0399999999999991 112.088 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' TRP . . . . . 0.552 ' HB2' ' CE2' ' B' ' 55' ' ' PHE . 23.2 m0 -113.88 162.15 16.72 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.285 -0.871 . . . . 9.0399999999999991 109.201 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -114.19 131.25 56.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.086 0.469 . . . . 9.0399999999999991 110.89 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.83 174.73 22.22 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.454 -0.794 . . . . 9.0399999999999991 112.073 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.26 132.81 52.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.143 0.497 . . . . 9.0399999999999991 110.272 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 50' ' ' GLY . 19.8 tp -129.81 170.28 14.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.192 -0.913 . . . . 9.0399999999999991 109.755 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.48 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 67.7 m-20 -17.7 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.33 1.604 . . . . 9.0399999999999991 115.33 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.4 -12.57 54.94 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.545 0.578 . . . . 9.0399999999999991 114.545 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -119.5 134.36 55.25 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.461 0.63 . . . . 9.0399999999999991 111.105 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.46 146.5 31.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.07 -0.514 . . . . 9.0399999999999991 110.18 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.47 -177.48 41.93 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.541 -0.838 . . . . 9.0399999999999991 112.55 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.98 160.99 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 112.126 0.417 . . . . 9.0399999999999991 112.126 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' B' ' 44' ' ' TRP . 2.7 p90 -124.79 149.55 62.97 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.665 -0.698 . . . . 9.0399999999999991 111.106 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.69 122.4 5.45 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.828 2.352 . . . . 9.0399999999999991 115.171 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 51.26 43.76 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 114.171 1.174 . . . . 9.0399999999999991 114.171 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.48 92.26 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.166 1.172 . . . . 9.0399999999999991 114.166 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -102.84 17.52 23.72 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.425 -0.954 . . . . 9.0399999999999991 108.425 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.439 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -146.26 138.2 24.96 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.591 0.219 . . . . 9.0399999999999991 111.591 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 p -109.11 121.59 62.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.498 -0.319 . . . . 9.0399999999999991 111.336 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.45 155.93 3.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.82 0.343 . . . . 9.0399999999999991 110.594 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.87 -51.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 9.0399999999999991 110.639 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.301 -0.856 . . . . 9.0399999999999991 110.714 -179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.724 0.297 . . . . 16.5 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -84.58 148.03 26.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 13.859999999999999 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.4 pt -139.52 154.77 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.632 . . . . 12.19 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.87 134.57 53.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.023 -0.535 . . . . 11.640000000000001 110.376 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.8 t -118.16 100.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.376 -0.601 . . . . 9.0399999999999991 109.376 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 14.5 tmtt? -88.82 131.2 35.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 9.0399999999999991 112.155 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -106.08 163.17 12.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.252 -0.885 . . . . 9.0399999999999991 110.841 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.74 -21.97 66.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.275 -0.421 . . . . 9.0399999999999991 111.348 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 t -81.23 -8.51 59.76 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.382 -0.372 . . . . 9.0399999999999991 111.18 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.1 54.99 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.179 -0.534 . . . . 9.0399999999999991 112.965 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -97.0 108.58 21.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 9.0399999999999991 111.337 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p -99.93 124.33 45.15 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.928 -0.578 . . . . 9.0399999999999991 110.261 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.57 143.85 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.368 . . . . 9.0399999999999991 111.185 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.1 m -98.13 135.66 39.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.865 -0.607 . . . . 9.0399999999999991 110.786 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.89 152.95 52.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 10.02 110.985 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.48 121.01 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 12.19 109.753 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -140.12 -178.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.086 0.469 . . . . 14.73 111.446 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 38.8 tt0 -145.63 146.28 28.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.49 -0.777 . . . . 18.57 109.873 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 72.2 Cg_exo -50.47 -26.4 16.3 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 19.890000000000001 112.91 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 m -85.64 -23.85 27.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.323 -0.399 . . . . 21.489999999999998 111.28 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.6 148.96 8.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.381 . . . . 18.559999999999999 111.392 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 m -95.85 144.19 26.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.904 -0.589 . . . . 20.149999999999999 111.139 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -51.86 -44.58 37.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.132 -0.485 . . . . 17.16 111.433 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.18 -38.06 67.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.853 0.359 . . . . 19.989999999999998 110.329 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -68.07 -38.84 82.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.556 . . . . 16.559999999999999 110.087 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -58.99 -48.57 86.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.144 -0.48 . . . . 14.390000000000001 110.416 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HZ3' ' HG ' ' A' ' 43' ' ' LEU . 68.6 mttm -60.75 -32.67 71.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.05 -0.523 . . . . 14.57 110.885 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.19 78.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.147 -0.479 . . . . 14.550000000000001 110.351 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -70.09 -42.75 72.31 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 14.15 110.228 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.3 mt -61.05 -41.46 89.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.093 0.473 . . . . 10.06 109.985 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -32.87 74.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.819 -0.628 . . . . 15.880000000000001 110.989 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -66.12 -35.91 81.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 12.470000000000001 111.402 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.32 -59.25 2.13 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.399 0.518 . . . . 9.2300000000000004 112.399 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -81.66 -11.41 59.09 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.999 0.74 . . . . 9.5999999999999996 112.999 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.83 -21.11 4.91 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.636 -0.792 . . . . 12.199999999999999 114.454 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.8 pt -54.54 135.49 62.92 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 117.469 0.634 . . . . 11.27 111.92 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.98 135.41 12.4 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.819 2.346 . . . . 14.23 112.468 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.33 -27.16 46.95 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.799 2.333 . . . . 14.34 112.965 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.51 -24.11 67.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.427 -0.351 . . . . 16.960000000000001 111.339 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -110.79 -5.16 15.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 14.449999999999999 111.363 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -80.93 128.09 33.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 11.609999999999999 111.495 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 42' ' ' ARG . 27.9 ttt-85 -125.18 114.21 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.18 -0.674 . . . . 9.6099999999999994 109.18 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.423 ' HG ' ' HZ3' ' A' ' 27' ' ' LYS . 92.3 mt -101.94 126.54 48.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 10.56 110.858 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.85 134.39 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 9.75 110.893 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -151.53 123.14 7.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.585 -0.734 . . . . 15.27 110.187 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 18.55 7.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.803 -0.635 . . . . 14.76 111.614 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.55 -12.07 70.63 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.704 -0.76 . . . . 12.99 112.678 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -107.72 148.49 29.36 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.05 0.452 . . . . 17.59 111.442 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -82.45 129.26 34.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.727 -0.669 . . . . 14.970000000000001 110.096 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.97 130.87 44.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 14.81 111.225 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HB2' ' CG ' ' A' ' 54' ' ' ARG . 11.5 mm-40 -86.74 128.54 35.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 21.0 110.41 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.03 -31.48 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.747 -0.66 . . . . 18.5 112.759 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.53 3.76 85.17 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.736 -0.745 . . . . 21.789999999999999 113.867 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.453 ' CG ' ' HB2' ' A' ' 51' ' ' GLU . 34.6 mmt180 -103.15 177.44 4.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.992 0.396 . . . . 24.890000000000001 110.829 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -123.16 160.5 26.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.364 . . . . 21.530000000000001 111.087 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -51.91 -31.01 26.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 18.41 111.753 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 p -71.04 -25.85 62.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.735 0.272 . . . . 21.809999999999999 111.735 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.81 -37.52 87.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.647 0.26 . . . . 23.140000000000001 111.059 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.91 7.46 46.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 19.370000000000001 111.829 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 61.97 36.27 15.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.864 0.364 . . . . 22.789999999999999 111.54 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -78.65 107.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 18.120000000000001 111.272 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -95.21 -179.14 4.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.224 -0.444 . . . . 21.52 111.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.06 155.34 24.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.108 -0.496 . . . . 19.190000000000001 111.936 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 58.48 31.11 20.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.686 -0.688 . . . . 16.920000000000002 111.455 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -86.19 158.26 19.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 15.09 110.631 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 t -114.26 125.33 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 11.93 110.728 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -115.09 122.59 46.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.902 -0.59 . . . . 10.94 110.229 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.69 111.66 20.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.904 0.383 . . . . 9.0399999999999991 111.611 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -92.34 115.0 27.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.032 -0.531 . . . . 9.0399999999999991 109.807 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.332 -0.159 0 N-CA-C 112.271 0.471 . . . . 9.0399999999999991 112.271 -178.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.444 -0.576 . . . . 9.0399999999999991 109.444 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.9 160.05 33.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.327 0.584 . . . . 9.0399999999999991 112.056 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 32.5 m -141.49 146.93 37.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.982 -1.008 . . . . 9.0399999999999991 110.201 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -102.04 143.79 31.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.829 0.347 . . . . 9.0399999999999991 111.078 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.5 m -82.01 123.64 29.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.999 -0.546 . . . . 9.0399999999999991 111.515 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.37 -20.68 22.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.923 0.342 . . . . 9.0399999999999991 111.923 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.453 ' CD1' ' HD2' ' B' ' 14' ' ' PRO . 30.6 t80 -154.94 144.64 15.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 117.921 0.328 . . . . 9.0399999999999991 111.02 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' B' ' 13' ' ' PHE . 32.3 Cg_exo -59.45 138.46 84.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.416 2.077 . . . . 9.0399999999999991 112.608 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.545 ' CZ ' ' HD3' ' B' ' 56' ' ' PRO . 29.2 t80 -133.72 131.1 39.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.687 -0.688 . . . . 9.0399999999999991 110.839 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' THR . . . . . 0.406 ' HA ' HG23 ' B' ' 24' ' ' THR . 54.5 m -111.89 117.92 34.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.989 0.423 . . . . 9.0399999999999991 111.049 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.45 138.01 47.19 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.973 -0.632 . . . . 9.0399999999999991 112.366 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 15.7 m -104.51 -21.44 13.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.352 0.596 . . . . 9.0399999999999991 110.241 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -118.46 156.06 29.69 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.948 -1.024 . . . . 9.0399999999999991 109.861 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.72 -38.62 91.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 9.0399999999999991 111.186 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.8 -3.21 33.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.809 0.338 . . . . 9.0399999999999991 110.963 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -88.65 160.98 17.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 9.0399999999999991 110.919 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.449 HD23 ' HB3' ' B' ' 48' ' ' LEU . 0.6 OUTLIER -103.87 140.66 37.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.542 -0.54 . . . . 9.0399999999999991 109.542 178.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' THR . . . . . 0.414 ' H ' HD21 ' B' ' 23' ' ' LEU . 56.0 m -116.07 121.73 43.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.297 -0.865 . . . . 9.0399999999999991 109.992 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' B' ' 15' ' ' TYR . 17.8 p90 -140.23 159.06 43.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.913 0.709 . . . . 9.0399999999999991 112.913 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.495 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 81.4 mtt-85 -109.74 179.36 4.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.328 -0.249 . . . . 9.0399999999999991 110.328 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -82.23 140.53 33.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.051 0.453 . . . . 9.0399999999999991 110.048 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.61 21.87 49.23 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.602 -0.999 . . . . 9.0399999999999991 110.602 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 5.3 mm-40 -97.96 179.45 4.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.471 0.915 . . . . 9.0399999999999991 113.471 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -130.5 123.56 55.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.821 -1.536 . . . . 9.0399999999999991 111.417 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -122.07 135.67 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.725 -0.671 . . . . 9.0399999999999991 111.191 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.48 132.72 42.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.703 -0.481 . . . . 9.0399999999999991 109.703 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 tt -72.98 100.46 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 9.0399999999999991 110.798 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.18 -62.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.554 -0.748 . . . . 9.0399999999999991 110.824 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.5 m -158.37 110.11 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.647 0.61 . . . . 9.0399999999999991 112.647 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.409 ' O ' HG21 ' B' ' 38' ' ' THR . 35.0 mtmt -57.91 -71.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.383 -0.599 . . . . 9.0399999999999991 109.383 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -45.72 94.43 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.325 -0.398 . . . . 9.0399999999999991 111.502 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.409 HG21 ' O ' ' B' ' 36' ' ' LYS . 68.6 p -106.58 -9.02 16.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.241 -0.436 . . . . 9.0399999999999991 111.051 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.29 -5.0 62.68 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.909 -0.662 . . . . 9.0399999999999991 112.345 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -129.98 120.79 25.34 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.873 0.368 . . . . 9.0399999999999991 110.554 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 133.3 55.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.57 . . . . 9.0399999999999991 111.61 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 -0.64 85.48 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.586 -0.734 . . . . 9.0399999999999991 112.699 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.425 ' CH2' ' HB3' ' B' ' 56' ' ' PRO . 79.6 m95 -121.86 123.6 42.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.324 0.562 . . . . 9.0399999999999991 111.799 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' TRP . . . . . 0.542 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 21.8 m0 -110.32 172.11 7.06 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.504 -0.771 . . . . 9.0399999999999991 109.322 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -125.39 130.61 52.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 9.0399999999999991 110.905 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.2 176.31 21.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.488 -0.778 . . . . 9.0399999999999991 111.77 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -124.7 133.79 53.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.303 0.573 . . . . 9.0399999999999991 110.207 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.677 ' O ' ' N ' ' B' ' 50' ' ' GLY . 27.3 tp -129.56 170.1 14.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.098 -0.955 . . . . 9.0399999999999991 109.778 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.498 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 31.5 p-10 -17.58 63.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.126 1.528 . . . . 9.0399999999999991 115.126 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.61 -12.37 52.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 114.429 0.532 . . . . 9.0399999999999991 114.429 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.32 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.545 0.672 . . . . 9.0399999999999991 111.068 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' B' ' 52' ' ' GLU . 0.0 OUTLIER -112.27 146.18 38.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.07 -0.514 . . . . 9.0399999999999991 110.506 179.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . 0.417 ' N ' ' HG ' ' B' ' 23' ' ' LEU . . . -174.74 -176.06 42.75 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.666 -0.778 . . . . 9.0399999999999991 113.017 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -113.5 160.47 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 112.51 0.559 . . . . 9.0399999999999991 112.51 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 6.2 p90 -125.19 148.49 60.79 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.563 -0.744 . . . . 9.0399999999999991 110.976 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.545 ' HD3' ' CZ ' ' B' ' 15' ' ' TYR . 89.2 Cg_endo -79.05 123.24 5.59 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.035 2.49 . . . . 9.0399999999999991 115.369 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 52.32 43.55 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.553 1.316 . . . . 9.0399999999999991 114.553 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ASN . . . . . 0.636 HD21 ' N ' ' B' ' 58' ' ' ASN . 0.8 OUTLIER 60.52 93.55 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.692 1.367 . . . . 9.0399999999999991 114.692 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.27 12.8 35.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.748 -0.834 . . . . 9.0399999999999991 108.748 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.6 29.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 9.0399999999999991 111.622 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.46 126.99 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.501 -0.318 . . . . 9.0399999999999991 111.823 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.52 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 53.6 tt0 -59.37 140.69 55.87 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 110.167 -0.309 . . . . 9.0399999999999991 110.167 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.406 HG22 HD13 ' B' ' 63' ' ' ILE . 56.3 mt -101.63 -60.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 9.0399999999999991 110.705 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.149 -0.929 . . . . 9.0399999999999991 110.76 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.877 0.37 . . . . 16.5 111.011 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -79.24 149.03 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.837 -0.62 . . . . 13.859999999999999 110.544 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.0 pt -142.94 147.88 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 12.19 110.678 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -97.55 137.24 36.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 11.640000000000001 110.597 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.41 91.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.573 -0.529 . . . . 9.0399999999999991 109.573 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' A' ' 7' ' ' THR . 61.7 tttm -77.03 164.29 25.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.916 -0.584 . . . . 9.0399999999999991 111.425 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.411 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.8 m -143.57 159.43 42.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.427 -0.806 . . . . 9.0399999999999991 110.041 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 pp -62.31 -22.37 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 9.0399999999999991 111.37 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -81.75 -13.7 57.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.369 . . . . 9.0399999999999991 111.272 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.98 47.63 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.057 -0.592 . . . . 9.0399999999999991 112.468 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -93.59 111.31 22.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 9.0399999999999991 111.492 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.03 125.0 44.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.759 -0.655 . . . . 9.0399999999999991 110.134 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -117.01 142.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.384 . . . . 9.0399999999999991 111.215 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.9 p -97.79 139.12 34.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 9.0399999999999991 110.704 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD11 ' H ' ' A' ' 16' ' ' GLU . 59.3 tp -139.89 150.77 45.0 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.548 -0.296 . . . . 10.02 110.524 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.406 ' H ' HD11 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -111.92 106.31 14.97 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.569 -0.287 . . . . 12.19 111.373 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.65 113.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.216 -0.447 . . . . 14.73 111.299 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 14.6 mp0 -60.78 172.15 0.91 Allowed Pre-proline 0 N--CA 1.467 0.408 0 N-CA-C 112.89 0.7 . . . . 18.57 112.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 41.2 Cg_exo -59.45 -39.74 73.33 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.32 2.68 . . . . 19.890000000000001 113.251 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.9 p -61.61 -26.2 67.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.38 -0.373 . . . . 21.489999999999998 111.759 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.04 151.26 9.23 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.921 0.391 . . . . 18.559999999999999 111.646 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -95.24 149.46 21.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.837 -0.62 . . . . 20.149999999999999 110.841 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.6 mm -58.62 -37.66 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 17.16 111.1 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.63 -40.48 92.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.902 0.382 . . . . 19.989999999999998 109.995 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.99 -41.8 95.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.935 -0.575 . . . . 16.559999999999999 110.013 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.65 -47.22 82.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.994 -0.548 . . . . 14.390000000000001 110.464 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -60.55 -36.37 78.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.922 -0.581 . . . . 14.57 110.541 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.86 84.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.03 -0.532 . . . . 14.550000000000001 110.375 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -65.44 -49.81 67.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.926 -0.579 . . . . 14.15 110.028 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -57.55 -40.5 75.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.959 -0.564 . . . . 10.06 110.457 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -63.76 -30.09 71.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.037 -0.529 . . . . 15.880000000000001 111.025 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.59 -38.51 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 12.470000000000001 111.235 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.13 -59.93 2.06 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.087 0.403 . . . . 9.2300000000000004 112.087 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.8 -11.93 60.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.022 0.749 . . . . 9.5999999999999996 113.022 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.0 -17.71 4.51 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.537 -0.84 . . . . 12.199999999999999 114.213 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.5 pt -59.43 132.0 88.12 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 117.337 0.569 . . . . 11.27 112.043 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.79 144.38 38.94 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 14.23 112.231 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.88 -22.26 63.35 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.745 2.297 . . . . 14.34 112.374 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.59 -25.49 66.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 16.960000000000001 111.176 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -106.25 -13.11 15.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.358 -0.383 . . . . 14.449999999999999 111.42 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -73.59 132.8 43.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.12 0.486 . . . . 11.609999999999999 111.954 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.424 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 61.7 mtp180 -127.73 114.5 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.356 -0.838 . . . . 9.6099999999999994 109.156 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -101.3 122.16 43.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.836 0.351 . . . . 10.56 110.907 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -113.3 133.17 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.899 -0.591 . . . . 9.75 110.442 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -151.06 124.28 8.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 15.27 110.578 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.77 19.35 11.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 14.76 111.967 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.57 80.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.566 -0.826 . . . . 12.99 112.97 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.21 147.92 42.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.745 0.307 . . . . 17.59 110.729 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -81.88 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 14.970000000000001 110.3 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.4 133.23 48.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 14.81 111.183 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.87 126.75 35.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 21.0 110.515 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.34 -35.03 25.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.921 -0.581 . . . . 18.5 112.351 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.7 1.87 88.02 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.954 -0.641 . . . . 21.789999999999999 114.273 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.78 177.64 4.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.172 0.486 . . . . 24.890000000000001 110.977 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -122.4 158.7 29.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.333 -0.394 . . . . 21.530000000000001 110.952 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.6 mm? -52.24 -24.29 7.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 18.41 111.744 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 m -75.04 -25.56 58.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.629 0.252 . . . . 21.809999999999999 111.515 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.18 -41.8 96.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 23.140000000000001 111.123 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -94.75 10.43 35.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.304 -0.407 . . . . 19.370000000000001 111.665 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 56.37 42.91 27.06 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.062 0.458 . . . . 22.789999999999999 111.207 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.9 mt -85.49 104.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 18.120000000000001 111.198 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -91.56 178.03 6.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.14 -0.482 . . . . 21.52 111.313 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -60.5 155.29 18.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.987 -0.552 . . . . 19.190000000000001 111.585 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 60.51 33.46 20.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.843 -0.617 . . . . 16.920000000000002 111.364 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 p -92.04 157.61 16.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 15.09 110.649 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 t -113.74 124.4 52.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 11.93 110.712 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -115.89 119.41 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 10.94 110.4 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -77.99 120.87 23.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.381 -0.372 . . . . 9.0399999999999991 111.148 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.51 109.75 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 9.0399999999999991 111.273 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 19.4 t -92.44 123.72 44.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 9.0399999999999991 109.962 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.9 mt -123.49 131.47 53.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 9.0399999999999991 111.059 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 53.95 87.44 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.844 -0.616 . . . . 14.67 110.609 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.9 tp -87.03 87.2 7.4 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.155 -0.475 . . . . 13.68 110.722 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -81.55 -22.9 37.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 20.530000000000001 110.85 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.67 -110.91 0.56 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.898 -0.667 . . . . 17.34 112.118 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.418 -1.212 . . . . 17.600000000000001 112.414 179.707 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.854 0.359 . . . . 9.1500000000000004 110.899 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -165.69 116.98 1.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.943 -0.572 . . . . 10.77 109.533 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -133.38 102.64 5.61 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.661 -0.699 . . . . 9.0399999999999991 109.734 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . 0.429 ' H ' ' HB2' ' B' ' 64' ' ' SER . 20.0 m-85 -124.05 172.08 9.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 9.0399999999999991 110.745 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 35.1 m -142.27 149.09 39.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 9.0399999999999991 111.027 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -99.51 138.0 37.21 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.519 -0.309 . . . . 9.0399999999999991 110.456 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -78.54 123.46 27.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.497 -0.32 . . . . 9.0399999999999991 110.856 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.54 -21.31 19.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.331 0.493 . . . . 9.0399999999999991 112.331 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -145.84 155.01 52.11 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 117.954 0.343 . . . . 9.0399999999999991 111.409 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.11 136.42 26.99 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.518 2.145 . . . . 9.0399999999999991 112.728 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -137.96 127.68 25.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.889 -1.05 . . . . 9.0399999999999991 109.539 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.2 m -112.06 121.67 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 9.0399999999999991 111.322 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.85 143.71 48.74 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.744 -0.741 . . . . 9.0399999999999991 111.926 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.1 p -107.17 -18.63 13.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.519 . . . . 9.0399999999999991 110.825 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -119.49 159.11 24.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 9.0399999999999991 110.222 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.51 -30.65 71.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 9.0399999999999991 111.357 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.31 -5.88 59.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 9.0399999999999991 111.012 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -81.76 157.65 24.44 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.146 -0.479 . . . . 9.0399999999999991 110.988 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.539 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 2.7 mt -110.59 151.61 27.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.626 -0.509 . . . . 9.0399999999999991 109.626 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -115.72 129.23 56.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.328 -0.396 . . . . 9.0399999999999991 110.468 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.539 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 29.9 m-85 -130.6 133.8 46.46 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.263 0.468 . . . . 9.0399999999999991 112.263 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.458 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 97.7 mtt180 -104.04 175.24 5.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.763 -0.458 . . . . 9.0399999999999991 109.763 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -81.5 134.44 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 9.0399999999999991 110.006 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.17 50.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.925 -0.87 . . . . 9.0399999999999991 110.925 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.2 mm-40 -98.42 179.42 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.423 0.898 . . . . 9.0399999999999991 113.423 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -131.34 113.55 23.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.76 -1.564 . . . . 9.0399999999999991 111.233 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.472 HG12 ' CD1' ' B' ' 25' ' ' PHE . 42.6 mt -106.89 129.41 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 9.0399999999999991 110.677 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -89.96 127.27 36.0 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.894 -0.41 . . . . 9.0399999999999991 109.894 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.28 128.04 34.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.044 0.45 . . . . 9.0399999999999991 110.923 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.41 -48.97 6.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 9.0399999999999991 110.785 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 79.3 p -167.06 113.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 9.0399999999999991 111.983 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -69.32 5.11 1.39 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.907 -0.588 . . . . 9.0399999999999991 111.32 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -121.85 101.89 7.85 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 116.63 -0.259 . . . . 9.0399999999999991 110.305 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 30.5 p -112.33 -2.96 14.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.454 -0.339 . . . . 9.0399999999999991 111.752 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.03 -5.14 78.68 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.685 . . . . 9.0399999999999991 112.014 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -125.99 119.7 28.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 9.0399999999999991 110.39 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.56 132.46 53.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 9.0399999999999991 111.302 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.32 -0.46 85.53 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.9 -0.591 . . . . 9.0399999999999991 112.704 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -122.92 123.74 41.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.454 0.627 . . . . 9.0399999999999991 112.016 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' TRP . . . . . 0.539 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 19.4 m0 -109.66 165.15 11.9 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.477 -0.783 . . . . 9.0399999999999991 109.428 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -115.91 131.72 56.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.021 0.439 . . . . 9.0399999999999991 110.965 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.7 174.82 21.86 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.411 -0.813 . . . . 9.0399999999999991 111.717 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.05 133.36 52.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.291 0.567 . . . . 9.0399999999999991 110.364 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' B' ' 50' ' ' GLY . 11.8 tp -130.06 170.99 13.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.929 -1.032 . . . . 9.0399999999999991 109.675 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.478 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 60.3 m-20 -17.69 64.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.424 1.638 . . . . 9.0399999999999991 115.424 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 82.97 -10.4 57.87 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 114.732 0.653 . . . . 9.0399999999999991 114.732 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -118.93 143.39 47.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.544 0.672 . . . . 9.0399999999999991 111.099 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.05 142.85 46.08 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.055 -0.52 . . . . 9.0399999999999991 110.585 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.34 -179.19 41.1 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.943 -0.646 . . . . 9.0399999999999991 112.481 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 33.7 m -113.44 163.36 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 112.441 0.534 . . . . 9.0399999999999991 112.441 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 3.3 p90 -124.57 152.92 69.53 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.602 -0.726 . . . . 9.0399999999999991 110.92 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.45 122.88 4.69 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.93 2.42 . . . . 9.0399999999999991 115.683 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 50.95 44.51 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.983 1.105 . . . . 9.0399999999999991 113.983 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 60.0 92.92 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.125 1.157 . . . . 9.0399999999999991 114.125 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -103.38 15.97 27.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.723 -0.843 . . . . 9.0399999999999991 108.723 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.09 138.58 29.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.977 0.362 . . . . 9.0399999999999991 111.977 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.59 119.43 59.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.366 -0.379 . . . . 9.0399999999999991 111.445 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.571 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 63.5 tt0 -54.47 105.62 0.16 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.847 0.356 . . . . 9.0399999999999991 110.611 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 33.0 pt -86.61 -30.12 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 9.0399999999999991 110.733 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' SER . . . . . 0.429 ' HB2' ' H ' ' B' ' 8' ' ' TYR . 48.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.251 -0.88 . . . . 9.0399999999999991 110.696 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 66.2 mtm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.716 0.293 . . . . 16.5 110.775 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.08 147.02 28.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 13.859999999999999 110.863 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.2 pt -146.53 156.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 12.19 110.765 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -108.74 147.13 32.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.854 -0.612 . . . . 11.640000000000001 110.424 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.25 103.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.009 -0.542 . . . . 9.0399999999999991 110.587 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 7' ' ' THR . 85.6 tttt -78.33 164.51 24.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 9.0399999999999991 111.077 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.442 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 8.4 m -139.91 147.09 40.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 9.0399999999999991 109.823 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 71' ' ' LEU . 4.4 pp -60.67 -18.42 53.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.801 0.334 . . . . 9.0399999999999991 111.401 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.428 ' N ' HD13 ' A' ' 8' ' ' LEU . 69.4 p -73.89 -35.7 64.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 9.0399999999999991 110.531 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.43 -15.28 5.78 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.987 -0.552 . . . . 9.0399999999999991 112.607 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -83.16 136.62 34.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.388 0.514 . . . . 9.0399999999999991 112.388 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -115.68 124.53 51.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.283 -0.871 . . . . 9.0399999999999991 109.332 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.13 144.01 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.02 0.438 . . . . 9.0399999999999991 111.854 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -100.14 136.2 40.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.493 -0.776 . . . . 9.0399999999999991 110.737 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.3 153.14 52.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.841 0.353 . . . . 10.02 110.84 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -120.5 102.91 8.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.009 -0.541 . . . . 12.19 111.391 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -153.89 116.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 14.73 110.711 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 167.21 1.19 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.753 1.02 . . . . 18.57 113.753 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 21' ' ' ASP . 31.7 Cg_exo -60.12 -32.3 94.45 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.831 3.021 . . . . 19.890000000000001 114.08 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -77.87 31.18 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.762 0.315 . . . . 21.489999999999998 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 19' ' ' PRO . 9.5 t70 -115.23 129.89 56.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.317 -0.401 . . . . 18.559999999999999 110.942 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 70.6 p -68.89 145.95 53.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 20.149999999999999 111.278 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.454 HG12 ' HB3' ' A' ' 50' ' ' LEU . 1.1 mp -56.41 -35.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 17.16 110.755 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.48 -43.11 98.25 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 19.989999999999998 109.899 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -64.26 -39.63 94.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.973 -0.558 . . . . 16.559999999999999 109.931 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.105 -0.498 . . . . 14.390000000000001 110.036 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.94 -33.18 74.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.905 -0.588 . . . . 14.57 110.526 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.36 -34.1 76.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.066 -0.516 . . . . 14.550000000000001 110.217 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -71.36 -42.3 68.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 14.15 109.571 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.42 -47.97 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 115.866 -0.606 . . . . 10.06 109.741 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -58.42 -33.91 70.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 15.880000000000001 110.494 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.21 -33.71 76.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 12.470000000000001 110.931 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.11 -62.04 1.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 9.2300000000000004 112.165 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.7 -13.74 59.66 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.449 0.907 . . . . 9.5999999999999996 113.449 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 15.75 75.24 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.387 -0.911 . . . . 12.199999999999999 113.871 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -90.53 123.45 65.28 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 117.255 0.527 . . . . 11.27 110.932 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.9 138.82 87.52 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.723 2.282 . . . . 14.23 112.348 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.11 -30.29 88.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.521 2.147 . . . . 14.34 112.156 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.14 -20.61 66.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.779 -0.646 . . . . 16.960000000000001 111.074 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.61 -35.11 13.03 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.265 -0.425 . . . . 14.449999999999999 110.835 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -61.21 146.4 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 11.609999999999999 110.904 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 3.0 tpp180 -142.77 38.04 1.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 9.6099999999999994 111.296 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 42' ' ' ARG . 69.5 mt -20.83 127.59 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.727 1.01 . . . . 10.56 113.727 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 mm -114.95 136.33 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.183 -0.917 . . . . 9.75 109.734 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 81.7 t80 -138.7 123.75 19.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 15.27 111.276 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 13.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.545 0.572 . . . . 14.76 112.545 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.5 -29.34 9.16 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.829 -0.701 . . . . 12.99 113.191 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 49' ' ' GLN . 14.6 ptpt -70.27 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.941 0.37 . . . . 17.59 111.02 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.504 ' N ' ' HG3' ' A' ' 48' ' ' LYS . 30.3 tt0 -148.53 107.65 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.93 -0.767 . . . . 14.970000000000001 108.93 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' HB3' HG12 ' A' ' 23' ' ' ILE . 51.3 mt -57.75 127.22 30.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.875 0.695 . . . . 14.81 112.875 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.61 123.62 36.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.392 -0.822 . . . . 21.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -34.54 -61.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.713 -0.676 . . . . 18.5 112.168 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -47.96 -73.5 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 21.789999999999999 112.524 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 53' ' ' GLY . 31.0 mmt180 -34.24 163.2 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.366 0.876 . . . . 24.890000000000001 113.366 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.549 ' HG1' ' H ' ' A' ' 56' ' ' LEU . 8.8 t -115.1 165.28 13.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.211 -0.904 . . . . 21.530000000000001 111.278 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.549 ' H ' ' HG1' ' A' ' 55' ' ' THR . 91.0 mt -55.69 -38.46 69.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 18.41 111.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.0 -26.57 68.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.366 . . . . 21.809999999999999 111.383 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.59 -29.07 69.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 23.140000000000001 110.992 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.11 16.57 24.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 19.370000000000001 111.125 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.55 39.62 31.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.083 -0.508 . . . . 22.789999999999999 111.306 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -87.74 113.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 18.120000000000001 111.094 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -105.47 -165.42 1.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 21.52 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 22.5 pttp -68.16 162.72 24.21 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 19.190000000000001 111.255 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 55.99 32.37 19.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.933 -0.576 . . . . 16.920000000000002 111.252 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -91.56 138.48 31.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 15.09 110.712 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -98.99 122.46 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 11.93 111.146 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.1 mt -116.71 117.95 31.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 10.94 110.173 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -88.66 114.12 24.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 9.0399999999999991 111.831 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 45.8 mt -63.94 -172.13 0.06 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.958 -0.565 . . . . 9.0399999999999991 109.903 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 90.4 t -162.94 106.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.763 -0.458 . . . . 9.0399999999999991 109.763 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.456 ' HB2' HD21 ' A' ' 8' ' ' LEU . 5.6 mp -112.41 76.42 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.216 0.532 . . . . 9.0399999999999991 109.922 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -77.88 118.56 20.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.443 -0.799 . . . . 14.67 110.977 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 tp -111.0 -42.16 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.619 . . . . 13.68 110.348 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -116.03 -36.31 4.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 20.530000000000001 110.68 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.4 -59.52 0.02 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.931 -0.652 . . . . 17.34 112.81 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.456 -1.191 . . . . 17.600000000000001 112.71 -179.585 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.776 0.322 . . . . 9.1500000000000004 111.21 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -169.37 117.18 0.62 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.165 0.507 . . . . 10.77 110.133 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -123.08 113.94 19.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.37 -0.832 . . . . 9.0399999999999991 109.498 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -133.04 170.42 15.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.013 0.435 . . . . 9.0399999999999991 112.039 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.419 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 13.7 p -153.45 150.23 28.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.656 -0.702 . . . . 9.0399999999999991 111.036 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -102.5 138.2 39.73 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.384 -0.371 . . . . 9.0399999999999991 110.245 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 35.9 p -80.47 125.64 30.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 9.0399999999999991 111.825 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.1 -20.4 24.36 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.401 -0.363 . . . . 9.0399999999999991 111.448 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -149.26 158.0 38.87 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.739 0.304 . . . . 9.0399999999999991 111.468 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.21 140.34 24.77 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.736 2.291 . . . . 9.0399999999999991 112.88 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -136.0 130.97 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.377 -0.829 . . . . 9.0399999999999991 110.467 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 88.0 m -111.54 118.21 35.11 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.942 0.401 . . . . 9.0399999999999991 111.213 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.52 139.35 48.16 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.981 -0.628 . . . . 9.0399999999999991 112.127 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -107.19 -21.47 12.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.199 0.523 . . . . 9.0399999999999991 111.092 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -119.08 159.58 23.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.328 -0.851 . . . . 9.0399999999999991 110.011 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -64.41 -36.09 83.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 9.0399999999999991 111.505 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.75 -4.55 52.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 9.0399999999999991 110.817 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 150.58 29.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.038 -0.528 . . . . 9.0399999999999991 110.981 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.421 HD22 ' H ' ' B' ' 24' ' ' THR . 1.4 tt -100.07 137.48 38.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.526 -1.287 . . . . 9.0399999999999991 107.526 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' THR . . . . . 0.421 ' H ' HD22 ' B' ' 23' ' ' LEU . 89.5 m -114.55 123.9 50.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.745 -0.661 . . . . 9.0399999999999991 110.646 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -138.65 156.82 47.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.502 0.556 . . . . 9.0399999999999991 112.502 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -111.55 179.45 4.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.176 -0.305 . . . . 9.0399999999999991 110.176 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.93 143.55 31.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 9.0399999999999991 110.43 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.57 19.96 67.33 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.088 -0.805 . . . . 9.0399999999999991 111.088 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -98.15 179.11 4.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.517 0.932 . . . . 9.0399999999999991 113.517 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -132.37 116.6 29.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 113.557 -1.656 . . . . 9.0399999999999991 111.297 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.1 140.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 9.0399999999999991 111.152 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -91.38 127.55 36.86 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.397 -0.594 . . . . 9.0399999999999991 109.397 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tt -74.32 102.76 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 9.0399999999999991 110.636 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 31.9 mm -80.72 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 9.0399999999999991 111.243 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 89.1 p -157.86 120.28 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.098 0.777 . . . . 9.0399999999999991 113.098 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -65.18 -72.2 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.987 -0.552 . . . . 9.0399999999999991 109.911 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -44.8 100.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.099 -0.501 . . . . 9.0399999999999991 111.732 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 25.2 p -116.33 -3.69 11.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.964 -0.562 . . . . 9.0399999999999991 110.881 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.86 -7.6 76.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.978 -0.629 . . . . 9.0399999999999991 111.882 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -130.87 120.75 24.1 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.693 0.282 . . . . 9.0399999999999991 110.483 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.51 137.55 58.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 9.0399999999999991 110.878 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.808 -0.633 . . . . 9.0399999999999991 112.614 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.588 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 64.1 m95 -120.79 117.41 27.35 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.831 0.348 . . . . 9.0399999999999991 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -109.89 160.82 16.05 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.247 -0.649 . . . . 9.0399999999999991 109.247 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -116.09 129.56 56.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.894 0.378 . . . . 9.0399999999999991 110.389 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.37 175.63 22.24 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.731 -0.747 . . . . 9.0399999999999991 112.179 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -126.51 135.42 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.499 . . . . 9.0399999999999991 110.077 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.638 ' O ' ' N ' ' B' ' 50' ' ' GLY . 32.8 tp -128.53 170.16 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.31 -0.859 . . . . 9.0399999999999991 110.242 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.428 HD21 ' HG ' ' B' ' 48' ' ' LEU . 50.9 m-80 -18.3 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.403 1.631 . . . . 9.0399999999999991 115.403 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.69 -11.48 61.73 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 114.894 0.717 . . . . 9.0399999999999991 114.894 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -118.23 132.25 56.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.831 0.816 . . . . 9.0399999999999991 111.29 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.01 152.25 24.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.46 -0.57 . . . . 9.0399999999999991 109.46 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.11 -174.65 44.59 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.113 -1.041 . . . . 9.0399999999999991 113.353 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.24 149.75 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 110.398 -0.223 . . . . 9.0399999999999991 110.398 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -139.32 141.11 28.0 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.784 0.661 . . . . 9.0399999999999991 112.784 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.588 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.3 Cg_endo -95.19 175.17 1.06 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.444 3.429 . . . . 9.0399999999999991 111.511 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.408 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.1 m-20 79.57 -13.55 0.95 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.981 1.474 . . . . 9.0399999999999991 114.981 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.22 76.6 0.28 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.873 -0.788 . . . . 9.0399999999999991 108.873 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 13.1 m-85 -103.87 8.81 37.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.296 -0.865 . . . . 9.0399999999999991 112.268 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.419 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -133.84 138.98 45.95 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.292 0.478 . . . . 9.0399999999999991 112.292 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -113.53 136.16 50.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.882 -0.599 . . . . 9.0399999999999991 111.366 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.08 144.48 28.97 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 120.742 0.306 . . . . 9.0399999999999991 110.906 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 pt -137.9 -13.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.192 -0.458 . . . . 9.0399999999999991 111.087 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.272 -0.871 . . . . 9.0399999999999991 110.627 179.91 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.612 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 92.3 mtp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.853 0.359 . . . . 16.5 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -79.94 151.82 29.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 13.859999999999999 111.068 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.06 145.24 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.914 -0.585 . . . . 12.19 110.52 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -100.82 135.33 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 11.640000000000001 110.113 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 58.4 t -120.42 96.24 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.519 -0.549 . . . . 9.0399999999999991 109.519 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 7' ' ' THR . 86.5 tttt -76.3 164.02 26.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.816 -0.629 . . . . 9.0399999999999991 111.326 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.429 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 77.0 p -143.9 158.85 43.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 9.0399999999999991 110.268 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.529 ' HB3' ' HE1' ' B' ' 43' ' ' TRP . 4.0 pp -61.91 -24.59 67.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.535 . . . . 9.0399999999999991 111.219 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 p -78.59 -19.93 51.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.118 -0.492 . . . . 9.0399999999999991 111.205 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.37 13.39 33.19 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.089 -0.577 . . . . 9.0399999999999991 112.339 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.45 108.93 21.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.891 0.377 . . . . 9.0399999999999991 111.407 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.38 125.69 45.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 9.0399999999999991 110.128 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.433 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 31.2 pt -118.3 145.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.861 0.362 . . . . 9.0399999999999991 111.027 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 m -98.36 134.26 41.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 9.0399999999999991 111.213 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.44 149.75 49.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.098 -0.501 . . . . 10.02 110.369 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.47 98.88 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.31 -0.405 . . . . 12.19 110.701 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.88 -172.74 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.099 0.476 . . . . 14.73 111.816 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -143.14 159.25 56.53 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 18.57 110.276 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.612 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 Cg_endo -59.93 -31.72 94.08 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.584 2.189 . . . . 19.890000000000001 112.212 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.3 t -82.36 -21.36 35.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 21.489999999999998 111.504 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.91 150.92 9.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.7 0.286 . . . . 18.559999999999999 111.125 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.3 p -97.35 141.7 30.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 20.149999999999999 111.073 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mt -53.73 -32.02 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 17.16 111.466 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.91 -42.47 99.8 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.615 -0.513 . . . . 19.989999999999998 109.615 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -67.06 -36.16 81.43 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.752 -0.658 . . . . 16.559999999999999 110.133 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.2 t -57.59 -46.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.378 -0.374 . . . . 14.390000000000001 110.197 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.39 -37.76 84.6 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.039 -0.528 . . . . 14.57 110.451 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.05 86.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 14.550000000000001 110.432 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -64.68 -49.2 71.86 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.033 -0.531 . . . . 14.15 109.956 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.69 -40.75 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 10.06 110.368 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -61.4 -34.78 75.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.018 -0.537 . . . . 15.880000000000001 110.816 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.96 -36.26 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 12.470000000000001 111.329 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.23 -63.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.234 -0.439 . . . . 9.2300000000000004 112.025 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -78.4 -12.58 60.01 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.386 0.884 . . . . 9.5999999999999996 113.386 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.14 -12.5 12.26 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.294 -0.955 . . . . 12.199999999999999 113.38 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 tp -60.52 128.07 87.68 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.856 0.328 . . . . 11.27 111.565 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.06 137.2 26.04 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.623 2.215 . . . . 14.23 112.622 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.13 -29.0 73.15 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.026 2.484 . . . . 14.34 112.782 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.96 -24.85 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 16.960000000000001 111.271 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -108.54 -6.64 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 14.449999999999999 111.467 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -81.17 127.19 32.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.066 0.46 . . . . 11.609999999999999 111.984 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -121.24 112.53 18.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.466 -0.788 . . . . 9.6099999999999994 109.275 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.32 122.63 43.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.42 -0.355 . . . . 10.56 110.951 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mm -116.55 137.05 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.526 . . . . 9.75 110.983 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -155.86 127.57 7.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.772 -0.649 . . . . 15.27 110.541 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.5 17.12 10.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.934 -0.575 . . . . 14.76 111.767 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.96 -2.41 79.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 12.99 112.964 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -117.82 148.56 41.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.749 0.309 . . . . 17.59 110.777 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -81.91 131.34 35.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 14.970000000000001 110.196 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.9 mt -69.74 130.13 41.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.95 0.405 . . . . 14.81 111.288 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.565 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -86.84 126.19 34.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.62 . . . . 21.0 110.174 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -48.58 -40.35 27.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.551 0.574 . . . . 18.5 112.551 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.28 3.52 71.91 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.971 -0.633 . . . . 21.789999999999999 114.194 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 6.0 mmp_? -103.5 173.79 6.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.115 0.457 . . . . 24.890000000000001 110.881 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -118.99 160.84 21.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.872 0.368 . . . . 21.530000000000001 111.576 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.78 -34.04 37.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.015 -0.538 . . . . 18.41 111.395 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -69.31 -24.97 64.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.485 -0.325 . . . . 21.809999999999999 111.303 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.412 . . . . 23.140000000000001 111.065 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.565 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 92.6 m-85 -101.09 11.45 39.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.233 -0.44 . . . . 19.370000000000001 111.288 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 56.32 49.47 15.11 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.851 0.358 . . . . 22.789999999999999 111.184 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -92.09 108.27 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 18.120000000000001 110.882 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -92.81 -177.98 4.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 21.52 110.899 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.97 158.88 24.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.337 -0.392 . . . . 19.190000000000001 111.125 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 59.46 29.05 18.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.946 -0.57 . . . . 16.920000000000002 111.509 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.5 t -89.1 153.19 21.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.308 -0.405 . . . . 15.09 110.843 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 t -110.9 126.02 54.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 11.93 111.124 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.29 125.72 53.63 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.923 -0.58 . . . . 10.94 110.395 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -85.39 115.47 23.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.401 . . . . 9.0399999999999991 111.589 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.7 tp -94.17 105.83 17.81 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.903 -0.59 . . . . 9.0399999999999991 110.6 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -85.76 141.48 14.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.13 -0.486 . . . . 9.0399999999999991 110.885 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.0 mt -129.0 141.55 51.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.091 -0.504 . . . . 9.0399999999999991 111.006 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.473 ' HE ' ' N ' ' A' ' 72' ' ' ARG . 2.7 mmp_? 61.37 95.14 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.785 -0.643 . . . . 14.67 110.98 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.07 -27.84 64.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 13.68 110.988 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -63.46 112.26 2.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.222 -0.445 . . . . 20.530000000000001 110.165 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.98 -105.94 1.49 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.885 -0.674 . . . . 17.34 111.99 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.466 -1.186 . . . . 17.600000000000001 112.595 179.848 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.539 0.209 . . . . 9.1500000000000004 110.93 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.02 175.26 5.51 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.182 0.515 . . . . 10.77 111.028 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -101.79 134.56 44.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.345 -0.843 . . . . 9.0399999999999991 109.045 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.15 169.13 15.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.988 0.423 . . . . 9.0399999999999991 111.9 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.621 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 6.7 p -152.63 147.69 26.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 9.0399999999999991 110.478 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -100.19 141.3 33.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.434 -0.348 . . . . 9.0399999999999991 110.684 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 54.4 p -80.25 124.78 29.12 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.271 -0.422 . . . . 9.0399999999999991 111.743 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.24 -21.49 19.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.616 -0.265 . . . . 9.0399999999999991 111.05 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -151.3 156.61 35.08 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.607 0.241 . . . . 9.0399999999999991 110.83 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.68 140.58 29.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.549 2.166 . . . . 9.0399999999999991 113.112 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -136.59 128.7 29.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.085 -0.961 . . . . 9.0399999999999991 110.044 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 88.3 m -112.2 120.4 41.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.8 0.333 . . . . 9.0399999999999991 111.579 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.412 ' H ' ' HG1' ' B' ' 24' ' ' THR . . . -63.47 144.64 49.37 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.828 -0.701 . . . . 9.0399999999999991 111.93 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -107.56 -22.19 12.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.057 0.456 . . . . 9.0399999999999991 111.292 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.79 158.67 25.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.476 -0.784 . . . . 9.0399999999999991 109.941 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.82 -35.91 82.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 9.0399999999999991 111.438 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.3 -4.47 45.18 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.934 0.397 . . . . 9.0399999999999991 110.535 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.91 156.58 22.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.762 -0.653 . . . . 9.0399999999999991 110.44 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 tp -107.14 146.33 31.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.354 -0.98 . . . . 9.0399999999999991 108.354 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' THR . . . . . 0.412 ' HG1' ' H ' ' B' ' 17' ' ' GLY . 93.8 m -115.83 130.93 57.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.44 . . . . 9.0399999999999991 111.099 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.49 ' CD1' HG12 ' B' ' 31' ' ' ILE . 31.3 m-85 -131.56 139.02 49.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.169 0.433 . . . . 9.0399999999999991 112.169 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.499 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 8.3 mpt_? -108.32 176.85 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.873 -0.418 . . . . 9.0399999999999991 109.873 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -80.41 138.17 36.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 9.0399999999999991 110.163 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.79 20.38 58.09 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.027 -0.829 . . . . 9.0399999999999991 111.027 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 22.9 mm-40 -98.29 179.73 4.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.04 0.924 . . . . 9.0399999999999991 113.391 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 mm -134.64 119.64 29.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 113.563 -1.653 . . . . 9.0399999999999991 110.707 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.621 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 39.5 mt -114.18 133.73 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.007 -0.542 . . . . 9.0399999999999991 111.591 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -93.43 126.68 38.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.384 -0.599 . . . . 9.0399999999999991 109.384 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 tt -74.37 102.77 4.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 9.0399999999999991 110.528 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mm -81.56 -64.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.498 -0.774 . . . . 9.0399999999999991 111.197 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' B' ' 45' ' ' LYS . 69.1 m -154.47 112.3 3.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.683 0.623 . . . . 9.0399999999999991 112.683 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.32 -72.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.979 -0.748 . . . . 9.0399999999999991 108.979 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -45.04 96.05 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.096 -0.502 . . . . 9.0399999999999991 111.381 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 4.5 t -112.08 -2.67 14.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.063 -0.517 . . . . 9.0399999999999991 111.077 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.18 0.41 67.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.993 -0.622 . . . . 9.0399999999999991 113.211 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -134.24 124.26 25.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.761 0.315 . . . . 9.0399999999999991 111.205 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.11 131.9 50.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 9.0399999999999991 111.035 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.16 -1.31 84.56 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.006 -0.616 . . . . 9.0399999999999991 112.588 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.529 ' HE1' ' HB3' ' A' ' 8' ' ' LEU . 69.5 m95 -117.76 135.3 54.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.188 0.518 . . . . 9.0399999999999991 111.543 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -123.51 155.42 37.58 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.086 -0.961 . . . . 9.0399999999999991 109.033 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' B' ' 35' ' ' SER . 23.9 ttmm -113.45 130.35 56.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.908 0.385 . . . . 9.0399999999999991 110.644 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.36 176.47 21.36 Favored Glycine 0 N--CA 1.453 -0.18 0 CA-C-N 115.73 -0.668 . . . . 9.0399999999999991 112.056 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.39 135.02 51.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 9.0399999999999991 110.414 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 50' ' ' GLY . 21.2 tp -130.12 170.02 14.58 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.332 -0.849 . . . . 9.0399999999999991 110.109 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.542 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 55.9 m-80 -17.88 65.19 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.401 1.63 . . . . 9.0399999999999991 115.401 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.33 -12.95 57.3 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.776 0.67 . . . . 9.0399999999999991 114.776 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -116.31 135.5 53.82 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.767 0.784 . . . . 9.0399999999999991 111.19 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -108.81 152.95 24.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.117 -0.492 . . . . 9.0399999999999991 109.853 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.18 -176.15 46.7 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.416 -0.897 . . . . 9.0399999999999991 112.808 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.57 154.88 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.468 0.175 . . . . 9.0399999999999991 110.571 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 46.5 p90 -141.49 140.18 20.05 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 112.755 0.65 . . . . 9.0399999999999991 112.755 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 55' ' ' PHE . 96.7 Cg_endo -94.61 174.72 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.457 3.438 . . . . 9.0399999999999991 110.637 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.464 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 79.75 -14.14 0.88 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.913 1.449 . . . . 9.0399999999999991 114.913 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 57.3 76.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.016 -0.735 . . . . 9.0399999999999991 109.016 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 19.5 m-85 -101.66 6.46 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 9.0399999999999991 111.948 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.1 139.01 40.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.466 0.543 . . . . 9.0399999999999991 112.466 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.28 130.53 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 9.0399999999999991 111.32 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -55.43 128.99 36.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.887 0.375 . . . . 9.0399999999999991 111.092 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -88.4 -61.01 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.965 -0.561 . . . . 9.0399999999999991 110.373 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.428 -0.796 . . . . 9.0399999999999991 110.69 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' CA ' ' A' ' 63' ' ' LYS . 45.5 tpp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.829 0.347 . . . . 16.5 110.92 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -82.03 145.62 30.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 13.859999999999999 110.91 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -147.59 151.69 13.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 12.19 111.008 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.21 146.1 34.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 11.640000000000001 110.89 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 50.9 t -136.52 97.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 9.0399999999999991 110.306 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.37 133.37 36.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 9.0399999999999991 111.439 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.7 m -106.89 152.43 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 9.0399999999999991 110.374 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.403 HD13 ' CD1' ' B' ' 43' ' ' TRP . 40.7 tp -56.45 -36.64 69.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 9.0399999999999991 111.073 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -56.47 -36.11 68.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.056 -0.52 . . . . 9.0399999999999991 111.209 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.29 8.62 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.068 -0.515 . . . . 9.0399999999999991 112.351 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -100.16 124.79 45.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.942 0.401 . . . . 9.0399999999999991 112.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -101.37 134.33 44.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.756 -0.656 . . . . 9.0399999999999991 109.365 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.427 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 23.0 pt -119.72 143.67 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 9.0399999999999991 111.623 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.6 p -101.32 137.62 39.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.484 -0.78 . . . . 9.0399999999999991 110.952 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 mp -137.85 160.85 38.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.268 -0.423 . . . . 10.02 110.526 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.52 103.04 7.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 12.19 110.771 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.03 113.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.303 -0.408 . . . . 14.73 111.382 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 41.3 mt-10 -50.5 166.84 0.27 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.416 0.895 . . . . 18.57 113.416 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' CD ' ' HB3' ' A' ' 18' ' ' GLU . 28.7 Cg_exo -64.14 -33.62 60.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.442 2.761 . . . . 19.890000000000001 113.279 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -20.12 64.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.546 -0.297 . . . . 21.489999999999998 111.752 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.16 147.32 53.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 18.559999999999999 111.716 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.478 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 67.2 p -88.83 152.98 21.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.932 -0.576 . . . . 20.149999999999999 110.707 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.6 mm -57.07 -36.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.459 -0.337 . . . . 17.16 111.036 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -46.39 80.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 19.989999999999998 110.156 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.9 OUTLIER -58.71 -42.84 89.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.863 -0.608 . . . . 16.559999999999999 110.303 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.18 -41.64 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 14.390000000000001 110.524 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.52 -28.69 70.03 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.286 -0.415 . . . . 14.57 110.599 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.37 70.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 14.550000000000001 109.843 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -67.71 -46.24 72.78 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.831 -0.622 . . . . 14.15 109.48 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -61.49 -38.73 80.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.884 -0.598 . . . . 10.06 110.113 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -66.88 -32.28 73.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 15.880000000000001 110.697 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.99 -38.49 82.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 12.470000000000001 111.234 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -88.99 -51.18 5.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.265 0.469 . . . . 9.2300000000000004 112.265 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.53 -10.87 47.41 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.487 0.921 . . . . 9.5999999999999996 113.487 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.59 -37.39 2.06 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.533 -0.841 . . . . 12.199999999999999 114.3 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 pt -45.84 124.48 6.48 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 112.133 0.42 . . . . 11.27 112.133 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.68 144.48 89.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.969 2.446 . . . . 14.23 112.881 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.61 -28.31 82.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.84 2.36 . . . . 14.34 112.583 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.3 -27.51 68.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 16.960000000000001 111.359 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -100.3 -9.27 22.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.314 -0.403 . . . . 14.449999999999999 111.12 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -84.43 120.92 26.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 11.609999999999999 112.113 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -118.25 117.01 27.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.56 -0.746 . . . . 9.6099999999999994 109.101 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.58 122.61 46.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.961 0.41 . . . . 10.56 111.963 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.534 ' CG1' ' HB3' ' A' ' 68' ' ' HIS . 40.6 pt -111.03 127.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.639 -0.71 . . . . 9.75 110.439 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -129.48 120.52 25.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.489 -0.778 . . . . 15.27 110.795 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.35 19.69 9.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.615 . . . . 14.76 112.272 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.7 5.64 62.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.588 -0.815 . . . . 12.99 113.127 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 144.39 47.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.589 0.233 . . . . 17.59 110.491 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.14 140.46 37.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.235 -0.283 . . . . 14.970000000000001 110.235 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.27 133.57 34.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.456 -0.338 . . . . 14.81 110.684 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.56 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 38.0 mt-10 -90.1 127.13 36.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 21.0 111.336 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -40.39 -51.38 2.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.793 -0.639 . . . . 18.5 111.373 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.71 -78.23 0.14 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.487 -0.863 . . . . 21.789999999999999 111.237 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -26.77 152.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.558 0.947 . . . . 24.890000000000001 113.558 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.4 p -107.05 164.09 12.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.194 -0.912 . . . . 21.530000000000001 111.256 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -53.08 -39.19 63.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 18.41 111.241 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 m -61.63 -28.58 69.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 21.809999999999999 111.352 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.06 -38.31 90.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 23.140000000000001 111.055 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.56 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 68.9 m-85 -96.05 12.54 30.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.443 . . . . 19.370000000000001 111.672 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 57.97 43.2 21.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.998 0.428 . . . . 22.789999999999999 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.7 mt -92.79 119.6 40.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.136 -0.484 . . . . 18.120000000000001 111.19 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -113.55 -170.43 1.69 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.256 -0.429 . . . . 21.52 111.491 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' CA ' ' SD ' ' A' ' 1' ' ' MET . 83.1 tttt -62.78 157.74 20.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.09 -0.505 . . . . 19.190000000000001 111.454 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 59.88 28.72 18.26 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.782 -0.645 . . . . 16.920000000000002 111.784 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -89.77 143.86 26.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.447 -0.342 . . . . 15.09 110.827 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -99.39 134.8 41.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 11.93 111.205 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.33 113.55 13.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.019 -0.537 . . . . 10.94 111.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.534 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 38.9 t-80 -83.62 119.32 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.999 0.428 . . . . 9.0399999999999991 110.487 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.9 tp -95.25 121.3 36.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 9.0399999999999991 110.777 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 t -103.23 133.64 46.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.898 -0.592 . . . . 9.0399999999999991 110.527 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.48 125.14 45.18 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.495 -0.321 . . . . 9.0399999999999991 111.378 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 50.31 100.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.979 -0.555 . . . . 14.67 112.072 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 74' ' ' ARG . 1.7 pt? -53.06 -51.67 61.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 13.68 111.059 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' N ' ' HG ' ' A' ' 73' ' ' LEU . 97.9 mtt180 54.19 20.52 2.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.507 -0.315 . . . . 20.530000000000001 111.165 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.53 9.38 10.28 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.049 -0.523 . . . . 17.34 111.927 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.361 -1.244 . . . . 17.600000000000001 112.264 -179.763 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.426 0.155 . . . . 9.1500000000000004 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -112.67 175.63 5.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.102 0.477 . . . . 10.77 110.775 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -103.02 133.49 48.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.449 -0.796 . . . . 9.0399999999999991 109.105 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -128.4 165.1 21.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.185 0.517 . . . . 9.0399999999999991 111.91 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 26.2 p -145.77 148.15 32.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.187 -0.915 . . . . 9.0399999999999991 110.762 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -99.13 143.12 29.76 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.391 -0.368 . . . . 9.0399999999999991 110.684 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -86.66 124.18 32.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.083 -0.508 . . . . 9.0399999999999991 111.33 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -94.73 -21.13 18.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.223 0.453 . . . . 9.0399999999999991 112.223 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' B' ' 14' ' ' PRO . 79.6 t80 -145.68 140.9 16.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.886 0.328 . . . . 9.0399999999999991 111.886 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 13' ' ' PHE . 36.7 Cg_exo -61.61 139.75 82.98 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.809 2.339 . . . . 9.0399999999999991 112.488 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.418 ' HH ' ' HG3' ' B' ' 56' ' ' PRO . 77.7 t80 -138.69 133.64 32.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.72 -0.673 . . . . 9.0399999999999991 111.288 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.479 ' HG1' HH12 ' B' ' 26' ' ' ARG . 68.9 m -111.65 119.13 37.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.426 . . . . 9.0399999999999991 110.754 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.82 139.08 48.61 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.887 -0.673 . . . . 9.0399999999999991 112.553 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 24.9 p -103.94 -23.46 13.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.181 0.515 . . . . 9.0399999999999991 110.705 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -120.38 154.6 34.87 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.197 -0.91 . . . . 9.0399999999999991 109.757 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.5 -39.66 92.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 9.0399999999999991 111.458 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.13 -4.8 34.97 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.908 0.385 . . . . 9.0399999999999991 110.589 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.2 158.82 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.973 -0.558 . . . . 9.0399999999999991 110.949 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.451 ' HB2' ' C ' ' B' ' 53' ' ' GLY . 3.6 tt -102.62 139.99 37.49 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.812 -0.811 . . . . 9.0399999999999991 108.812 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 98.6 m -112.38 123.88 51.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.531 -0.759 . . . . 9.0399999999999991 109.474 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -135.61 146.01 47.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.962 0.727 . . . . 9.0399999999999991 112.962 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.479 HH12 ' HG1' ' B' ' 16' ' ' THR . 31.9 mmt180 -109.56 178.29 4.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.116 -0.327 . . . . 9.0399999999999991 110.116 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -81.35 142.77 32.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 9.0399999999999991 110.328 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 20.23 61.72 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.878 -0.889 . . . . 9.0399999999999991 110.878 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.6 mm-40 -98.53 178.81 4.9 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.343 0.868 . . . . 9.0399999999999991 113.343 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 21.9 mm -136.05 116.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.648 -1.615 . . . . 9.0399999999999991 110.943 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.435 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 55.2 mt -112.35 137.84 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 9.0399999999999991 111.083 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' HIS . . . . . 0.466 ' O ' ' HA2' ' B' ' 46' ' ' GLY . 1.8 m-70 -92.51 128.19 38.27 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.326 -0.62 . . . . 9.0399999999999991 109.326 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 tt -73.81 102.26 3.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 9.0399999999999991 111.113 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.422 HD12 ' HB2' ' B' ' 47' ' ' GLU . 55.1 mt -81.1 -64.61 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.666 -0.697 . . . . 9.0399999999999991 111.098 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.0 t -154.12 116.7 4.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 9.0399999999999991 112.286 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.459 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 52.3 mtpt -69.52 6.22 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.984 -0.553 . . . . 9.0399999999999991 111.398 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -121.61 98.46 5.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.593 0.235 . . . . 9.0399999999999991 110.64 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.427 HG22 ' HB2' ' B' ' 45' ' ' LYS . 48.1 p -108.07 -1.4 20.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.544 -0.298 . . . . 9.0399999999999991 111.423 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.83 -4.2 75.09 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.782 -0.723 . . . . 9.0399999999999991 111.565 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -129.31 121.49 27.61 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.385 0.274 . . . . 9.0399999999999991 110.65 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.87 133.28 55.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 9.0399999999999991 110.507 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.25 82.11 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.927 -0.654 . . . . 9.0399999999999991 112.387 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' B' ' 56' ' ' PRO . 86.3 m95 -120.35 122.32 40.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.053 0.427 . . . . 9.0399999999999991 111.443 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' TRP . . . . . 0.459 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 30.7 m0 -111.56 162.73 14.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.103 -0.703 . . . . 9.0399999999999991 109.103 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.427 ' HB2' HG22 ' B' ' 38' ' ' THR . 63.6 tttm -115.58 129.98 56.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.795 0.331 . . . . 9.0399999999999991 110.405 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' B' ' 32' ' ' HIS . . . -142.82 177.43 21.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.654 -0.784 . . . . 9.0399999999999991 112.359 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.422 ' HB2' HD12 ' B' ' 34' ' ' ILE . 36.5 tt0 -125.13 133.55 52.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.294 0.568 . . . . 9.0399999999999991 110.778 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.675 ' O ' ' N ' ' B' ' 50' ' ' GLY . 42.5 tp -127.45 169.96 13.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.987 -1.006 . . . . 9.0399999999999991 109.269 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.436 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 58.2 m-20 -17.92 64.45 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.256 1.576 . . . . 9.0399999999999991 115.256 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.71 -10.84 63.52 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 114.937 0.735 . . . . 9.0399999999999991 114.937 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.45 152.62 24.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.162 0.981 . . . . 9.0399999999999991 110.988 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 1.2 pm0 -125.73 142.15 51.65 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.948 -0.76 . . . . 9.0399999999999991 108.948 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . 0.451 ' C ' ' HB2' ' B' ' 23' ' ' LEU . . . -179.84 -171.27 42.57 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 120.254 -0.974 . . . . 9.0399999999999991 113.101 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 33.4 m -111.77 151.11 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 120.704 0.288 . . . . 9.0399999999999991 111.055 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 38.4 p90 -131.34 139.52 35.68 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 112.219 0.451 . . . . 9.0399999999999991 112.219 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.426 ' HB3' ' CZ2' ' B' ' 43' ' ' TRP . 94.4 Cg_endo -97.95 174.26 0.57 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.297 3.332 . . . . 9.0399999999999991 111.546 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.491 ' HB2' ' CD2' ' B' ' 59' ' ' PHE . 16.6 m-20 78.78 -10.68 1.31 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.49 1.293 . . . . 9.0399999999999991 114.49 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' B' ' 60' ' ' ALA . 15.8 m120 58.15 26.68 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 118.43 0.559 . . . . 9.0399999999999991 110.201 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' B' ' 57' ' ' ASP . 9.3 m-85 -56.64 3.97 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.201 0.815 . . . . 9.0399999999999991 113.201 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' B' ' 58' ' ' ASN . . . -129.47 138.87 51.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.225 0.454 . . . . 9.0399999999999991 112.225 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 128.06 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 9.0399999999999991 111.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -53.72 156.64 2.61 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 120.932 0.396 . . . . 9.0399999999999991 110.746 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.46 -32.71 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 9.0399999999999991 110.45 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 74.5 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.369 -0.824 . . . . 9.0399999999999991 110.529 179.75 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 tpp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.678 0.275 . . . . 16.5 110.835 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -84.7 142.37 29.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 13.859999999999999 110.794 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -145.42 151.43 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 12.19 110.712 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -109.93 145.48 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 11.640000000000001 110.795 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 m -136.27 106.4 5.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.184 0.516 . . . . 9.0399999999999991 110.678 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' A' ' 7' ' ' THR . 81.5 tttt -75.94 163.14 27.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 9.0399999999999991 111.076 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.45 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.3 m -137.43 142.16 41.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.681 -0.69 . . . . 9.0399999999999991 109.895 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.31 -21.86 16.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.453 -0.34 . . . . 9.0399999999999991 111.65 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.431 ' H ' HG21 ' A' ' 7' ' ' THR . 31.5 m -71.18 -39.37 71.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.397 -0.365 . . . . 9.0399999999999991 110.575 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.78 -1.95 5.97 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.076 -0.583 . . . . 9.0399999999999991 112.872 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -98.99 129.4 45.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.011 0.434 . . . . 9.0399999999999991 112.073 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -104.57 136.15 44.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.577 -0.738 . . . . 9.0399999999999991 109.448 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.0 152.72 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 9.0399999999999991 111.471 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -108.89 135.07 50.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 9.0399999999999991 110.425 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.4 tp -135.53 154.14 51.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.491 -0.322 . . . . 10.02 110.728 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.64 99.74 6.71 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.306 -0.406 . . . . 12.19 111.278 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -149.95 111.81 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.532 -0.303 . . . . 14.73 111.54 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -52.14 166.18 0.43 Allowed Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 114.176 1.176 . . . . 18.57 114.176 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.9 Cg_exo -60.16 -30.66 91.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.715 2.943 . . . . 19.890000000000001 113.864 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 m -80.95 32.92 0.32 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 21.489999999999998 111.552 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -118.7 126.9 52.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 18.559999999999999 110.896 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 77.1 p -64.71 148.87 50.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 20.149999999999999 111.151 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 54' ' ' ARG . 41.0 mm -58.51 -37.68 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 17.16 110.88 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 11.0 pt-20 -61.77 -40.52 95.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 19.989999999999998 110.091 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -64.16 -43.8 94.05 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.883 -0.599 . . . . 16.559999999999999 109.785 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.28 -41.07 88.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.884 -0.598 . . . . 14.390000000000001 110.434 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.89 -29.22 70.6 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.228 -0.442 . . . . 14.57 110.415 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.62 74.73 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.106 -0.497 . . . . 14.550000000000001 109.691 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -64.34 -47.62 78.67 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.586 -0.733 . . . . 14.15 109.559 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.46 -40.61 86.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 115.856 -0.611 . . . . 10.06 110.134 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -63.38 -30.38 71.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 15.880000000000001 110.909 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.19 -35.94 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 12.470000000000001 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -88.89 -58.97 2.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.114 -0.494 . . . . 9.2300000000000004 112.003 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -82.5 -11.43 58.49 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.396 0.887 . . . . 9.5999999999999996 113.396 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.36 -29.99 1.93 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.498 -0.858 . . . . 12.199999999999999 114.056 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.8 mm -50.09 124.72 17.69 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.994 0.397 . . . . 11.27 111.917 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.86 151.97 60.99 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.774 2.316 . . . . 14.23 112.341 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.09 -32.82 16.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.688 2.259 . . . . 14.34 112.114 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.84 -22.98 67.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.061 -0.518 . . . . 16.960000000000001 111.077 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -97.2 -18.06 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 14.449999999999999 110.86 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -78.73 124.17 27.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.046 0.451 . . . . 11.609999999999999 112.036 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.407 ' NH1' ' HE ' ' A' ' 72' ' ' ARG . 37.6 ttp180 -121.23 118.89 30.74 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.459 -0.941 . . . . 9.6099999999999994 108.459 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.56 127.96 50.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.142 0.496 . . . . 10.56 112.046 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.5 mm -115.49 120.33 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.273 -0.876 . . . . 9.75 110.474 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -130.12 119.46 23.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.031 -0.531 . . . . 15.27 111.028 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.95 18.33 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 14.76 112.097 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.7 1.84 63.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.603 -0.808 . . . . 12.99 112.989 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -117.36 143.49 45.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 17.59 110.893 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.83 131.83 35.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 14.970000000000001 110.719 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.22 134.72 36.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.921 0.391 . . . . 14.81 111.403 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 130.29 35.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.837 -0.62 . . . . 21.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 4.0 p30 -44.28 -49.34 9.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 18.5 111.214 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -58.79 -76.11 0.23 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.62 -0.8 . . . . 21.789999999999999 111.573 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' GLY . 60.7 mtp180 -28.55 156.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.584 0.957 . . . . 24.890000000000001 113.584 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.548 ' HG1' ' H ' ' A' ' 56' ' ' LEU . 9.3 t -110.9 164.1 13.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.061 -0.972 . . . . 21.530000000000001 110.506 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.548 ' H ' ' HG1' ' A' ' 55' ' ' THR . 92.7 mt -53.73 -36.57 62.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 18.41 111.629 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.7 t -62.34 -29.69 70.64 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.749 0.278 . . . . 21.809999999999999 111.749 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.33 -34.83 79.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.677 0.275 . . . . 23.140000000000001 110.945 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -93.77 4.71 53.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.472 . . . . 19.370000000000001 111.275 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 64.03 33.02 12.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.001 0.429 . . . . 22.789999999999999 110.897 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.8 mt -80.93 116.93 26.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.53 . . . . 18.120000000000001 111.582 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -107.4 -170.82 1.76 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.72 -0.673 . . . . 21.52 110.46 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.38 160.7 21.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.467 -0.333 . . . . 19.190000000000001 111.01 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.6 26.8 15.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.172 -0.467 . . . . 16.920000000000002 111.744 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 t -87.47 139.13 30.86 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.761 0.315 . . . . 15.09 111.09 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -100.03 129.15 46.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 11.93 110.975 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -127.36 114.89 18.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.125 -0.489 . . . . 10.94 110.783 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.96 122.32 25.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 9.0399999999999991 110.937 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.47 116.27 28.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.912 -0.585 . . . . 9.0399999999999991 110.335 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.49 139.24 30.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 9.0399999999999991 111.735 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -122.14 110.79 16.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.476 -0.784 . . . . 9.0399999999999991 110.037 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.407 ' HE ' ' NH1' ' A' ' 42' ' ' ARG . 35.8 mmt180 -96.6 112.75 24.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 14.67 110.82 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.18 -44.15 5.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.008 -0.542 . . . . 13.68 110.441 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -176.43 147.82 0.7 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.739 -0.664 . . . . 20.530000000000001 110.629 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.09 -30.63 5.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.923 -0.656 . . . . 17.34 112.918 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.374 -1.237 . . . . 17.600000000000001 112.659 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.757 0.313 . . . . 9.1500000000000004 110.964 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -156.85 118.05 3.72 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.033 -0.531 . . . . 10.77 109.627 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -126.2 106.4 9.52 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.685 -0.688 . . . . 9.0399999999999991 109.712 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.11 171.64 12.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.271 -0.422 . . . . 9.0399999999999991 111.558 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 36.6 m -148.03 151.17 35.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.865 -0.607 . . . . 9.0399999999999991 111.345 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -99.81 139.47 35.43 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.985 -0.376 . . . . 9.0399999999999991 109.985 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 60.3 p -83.28 121.81 27.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.42 -0.355 . . . . 9.0399999999999991 111.611 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.04 -20.85 23.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.552 -0.295 . . . . 9.0399999999999991 111.309 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -147.57 157.46 44.64 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 9.0399999999999991 111.13 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.76 140.77 26.57 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.665 2.243 . . . . 9.0399999999999991 112.71 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.419 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 66.9 t80 -136.71 129.91 31.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 9.0399999999999991 110.375 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -113.0 121.33 44.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 9.0399999999999991 111.52 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.43 ' H ' ' HG1' ' B' ' 24' ' ' THR . . . -64.29 145.61 49.73 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.822 -0.704 . . . . 9.0399999999999991 111.865 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -107.98 -21.75 12.69 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.038 0.447 . . . . 9.0399999999999991 111.255 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -118.61 162.35 18.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.539 -0.755 . . . . 9.0399999999999991 110.516 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.13 -27.94 66.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.897 -0.592 . . . . 9.0399999999999991 112.544 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.73 -53.28 6.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.553 -0.459 . . . . 9.0399999999999991 110.59 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -32.35 146.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.704 -0.68 . . . . 9.0399999999999991 112.167 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tt -98.27 141.41 31.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.288 -1.005 . . . . 9.0399999999999991 108.288 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' THR . . . . . 0.43 ' HG1' ' H ' ' B' ' 17' ' ' GLY . 95.9 m -113.96 122.9 48.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.84 -0.618 . . . . 9.0399999999999991 110.374 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.449 ' CG ' HD13 ' B' ' 31' ' ' ILE . 37.1 p90 -138.54 155.27 48.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.614 0.598 . . . . 9.0399999999999991 112.614 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.41 -179.86 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.222 -0.288 . . . . 9.0399999999999991 110.222 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.18 141.49 32.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 9.0399999999999991 110.177 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.87 58.94 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.736 -0.946 . . . . 9.0399999999999991 110.736 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' B' ' 30' ' ' ILE . 4.4 tt0 -99.29 179.28 4.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.23 0.826 . . . . 9.0399999999999991 113.23 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.564 ' H ' ' HG2' ' B' ' 29' ' ' GLU . 30.3 mm -135.86 115.33 16.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.877 -1.51 . . . . 9.0399999999999991 110.979 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.449 HD13 ' CG ' ' B' ' 25' ' ' PHE . 51.5 mt -114.49 145.88 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 9.0399999999999991 111.166 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -97.43 129.22 44.67 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.514 -0.55 . . . . 9.0399999999999991 109.514 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.11 110.62 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 9.0399999999999991 111.172 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -84.11 -58.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 9.0399999999999991 111.264 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 70.6 m -158.92 121.43 3.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.32 0.489 . . . . 9.0399999999999991 112.32 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.08 6.38 2.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.915 -0.584 . . . . 9.0399999999999991 111.435 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.9 105.82 10.69 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.767 -0.197 . . . . 9.0399999999999991 110.558 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.417 HG23 ' HB2' ' B' ' 45' ' ' LYS . 28.0 p -115.0 -3.3 12.65 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.806 0.299 . . . . 9.0399999999999991 111.806 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.8 -9.04 77.69 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.759 -0.734 . . . . 9.0399999999999991 112.233 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.73 118.69 30.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.698 0.285 . . . . 9.0399999999999991 110.513 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.2 130.55 46.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 9.0399999999999991 111.229 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 2.41 79.72 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.881 -0.599 . . . . 9.0399999999999991 112.461 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.429 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 68.3 m95 -120.39 126.39 50.35 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.052 0.453 . . . . 9.0399999999999991 112.023 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -110.85 165.08 12.14 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.589 -0.893 . . . . 9.0399999999999991 108.589 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.417 ' HB2' HG23 ' B' ' 38' ' ' THR . 36.5 ttpt -119.86 129.95 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.956 0.408 . . . . 9.0399999999999991 110.874 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.23 175.41 20.93 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.566 -0.743 . . . . 9.0399999999999991 112.126 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -134.55 134.34 41.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 9.0399999999999991 110.366 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 50' ' ' GLY . 52.5 tp -123.97 133.23 53.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 9.0399999999999991 109.029 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -22.03 80.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.143 1.164 . . . . 9.0399999999999991 114.143 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 125.24 -50.85 0.85 Allowed Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.57 -0.741 . . . . 9.0399999999999991 114.753 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -112.06 153.87 26.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.998 0.899 . . . . 9.0399999999999991 112.127 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.41 142.14 51.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.205 -0.907 . . . . 9.0399999999999991 108.591 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.78 -176.08 41.96 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.086 -1.054 . . . . 9.0399999999999991 113.245 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -112.85 152.91 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.576 0.227 . . . . 9.0399999999999991 111.047 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 51.7 p90 -135.68 140.36 33.56 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.612 0.597 . . . . 9.0399999999999991 112.612 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 64.6 Cg_endo -96.16 175.05 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.657 3.572 . . . . 9.0399999999999991 110.976 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.527 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 3.2 m-20 77.34 -12.45 1.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.184 1.55 . . . . 9.0399999999999991 115.184 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . 0.466 ' C ' HD21 ' B' ' 58' ' ' ASN . 0.2 OUTLIER 58.19 75.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.424 -0.954 . . . . 9.0399999999999991 108.424 -177.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 17.3 m-85 -102.96 6.62 39.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.276 -0.874 . . . . 9.0399999999999991 112.211 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.57 139.01 43.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.479 0.548 . . . . 9.0399999999999991 112.479 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.84 130.0 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.942 -0.572 . . . . 9.0399999999999991 111.561 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.463 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 8.9 tp-100 -54.19 112.68 1.02 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.738 0.304 . . . . 9.0399999999999991 110.527 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 pt -90.6 -31.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 9.0399999999999991 110.933 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.356 -0.83 . . . . 9.0399999999999991 110.586 -179.827 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.823 0.344 . . . . 16.5 110.822 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.63 141.94 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 13.859999999999999 110.583 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.02 149.81 15.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.414 -0.357 . . . . 12.19 110.975 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -103.98 152.37 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 11.640000000000001 111.156 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.76 101.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.772 -0.649 . . . . 9.0399999999999991 109.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -89.43 133.56 34.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.182 0.438 . . . . 9.0399999999999991 112.182 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -103.15 160.0 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 9.0399999999999991 111.158 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 9' ' ' THR . 3.8 pp -64.78 -24.72 67.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.047 -0.524 . . . . 9.0399999999999991 111.178 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.436 ' N ' HD12 ' A' ' 8' ' ' LEU . 77.1 p -67.79 -35.88 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.288 -0.415 . . . . 9.0399999999999991 110.985 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.69 3.64 7.68 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.109 -0.567 . . . . 9.0399999999999991 112.675 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -99.65 126.64 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.275 0.472 . . . . 9.0399999999999991 112.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -101.07 133.67 45.24 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.712 -0.676 . . . . 9.0399999999999991 109.467 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 13' ' ' ILE . 4.6 mp -117.59 142.03 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 9.0399999999999991 111.68 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.717 -0.674 . . . . 9.0399999999999991 110.029 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.9 mt -134.58 155.22 50.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.525 -0.307 . . . . 10.02 110.959 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -123.0 99.82 6.57 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.199 -0.455 . . . . 12.19 111.028 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -153.04 115.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.542 -0.299 . . . . 14.73 111.731 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 43.6 mt-10 -51.46 168.77 0.25 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 113.867 1.062 . . . . 18.57 113.867 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 18' ' ' GLU . 16.7 Cg_exo -69.39 -23.19 32.76 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.572 2.848 . . . . 19.890000000000001 113.344 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -84.12 28.96 0.58 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.673 0.273 . . . . 21.489999999999998 111.546 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -116.58 139.83 50.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.428 -0.351 . . . . 18.559999999999999 110.839 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 p -73.76 151.37 40.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 20.149999999999999 111.41 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.25 -36.54 69.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.352 -0.386 . . . . 17.16 110.384 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -43.15 99.53 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.4 -0.593 . . . . 19.989999999999998 109.4 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -60.62 -43.21 97.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.789 -0.641 . . . . 16.559999999999999 110.081 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.57 -42.5 96.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.937 -0.574 . . . . 14.390000000000001 110.4 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.01 -28.7 69.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.125 -0.489 . . . . 14.57 110.421 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.89 71.68 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.59 -0.522 . . . . 14.550000000000001 109.59 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -62.93 -48.47 78.77 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.598 -0.728 . . . . 14.15 109.367 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.7 mt -61.1 -42.67 94.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.518 -0.764 . . . . 10.06 109.904 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -60.38 -28.41 68.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.602 -0.727 . . . . 15.880000000000001 110.833 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -75.74 -36.57 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 12.470000000000001 110.936 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.45 -64.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.05 -0.523 . . . . 9.2300000000000004 112.035 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -78.49 -8.36 58.46 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.719 1.007 . . . . 9.5999999999999996 113.719 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.66 26.96 67.45 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.388 -0.911 . . . . 12.199999999999999 113.416 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -98.27 118.59 63.31 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.799 0.299 . . . . 11.27 110.559 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.99 135.97 51.95 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.583 2.188 . . . . 14.23 112.219 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.79 -29.32 76.74 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.219 . . . . 14.34 112.046 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.1 -24.63 66.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.886 -0.597 . . . . 16.960000000000001 111.036 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -99.28 -16.3 18.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.025 -0.534 . . . . 14.449999999999999 110.979 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.411 ' HB3' HE21 ' A' ' 41' ' ' GLN . 21.8 mt-30 -80.03 123.8 28.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.005 0.431 . . . . 11.609999999999999 111.769 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.476 ' HB3' HG11 ' A' ' 70' ' ' VAL . 47.8 ttp180 -122.21 121.99 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.337 -0.986 . . . . 9.6099999999999994 108.337 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -106.11 129.69 54.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.024 0.44 . . . . 10.56 112.031 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.403 HD13 ' HD1' ' A' ' 68' ' ' HIS . 24.3 mt -116.17 121.03 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 9.75 110.52 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' N ' HD23 ' A' ' 50' ' ' LEU . 72.2 t80 -128.05 117.29 21.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 15.27 110.57 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.58 22.14 10.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 14.76 111.392 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -10.25 67.47 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.01 -0.614 . . . . 12.99 112.767 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.07 -163.04 0.08 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.244 0.218 . . . . 17.59 111.124 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 -13.51 6.59 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.711 1.004 . . . . 14.970000000000001 113.711 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 45' ' ' PHE . 2.2 mm? 58.5 106.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.788 0.328 . . . . 14.81 111.421 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.532 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 12.5 tp10 -92.13 130.23 37.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.337 -0.392 . . . . 21.0 111.601 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -40.23 -60.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.82 -0.627 . . . . 18.5 111.35 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -50.75 -75.49 0.21 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.529 -0.843 . . . . 21.789999999999999 111.552 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' GLY . 32.4 mmt180 -27.53 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 24.890000000000001 113.479 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.3 t -111.72 164.04 13.47 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.154 -0.93 . . . . 21.530000000000001 111.093 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.3 mm? -51.72 -44.29 63.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.344 -0.389 . . . . 18.41 111.2 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 t -58.33 -29.37 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.14 -0.482 . . . . 21.809999999999999 111.602 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.85 -35.6 81.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 23.140000000000001 110.892 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.532 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 91.9 m-85 -98.68 11.84 37.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 19.370000000000001 111.327 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 58.11 38.26 26.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.907 0.384 . . . . 22.789999999999999 111.317 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.32 115.96 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 18.120000000000001 110.864 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -109.35 -168.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.849 -0.614 . . . . 21.52 110.948 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.84 160.71 11.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 19.190000000000001 111.338 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 57.99 29.81 18.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.853 -0.612 . . . . 16.920000000000002 111.701 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.0 p -89.79 138.1 31.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 15.09 111.299 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.0 p -99.94 127.25 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 11.93 110.797 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -122.46 121.26 36.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.406 . . . . 10.94 110.884 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.403 ' HD1' HD13 ' A' ' 44' ' ' ILE . 28.0 t-80 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 9.0399999999999991 110.941 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.9 113.89 25.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 9.0399999999999991 110.244 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -118.7 143.45 29.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 9.0399999999999991 110.993 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 71' ' ' LEU . 2.2 mm? -105.0 148.15 27.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.919 -0.582 . . . . 9.0399999999999991 110.3 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HD3' ' CZ ' ' A' ' 42' ' ' ARG . 27.9 mmm180 -127.34 104.46 7.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 14.67 110.375 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.0 pt? -144.94 -150.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 13.68 110.226 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -55.14 92.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.034 0.445 . . . . 20.530000000000001 110.285 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.9 -157.41 22.4 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.754 -0.657 . . . . 17.34 112.13 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.396 -1.224 . . . . 17.600000000000001 112.501 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.136 0.493 . . . . 9.1500000000000004 110.951 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -171.2 124.98 0.63 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.375 -0.829 . . . . 10.77 109.863 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -127.95 104.55 7.86 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.763 -0.653 . . . . 9.0399999999999991 109.365 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.05 173.02 12.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 9.0399999999999991 111.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.401 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 7.5 p -148.23 151.69 35.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.7 -0.682 . . . . 9.0399999999999991 111.527 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -99.6 141.33 32.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.29 -0.414 . . . . 9.0399999999999991 110.033 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.412 ' HG1' ' H ' ' B' ' 29' ' ' GLU . 46.2 p -84.56 123.69 30.59 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.373 -0.376 . . . . 9.0399999999999991 111.557 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.81 -21.03 23.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 9.0399999999999991 110.514 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -148.53 156.25 42.08 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 9.0399999999999991 110.703 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.04 143.62 36.51 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.608 2.205 . . . . 9.0399999999999991 113.027 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.526 ' O ' ' CG ' ' B' ' 15' ' ' TYR . 11.9 t80 -130.58 68.67 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 9.0399999999999991 110.377 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 90.1 m -53.92 115.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 9.0399999999999991 110.707 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.61 140.01 47.16 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.772 -0.649 . . . . 9.0399999999999991 112.181 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -102.68 -24.37 13.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.148 0.499 . . . . 9.0399999999999991 110.925 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -119.11 165.14 14.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.491 -0.777 . . . . 9.0399999999999991 110.324 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.33 -38.61 78.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 9.0399999999999991 111.781 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.57 -6.01 43.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.884 0.373 . . . . 9.0399999999999991 110.6 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.99 162.63 15.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.779 -0.646 . . . . 9.0399999999999991 110.868 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 36.3 mt -108.47 150.8 26.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.197 -0.668 . . . . 9.0399999999999991 109.197 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 32.1 m -114.15 127.41 55.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 9.0399999999999991 110.155 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.557 ' CE1' HG12 ' B' ' 31' ' ' ILE . 50.3 m-85 -133.28 144.97 50.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.037 0.754 . . . . 9.0399999999999991 113.037 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.449 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 11.1 ptp180 -109.42 176.49 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.698 -0.853 . . . . 9.0399999999999991 108.698 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.27 126.41 31.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.65 0.738 . . . . 9.0399999999999991 109.921 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 26.2 7.14 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.347 -1.297 . . . . 9.0399999999999991 110.734 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 23.3 mm-40 -98.53 178.9 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.773 1.027 . . . . 9.0399999999999991 113.773 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 mm -135.95 116.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.557 -1.656 . . . . 9.0399999999999991 110.826 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.557 HG12 ' CE1' ' B' ' 25' ' ' PHE . 53.7 mt -108.36 132.21 56.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.044 -0.525 . . . . 9.0399999999999991 111.446 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -91.67 125.53 36.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.029 -0.73 . . . . 9.0399999999999991 109.029 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.82 100.67 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 9.0399999999999991 110.966 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 45.4 mm -82.73 -58.31 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 9.0399999999999991 110.972 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' SER . . . . . 0.424 ' C ' ' H ' ' B' ' 37' ' ' GLU . 66.8 m -157.18 105.89 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 9.0399999999999991 111.656 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.437 ' HB2' ' NZ ' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -66.66 5.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 9.0399999999999991 111.896 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' B' ' 35' ' ' SER . 10.6 tp10 -121.19 102.03 8.04 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 120.562 0.22 . . . . 9.0399999999999991 110.459 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.402 HG23 ' HB2' ' B' ' 45' ' ' LYS . 42.9 p -110.71 -4.66 15.24 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.488 -0.323 . . . . 9.0399999999999991 111.713 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.54 -1.2 71.89 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.967 -0.635 . . . . 9.0399999999999991 112.446 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -129.45 120.54 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.189 -0.3 . . . . 9.0399999999999991 110.189 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.03 132.74 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 9.0399999999999991 111.108 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 1.57 81.79 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.688 -0.687 . . . . 9.0399999999999991 112.394 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.61 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 53.6 m95 -120.78 123.15 41.94 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.937 0.398 . . . . 9.0399999999999991 111.731 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -112.93 161.43 17.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.062 -0.718 . . . . 9.0399999999999991 109.062 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.402 ' HB2' HG23 ' B' ' 38' ' ' THR . 64.1 tttp -116.07 130.56 56.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.09 0.471 . . . . 9.0399999999999991 111.216 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.54 175.45 21.22 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.407 -0.815 . . . . 9.0399999999999991 111.562 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.1 132.66 53.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.223 0.535 . . . . 9.0399999999999991 110.32 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.627 ' O ' ' N ' ' B' ' 50' ' ' GLY . 60.0 tp -124.87 169.22 12.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.219 -0.901 . . . . 9.0399999999999991 110.224 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.498 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 62.5 m-20 -18.62 67.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.283 1.586 . . . . 9.0399999999999991 115.283 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.98 -10.22 63.64 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.981 0.753 . . . . 9.0399999999999991 114.981 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -110.38 155.11 22.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.92 0.86 . . . . 9.0399999999999991 111.045 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.58 140.29 52.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.909 -0.774 . . . . 9.0399999999999991 108.909 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.8 -175.46 40.71 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.041 -1.076 . . . . 9.0399999999999991 113.455 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.21 150.02 15.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.451 0.167 . . . . 9.0399999999999991 111.076 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 50.6 p90 -134.97 140.45 35.06 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.049 0.452 . . . . 9.0399999999999991 112.167 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.61 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.6 Cg_endo -95.09 174.61 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.458 3.439 . . . . 9.0399999999999991 111.641 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.558 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 78.09 -12.83 1.03 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.255 1.576 . . . . 9.0399999999999991 115.255 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 14.9 m120 56.27 77.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.832 0.742 . . . . 9.0399999999999991 109.103 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.9 m-85 -101.87 6.84 41.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.382 -0.826 . . . . 9.0399999999999991 111.694 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.78 138.22 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.575 0.583 . . . . 9.0399999999999991 112.575 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.69 130.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.866 -0.606 . . . . 9.0399999999999991 111.77 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.417 HE22 ' C ' ' B' ' 64' ' ' SER . 0.0 OUTLIER -59.85 132.2 53.23 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.749 -0.463 . . . . 9.0399999999999991 109.749 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 24.7 pt -139.31 37.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.924 0.392 . . . . 9.0399999999999991 111.626 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' SER . . . . . 0.417 ' C ' HE22 ' B' ' 62' ' ' GLN . 30.4 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.23 -0.89 . . . . 9.0399999999999991 110.85 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.604 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 95.2 mtp . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.836 0.35 . . . . 16.5 110.786 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -81.55 151.75 27.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.821 -0.627 . . . . 13.859999999999999 110.786 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -143.7 146.75 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 12.19 110.341 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -95.82 139.17 32.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 11.640000000000001 110.503 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.32 91.33 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.45 -0.574 . . . . 9.0399999999999991 109.45 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.14 153.29 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.843 -0.617 . . . . 9.0399999999999991 111.678 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -133.6 159.82 39.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 9.0399999999999991 109.398 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.518 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 2.0 mm? -58.67 -37.95 77.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.944 0.402 . . . . 9.0399999999999991 110.761 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.9 m -61.14 -22.35 64.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.812 -0.631 . . . . 9.0399999999999991 111.262 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.36 17.66 21.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.079 -0.582 . . . . 9.0399999999999991 112.141 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -99.38 110.37 22.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.299 . . . . 9.0399999999999991 111.189 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -98.64 129.67 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 9.0399999999999991 110.028 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.96 144.67 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.954 0.406 . . . . 9.0399999999999991 111.285 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 p -96.6 136.54 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 9.0399999999999991 110.867 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 tp -137.64 151.47 48.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.317 -0.401 . . . . 10.02 110.284 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.96 105.24 13.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.63 -0.259 . . . . 12.19 111.474 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -152.83 112.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.436 0.532 . . . . 14.73 112.436 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.432 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 1.5 mp0 -56.63 172.89 0.33 Allowed Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 112.881 0.696 . . . . 18.57 112.881 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.604 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 30.1 Cg_exo -63.99 -37.47 43.2 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.42 2.746 . . . . 19.890000000000001 112.73 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -63.67 -25.55 68.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 21.489999999999998 111.541 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.4 147.59 25.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.472 -0.331 . . . . 18.559999999999999 111.188 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -93.89 145.51 24.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.059 -0.519 . . . . 20.149999999999999 110.948 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 50' ' ' LEU . 24.8 mt -55.93 -31.8 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 17.16 111.505 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.28 -38.68 90.28 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.943 -0.391 . . . . 19.989999999999998 109.943 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -69.84 -40.72 75.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.966 -0.561 . . . . 16.559999999999999 109.95 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.28 -49.79 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 115.977 -0.556 . . . . 14.390000000000001 110.355 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.07 -37.5 77.22 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.079 -0.509 . . . . 14.57 110.975 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.18 -38.28 87.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.294 -0.412 . . . . 14.550000000000001 110.944 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.59 -43.29 80.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.122 -0.49 . . . . 14.15 110.192 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.88 -36.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.143 -0.48 . . . . 10.06 109.772 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.427 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 59.0 tt0 -67.07 -29.17 68.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.898 -0.592 . . . . 15.880000000000001 111.164 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.3 -37.62 74.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 12.470000000000001 111.119 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -89.82 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.12 0.415 . . . . 9.2300000000000004 112.12 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -83.15 -9.44 59.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.112 0.782 . . . . 9.5999999999999996 113.112 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 62.54 25.02 66.64 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.427 -0.892 . . . . 12.199999999999999 113.208 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.1 mt -97.39 116.62 65.92 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.792 0.296 . . . . 11.27 110.829 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.95 138.71 70.07 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.698 2.266 . . . . 14.23 112.438 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.97 -22.7 55.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.585 2.19 . . . . 14.34 112.191 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.58 -25.28 66.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.535 . . . . 16.960000000000001 111.311 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -106.9 -5.48 18.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.368 -0.378 . . . . 14.449999999999999 111.572 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -88.95 127.0 35.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.948 0.404 . . . . 11.609999999999999 111.923 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 17.0 tpt180 -125.12 121.78 35.25 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.852 -0.796 . . . . 9.6099999999999994 108.852 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.4 mp -102.8 126.55 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 10.56 111.186 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.468 ' N ' HD11 ' A' ' 44' ' ' ILE . 3.6 mp -112.65 129.76 67.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 9.75 110.406 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -147.36 124.41 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 15.27 110.421 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.8 17.51 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 14.76 111.454 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.52 -3.62 81.79 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.786 -0.721 . . . . 12.99 112.593 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.22 150.32 32.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.778 0.323 . . . . 17.59 110.982 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -83.24 124.94 31.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 14.970000000000001 110.506 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 48.9 mt -64.7 131.65 47.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 14.81 111.109 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -90.31 127.29 36.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.996 -0.547 . . . . 21.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -41.45 34.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.599 -0.728 . . . . 18.5 112.301 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -0.12 83.79 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.982 -0.628 . . . . 21.789999999999999 114.208 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -99.69 173.95 6.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.044 0.422 . . . . 24.890000000000001 110.961 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.2 p -119.19 158.21 26.43 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.22 -0.445 . . . . 21.530000000000001 111.04 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 8.4 mp -52.97 -28.91 26.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 18.41 111.826 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 p -72.78 -21.77 60.94 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.735 0.303 . . . . 21.809999999999999 111.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.58 -42.37 87.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.193 -0.458 . . . . 23.140000000000001 110.958 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.2 10.18 32.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.251 -0.431 . . . . 19.370000000000001 111.579 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.81 24.27 11.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.48 0.548 . . . . 22.789999999999999 112.48 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -57.56 155.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.721 -0.474 . . . . 18.120000000000001 109.721 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -149.59 165.63 31.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.737 -0.468 . . . . 21.52 109.737 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -52.4 146.98 8.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 19.190000000000001 111.506 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.56 30.04 10.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.869 -0.605 . . . . 16.920000000000002 111.776 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.1 p -86.72 160.9 18.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 15.09 110.898 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.6 m -115.48 124.74 51.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 11.93 110.635 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.39 122.45 47.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.23 -0.441 . . . . 10.94 110.294 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -85.94 112.82 21.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 9.0399999999999991 111.078 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.56 118.12 31.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.009 -0.541 . . . . 9.0399999999999991 110.737 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 71' ' ' LEU . 39.5 t -140.72 166.57 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 9.0399999999999991 110.881 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' ' 70' ' ' VAL . 6.9 mp -93.86 128.6 40.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.359 -0.382 . . . . 9.0399999999999991 110.122 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.43 ' HG2' ' H ' ' A' ' 73' ' ' LEU . 36.7 ttt180 -72.42 -146.03 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.56 -0.291 . . . . 14.67 110.257 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' H ' ' HG2' ' A' ' 72' ' ' ARG . 85.9 mt -50.47 101.85 0.04 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.941 0.4 . . . . 13.68 110.444 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' C ' ' HD3' ' A' ' 74' ' ' ARG . 2.4 tmt_? -175.15 -48.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 20.530000000000001 109.866 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.83 -116.23 1.8 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.683 -0.689 . . . . 17.34 111.999 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.207 -1.33 . . . . 17.600000000000001 112.161 179.908 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.341 0.115 . . . . 9.1500000000000004 110.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.413 ' HB2' ' CE2' ' B' ' 8' ' ' TYR . 74.6 mmtt -111.43 176.66 4.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.294 0.568 . . . . 10.77 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.55 129.2 55.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.233 -0.894 . . . . 9.0399999999999991 109.383 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' B' ' 6' ' ' LYS . 90.3 m-85 -130.44 169.36 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.978 0.418 . . . . 9.0399999999999991 111.622 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.57 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 9.5 p -149.02 151.86 35.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 9.0399999999999991 111.114 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -99.22 143.38 29.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.211 -0.45 . . . . 9.0399999999999991 110.835 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 41.7 p -84.7 125.23 32.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.165 -0.47 . . . . 9.0399999999999991 111.84 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.54 -21.85 20.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.327 -0.397 . . . . 9.0399999999999991 111.379 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.26 160.64 59.08 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 120.714 0.292 . . . . 9.0399999999999991 111.622 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 26' ' ' ARG . 92.6 Cg_endo -81.23 71.61 6.88 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.86 2.373 . . . . 9.0399999999999991 113.619 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -64.58 127.65 32.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.042 -0.526 . . . . 9.0399999999999991 111.309 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 30.1 m -112.97 120.19 40.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.505 -0.316 . . . . 9.0399999999999991 111.39 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.09 138.41 47.87 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.962 -0.637 . . . . 9.0399999999999991 111.932 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.437 HG22 ' ND2' ' B' ' 19' ' ' ASN . 13.4 t -104.26 -24.58 13.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.936 0.398 . . . . 9.0399999999999991 111.536 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.437 ' ND2' HG22 ' B' ' 18' ' ' THR . 40.8 m-80 -116.37 162.88 16.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.785 -0.643 . . . . 9.0399999999999991 110.052 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.14 -41.05 86.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.211 -0.449 . . . . 9.0399999999999991 111.044 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.48 -4.89 36.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.088 0.47 . . . . 9.0399999999999991 109.961 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -83.34 156.87 22.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.53 -0.759 . . . . 9.0399999999999991 110.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.478 HD13 ' H ' ' B' ' 24' ' ' THR . 0.4 OUTLIER -107.11 146.61 31.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.803 -1.184 . . . . 9.0399999999999991 107.803 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' THR . . . . . 0.478 ' H ' HD13 ' B' ' 23' ' ' LEU . 53.3 m -111.83 128.08 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 9.0399999999999991 110.352 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.51 ' CD1' HG12 ' B' ' 31' ' ' ILE . 73.3 m-85 -128.02 128.62 45.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.323 0.49 . . . . 9.0399999999999991 112.323 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' B' ' 14' ' ' PRO . 24.4 mmm180 -100.58 174.37 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.285 -0.635 . . . . 9.0399999999999991 109.285 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.71 137.7 35.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.169 0.509 . . . . 9.0399999999999991 110.229 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.24 21.65 51.21 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.704 -0.958 . . . . 9.0399999999999991 110.704 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 21.6 mm-40 -99.36 -179.81 4.34 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.393 0.886 . . . . 9.0399999999999991 113.393 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.2 mm -135.07 118.7 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.83 -1.532 . . . . 9.0399999999999991 110.748 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.57 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 17.3 mt -112.23 136.74 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.911 -0.586 . . . . 9.0399999999999991 112.1 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -95.06 125.8 39.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.901 -0.777 . . . . 9.0399999999999991 108.901 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 tt -74.34 105.89 5.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 9.0399999999999991 111.622 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' B' ' 47' ' ' GLU . 75.5 mt -80.8 -65.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.577 -0.738 . . . . 9.0399999999999991 110.793 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -153.08 129.65 10.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.86 -0.609 . . . . 9.0399999999999991 111.929 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.407 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 48.9 mtpt -84.04 6.44 22.08 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.901 -0.591 . . . . 9.0399999999999991 111.535 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 94.84 4.46 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.224 -0.287 . . . . 9.0399999999999991 110.224 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 76.2 p -104.81 -1.96 25.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.413 -0.358 . . . . 9.0399999999999991 111.706 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.3 -3.18 72.15 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.974 -0.632 . . . . 9.0399999999999991 112.452 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -135.41 124.42 24.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.767 0.318 . . . . 9.0399999999999991 110.49 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.07 57.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 9.0399999999999991 110.881 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.59 2.38 82.2 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.639 -0.709 . . . . 9.0399999999999991 112.404 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.443 ' HE1' ' HG ' ' A' ' 8' ' ' LEU . 69.5 m95 -119.12 121.64 40.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.901 0.381 . . . . 9.0399999999999991 111.443 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' TRP . . . . . 0.407 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 36.5 m0 -113.07 168.57 9.59 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.813 -0.81 . . . . 9.0399999999999991 108.813 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -125.11 129.65 50.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 9.0399999999999991 110.704 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.11 174.69 21.79 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.812 -0.709 . . . . 9.0399999999999991 112.316 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.446 ' HB2' HD11 ' B' ' 34' ' ' ILE . 34.0 tt0 -125.7 133.25 52.2 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.225 0.536 . . . . 9.0399999999999991 110.728 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 50' ' ' GLY . 28.6 tp -127.93 171.18 12.04 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.184 -0.916 . . . . 9.0399999999999991 109.889 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.469 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 14.2 m120 -17.81 67.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.43 1.641 . . . . 9.0399999999999991 115.43 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.6 -10.02 63.26 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 115.128 0.811 . . . . 9.0399999999999991 115.128 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -109.94 154.41 23.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.15 0.975 . . . . 9.0399999999999991 111.197 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.68 140.79 51.86 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.996 -0.742 . . . . 9.0399999999999991 108.996 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.33 -176.03 42.38 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.012 -1.089 . . . . 9.0399999999999991 113.358 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.416 HG23 ' CZ3' ' B' ' 43' ' ' TRP . 29.9 m -113.82 152.72 15.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.432 0.158 . . . . 9.0399999999999991 110.985 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 52.3 p90 -136.56 141.02 33.95 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.384 0.513 . . . . 9.0399999999999991 112.384 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 95.2 Cg_endo -94.99 174.73 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.498 3.465 . . . . 9.0399999999999991 111.275 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.557 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 24.2 m-20 75.43 -11.01 1.15 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.079 1.511 . . . . 9.0399999999999991 115.079 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 56.33 76.63 0.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.829 -0.804 . . . . 9.0399999999999991 108.829 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.557 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.1 m-85 -100.9 8.27 43.2 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.16 -0.927 . . . . 9.0399999999999991 111.553 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.89 138.63 40.9 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.664 0.616 . . . . 9.0399999999999991 112.664 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -113.42 127.17 70.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 9.0399999999999991 111.296 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -54.47 108.23 0.36 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.851 0.358 . . . . 9.0399999999999991 110.503 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.29 -36.37 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 9.0399999999999991 110.934 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.38 -0.819 . . . . 9.0399999999999991 110.746 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.01 0.433 . . . . 16.5 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -84.22 149.9 25.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.822 -0.626 . . . . 13.859999999999999 110.537 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -144.04 149.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 12.19 110.692 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.34 136.32 42.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 11.640000000000001 110.479 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 40.8 t -121.19 96.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.574 -0.528 . . . . 9.0399999999999991 109.574 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 7' ' ' THR . 52.5 tttm -77.34 162.99 26.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.672 -0.694 . . . . 9.0399999999999991 111.527 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.436 ' HG1' ' H ' ' A' ' 11' ' ' LYS . 56.8 p -142.16 160.99 39.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.467 -0.788 . . . . 9.0399999999999991 110.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -64.33 -22.76 67.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 9.0399999999999991 111.175 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -81.82 -12.37 58.54 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.263 -0.426 . . . . 9.0399999999999991 111.618 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 16.69 41.79 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.886 -0.673 . . . . 9.0399999999999991 112.547 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' H ' ' HG1' ' A' ' 7' ' ' THR . 58.0 tptt -97.86 108.31 20.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.899 0.38 . . . . 9.0399999999999991 111.354 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 p -100.06 126.01 46.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 9.0399999999999991 110.256 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.415 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 36.1 pt -120.83 146.55 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.39 . . . . 9.0399999999999991 111.253 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.5 p -97.06 140.46 31.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.87 -0.605 . . . . 9.0399999999999991 111.123 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.2 tp -138.4 149.7 45.79 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.247 -0.433 . . . . 10.02 110.258 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -109.46 103.79 12.75 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.872 0.323 . . . . 12.19 111.872 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -153.83 112.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.268 -0.424 . . . . 14.73 111.615 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.506 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 25.0 mt-10 -63.71 173.32 1.35 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.708 0.633 . . . . 18.57 112.708 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' CD ' ' HB3' ' A' ' 18' ' ' GLU . 50.7 Cg_exo -57.98 -42.35 59.08 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.333 2.688 . . . . 19.890000000000001 113.741 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.0 m -60.42 -23.99 64.83 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.039 0.385 . . . . 21.489999999999998 112.039 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.31 148.48 32.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.845 0.355 . . . . 18.559999999999999 111.276 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 82.7 p -92.74 145.87 24.08 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.107 -0.497 . . . . 20.149999999999999 111.14 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.409 HD11 ' O ' ' A' ' 54' ' ' ARG . 1.1 mp -55.82 -34.49 37.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 17.16 111.205 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.2 -41.07 98.02 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.894 -0.41 . . . . 19.989999999999998 109.894 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.443 ' H ' ' HG1' ' A' ' 22' ' ' THR . 5.3 m-20 -66.22 -37.49 85.68 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.825 -0.625 . . . . 16.559999999999999 110.035 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 CA-C-N 116.152 -0.476 . . . . 14.390000000000001 110.037 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -58.61 -34.71 71.45 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.888 -0.597 . . . . 14.57 110.628 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 31' ' ' GLN . . . -68.23 -34.64 76.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 14.550000000000001 111.102 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -73.71 -38.46 64.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 14.15 110.383 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -65.01 -40.11 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 10.06 110.742 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 21.1 pt20 -69.72 -19.39 63.55 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.61 -0.268 . . . . 15.880000000000001 111.226 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -75.27 -35.33 61.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 12.470000000000001 110.467 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -93.1 -53.81 3.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.992 -0.549 . . . . 9.2300000000000004 112.021 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.69 -11.62 55.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.842 0.682 . . . . 9.5999999999999996 112.842 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 5.08 52.09 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.556 -0.83 . . . . 12.199999999999999 114.015 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.2 pt -79.82 128.91 72.67 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 117.355 0.578 . . . . 11.27 111.02 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.56 142.66 59.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.572 2.181 . . . . 14.23 112.738 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -24.66 64.74 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.881 2.387 . . . . 14.34 112.109 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.59 -24.9 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.894 -0.594 . . . . 16.960000000000001 111.142 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -108.59 -7.03 15.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.302 -0.408 . . . . 14.449999999999999 111.469 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -80.95 126.48 31.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 11.609999999999999 111.547 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -124.29 112.07 16.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 9.6099999999999994 109.327 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.4 mp -98.06 124.59 42.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 10.56 111.16 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.71 131.52 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.833 -0.621 . . . . 9.75 110.646 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -147.53 119.22 8.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.616 . . . . 15.27 110.439 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.35 29.97 9.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.993 -0.549 . . . . 14.76 112.154 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.37 -3.69 76.48 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.426 -0.892 . . . . 12.99 113.239 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -114.84 146.84 40.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.803 0.335 . . . . 17.59 111.116 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -82.49 128.75 34.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 14.970000000000001 110.381 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.76 130.62 43.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 14.81 110.995 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.48 123.89 33.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.927 -0.578 . . . . 21.0 111.017 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -36.26 -57.18 0.74 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.992 -0.549 . . . . 18.5 111.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -52.93 -75.04 0.24 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.771 -0.728 . . . . 21.789999999999999 112.019 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.409 ' O ' HD11 ' A' ' 23' ' ' ILE . 29.5 mmt180 -29.17 158.11 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.911 1.078 . . . . 24.890000000000001 113.911 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -111.4 165.72 11.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.087 -0.96 . . . . 21.530000000000001 111.322 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.5 mm? -53.42 -32.48 49.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.189 -0.46 . . . . 18.41 111.86 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -70.05 -21.7 63.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.653 0.263 . . . . 21.809999999999999 111.5 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.97 -38.45 86.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 23.140000000000001 111.041 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -97.91 8.47 44.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 19.370000000000001 111.615 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 59.3 46.96 12.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.954 0.407 . . . . 22.789999999999999 111.137 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.03 107.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 18.120000000000001 110.912 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.66 -178.87 5.19 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.016 -0.538 . . . . 21.52 110.936 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.55 157.06 33.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.835 0.35 . . . . 19.190000000000001 111.124 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.2 24.95 14.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.809 -0.632 . . . . 16.920000000000002 111.684 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -85.78 161.18 19.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.712 0.292 . . . . 15.09 110.814 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 t -116.73 126.85 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 11.93 110.84 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -115.27 121.48 43.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 10.94 110.164 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -83.96 112.47 20.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.944 0.402 . . . . 9.0399999999999991 111.778 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.4 tp -91.8 119.71 31.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 9.0399999999999991 109.62 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.67 169.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.241 0.544 . . . . 9.0399999999999991 112.346 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.65 134.47 50.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.277 -0.874 . . . . 9.0399999999999991 110.219 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -76.27 78.2 3.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 14.67 111.073 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' A' ' 75' ' ' GLY . 66.6 mt -121.81 68.86 0.92 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.112 -0.494 . . . . 13.68 110.77 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? 70.78 -18.06 0.27 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.912 -0.586 . . . . 20.530000000000001 111.6 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 73' ' ' LEU . . . -153.26 61.76 0.38 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.839 -0.696 . . . . 17.34 112.604 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.419 -1.212 . . . . 17.600000000000001 112.429 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.454 0.169 . . . . 9.1500000000000004 111.061 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.84 173.26 6.42 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.067 0.46 . . . . 10.77 110.753 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -102.21 130.94 49.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.834 -0.802 . . . . 9.0399999999999991 108.834 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -124.76 159.92 29.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 9.0399999999999991 111.828 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 16.8 m -141.14 146.35 36.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.186 -0.915 . . . . 9.0399999999999991 110.569 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -100.47 133.23 45.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 9.0399999999999991 110.199 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.3 m -73.85 127.13 32.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 9.0399999999999991 110.913 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.8 mt -95.87 -22.1 17.66 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.144 0.424 . . . . 9.0399999999999991 112.144 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -142.66 154.51 62.99 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 117.981 0.355 . . . . 9.0399999999999991 111.614 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.01 136.25 20.12 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.525 2.15 . . . . 9.0399999999999991 112.913 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.421 ' HH ' ' HG2' ' B' ' 22' ' ' GLU . 54.5 t80 -139.16 129.12 25.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 9.0399999999999991 109.883 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 31.8 m -110.84 121.35 45.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.85 0.357 . . . . 9.0399999999999991 110.617 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.73 128.76 43.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.98 -0.629 . . . . 9.0399999999999991 112.586 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 5.3 t -103.16 -23.07 13.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.182 0.515 . . . . 9.0399999999999991 110.63 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -119.89 159.41 24.7 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.123 -0.944 . . . . 9.0399999999999991 109.853 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.5 -29.13 69.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.386 0.513 . . . . 9.0399999999999991 112.386 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -86.53 -2.64 58.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.945 -0.302 . . . . 9.0399999999999991 111.682 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.421 ' HG2' ' HH ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -89.55 160.17 16.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 9.0399999999999991 111.281 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -117.24 165.46 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.246 -0.65 . . . . 9.0399999999999991 109.246 178.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 61.7 m -115.42 128.65 56.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 9.0399999999999991 110.187 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 10.8 m-85 -131.92 133.43 44.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.301 0.482 . . . . 9.0399999999999991 112.301 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.53 176.26 5.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.826 -0.435 . . . . 9.0399999999999991 109.826 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.21 136.68 35.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 9.0399999999999991 110.323 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.79 55.42 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.571 -0.74 . . . . 9.0399999999999991 111.318 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -100.13 179.72 4.4 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.877 1.066 . . . . 9.0399999999999991 113.877 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.49 136.11 60.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.781 -1.554 . . . . 9.0399999999999991 111.129 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 35.8 mt -132.86 133.09 59.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 9.0399999999999991 111.207 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -90.21 126.49 35.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.58 -0.526 . . . . 9.0399999999999991 109.58 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.405 ' C ' ' CD2' ' B' ' 33' ' ' LEU . 4.3 tt -73.47 102.08 3.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.995 0.426 . . . . 9.0399999999999991 111.149 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 23.5 mm -84.08 -61.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.765 -0.652 . . . . 9.0399999999999991 111.418 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' SER . . . . . 0.43 ' C ' ' H ' ' B' ' 37' ' ' GLU . 48.2 t -155.17 108.5 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.194 0.442 . . . . 9.0399999999999991 112.194 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -65.95 5.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.598 . . . . 9.0399999999999991 111.722 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' B' ' 35' ' ' SER . 0.0 OUTLIER -121.44 101.07 7.39 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.535 0.207 . . . . 9.0399999999999991 110.678 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 68.8 p -111.11 -4.38 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.449 -0.341 . . . . 9.0399999999999991 111.184 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.18 -1.77 62.99 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.018 -0.611 . . . . 9.0399999999999991 112.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.77 120.89 27.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.811 0.338 . . . . 9.0399999999999991 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.79 56.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 9.0399999999999991 110.962 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.63 1.56 85.41 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.826 -0.625 . . . . 9.0399999999999991 112.421 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -123.31 120.39 32.95 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.289 0.544 . . . . 9.0399999999999991 111.751 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' TRP . . . . . 0.541 ' HB2' ' CZ ' ' B' ' 55' ' ' PHE . 37.4 m0 -108.43 166.33 10.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.515 -0.766 . . . . 9.0399999999999991 109.494 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.427 ' HZ2' ' HA2' ' B' ' 53' ' ' GLY . 45.4 tptt -117.28 131.64 56.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.959 0.409 . . . . 9.0399999999999991 110.98 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.56 175.33 21.53 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.454 -0.794 . . . . 9.0399999999999991 111.752 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.61 134.75 50.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.196 0.522 . . . . 9.0399999999999991 110.629 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 50' ' ' GLY . 2.6 mt -130.9 171.73 12.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.105 -0.952 . . . . 9.0399999999999991 110.159 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.425 ' ND2' HD23 ' B' ' 48' ' ' LEU . 11.8 m-80 -17.35 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.127 1.529 . . . . 9.0399999999999991 115.127 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.54 -12.79 50.3 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 114.319 0.488 . . . . 9.0399999999999991 114.319 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.404 ' C ' HD22 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -123.07 133.79 54.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.314 0.557 . . . . 9.0399999999999991 111.337 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -107.11 146.72 30.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.958 -0.565 . . . . 9.0399999999999991 110.344 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' HZ2' ' B' ' 45' ' ' LYS . . . -166.51 -177.85 38.73 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.663 -0.78 . . . . 9.0399999999999991 112.855 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.99 160.51 12.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.453 0.538 . . . . 9.0399999999999991 112.453 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' B' ' 44' ' ' TRP . 3.0 p90 -124.79 157.49 65.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.375 -0.83 . . . . 9.0399999999999991 110.807 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.03 123.02 2.65 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.69 2.26 . . . . 9.0399999999999991 115.865 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p30 51.02 45.02 28.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.638 1.347 . . . . 9.0399999999999991 114.638 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 m120 62.7 88.64 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.772 1.027 . . . . 9.0399999999999991 113.772 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.1 16.26 27.1 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.908 -0.775 . . . . 9.0399999999999991 108.908 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.64 138.49 30.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.81 0.3 . . . . 9.0399999999999991 111.81 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.5 p -110.17 120.77 61.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 116.352 -0.385 . . . . 9.0399999999999991 111.323 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.445 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 34.1 tt0 -51.51 150.86 3.43 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 121.023 0.44 . . . . 9.0399999999999991 111.062 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.98 -37.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.671 . . . . 9.0399999999999991 110.403 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.237 -0.887 . . . . 9.0399999999999991 110.55 179.668 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttt . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.92 0.391 . . . . 16.5 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -82.93 152.7 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.587 . . . . 13.859999999999999 109.916 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 pt -145.32 150.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 12.19 110.249 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -102.73 135.15 44.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.189 -0.46 . . . . 11.640000000000001 110.691 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.37 99.4 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.327 -0.62 . . . . 9.0399999999999991 109.327 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.413 ' HG2' ' CG2' ' A' ' 12' ' ' THR . 6.7 tmtt? -86.81 111.78 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 9.0399999999999991 111.663 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.2 p -84.83 -178.48 6.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 9.0399999999999991 110.699 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp -85.93 -10.65 54.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.546 -0.297 . . . . 9.0399999999999991 111.68 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -97.29 21.06 10.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.928 0.394 . . . . 9.0399999999999991 110.684 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.62 13.09 65.26 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.911 -0.662 . . . . 9.0399999999999991 112.377 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -96.1 112.05 23.9 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.054 0.454 . . . . 9.0399999999999991 111.933 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.413 ' CG2' ' HG2' ' A' ' 6' ' ' LYS . 31.4 p -104.28 122.39 45.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.647 -0.706 . . . . 9.0399999999999991 110.012 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.1 pt -114.75 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.382 . . . . 9.0399999999999991 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.5 p -87.72 135.31 33.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 9.0399999999999991 110.36 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tp -134.67 146.45 49.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 10.02 110.556 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -102.67 130.92 49.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 12.19 110.498 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.76 -174.21 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.167 0.508 . . . . 14.73 111.575 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -138.97 145.95 47.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 18.57 109.044 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.09 -23.18 12.07 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.332 2.021 . . . . 19.890000000000001 112.709 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -87.85 -23.85 23.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 21.489999999999998 111.753 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.33 150.92 4.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.875 0.369 . . . . 18.559999999999999 111.656 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -96.49 140.71 30.73 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.931 -0.577 . . . . 20.149999999999999 111.259 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.7 mm -49.55 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.091 -0.504 . . . . 17.16 111.164 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.08 -41.06 78.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.87 0.367 . . . . 19.989999999999998 110.153 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -69.29 -35.55 76.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 16.559999999999999 110.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.05 -45.36 98.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.153 -0.476 . . . . 14.390000000000001 110.573 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -59.84 -37.19 78.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 14.57 110.826 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.01 66.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 14.550000000000001 110.82 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.21 -41.13 83.38 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.174 -0.676 . . . . 14.15 109.174 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.25 -37.79 79.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.353 -0.84 . . . . 10.06 110.546 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 60.2 tt0 -61.63 -33.97 74.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.024 -0.535 . . . . 15.880000000000001 110.84 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -56.86 -27.11 59.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 12.470000000000001 110.074 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -99.85 -71.03 0.71 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.861 -0.609 . . . . 9.2300000000000004 112.608 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.68 -10.98 60.25 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.537 0.569 . . . . 9.5999999999999996 112.537 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 63.26 7.29 17.78 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.595 -0.812 . . . . 12.199999999999999 113.305 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.5 pt -71.9 122.22 86.69 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.798 0.299 . . . . 11.27 111.017 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.56 142.76 70.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.405 2.07 . . . . 14.23 111.873 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.15 -25.32 43.55 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.712 2.275 . . . . 14.34 112.837 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.71 -23.62 66.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.918 0.71 . . . . 16.960000000000001 112.918 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -107.92 -5.62 17.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.612 . . . . 14.449999999999999 109.349 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -83.14 100.93 10.85 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.247 -0.888 . . . . 11.609999999999999 110.888 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.459 ' HE ' ' N ' ' A' ' 43' ' ' LEU . 6.4 tpm_? -100.35 113.58 26.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.485 -0.932 . . . . 9.6099999999999994 108.485 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' N ' ' HE ' ' A' ' 42' ' ' ARG . 61.9 mt -98.8 120.11 38.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.901 0.381 . . . . 10.56 110.887 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mm -109.43 137.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.681 -0.69 . . . . 9.75 110.367 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' CE2' HG12 ' A' ' 61' ' ' ILE . 62.5 t80 -156.47 132.34 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 15.27 111.182 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.72 6.23 2.58 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.837 -0.62 . . . . 14.76 111.87 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.41 -4.02 40.32 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.903 -0.665 . . . . 12.99 112.995 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -122.01 152.16 40.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.747 0.308 . . . . 17.59 110.663 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -81.43 119.98 24.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 14.970000000000001 110.574 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.85 128.81 38.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.321 -0.4 . . . . 14.81 110.5 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -81.08 124.97 29.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.323 -0.398 . . . . 21.0 109.986 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.47 -33.05 13.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.826 -0.624 . . . . 18.5 112.603 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.98 5.99 84.07 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.997 0.759 . . . . 21.789999999999999 114.997 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.516 ' HE ' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -105.55 173.04 6.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.672 0.736 . . . . 24.890000000000001 111.463 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -109.59 155.57 21.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.128 -0.487 . . . . 21.530000000000001 110.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.7 mt -53.97 -16.32 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 18.41 111.795 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -78.93 -26.01 43.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.647 0.26 . . . . 21.809999999999999 111.531 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.8 -36.98 84.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.39 -0.368 . . . . 23.140000000000001 110.765 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -99.44 12.23 36.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.155 -0.475 . . . . 19.370000000000001 111.878 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 m120 57.07 27.45 13.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.846 0.355 . . . . 22.789999999999999 111.416 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.427 HG12 ' CE2' ' A' ' 45' ' ' PHE . 98.1 mt -68.61 108.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.294 -0.412 . . . . 18.120000000000001 111.541 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.37 -179.54 4.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.207 -0.451 . . . . 21.52 111.108 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.37 156.77 28.17 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.949 0.404 . . . . 19.190000000000001 111.51 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 58.33 28.88 17.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.765 -0.652 . . . . 16.920000000000002 111.461 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 p -88.14 150.86 23.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 15.09 110.686 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.5 t -101.83 121.48 42.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 11.93 110.849 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -110.82 117.17 32.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 10.94 109.864 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -79.3 109.3 13.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 9.0399999999999991 112.074 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -92.55 115.12 27.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.076 -0.511 . . . . 9.0399999999999991 110.399 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.4 171.22 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 9.0399999999999991 111.466 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.4 tp -85.8 112.43 21.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 9.0399999999999991 110.381 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -55.56 170.43 0.25 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.226 -0.443 . . . . 14.67 110.4 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.4 mt -39.03 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.448 -0.342 . . . . 13.68 110.735 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -172.0 -30.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.042 -0.526 . . . . 20.530000000000001 110.538 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.12 148.06 19.42 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.18 -0.533 . . . . 17.34 112.392 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.504 -1.164 . . . . 17.600000000000001 112.557 -179.871 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.594 0.235 . . . . 9.1500000000000004 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -110.81 173.82 6.15 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.095 0.474 . . . . 10.77 110.882 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.51 131.48 46.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.329 -0.851 . . . . 9.0399999999999991 109.252 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -127.42 158.58 36.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.302 0.572 . . . . 9.0399999999999991 112.063 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.439 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 24.0 p -145.22 145.78 31.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.023 -0.99 . . . . 9.0399999999999991 110.581 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -101.76 137.15 40.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.824 0.345 . . . . 9.0399999999999991 110.555 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -76.87 126.0 30.24 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.106 -0.497 . . . . 9.0399999999999991 111.467 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 39.0 mt -88.73 -20.87 24.24 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.86 0.319 . . . . 9.0399999999999991 111.86 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -147.37 156.73 45.97 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 121.052 -0.259 . . . . 9.0399999999999991 111.399 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 138.47 29.24 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.48 2.12 . . . . 9.0399999999999991 112.378 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -136.74 130.55 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.489 -0.778 . . . . 9.0399999999999991 110.801 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.497 ' HG1' HH12 ' B' ' 26' ' ' ARG . 34.2 m -111.83 119.56 38.99 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.884 0.373 . . . . 9.0399999999999991 111.034 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.72 142.28 48.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.816 -0.629 . . . . 9.0399999999999991 112.319 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -111.14 -22.24 11.53 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.95 0.405 . . . . 9.0399999999999991 111.534 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -117.45 160.56 20.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.698 -0.683 . . . . 9.0399999999999991 110.206 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -33.46 75.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 9.0399999999999991 111.652 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -84.77 -4.26 58.97 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.834 0.35 . . . . 9.0399999999999991 110.952 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -81.74 153.88 26.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.068 -0.515 . . . . 9.0399999999999991 110.557 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.459 HD23 ' HB3' ' B' ' 48' ' ' LEU . 0.5 OUTLIER -104.43 144.05 32.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.961 -0.755 . . . . 9.0399999999999991 108.961 178.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' THR . . . . . 0.457 HG22 ' HA ' ' B' ' 16' ' ' THR . 99.8 m -114.81 121.94 44.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.767 -0.651 . . . . 9.0399999999999991 110.172 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -138.57 153.41 48.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.833 0.679 . . . . 9.0399999999999991 112.833 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.497 HH12 ' HG1' ' B' ' 16' ' ' THR . 27.0 mmt180 -109.52 -179.59 3.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.839 -0.43 . . . . 9.0399999999999991 109.839 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.5 135.45 35.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.114 0.483 . . . . 9.0399999999999991 109.842 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.03 31.97 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.524 -1.03 . . . . 9.0399999999999991 110.524 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' B' ' 30' ' ' ILE . 1.9 tp10 -96.79 178.69 5.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.793 0.806 . . . . 9.0399999999999991 113.001 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.413 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 27.7 mm -135.76 114.16 15.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 113.763 -1.562 . . . . 9.0399999999999991 111.245 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.07 139.58 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 9.0399999999999991 110.861 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' HIS . . . . . 0.409 ' N ' ' CD2' ' B' ' 32' ' ' HIS . 7.2 m170 -91.68 128.81 37.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.456 -0.572 . . . . 9.0399999999999991 109.456 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.08 98.7 2.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 9.0399999999999991 110.58 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.3 mm -79.54 -63.11 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 9.0399999999999991 111.125 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -157.97 110.13 2.33 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.824 0.676 . . . . 9.0399999999999991 112.824 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.421 ' O ' HG21 ' B' ' 38' ' ' THR . 58.6 mtmt -56.29 -69.81 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.999 -0.741 . . . . 9.0399999999999991 108.999 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.51 98.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.426 -0.352 . . . . 9.0399999999999991 111.394 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.421 HG21 ' O ' ' B' ' 36' ' ' LYS . 23.7 p -111.37 -5.3 14.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.34 -0.391 . . . . 9.0399999999999991 111.104 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.27 -8.36 72.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.81 -0.71 . . . . 9.0399999999999991 111.649 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.24 120.43 31.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.812 0.339 . . . . 9.0399999999999991 110.656 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.31 55.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.496 . . . . 9.0399999999999991 111.35 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 -0.7 83.72 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.807 -0.633 . . . . 9.0399999999999991 112.675 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -121.63 127.37 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.333 0.566 . . . . 9.0399999999999991 112.088 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' TRP . . . . . 0.552 ' HB2' ' CE2' ' B' ' 55' ' ' PHE . 23.2 m0 -113.88 162.15 16.72 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.285 -0.871 . . . . 9.0399999999999991 109.201 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -114.19 131.25 56.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.086 0.469 . . . . 9.0399999999999991 110.89 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.83 174.73 22.22 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.454 -0.794 . . . . 9.0399999999999991 112.073 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.26 132.81 52.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.143 0.497 . . . . 9.0399999999999991 110.272 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 50' ' ' GLY . 19.8 tp -129.81 170.28 14.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.192 -0.913 . . . . 9.0399999999999991 109.755 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.48 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 67.7 m-20 -17.7 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.33 1.604 . . . . 9.0399999999999991 115.33 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.4 -12.57 54.94 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.545 0.578 . . . . 9.0399999999999991 114.545 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -119.5 134.36 55.25 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.461 0.63 . . . . 9.0399999999999991 111.105 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.46 146.5 31.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.07 -0.514 . . . . 9.0399999999999991 110.18 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.47 -177.48 41.93 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.541 -0.838 . . . . 9.0399999999999991 112.55 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.98 160.99 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 112.126 0.417 . . . . 9.0399999999999991 112.126 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' B' ' 44' ' ' TRP . 2.7 p90 -124.79 149.55 62.97 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.665 -0.698 . . . . 9.0399999999999991 111.106 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.69 122.4 5.45 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.828 2.352 . . . . 9.0399999999999991 115.171 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 51.26 43.76 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 114.171 1.174 . . . . 9.0399999999999991 114.171 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.48 92.26 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.166 1.172 . . . . 9.0399999999999991 114.166 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -102.84 17.52 23.72 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.425 -0.954 . . . . 9.0399999999999991 108.425 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.439 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -146.26 138.2 24.96 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.591 0.219 . . . . 9.0399999999999991 111.591 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 p -109.11 121.59 62.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.498 -0.319 . . . . 9.0399999999999991 111.336 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.45 155.93 3.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.82 0.343 . . . . 9.0399999999999991 110.594 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.87 -51.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 9.0399999999999991 110.639 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.301 -0.856 . . . . 9.0399999999999991 110.714 -179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.724 0.297 . . . . 16.5 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -84.58 148.03 26.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 13.859999999999999 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.4 pt -139.52 154.77 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.632 . . . . 12.19 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.87 134.57 53.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.023 -0.535 . . . . 11.640000000000001 110.376 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.8 t -118.16 100.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.376 -0.601 . . . . 9.0399999999999991 109.376 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 14.5 tmtt? -88.82 131.2 35.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 9.0399999999999991 112.155 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -106.08 163.17 12.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.252 -0.885 . . . . 9.0399999999999991 110.841 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.74 -21.97 66.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.275 -0.421 . . . . 9.0399999999999991 111.348 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 t -81.23 -8.51 59.76 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.382 -0.372 . . . . 9.0399999999999991 111.18 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.1 54.99 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.179 -0.534 . . . . 9.0399999999999991 112.965 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -97.0 108.58 21.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 9.0399999999999991 111.337 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p -99.93 124.33 45.15 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.928 -0.578 . . . . 9.0399999999999991 110.261 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.57 143.85 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.368 . . . . 9.0399999999999991 111.185 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.1 m -98.13 135.66 39.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.865 -0.607 . . . . 9.0399999999999991 110.786 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.89 152.95 52.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 10.02 110.985 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.48 121.01 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 12.19 109.753 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -140.12 -178.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.086 0.469 . . . . 14.73 111.446 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 38.8 tt0 -145.63 146.28 28.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.49 -0.777 . . . . 18.57 109.873 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 72.2 Cg_exo -50.47 -26.4 16.3 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 19.890000000000001 112.91 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 m -85.64 -23.85 27.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.323 -0.399 . . . . 21.489999999999998 111.28 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.6 148.96 8.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.381 . . . . 18.559999999999999 111.392 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 m -95.85 144.19 26.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.904 -0.589 . . . . 20.149999999999999 111.139 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -51.86 -44.58 37.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.132 -0.485 . . . . 17.16 111.433 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.18 -38.06 67.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.853 0.359 . . . . 19.989999999999998 110.329 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -68.07 -38.84 82.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.556 . . . . 16.559999999999999 110.087 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -58.99 -48.57 86.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.144 -0.48 . . . . 14.390000000000001 110.416 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HZ3' ' HG ' ' A' ' 43' ' ' LEU . 68.6 mttm -60.75 -32.67 71.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.05 -0.523 . . . . 14.57 110.885 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.19 78.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.147 -0.479 . . . . 14.550000000000001 110.351 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -70.09 -42.75 72.31 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 14.15 110.228 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.3 mt -61.05 -41.46 89.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.093 0.473 . . . . 10.06 109.985 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -32.87 74.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.819 -0.628 . . . . 15.880000000000001 110.989 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -66.12 -35.91 81.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 12.470000000000001 111.402 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.32 -59.25 2.13 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.399 0.518 . . . . 9.2300000000000004 112.399 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -81.66 -11.41 59.09 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.999 0.74 . . . . 9.5999999999999996 112.999 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.83 -21.11 4.91 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.636 -0.792 . . . . 12.199999999999999 114.454 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.8 pt -54.54 135.49 62.92 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 117.469 0.634 . . . . 11.27 111.92 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.98 135.41 12.4 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.819 2.346 . . . . 14.23 112.468 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.33 -27.16 46.95 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.799 2.333 . . . . 14.34 112.965 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.51 -24.11 67.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.427 -0.351 . . . . 16.960000000000001 111.339 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -110.79 -5.16 15.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 14.449999999999999 111.363 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -80.93 128.09 33.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 11.609999999999999 111.495 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 42' ' ' ARG . 27.9 ttt-85 -125.18 114.21 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.18 -0.674 . . . . 9.6099999999999994 109.18 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.423 ' HG ' ' HZ3' ' A' ' 27' ' ' LYS . 92.3 mt -101.94 126.54 48.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 10.56 110.858 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.85 134.39 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 9.75 110.893 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -151.53 123.14 7.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.585 -0.734 . . . . 15.27 110.187 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 18.55 7.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.803 -0.635 . . . . 14.76 111.614 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.55 -12.07 70.63 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.704 -0.76 . . . . 12.99 112.678 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -107.72 148.49 29.36 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.05 0.452 . . . . 17.59 111.442 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -82.45 129.26 34.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.727 -0.669 . . . . 14.970000000000001 110.096 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.97 130.87 44.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 14.81 111.225 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HB2' ' CG ' ' A' ' 54' ' ' ARG . 11.5 mm-40 -86.74 128.54 35.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 21.0 110.41 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.03 -31.48 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.747 -0.66 . . . . 18.5 112.759 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.53 3.76 85.17 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.736 -0.745 . . . . 21.789999999999999 113.867 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.453 ' CG ' ' HB2' ' A' ' 51' ' ' GLU . 34.6 mmt180 -103.15 177.44 4.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.992 0.396 . . . . 24.890000000000001 110.829 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -123.16 160.5 26.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.364 . . . . 21.530000000000001 111.087 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -51.91 -31.01 26.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 18.41 111.753 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 p -71.04 -25.85 62.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.735 0.272 . . . . 21.809999999999999 111.735 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.81 -37.52 87.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.647 0.26 . . . . 23.140000000000001 111.059 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.91 7.46 46.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 19.370000000000001 111.829 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 61.97 36.27 15.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.864 0.364 . . . . 22.789999999999999 111.54 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -78.65 107.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 18.120000000000001 111.272 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -95.21 -179.14 4.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.224 -0.444 . . . . 21.52 111.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.06 155.34 24.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.108 -0.496 . . . . 19.190000000000001 111.936 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 58.48 31.11 20.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.686 -0.688 . . . . 16.920000000000002 111.455 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -86.19 158.26 19.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 15.09 110.631 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 t -114.26 125.33 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 11.93 110.728 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -115.09 122.59 46.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.902 -0.59 . . . . 10.94 110.229 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.69 111.66 20.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.904 0.383 . . . . 9.0399999999999991 111.611 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -92.34 115.0 27.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.032 -0.531 . . . . 9.0399999999999991 109.807 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.5 -161.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.271 0.471 . . . . 9.0399999999999991 112.271 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 tp -125.81 121.28 32.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.511 -0.768 . . . . 9.0399999999999991 110.065 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -43.11 -70.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.083 -0.508 . . . . 14.67 111.909 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.7 tp -140.05 137.67 34.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.561 -0.291 . . . . 13.68 110.343 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? 179.8 -58.98 0.01 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.91 0.386 . . . . 20.530000000000001 110.403 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.17 35.94 0.36 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.042 -0.599 . . . . 17.34 112.413 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.377 -1.235 . . . . 17.600000000000001 112.417 179.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.496 0.188 . . . . 9.1500000000000004 111.142 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -109.24 175.31 5.5 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.253 0.549 . . . . 10.77 110.954 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.59 132.39 49.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.27 -0.877 . . . . 9.0399999999999991 109.444 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.9 160.05 33.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.327 0.584 . . . . 9.0399999999999991 112.056 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 32.5 m -141.49 146.93 37.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.982 -1.008 . . . . 9.0399999999999991 110.201 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -102.04 143.79 31.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.829 0.347 . . . . 9.0399999999999991 111.078 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.5 m -82.01 123.64 29.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.999 -0.546 . . . . 9.0399999999999991 111.515 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.37 -20.68 22.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.923 0.342 . . . . 9.0399999999999991 111.923 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.453 ' CD1' ' HD2' ' B' ' 14' ' ' PRO . 30.6 t80 -154.94 144.64 15.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 117.921 0.328 . . . . 9.0399999999999991 111.02 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' B' ' 13' ' ' PHE . 32.3 Cg_exo -59.45 138.46 84.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.416 2.077 . . . . 9.0399999999999991 112.608 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.545 ' CZ ' ' HD3' ' B' ' 56' ' ' PRO . 29.2 t80 -133.72 131.1 39.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.687 -0.688 . . . . 9.0399999999999991 110.839 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.406 ' HA ' HG23 ' B' ' 24' ' ' THR . 54.5 m -111.89 117.92 34.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.989 0.423 . . . . 9.0399999999999991 111.049 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.45 138.01 47.19 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.973 -0.632 . . . . 9.0399999999999991 112.366 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 15.7 m -104.51 -21.44 13.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.352 0.596 . . . . 9.0399999999999991 110.241 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -118.46 156.06 29.69 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.948 -1.024 . . . . 9.0399999999999991 109.861 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.72 -38.62 91.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 9.0399999999999991 111.186 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.8 -3.21 33.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.809 0.338 . . . . 9.0399999999999991 110.963 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -88.65 160.98 17.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 9.0399999999999991 110.919 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.449 HD23 ' HB3' ' B' ' 48' ' ' LEU . 0.6 OUTLIER -103.87 140.66 37.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.542 -0.54 . . . . 9.0399999999999991 109.542 178.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' THR . . . . . 0.414 ' H ' HD21 ' B' ' 23' ' ' LEU . 56.0 m -116.07 121.73 43.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.297 -0.865 . . . . 9.0399999999999991 109.992 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' B' ' 15' ' ' TYR . 17.8 p90 -140.23 159.06 43.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.913 0.709 . . . . 9.0399999999999991 112.913 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.495 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 81.4 mtt-85 -109.74 179.36 4.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.328 -0.249 . . . . 9.0399999999999991 110.328 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -82.23 140.53 33.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.051 0.453 . . . . 9.0399999999999991 110.048 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.61 21.87 49.23 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.602 -0.999 . . . . 9.0399999999999991 110.602 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 5.3 mm-40 -97.96 179.45 4.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.471 0.915 . . . . 9.0399999999999991 113.471 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -130.5 123.56 55.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.821 -1.536 . . . . 9.0399999999999991 111.417 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -122.07 135.67 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.725 -0.671 . . . . 9.0399999999999991 111.191 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.48 132.72 42.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.703 -0.481 . . . . 9.0399999999999991 109.703 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 tt -72.98 100.46 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 9.0399999999999991 110.798 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.18 -62.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.554 -0.748 . . . . 9.0399999999999991 110.824 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.5 m -158.37 110.11 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.647 0.61 . . . . 9.0399999999999991 112.647 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.409 ' O ' HG21 ' B' ' 38' ' ' THR . 35.0 mtmt -57.91 -71.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.383 -0.599 . . . . 9.0399999999999991 109.383 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -45.72 94.43 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.325 -0.398 . . . . 9.0399999999999991 111.502 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.409 HG21 ' O ' ' B' ' 36' ' ' LYS . 68.6 p -106.58 -9.02 16.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.241 -0.436 . . . . 9.0399999999999991 111.051 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.29 -5.0 62.68 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.909 -0.662 . . . . 9.0399999999999991 112.345 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -129.98 120.79 25.34 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.873 0.368 . . . . 9.0399999999999991 110.554 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 133.3 55.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.57 . . . . 9.0399999999999991 111.61 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 -0.64 85.48 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.586 -0.734 . . . . 9.0399999999999991 112.699 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.425 ' CH2' ' HB3' ' B' ' 56' ' ' PRO . 79.6 m95 -121.86 123.6 42.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.324 0.562 . . . . 9.0399999999999991 111.799 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' TRP . . . . . 0.542 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 21.8 m0 -110.32 172.11 7.06 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.504 -0.771 . . . . 9.0399999999999991 109.322 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -125.39 130.61 52.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 9.0399999999999991 110.905 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.2 176.31 21.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.488 -0.778 . . . . 9.0399999999999991 111.77 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -124.7 133.79 53.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.303 0.573 . . . . 9.0399999999999991 110.207 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.677 ' O ' ' N ' ' B' ' 50' ' ' GLY . 27.3 tp -129.56 170.1 14.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.098 -0.955 . . . . 9.0399999999999991 109.778 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.498 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 31.5 p-10 -17.58 63.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.126 1.528 . . . . 9.0399999999999991 115.126 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.61 -12.37 52.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 114.429 0.532 . . . . 9.0399999999999991 114.429 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.32 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.545 0.672 . . . . 9.0399999999999991 111.068 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' B' ' 52' ' ' GLU . 0.0 OUTLIER -112.27 146.18 38.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.07 -0.514 . . . . 9.0399999999999991 110.506 179.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . 0.417 ' N ' ' HG ' ' B' ' 23' ' ' LEU . . . -174.74 -176.06 42.75 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.666 -0.778 . . . . 9.0399999999999991 113.017 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -113.5 160.47 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 112.51 0.559 . . . . 9.0399999999999991 112.51 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 6.2 p90 -125.19 148.49 60.79 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.563 -0.744 . . . . 9.0399999999999991 110.976 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.545 ' HD3' ' CZ ' ' B' ' 15' ' ' TYR . 89.2 Cg_endo -79.05 123.24 5.59 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.035 2.49 . . . . 9.0399999999999991 115.369 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 52.32 43.55 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.553 1.316 . . . . 9.0399999999999991 114.553 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ASN . . . . . 0.636 HD21 ' N ' ' B' ' 58' ' ' ASN . 0.8 OUTLIER 60.52 93.55 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.692 1.367 . . . . 9.0399999999999991 114.692 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.27 12.8 35.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.748 -0.834 . . . . 9.0399999999999991 108.748 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.6 29.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 9.0399999999999991 111.622 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.46 126.99 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.501 -0.318 . . . . 9.0399999999999991 111.823 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.52 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 53.6 tt0 -59.37 140.69 55.87 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 110.167 -0.309 . . . . 9.0399999999999991 110.167 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.406 HG22 HD13 ' B' ' 63' ' ' ILE . 56.3 mt -101.63 -60.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 9.0399999999999991 110.705 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.149 -0.929 . . . . 9.0399999999999991 110.76 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.877 0.37 . . . . 16.5 111.011 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -79.24 149.03 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.837 -0.62 . . . . 13.22 110.544 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.0 pt -142.94 147.88 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 12.19 110.678 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -97.55 137.24 36.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 11.64 110.597 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.41 91.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.573 -0.529 . . . . 6.66 109.573 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 7' ' ' THR . 61.7 tttm -77.03 164.29 25.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.916 -0.584 . . . . 6.86 111.425 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.427 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.8 m -143.57 159.43 42.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.427 -0.806 . . . . 3.79 110.041 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.418 ' N ' HG22 ' A' ' 7' ' ' THR . 3.4 pp -62.31 -22.37 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 5.48 111.37 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -81.75 -13.7 57.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.369 . . . . 7.65 111.272 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.98 47.63 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.057 -0.592 . . . . 7.08 112.468 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -93.59 111.31 22.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 6.58 111.492 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.03 125.0 44.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.759 -0.655 . . . . 6.95 110.134 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -117.01 142.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.384 . . . . 5.97 111.215 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.9 p -97.79 139.12 34.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 8.28 110.704 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 16' ' ' GLU . 59.3 tp -139.89 150.77 45.0 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.548 -0.296 . . . . 10.02 110.524 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.431 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -111.92 106.31 14.97 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.569 -0.287 . . . . 12.19 111.373 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.65 113.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.216 -0.447 . . . . 14.73 111.299 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 14.6 mp0 -60.78 172.15 0.91 Allowed Pre-proline 0 N--CA 1.467 0.408 0 N-CA-C 112.89 0.7 . . . . 18.57 112.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 41.2 Cg_exo -59.45 -39.74 73.33 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.32 2.68 . . . . 19.89 113.251 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.9 p -61.61 -26.2 67.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.38 -0.373 . . . . 21.46 111.759 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.04 151.26 9.23 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.921 0.391 . . . . 18.56 111.646 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -95.24 149.46 21.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.837 -0.62 . . . . 20.15 110.841 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 HD13 ' A' ' 50' ' ' LEU . 45.6 mm -58.62 -37.66 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 16.47 111.1 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.63 -40.48 92.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.902 0.382 . . . . 19.99 109.995 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.99 -41.8 95.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.935 -0.575 . . . . 16.38 110.013 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.65 -47.22 82.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.994 -0.548 . . . . 13.8 110.464 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -60.55 -36.37 78.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.922 -0.581 . . . . 13.67 110.541 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.86 84.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.03 -0.532 . . . . 14.55 110.375 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -65.44 -49.81 67.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.926 -0.579 . . . . 13.7 110.028 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.56 ' CG2' HD11 ' A' ' 36' ' ' ILE . 84.5 mt -57.55 -40.5 75.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.959 -0.564 . . . . 9.57 110.457 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -63.76 -30.09 71.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.037 -0.529 . . . . 15.04 111.025 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.59 -38.51 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 12.47 111.235 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -90.13 -59.93 2.06 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.087 0.403 . . . . 9.23 112.087 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HG3' HG23 ' A' ' 36' ' ' ILE . 9.3 tp10 -78.8 -11.93 60.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.022 0.749 . . . . 9.6 113.022 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.0 -17.71 4.51 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.537 -0.84 . . . . 12.2 114.213 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.56 HD11 ' CG2' ' A' ' 30' ' ' ILE . 16.5 pt -59.43 132.0 88.12 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 117.337 0.569 . . . . 11.27 112.043 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.79 144.38 38.94 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 14.23 112.231 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.88 -22.26 63.35 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.745 2.297 . . . . 14.34 112.374 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.59 -25.49 66.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 16.96 111.176 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -106.25 -13.11 15.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.358 -0.383 . . . . 14.45 111.42 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -73.59 132.8 43.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.12 0.486 . . . . 10.91 111.954 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 61.7 mtp180 -127.73 114.5 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.356 -0.838 . . . . 9.32 109.156 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB3' HD12 ' A' ' 50' ' ' LEU . 9.6 mp -101.3 122.16 43.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.836 0.351 . . . . 10.56 110.907 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 18.7 mm -113.3 133.17 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.899 -0.591 . . . . 9.75 110.442 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HB3' HD21 ' A' ' 50' ' ' LEU . 60.6 t80 -151.06 124.28 8.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 15.27 110.578 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.77 19.35 11.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 14.76 111.967 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.57 80.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.566 -0.826 . . . . 12.99 112.97 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.21 147.92 42.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.745 0.307 . . . . 17.08 110.729 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -81.88 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 14.97 110.3 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD13 HD12 ' A' ' 23' ' ' ILE . 68.3 mt -68.4 133.23 48.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 14.81 111.183 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.87 126.75 35.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 21.0 110.515 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.34 -35.03 25.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.921 -0.581 . . . . 18.5 112.351 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.7 1.87 88.02 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.954 -0.641 . . . . 21.79 114.273 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.78 177.64 4.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.172 0.486 . . . . 24.16 110.977 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -122.4 158.7 29.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.333 -0.394 . . . . 21.36 110.952 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.6 mm? -52.24 -24.29 7.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 18.41 111.744 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 m -75.04 -25.56 58.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.629 0.252 . . . . 21.76 111.515 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.18 -41.8 96.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 23.14 111.123 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -94.75 10.43 35.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.304 -0.407 . . . . 19.37 111.665 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 56.37 42.91 27.06 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.062 0.458 . . . . 22.24 111.207 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.4 HG12 ' CE2' ' A' ' 45' ' ' PHE . 73.9 mt -85.49 104.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 17.93 111.198 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -91.56 178.03 6.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.14 -0.482 . . . . 21.49 111.313 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -60.5 155.29 18.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.987 -0.552 . . . . 19.19 111.585 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 60.51 33.46 20.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.843 -0.617 . . . . 16.92 111.364 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 p -92.04 157.61 16.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 14.92 110.649 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.501 ' C ' HD12 ' A' ' 67' ' ' LEU . 5.1 t -113.74 124.4 52.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 11.29 110.712 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 66' ' ' THR . 8.1 mp -115.89 119.41 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 10.94 110.4 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 58.2 t-80 -77.99 120.87 23.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.381 -0.372 . . . . 8.09 111.148 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.51 109.75 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 6.7 111.273 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 19.4 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 7.13 109.962 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 C--O 1.232 0.164 0 N-CA-C 109.734 -0.469 . . . . 7.56 109.734 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 8' ' ' TYR . . . . . 0.427 ' H ' ' HB2' ' B' ' 64' ' ' SER . 20.0 m-85 -124.05 172.08 9.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 7.84 110.745 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.577 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 35.1 m -142.27 149.09 39.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 4.73 111.027 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -99.51 138.0 37.21 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.519 -0.309 . . . . 4.43 110.456 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -78.54 123.46 27.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.497 -0.32 . . . . 2.72 110.856 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.54 -21.31 19.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.331 0.493 . . . . 3.78 112.331 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' B' ' 14' ' ' PRO . 75.5 m-85 -145.84 155.01 52.11 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 117.954 0.343 . . . . 4.88 111.409 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 13' ' ' PHE . 6.8 Cg_exo -72.11 136.42 26.99 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.518 2.145 . . . . 3.11 112.728 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -137.96 127.68 25.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.889 -1.05 . . . . 4.0 109.539 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.2 m -112.06 121.67 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 3.82 111.322 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.85 143.71 48.74 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.744 -0.741 . . . . 3.22 111.926 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 44' ' ' ILE . 41.1 p -107.17 -18.63 13.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.519 . . . . 4.64 110.825 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -119.49 159.11 24.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 4.05 110.222 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.51 -30.65 71.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 4.26 111.357 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.31 -5.88 59.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 4.22 111.012 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -81.76 157.65 24.44 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.146 -0.479 . . . . 3.77 110.988 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.555 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 2.7 mt -110.59 151.61 27.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.626 -0.509 . . . . 3.13 109.626 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -115.72 129.23 56.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.328 -0.396 . . . . 2.46 110.468 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 29.9 m-85 -130.6 133.8 46.46 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.263 0.468 . . . . 2.49 112.263 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.531 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 97.7 mtt180 -104.04 175.24 5.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.763 -0.458 . . . . 6.21 109.763 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -81.5 134.44 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 3.87 110.006 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.17 50.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.925 -0.87 . . . . 4.23 110.925 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.2 mm-40 -98.42 179.42 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.423 0.898 . . . . 4.19 113.423 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -131.34 113.55 23.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.76 -1.564 . . . . 5.23 111.233 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' B' ' 60' ' ' ALA . 42.6 mt -106.89 129.41 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 4.64 110.677 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -89.96 127.27 36.0 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.894 -0.41 . . . . 7.14 109.894 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.28 128.04 34.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.044 0.45 . . . . 6.33 110.923 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.41 -48.97 6.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 6.97 110.785 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 79.3 p -167.06 113.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 7.03 111.983 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -69.32 5.11 1.39 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.907 -0.588 . . . . 7.52 111.32 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -121.85 101.89 7.85 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 116.63 -0.259 . . . . 8.93 110.305 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.476 HG22 ' HB2' ' B' ' 45' ' ' LYS . 30.5 p -112.33 -2.96 14.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.454 -0.339 . . . . 7.05 111.752 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.03 -5.14 78.68 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.685 . . . . 8.42 112.014 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -125.99 119.7 28.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 7.96 110.39 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.411 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -58.56 132.46 53.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 8.2 111.302 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.32 -0.46 85.53 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.9 -0.591 . . . . 6.68 112.704 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.492 ' CE3' HG23 ' B' ' 54' ' ' VAL . 77.6 m95 -122.92 123.74 41.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.454 0.627 . . . . 5.83 112.016 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' TRP . . . . . 0.555 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 19.4 m0 -109.66 165.15 11.9 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.477 -0.783 . . . . 5.87 109.428 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.476 ' HB2' HG22 ' B' ' 38' ' ' THR . 64.0 tttp -115.91 131.72 56.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.021 0.439 . . . . 5.33 110.965 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.7 174.82 21.86 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.411 -0.813 . . . . 4.14 111.717 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.05 133.36 52.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.291 0.567 . . . . 6.02 110.364 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' B' ' 50' ' ' GLY . 11.8 tp -130.06 170.99 13.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.929 -1.032 . . . . 4.21 109.675 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.475 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 60.3 m-20 -17.69 64.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.424 1.638 . . . . 5.39 115.424 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 82.97 -10.4 57.87 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 114.732 0.653 . . . . 5.53 114.732 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -118.93 143.39 47.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.544 0.672 . . . . 5.33 111.099 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.05 142.85 46.08 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.055 -0.52 . . . . 5.79 110.585 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLY . . . . . 0.478 ' H ' HD12 ' B' ' 23' ' ' LEU . . . -169.34 -179.19 41.1 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.943 -0.646 . . . . 3.35 112.481 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.492 HG23 ' CE3' ' B' ' 43' ' ' TRP . 33.7 m -113.44 163.36 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 112.441 0.534 . . . . 4.3 112.441 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 3.3 p90 -124.57 152.92 69.53 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.602 -0.726 . . . . 3.72 110.92 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.45 122.88 4.69 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.93 2.42 . . . . 3.97 115.683 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 50.95 44.51 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.983 1.105 . . . . 5.85 113.983 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 60.0 92.92 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.125 1.157 . . . . 5.67 114.125 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -103.38 15.97 27.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.723 -0.843 . . . . 3.89 108.723 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 31' ' ' ILE . . . -143.09 138.58 29.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.977 0.362 . . . . 3.89 111.977 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.59 119.43 59.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.366 -0.379 . . . . 4.64 111.445 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.577 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 63.5 tt0 -54.47 105.62 0.16 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.847 0.356 . . . . 6.72 110.611 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 33.0 pt -86.61 -30.12 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 6.54 110.733 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' SER . . . . . 0.427 ' HB2' ' H ' ' B' ' 8' ' ' TYR . 48.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.251 -0.88 . . . . 7.43 110.696 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 66.2 mtm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.716 0.293 . . . . 16.5 110.775 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.08 147.02 28.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 13.22 110.863 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.2 pt -146.53 156.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 12.19 110.765 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -108.74 147.13 32.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.854 -0.612 . . . . 11.64 110.424 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.25 103.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.009 -0.542 . . . . 6.66 110.587 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG2' ' N ' ' A' ' 7' ' ' THR . 85.6 tttt -78.33 164.51 24.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 6.86 111.077 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.464 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 8.4 m -139.91 147.09 40.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 3.79 109.823 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 9' ' ' THR . 4.4 pp -60.67 -18.42 53.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.801 0.334 . . . . 5.48 111.401 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.447 ' N ' HD12 ' A' ' 8' ' ' LEU . 69.4 p -73.89 -35.7 64.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 7.65 110.531 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.43 -15.28 5.78 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.987 -0.552 . . . . 7.08 112.607 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -83.16 136.62 34.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.388 0.514 . . . . 6.58 112.388 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -115.68 124.53 51.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.283 -0.871 . . . . 6.95 109.332 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.13 144.01 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.02 0.438 . . . . 5.97 111.854 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -100.14 136.2 40.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.493 -0.776 . . . . 8.28 110.737 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.3 153.14 52.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.841 0.353 . . . . 10.02 110.84 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -120.5 102.91 8.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.009 -0.541 . . . . 12.19 111.391 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -153.89 116.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 14.73 110.711 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 167.21 1.19 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.753 1.02 . . . . 18.57 113.753 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.7 Cg_exo -60.12 -32.3 94.45 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.831 3.021 . . . . 19.89 114.08 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -77.87 31.18 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.762 0.315 . . . . 21.46 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -115.23 129.89 56.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.317 -0.401 . . . . 18.56 110.942 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 70.6 p -68.89 145.95 53.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 20.15 111.278 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 50' ' ' LEU . 1.1 mp -56.41 -35.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 16.47 110.755 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.48 -43.11 98.25 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 19.99 109.899 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -64.26 -39.63 94.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.973 -0.558 . . . . 16.38 109.931 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.105 -0.498 . . . . 13.8 110.036 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.94 -33.18 74.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.905 -0.588 . . . . 13.67 110.526 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.36 -34.1 76.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.066 -0.516 . . . . 14.55 110.217 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -71.36 -42.3 68.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 13.7 109.571 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.42 -47.97 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 115.866 -0.606 . . . . 9.57 109.741 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -58.42 -33.91 70.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 15.04 110.494 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.21 -33.71 76.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 12.47 110.931 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.11 -62.04 1.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 9.23 112.165 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.7 -13.74 59.66 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.449 0.907 . . . . 9.6 113.449 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 15.75 75.24 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.387 -0.911 . . . . 12.2 113.871 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -90.53 123.45 65.28 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 117.255 0.527 . . . . 11.27 110.932 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 48.3 Cg_exo -56.9 138.82 87.52 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.723 2.282 . . . . 14.23 112.348 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 33.5 Cg_exo -61.11 -30.29 88.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.521 2.147 . . . . 14.34 112.156 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.14 -20.61 66.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.779 -0.646 . . . . 16.96 111.074 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.61 -35.11 13.03 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.265 -0.425 . . . . 14.45 110.835 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -61.21 146.4 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 10.91 110.904 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 3.0 tpp180 -142.77 38.04 1.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 9.32 111.296 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 42' ' ' ARG . 69.5 mt -20.83 127.59 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.727 1.01 . . . . 10.56 113.727 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.567 HD12 HG21 ' B' ' 18' ' ' THR . 20.2 mm -114.95 136.33 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.183 -0.917 . . . . 9.75 109.734 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 81.7 t80 -138.7 123.75 19.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 15.27 111.276 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 13.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.545 0.572 . . . . 14.76 112.545 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.5 -29.34 9.16 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.829 -0.701 . . . . 12.99 113.191 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 14.6 ptpt -70.27 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.941 0.37 . . . . 17.08 111.02 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.509 ' N ' ' HG3' ' A' ' 48' ' ' LYS . 30.3 tt0 -148.53 107.65 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.93 -0.767 . . . . 14.97 108.93 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HB3' HG12 ' A' ' 23' ' ' ILE . 51.3 mt -57.75 127.22 30.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.875 0.695 . . . . 14.81 112.875 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.61 123.62 36.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.392 -0.822 . . . . 21.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -34.54 -61.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.713 -0.676 . . . . 18.5 112.168 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -47.96 -73.5 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 21.79 112.524 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.42 ' O ' HD13 ' A' ' 23' ' ' ILE . 31.0 mmt180 -34.24 163.2 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.366 0.876 . . . . 24.16 113.366 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 8.8 t -115.1 165.28 13.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.211 -0.904 . . . . 21.36 111.278 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 91.0 mt -55.69 -38.46 69.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 18.41 111.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.0 -26.57 68.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.366 . . . . 21.76 111.383 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.59 -29.07 69.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 23.14 110.992 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.11 16.57 24.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 19.37 111.125 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.55 39.62 31.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.083 -0.508 . . . . 22.24 111.306 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -87.74 113.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 17.93 111.094 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -105.47 -165.42 1.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 21.49 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 22.5 pttp -68.16 162.72 24.21 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 19.19 111.255 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 55.99 32.37 19.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.933 -0.576 . . . . 16.92 111.252 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -91.56 138.48 31.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 14.92 110.712 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -98.99 122.46 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 11.29 111.146 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.1 mt -116.71 117.95 31.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 10.94 110.173 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -88.66 114.12 24.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 8.09 111.831 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.419 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 45.8 mt -63.94 -172.13 0.06 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.958 -0.565 . . . . 6.7 109.903 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 90.4 t . . . . . 0 C--N 1.33 -0.272 0 N-CA-C 109.763 -0.458 . . . . 7.13 109.763 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 . . . . . 0 C--O 1.231 0.083 0 N-CA-C 109.498 -0.556 . . . . 7.56 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -133.04 170.42 15.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.013 0.435 . . . . 7.84 112.039 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.518 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 13.7 p -153.45 150.23 28.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.656 -0.702 . . . . 4.73 111.036 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -102.5 138.2 39.73 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.384 -0.371 . . . . 4.43 110.245 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 35.9 p -80.47 125.64 30.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 2.72 111.825 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.1 -20.4 24.36 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.401 -0.363 . . . . 3.78 111.448 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' B' ' 14' ' ' PRO . 97.2 m-85 -149.26 158.0 38.87 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.739 0.304 . . . . 4.88 111.468 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' B' ' 13' ' ' PHE . 74.5 Cg_endo -75.21 140.34 24.77 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.736 2.291 . . . . 3.11 112.88 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -136.0 130.97 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.377 -0.829 . . . . 4.0 110.467 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.518 ' HA ' HG23 ' B' ' 24' ' ' THR . 88.0 m -111.54 118.21 35.11 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.942 0.401 . . . . 3.82 111.213 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.52 139.35 48.16 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.981 -0.628 . . . . 3.22 112.127 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.567 HG21 HD12 ' A' ' 44' ' ' ILE . 76.1 p -107.19 -21.47 12.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.199 0.523 . . . . 4.64 111.092 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -119.08 159.58 23.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.328 -0.851 . . . . 4.05 110.011 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -64.41 -36.09 83.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 4.26 111.505 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.75 -4.55 52.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 4.22 110.817 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 150.58 29.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.038 -0.528 . . . . 3.77 110.981 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.603 HD23 ' N ' ' B' ' 24' ' ' THR . 1.4 tt -100.07 137.48 38.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.526 -1.287 . . . . 3.13 107.526 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.603 ' N ' HD23 ' B' ' 23' ' ' LEU . 89.5 m -114.55 123.9 50.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.745 -0.661 . . . . 2.46 110.646 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -138.65 156.82 47.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.502 0.556 . . . . 2.49 112.502 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.455 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 34.0 mmt180 -111.55 179.45 4.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.176 -0.305 . . . . 6.21 110.176 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.93 143.55 31.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 3.87 110.43 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.57 19.96 67.33 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.088 -0.805 . . . . 4.23 111.088 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 19.3 mm-40 -98.15 179.11 4.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.517 0.932 . . . . 4.19 113.517 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -132.37 116.6 29.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 113.557 -1.656 . . . . 5.23 111.297 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.1 140.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 4.64 111.152 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -91.38 127.55 36.86 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.397 -0.594 . . . . 7.14 109.397 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tt -74.32 102.76 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 6.33 110.636 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 31.9 mm -80.72 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 6.97 111.243 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 89.1 p -157.86 120.28 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.098 0.777 . . . . 7.03 113.098 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.512 ' O ' HG23 ' B' ' 38' ' ' THR . 58.7 mttp -65.18 -72.2 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.987 -0.552 . . . . 7.52 109.911 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -44.8 100.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.099 -0.501 . . . . 8.93 111.732 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.512 HG23 ' O ' ' B' ' 36' ' ' LYS . 25.2 p -116.33 -3.69 11.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.964 -0.562 . . . . 7.05 110.881 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.86 -7.6 76.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.978 -0.629 . . . . 8.42 111.882 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -130.87 120.75 24.1 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.693 0.282 . . . . 7.96 110.483 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.51 137.55 58.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 8.2 110.878 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.808 -0.633 . . . . 6.68 112.614 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.595 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 64.1 m95 -120.79 117.41 27.35 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.831 0.348 . . . . 5.83 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -109.89 160.82 16.05 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.247 -0.649 . . . . 5.87 109.247 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -116.09 129.56 56.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.894 0.378 . . . . 5.33 110.389 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.37 175.63 22.24 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.731 -0.747 . . . . 4.14 112.179 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -126.51 135.42 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.499 . . . . 6.02 110.077 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.638 ' O ' ' N ' ' B' ' 50' ' ' GLY . 32.8 tp -128.53 170.16 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.31 -0.859 . . . . 4.21 110.242 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.433 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 20.9 m120 -18.3 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.403 1.631 . . . . 5.39 115.403 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.69 -11.48 61.73 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 114.894 0.717 . . . . 5.53 114.894 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -118.23 132.25 56.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.831 0.816 . . . . 5.33 111.29 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.01 152.25 24.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.46 -0.57 . . . . 5.79 109.46 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.11 -174.65 44.59 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.113 -1.041 . . . . 3.35 113.353 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.24 149.75 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 110.398 -0.223 . . . . 4.3 110.398 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.432 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 49.1 p90 -139.32 141.11 28.0 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.784 0.661 . . . . 3.72 112.784 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.595 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.3 Cg_endo -95.19 175.17 1.06 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.444 3.429 . . . . 3.97 111.511 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.419 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.1 m-20 79.57 -13.55 0.95 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.981 1.474 . . . . 5.85 114.981 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.22 76.6 0.28 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.873 -0.788 . . . . 5.67 108.873 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 13.1 m-85 -103.87 8.81 37.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.296 -0.865 . . . . 3.89 112.268 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.518 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -133.84 138.98 45.95 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.292 0.478 . . . . 3.89 112.292 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -113.53 136.16 50.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.882 -0.599 . . . . 4.64 111.366 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.08 144.48 28.97 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 120.742 0.306 . . . . 6.72 110.906 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 pt -137.9 -13.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.192 -0.458 . . . . 6.54 111.087 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.272 -0.871 . . . . 7.43 110.627 179.91 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 92.3 mtp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.853 0.359 . . . . 16.5 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -79.94 151.82 29.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 13.22 111.068 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.06 145.24 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.914 -0.585 . . . . 12.19 110.52 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -100.82 135.33 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 11.64 110.113 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 58.4 t -120.42 96.24 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.519 -0.549 . . . . 6.66 109.519 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 7' ' ' THR . 86.5 tttt -76.3 164.02 26.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.816 -0.629 . . . . 6.86 111.326 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.448 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 77.0 p -143.9 158.85 43.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 3.79 110.268 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.556 ' HB3' ' HE1' ' B' ' 43' ' ' TRP . 4.0 pp -61.91 -24.59 67.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.535 . . . . 5.48 111.219 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 p -78.59 -19.93 51.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.118 -0.492 . . . . 7.65 111.205 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.37 13.39 33.19 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.089 -0.577 . . . . 7.08 112.339 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.45 108.93 21.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.891 0.377 . . . . 6.58 111.407 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.38 125.69 45.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 6.95 110.128 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.446 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 31.2 pt -118.3 145.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.861 0.362 . . . . 5.97 111.027 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.641 ' C ' HD22 ' A' ' 15' ' ' LEU . 17.3 m -98.36 134.26 41.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 8.28 111.213 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.641 HD22 ' C ' ' A' ' 14' ' ' THR . 3.8 mm? -127.44 149.75 49.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.098 -0.501 . . . . 10.02 110.369 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.47 98.88 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.31 -0.405 . . . . 12.19 110.701 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.88 -172.74 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.099 0.476 . . . . 14.73 111.816 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -143.14 159.25 56.53 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 18.57 110.276 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 Cg_endo -59.93 -31.72 94.08 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.584 2.189 . . . . 19.89 112.212 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.3 t -82.36 -21.36 35.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 21.46 111.504 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.91 150.92 9.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.7 0.286 . . . . 18.56 111.125 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.3 p -97.35 141.7 30.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 20.15 111.073 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 50' ' ' LEU . 16.0 mt -53.73 -32.02 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 16.47 111.466 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.91 -42.47 99.8 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.615 -0.513 . . . . 19.99 109.615 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.06 -36.16 81.43 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.752 -0.658 . . . . 16.38 110.133 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.2 t -57.59 -46.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.378 -0.374 . . . . 13.8 110.197 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.39 -37.76 84.6 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.039 -0.528 . . . . 13.67 110.451 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.05 86.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 14.55 110.432 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 6.9 mmpt? -64.68 -49.2 71.86 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.033 -0.531 . . . . 13.7 109.956 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.69 -40.75 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 9.57 110.368 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -61.4 -34.78 75.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.018 -0.537 . . . . 15.04 110.816 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.96 -36.26 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 12.47 111.329 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.23 -63.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.234 -0.439 . . . . 9.23 112.025 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -78.4 -12.58 60.01 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.386 0.884 . . . . 9.6 113.386 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.14 -12.5 12.26 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.294 -0.955 . . . . 12.2 113.38 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.514 HD12 ' HD2' ' A' ' 37' ' ' PRO . 5.2 tp -60.52 128.07 87.68 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.856 0.328 . . . . 11.27 111.565 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 36' ' ' ILE . 59.8 Cg_endo -73.06 137.2 26.04 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.623 2.215 . . . . 14.23 112.622 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 53.2 Cg_exo -56.13 -29.0 73.15 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.026 2.484 . . . . 14.34 112.782 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.96 -24.85 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 16.96 111.271 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -108.54 -6.64 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 14.45 111.467 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.401 HE21 ' N ' ' A' ' 38' ' ' PRO . 46.4 mt-30 -81.17 127.19 32.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.066 0.46 . . . . 10.91 111.984 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -121.24 112.53 18.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.466 -0.788 . . . . 9.32 109.275 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.32 122.63 43.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.42 -0.355 . . . . 10.56 110.951 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.804 HD12 HG21 ' B' ' 18' ' ' THR . 34.3 mm -116.55 137.05 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.526 . . . . 9.75 110.983 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 50' ' ' LEU . 85.2 t80 -155.86 127.57 7.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.772 -0.649 . . . . 15.27 110.541 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.5 17.12 10.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.934 -0.575 . . . . 14.76 111.767 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.428 ' O ' HG22 ' B' ' 18' ' ' THR . . . 90.96 -2.41 79.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 12.99 112.964 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -117.82 148.56 41.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.749 0.309 . . . . 17.08 110.777 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -81.91 131.34 35.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 14.97 110.196 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.536 ' HB3' HD13 ' A' ' 23' ' ' ILE . 52.9 mt -69.74 130.13 41.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.95 0.405 . . . . 14.81 111.288 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -86.84 126.19 34.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.62 . . . . 21.0 110.174 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -48.58 -40.35 27.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.551 0.574 . . . . 18.5 112.551 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.408 ' H ' ' CD ' ' A' ' 51' ' ' GLU . . . -80.28 3.52 71.91 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.971 -0.633 . . . . 21.79 114.194 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 6.0 mmp_? -103.5 173.79 6.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.115 0.457 . . . . 24.16 110.881 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -118.99 160.84 21.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.872 0.368 . . . . 21.36 111.576 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.458 ' H ' HD22 ' A' ' 56' ' ' LEU . 3.6 mm? -51.78 -34.04 37.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.015 -0.538 . . . . 18.41 111.395 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -69.31 -24.97 64.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.485 -0.325 . . . . 21.76 111.303 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.412 . . . . 23.14 111.065 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -101.09 11.45 39.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.233 -0.44 . . . . 19.37 111.288 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 56.32 49.47 15.11 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.851 0.358 . . . . 22.24 111.184 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.404 HG12 ' CE2' ' A' ' 45' ' ' PHE . 79.8 mt -92.09 108.27 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 17.93 110.882 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -92.81 -177.98 4.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 21.49 110.899 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.97 158.88 24.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.337 -0.392 . . . . 19.19 111.125 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 59.46 29.05 18.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.946 -0.57 . . . . 16.92 111.509 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.5 t -89.1 153.19 21.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.308 -0.405 . . . . 14.92 110.843 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 t -110.9 126.02 54.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 11.29 111.124 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.1 mp -115.29 125.72 53.63 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.923 -0.58 . . . . 10.94 110.395 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -85.39 115.47 23.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.401 . . . . 8.09 111.589 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.7 tp -94.17 105.83 17.81 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.903 -0.59 . . . . 6.7 110.6 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.13 -0.486 . . . . 7.13 110.885 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 . . . . . 0 C--O 1.231 0.111 0 N-CA-C 109.045 -0.724 . . . . 7.56 109.045 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.15 169.13 15.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.988 0.423 . . . . 7.84 111.9 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.627 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 6.7 p -152.63 147.69 26.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 4.73 110.478 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -100.19 141.3 33.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.434 -0.348 . . . . 4.43 110.684 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 54.4 p -80.25 124.78 29.12 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.271 -0.422 . . . . 2.72 111.743 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.24 -21.49 19.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.616 -0.265 . . . . 3.78 111.05 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -151.3 156.61 35.08 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.607 0.241 . . . . 4.88 110.83 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.68 140.58 29.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.549 2.166 . . . . 3.11 113.112 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -136.59 128.7 29.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.085 -0.961 . . . . 4.0 110.044 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.436 ' HA ' HG23 ' B' ' 24' ' ' THR . 88.3 m -112.2 120.4 41.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.8 0.333 . . . . 3.82 111.579 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.47 144.64 49.37 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.828 -0.701 . . . . 3.22 111.93 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.804 HG21 HD12 ' A' ' 44' ' ' ILE . 82.0 p -107.56 -22.19 12.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.057 0.456 . . . . 4.64 111.292 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.79 158.67 25.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.476 -0.784 . . . . 4.05 109.941 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.82 -35.91 82.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 4.26 111.438 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.3 -4.47 45.18 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.934 0.397 . . . . 4.22 110.535 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.91 156.58 22.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.762 -0.653 . . . . 3.77 110.44 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.513 HD23 ' HZ ' ' B' ' 25' ' ' PHE . 3.8 tp -107.14 146.33 31.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.354 -0.98 . . . . 3.13 108.354 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.436 HG23 ' HA ' ' B' ' 16' ' ' THR . 93.8 m -115.83 130.93 57.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.44 . . . . 2.46 111.099 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.513 ' HZ ' HD23 ' B' ' 23' ' ' LEU . 31.3 m-85 -131.56 139.02 49.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.169 0.433 . . . . 2.49 112.169 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.568 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 8.3 mpt_? -108.32 176.85 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.873 -0.418 . . . . 6.21 109.873 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -80.41 138.17 36.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 3.87 110.163 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.79 20.38 58.09 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.027 -0.829 . . . . 4.23 111.027 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.568 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 22.9 mm-40 -98.29 179.73 4.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.04 0.924 . . . . 4.19 113.391 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 mm -134.64 119.64 29.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 113.563 -1.653 . . . . 5.23 110.707 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.627 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 39.5 mt -114.18 133.73 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.007 -0.542 . . . . 4.64 111.591 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -93.43 126.68 38.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.384 -0.599 . . . . 7.14 109.384 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.47 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.9 tt -74.37 102.77 4.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 6.33 110.528 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mm -81.56 -64.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.498 -0.774 . . . . 6.97 111.197 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' B' ' 45' ' ' LYS . 69.1 m -154.47 112.3 3.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.683 0.623 . . . . 7.03 112.683 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.32 -72.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.979 -0.748 . . . . 7.52 108.979 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -45.04 96.05 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.096 -0.502 . . . . 8.93 111.381 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 4.5 t -112.08 -2.67 14.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.063 -0.517 . . . . 7.05 111.077 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.18 0.41 67.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.993 -0.622 . . . . 8.42 113.211 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -134.24 124.26 25.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.761 0.315 . . . . 7.96 111.205 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.11 131.9 50.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 8.2 111.035 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.16 -1.31 84.56 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.006 -0.616 . . . . 6.68 112.588 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.556 ' HE1' ' HB3' ' A' ' 8' ' ' LEU . 69.5 m95 -117.76 135.3 54.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.188 0.518 . . . . 5.83 111.543 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -123.51 155.42 37.58 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.086 -0.961 . . . . 5.87 109.033 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' B' ' 35' ' ' SER . 23.9 ttmm -113.45 130.35 56.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.908 0.385 . . . . 5.33 110.644 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.36 176.47 21.36 Favored Glycine 0 N--CA 1.453 -0.18 0 CA-C-N 115.73 -0.668 . . . . 4.14 112.056 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.39 135.02 51.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 6.02 110.414 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 50' ' ' GLY . 21.2 tp -130.12 170.02 14.58 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.332 -0.849 . . . . 4.21 110.109 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.53 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 25.3 m120 -17.88 65.19 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.401 1.63 . . . . 5.39 115.401 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.33 -12.95 57.3 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.776 0.67 . . . . 5.53 114.776 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -116.31 135.5 53.82 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.767 0.784 . . . . 5.33 111.19 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -108.81 152.95 24.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.117 -0.492 . . . . 5.79 109.853 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.18 -176.15 46.7 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.416 -0.897 . . . . 3.35 112.808 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.57 154.88 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.468 0.175 . . . . 4.3 110.571 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.475 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 46.5 p90 -141.49 140.18 20.05 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 112.755 0.65 . . . . 3.72 112.755 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 55' ' ' PHE . 96.7 Cg_endo -94.61 174.72 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.457 3.438 . . . . 3.97 110.637 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.472 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 79.75 -14.14 0.88 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.913 1.449 . . . . 5.85 114.913 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 58.5 t30 57.3 76.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.016 -0.735 . . . . 5.67 109.016 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 19.5 m-85 -101.66 6.46 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 3.89 111.948 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.1 139.01 40.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.466 0.543 . . . . 3.89 112.466 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.28 130.53 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 4.64 111.32 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -55.43 128.99 36.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.887 0.375 . . . . 6.72 111.092 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -88.4 -61.01 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.965 -0.561 . . . . 6.54 110.373 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.428 -0.796 . . . . 7.43 110.69 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' CA ' ' A' ' 63' ' ' LYS . 45.5 tpp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.829 0.347 . . . . 16.5 110.92 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -82.03 145.62 30.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 13.22 110.91 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -147.59 151.69 13.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 12.19 111.008 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.21 146.1 34.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 11.64 110.89 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 50.9 t -136.52 97.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 6.66 110.306 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.37 133.37 36.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 6.86 111.439 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.7 m -106.89 152.43 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 3.79 110.374 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.544 HD13 ' HE1' ' B' ' 43' ' ' TRP . 40.7 tp -56.45 -36.64 69.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 5.48 111.073 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -56.47 -36.11 68.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.056 -0.52 . . . . 7.65 111.209 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.29 8.62 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.068 -0.515 . . . . 7.08 112.351 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -100.16 124.79 45.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.942 0.401 . . . . 6.58 112.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -101.37 134.33 44.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.756 -0.656 . . . . 6.95 109.365 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.44 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 23.0 pt -119.72 143.67 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 5.97 111.623 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.6 p -101.32 137.62 39.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.484 -0.78 . . . . 8.28 110.952 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 mp -137.85 160.85 38.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.268 -0.423 . . . . 10.02 110.526 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.52 103.04 7.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 12.19 110.771 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.03 113.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.303 -0.408 . . . . 14.73 111.382 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.405 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 41.3 mt-10 -50.5 166.84 0.27 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.416 0.895 . . . . 18.57 113.416 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 28.7 Cg_exo -64.14 -33.62 60.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.442 2.761 . . . . 19.89 113.279 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -20.12 64.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.546 -0.297 . . . . 21.46 111.752 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.16 147.32 53.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 18.56 111.716 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 67.2 p -88.83 152.98 21.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.932 -0.576 . . . . 20.15 110.707 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.47 HD12 HD13 ' A' ' 50' ' ' LEU . 47.6 mm -57.07 -36.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.459 -0.337 . . . . 16.47 111.036 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -46.39 80.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 19.99 110.156 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -58.71 -42.84 89.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.863 -0.608 . . . . 16.38 110.303 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 56' ' ' LEU . 78.7 t -62.18 -41.64 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 13.8 110.524 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.52 -28.69 70.03 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.286 -0.415 . . . . 13.67 110.599 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.37 70.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 14.55 109.843 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -67.71 -46.24 72.78 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.831 -0.622 . . . . 13.7 109.48 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -61.49 -38.73 80.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.884 -0.598 . . . . 9.57 110.113 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -66.88 -32.28 73.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 15.04 110.697 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.99 -38.49 82.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 12.47 111.234 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -88.99 -51.18 5.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.265 0.469 . . . . 9.23 112.265 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.53 -10.87 47.41 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.487 0.921 . . . . 9.6 113.487 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.59 -37.39 2.06 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.533 -0.841 . . . . 12.2 114.3 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.522 HD12 HD21 ' A' ' 69' ' ' LEU . 8.4 pt -45.84 124.48 6.48 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 112.133 0.42 . . . . 11.27 112.133 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.68 144.48 89.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.969 2.446 . . . . 14.23 112.881 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.61 -28.31 82.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.84 2.36 . . . . 14.34 112.583 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.3 -27.51 68.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 16.96 111.359 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -100.3 -9.27 22.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.314 -0.403 . . . . 14.45 111.12 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -84.43 120.92 26.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 10.91 112.113 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -118.25 117.01 27.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.56 -0.746 . . . . 9.32 109.101 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.58 122.61 46.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.961 0.41 . . . . 10.56 111.963 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.741 ' HB ' HG21 ' B' ' 18' ' ' THR . 40.6 pt -111.03 127.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.639 -0.71 . . . . 9.75 110.439 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -129.48 120.52 25.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.489 -0.778 . . . . 15.27 110.795 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.35 19.69 9.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.615 . . . . 14.76 112.272 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.842 ' C ' HG22 ' B' ' 18' ' ' THR . . . 93.7 5.64 62.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.588 -0.815 . . . . 12.99 113.127 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 144.39 47.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.589 0.233 . . . . 17.08 110.491 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -79.14 140.46 37.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.235 -0.283 . . . . 14.97 110.235 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD13 HD12 ' A' ' 23' ' ' ILE . 90.8 mt -89.27 133.57 34.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.456 -0.338 . . . . 14.81 110.684 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.1 127.13 36.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 21.0 111.336 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -40.39 -51.38 2.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.793 -0.639 . . . . 18.5 111.373 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.71 -78.23 0.14 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.487 -0.863 . . . . 21.79 111.237 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -26.77 152.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.558 0.947 . . . . 24.16 113.558 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.4 p -107.05 164.09 12.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.194 -0.912 . . . . 21.36 111.256 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD11 HG21 ' A' ' 26' ' ' VAL . 11.2 mp -53.08 -39.19 63.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 18.41 111.241 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 m -61.63 -28.58 69.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 21.76 111.352 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.06 -38.31 90.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 23.14 111.055 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -96.05 12.54 30.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.443 . . . . 19.37 111.672 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.97 43.2 21.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.998 0.428 . . . . 22.24 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.7 mt -92.79 119.6 40.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.136 -0.484 . . . . 17.93 111.19 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -113.55 -170.43 1.69 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.256 -0.429 . . . . 21.49 111.491 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' CA ' ' SD ' ' A' ' 1' ' ' MET . 83.1 tttt -62.78 157.74 20.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.09 -0.505 . . . . 19.19 111.454 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 59.88 28.72 18.26 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.782 -0.645 . . . . 16.92 111.784 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -89.77 143.86 26.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.447 -0.342 . . . . 14.92 110.827 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -99.39 134.8 41.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 11.29 111.205 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.33 113.55 13.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.019 -0.537 . . . . 10.94 111.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.544 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 38.9 t-80 -83.62 119.32 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.999 0.428 . . . . 8.09 110.487 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.522 HD21 HD12 ' A' ' 36' ' ' ILE . 22.9 tp -95.25 121.3 36.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 6.7 110.777 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.898 -0.592 . . . . 7.13 110.527 -179.82 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 C--O 1.231 0.124 0 N-CA-C 109.105 -0.702 . . . . 7.56 109.105 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -128.4 165.1 21.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.185 0.517 . . . . 7.84 111.91 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 26.2 p -145.77 148.15 32.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.187 -0.915 . . . . 4.73 110.762 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -99.13 143.12 29.76 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.391 -0.368 . . . . 4.43 110.684 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -86.66 124.18 32.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.083 -0.508 . . . . 2.72 111.33 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -94.73 -21.13 18.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.223 0.453 . . . . 3.78 112.223 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.445 ' HA ' ' HD3' ' B' ' 14' ' ' PRO . 79.6 t80 -145.68 140.9 16.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.886 0.328 . . . . 4.88 111.886 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 13' ' ' PHE . 36.7 Cg_exo -61.61 139.75 82.98 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.809 2.339 . . . . 3.11 112.488 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -138.69 133.64 32.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.72 -0.673 . . . . 4.0 111.288 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.43 ' HA ' HG23 ' B' ' 24' ' ' THR . 68.9 m -111.65 119.13 37.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.426 . . . . 3.82 110.754 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.82 139.08 48.61 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.887 -0.673 . . . . 3.22 112.553 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.842 HG22 ' C ' ' A' ' 47' ' ' GLY . 24.9 p -103.94 -23.46 13.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.181 0.515 . . . . 4.64 110.705 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -120.38 154.6 34.87 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.197 -0.91 . . . . 4.05 109.757 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.5 -39.66 92.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 4.26 111.458 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.13 -4.8 34.97 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.908 0.385 . . . . 4.22 110.589 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.2 158.82 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.973 -0.558 . . . . 3.77 110.949 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' B' ' 24' ' ' THR . 3.6 tt -102.62 139.99 37.49 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.812 -0.811 . . . . 3.13 108.812 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.754 ' N ' HD23 ' B' ' 23' ' ' LEU . 98.6 m -112.38 123.88 51.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.531 -0.759 . . . . 2.46 109.474 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' B' ' 55' ' ' PHE . 15.9 p90 -135.61 146.01 47.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.962 0.727 . . . . 2.49 112.962 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.501 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 31.9 mmt180 -109.56 178.29 4.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.116 -0.327 . . . . 6.21 110.116 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -81.35 142.77 32.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 3.87 110.328 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 20.23 61.72 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.878 -0.889 . . . . 4.23 110.878 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.6 mm-40 -98.53 178.81 4.9 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.343 0.868 . . . . 4.19 113.343 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 21.9 mm -136.05 116.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.648 -1.615 . . . . 5.23 110.943 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.443 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 55.2 mt -112.35 137.84 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 4.64 111.083 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' HIS . . . . . 0.488 ' O ' ' HA2' ' B' ' 46' ' ' GLY . 1.8 m-70 -92.51 128.19 38.27 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.326 -0.62 . . . . 7.14 109.326 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.533 ' C ' HD23 ' B' ' 33' ' ' LEU . 6.1 tt -73.81 102.26 3.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 6.33 111.113 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' B' ' 47' ' ' GLU . 55.1 mt -81.1 -64.61 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.666 -0.697 . . . . 6.97 111.098 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.0 t -154.12 116.7 4.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 7.03 112.286 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 52.3 mtpt -69.52 6.22 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.984 -0.553 . . . . 7.52 111.398 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -121.61 98.46 5.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.593 0.235 . . . . 8.93 110.64 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 45' ' ' LYS . 48.1 p -108.07 -1.4 20.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.544 -0.298 . . . . 7.05 111.423 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.83 -4.2 75.09 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.782 -0.723 . . . . 8.42 111.565 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -129.31 121.49 27.61 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.385 0.274 . . . . 7.96 110.65 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.425 ' O ' HD11 ' A' ' 8' ' ' LEU . . . -59.87 133.28 55.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 8.2 110.507 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.25 82.11 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.927 -0.654 . . . . 6.68 112.387 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.544 ' HE1' HD13 ' A' ' 8' ' ' LEU . 86.3 m95 -120.35 122.32 40.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.053 0.427 . . . . 5.83 111.443 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' TRP . . . . . 0.485 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 30.7 m0 -111.56 162.73 14.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.103 -0.703 . . . . 5.87 109.103 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' B' ' 38' ' ' THR . 63.6 tttm -115.58 129.98 56.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.795 0.331 . . . . 5.33 110.405 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' B' ' 32' ' ' HIS . . . -142.82 177.43 21.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.654 -0.784 . . . . 4.14 112.359 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' B' ' 34' ' ' ILE . 36.5 tt0 -125.13 133.55 52.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.294 0.568 . . . . 6.02 110.778 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.675 ' O ' ' N ' ' B' ' 50' ' ' GLY . 42.5 tp -127.45 169.96 13.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.987 -1.006 . . . . 4.21 109.269 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.456 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 58.2 m-20 -17.92 64.45 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.256 1.576 . . . . 5.39 115.256 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.71 -10.84 63.52 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 114.937 0.735 . . . . 5.53 114.937 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.45 152.62 24.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.162 0.981 . . . . 5.33 110.988 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 1.2 pm0 -125.73 142.15 51.65 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.948 -0.76 . . . . 5.79 108.948 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLY . . . . . 0.466 ' C ' ' HB2' ' B' ' 23' ' ' LEU . . . -179.84 -171.27 42.57 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 120.254 -0.974 . . . . 3.35 113.101 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 33.4 m -111.77 151.11 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 120.704 0.288 . . . . 4.3 111.055 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 38.4 p90 -131.34 139.52 35.68 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 112.219 0.451 . . . . 3.72 112.219 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 55' ' ' PHE . 94.4 Cg_endo -97.95 174.26 0.57 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.297 3.332 . . . . 3.97 111.546 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.503 ' HB2' ' CD2' ' B' ' 59' ' ' PHE . 16.6 m-20 78.78 -10.68 1.31 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.49 1.293 . . . . 5.85 114.49 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' B' ' 60' ' ' ALA . 15.8 m120 58.15 26.68 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 118.43 0.559 . . . . 5.67 110.201 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.503 ' CD2' ' HB2' ' B' ' 57' ' ' ASP . 9.3 m-85 -56.64 3.97 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.201 0.815 . . . . 3.89 113.201 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' B' ' 58' ' ' ASN . . . -129.47 138.87 51.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.225 0.454 . . . . 3.89 112.225 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 128.06 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 4.64 111.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -53.72 156.64 2.61 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 120.932 0.396 . . . . 6.72 110.746 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.46 -32.71 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 6.54 110.45 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 74.5 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.369 -0.824 . . . . 7.43 110.529 179.75 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 tpp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.678 0.275 . . . . 16.5 110.835 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -84.7 142.37 29.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 13.22 110.794 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -145.42 151.43 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 12.19 110.712 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -109.93 145.48 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 11.64 110.795 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 5' ' ' VAL . 31.3 m -136.27 106.4 5.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.184 0.516 . . . . 6.66 110.678 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 7' ' ' THR . 81.5 tttt -75.94 163.14 27.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 6.86 111.076 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.471 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.3 m -137.43 142.16 41.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.681 -0.69 . . . . 3.79 109.895 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 9' ' ' THR . 3.2 pp -55.31 -21.86 16.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.453 -0.34 . . . . 5.48 111.65 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.435 ' H ' HG22 ' A' ' 7' ' ' THR . 31.5 m -71.18 -39.37 71.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.397 -0.365 . . . . 7.65 110.575 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.78 -1.95 5.97 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.076 -0.583 . . . . 7.08 112.872 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -98.99 129.4 45.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.011 0.434 . . . . 6.58 112.073 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -104.57 136.15 44.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.577 -0.738 . . . . 6.95 109.448 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 13' ' ' ILE . 5.1 mp -118.0 152.72 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 5.97 111.471 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.404 ' N ' HG22 ' A' ' 13' ' ' ILE . 24.9 m -108.89 135.07 50.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 8.28 110.425 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.4 tp -135.53 154.14 51.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.491 -0.322 . . . . 10.02 110.728 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.64 99.74 6.71 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.306 -0.406 . . . . 12.19 111.278 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -149.95 111.81 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.532 -0.303 . . . . 14.73 111.54 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -52.14 166.18 0.43 Allowed Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 114.176 1.176 . . . . 18.57 114.176 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.9 Cg_exo -60.16 -30.66 91.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.715 2.943 . . . . 19.89 113.864 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 m -80.95 32.92 0.32 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 21.46 111.552 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -118.7 126.9 52.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 18.56 110.896 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 77.1 p -64.71 148.87 50.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 20.15 111.151 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.45 HD12 HD23 ' A' ' 50' ' ' LEU . 41.0 mm -58.51 -37.68 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 16.47 110.88 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 11.0 pt-20 -61.77 -40.52 95.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 19.99 110.091 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -64.16 -43.8 94.05 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.883 -0.599 . . . . 16.38 109.785 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.28 -41.07 88.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.884 -0.598 . . . . 13.8 110.434 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.89 -29.22 70.6 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.228 -0.442 . . . . 13.67 110.415 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.62 74.73 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.106 -0.497 . . . . 14.55 109.691 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -64.34 -47.62 78.67 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.586 -0.733 . . . . 13.7 109.559 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.46 -40.61 86.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 115.856 -0.611 . . . . 9.57 110.134 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -63.38 -30.38 71.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 15.04 110.909 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.19 -35.94 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 12.47 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -88.89 -58.97 2.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.114 -0.494 . . . . 9.23 112.003 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -82.5 -11.43 58.49 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.396 0.887 . . . . 9.6 113.396 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.36 -29.99 1.93 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.498 -0.858 . . . . 12.2 114.056 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 46.8 mm -50.09 124.72 17.69 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.994 0.397 . . . . 11.27 111.917 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 40.8 Cg_exo -58.86 151.97 60.99 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.774 2.316 . . . . 14.23 112.341 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.09 -32.82 16.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.688 2.259 . . . . 14.34 112.114 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.84 -22.98 67.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.061 -0.518 . . . . 16.96 111.077 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -97.2 -18.06 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 14.45 110.86 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -78.73 124.17 27.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.046 0.451 . . . . 10.91 112.036 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.466 HH21 HG21 ' A' ' 70' ' ' VAL . 37.6 ttp180 -121.23 118.89 30.74 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.459 -0.941 . . . . 9.32 108.459 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.56 127.96 50.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.142 0.496 . . . . 10.56 112.046 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.724 HG23 HG21 ' B' ' 18' ' ' THR . 39.5 mm -115.49 120.33 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.273 -0.876 . . . . 9.75 110.474 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CB ' HD11 ' A' ' 50' ' ' LEU . 60.3 t80 -130.12 119.46 23.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.031 -0.531 . . . . 15.27 111.028 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.95 18.33 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 14.76 112.097 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.689 ' O ' HG22 ' B' ' 18' ' ' THR . . . 94.7 1.84 63.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.603 -0.808 . . . . 12.99 112.989 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -117.36 143.49 45.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 17.08 110.893 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.83 131.83 35.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 14.97 110.719 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 50' ' ' LEU . 5.4 mp -80.22 134.72 36.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.921 0.391 . . . . 14.81 111.403 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 130.29 35.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.837 -0.62 . . . . 21.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 4.0 p30 -44.28 -49.34 9.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 18.5 111.214 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -58.79 -76.11 0.23 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.62 -0.8 . . . . 21.79 111.573 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' GLY . 60.7 mtp180 -28.55 156.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.584 0.957 . . . . 24.16 113.584 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 9.3 t -110.9 164.1 13.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.061 -0.972 . . . . 21.36 110.506 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 92.7 mt -53.73 -36.57 62.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 18.41 111.629 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.7 t -62.34 -29.69 70.64 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.749 0.278 . . . . 21.76 111.749 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.33 -34.83 79.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.677 0.275 . . . . 23.14 110.945 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -93.77 4.71 53.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.472 . . . . 19.37 111.275 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 64.03 33.02 12.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.001 0.429 . . . . 22.24 110.897 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.8 mt -80.93 116.93 26.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.53 . . . . 17.93 111.582 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -107.4 -170.82 1.76 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.72 -0.673 . . . . 21.49 110.46 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.38 160.7 21.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.467 -0.333 . . . . 19.19 111.01 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.6 26.8 15.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.172 -0.467 . . . . 16.92 111.744 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 t -87.47 139.13 30.86 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.761 0.315 . . . . 14.92 111.09 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -100.03 129.15 46.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 11.29 110.975 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -127.36 114.89 18.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.125 -0.489 . . . . 10.94 110.783 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.96 122.32 25.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 8.09 110.937 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.47 116.27 28.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.912 -0.585 . . . . 6.7 110.335 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.466 HG21 HH21 ' A' ' 42' ' ' ARG . 38.2 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 7.13 111.735 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 . . . . . 0 C--O 1.232 0.171 0 N-CA-C 109.712 -0.477 . . . . 7.56 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.11 171.64 12.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.271 -0.422 . . . . 7.84 111.558 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 36.6 m -148.03 151.17 35.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.865 -0.607 . . . . 4.73 111.345 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -99.81 139.47 35.43 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.985 -0.376 . . . . 4.43 109.985 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 60.3 p -83.28 121.81 27.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.42 -0.355 . . . . 2.72 111.611 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.04 -20.85 23.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.552 -0.295 . . . . 3.78 111.309 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -147.57 157.46 44.64 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 4.88 111.13 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.76 140.77 26.57 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.665 2.243 . . . . 3.11 112.71 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.438 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 66.9 t80 -136.71 129.91 31.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 4.0 110.375 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.513 ' HA ' HG23 ' B' ' 24' ' ' THR . 7.4 t -113.0 121.33 44.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 3.82 111.52 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.29 145.61 49.73 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.822 -0.704 . . . . 3.22 111.865 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.724 HG21 HG23 ' A' ' 44' ' ' ILE . 57.9 p -107.98 -21.75 12.69 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.038 0.447 . . . . 4.64 111.255 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.61 162.35 18.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.539 -0.755 . . . . 4.05 110.516 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' B' ' 20' ' ' GLU . 1.8 mp0 -59.13 -27.94 66.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.897 -0.592 . . . . 4.26 112.544 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.73 -53.28 6.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.553 -0.459 . . . . 4.22 110.59 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -32.35 146.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.704 -0.68 . . . . 3.77 112.167 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' B' ' 24' ' ' THR . 3.2 tt -98.27 141.41 31.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.288 -1.005 . . . . 3.13 108.288 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.754 ' N ' HD23 ' B' ' 23' ' ' LEU . 95.9 m -113.96 122.9 48.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.84 -0.618 . . . . 2.46 110.374 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.482 ' CG ' HD11 ' B' ' 31' ' ' ILE . 37.1 p90 -138.54 155.27 48.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.614 0.598 . . . . 2.49 112.614 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.41 -179.86 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.222 -0.288 . . . . 6.21 110.222 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.18 141.49 32.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 3.87 110.177 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.87 58.94 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.736 -0.946 . . . . 4.23 110.736 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.497 ' HG2' ' H ' ' B' ' 30' ' ' ILE . 4.4 tt0 -99.29 179.28 4.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.23 0.826 . . . . 4.19 113.23 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.497 ' H ' ' HG2' ' B' ' 29' ' ' GLU . 30.3 mm -135.86 115.33 16.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.877 -1.51 . . . . 5.23 110.979 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.482 HD11 ' CG ' ' B' ' 25' ' ' PHE . 51.5 mt -114.49 145.88 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 4.64 111.166 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -97.43 129.22 44.67 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.514 -0.55 . . . . 7.14 109.514 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.404 ' C ' HD13 ' B' ' 33' ' ' LEU . 3.1 tm? -78.11 110.62 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 6.33 111.172 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -84.11 -58.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 6.97 111.264 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 70.6 m -158.92 121.43 3.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.32 0.489 . . . . 7.03 112.32 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.08 6.38 2.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.915 -0.584 . . . . 7.52 111.435 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.9 105.82 10.69 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.767 -0.197 . . . . 8.93 110.558 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.568 HG22 ' HB2' ' B' ' 45' ' ' LYS . 28.0 p -115.0 -3.3 12.65 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.806 0.299 . . . . 7.05 111.806 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.8 -9.04 77.69 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.759 -0.734 . . . . 8.42 112.233 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.73 118.69 30.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.698 0.285 . . . . 7.96 110.513 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.2 130.55 46.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 8.2 111.229 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 2.41 79.72 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.881 -0.599 . . . . 6.68 112.461 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 68.3 m95 -120.39 126.39 50.35 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.052 0.453 . . . . 5.83 112.023 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -110.85 165.08 12.14 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.589 -0.893 . . . . 5.87 108.589 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' B' ' 38' ' ' THR . 36.5 ttpt -119.86 129.95 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.956 0.408 . . . . 5.33 110.874 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.23 175.41 20.93 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.566 -0.743 . . . . 4.14 112.126 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -134.55 134.34 41.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 6.02 110.366 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 50' ' ' GLY . 52.5 tp -123.97 133.23 53.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 4.21 109.029 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -22.03 80.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.143 1.164 . . . . 5.39 114.143 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 125.24 -50.85 0.85 Allowed Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.57 -0.741 . . . . 5.53 114.753 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -112.06 153.87 26.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.998 0.899 . . . . 5.33 112.127 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.41 142.14 51.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.205 -0.907 . . . . 5.79 108.591 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.78 -176.08 41.96 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.086 -1.054 . . . . 3.35 113.245 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -112.85 152.91 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.576 0.227 . . . . 4.3 111.047 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 51.7 p90 -135.68 140.36 33.56 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.612 0.597 . . . . 3.72 112.612 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 64.6 Cg_endo -96.16 175.05 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.657 3.572 . . . . 3.97 110.976 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.537 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 3.2 m-20 77.34 -12.45 1.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.184 1.55 . . . . 5.85 115.184 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 58.19 75.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.424 -0.954 . . . . 5.67 108.424 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.537 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 17.3 m-85 -102.96 6.62 39.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.276 -0.874 . . . . 3.89 112.211 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.57 139.01 43.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.479 0.548 . . . . 3.89 112.479 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.84 130.0 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.942 -0.572 . . . . 4.64 111.561 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.466 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 8.9 tp-100 -54.19 112.68 1.02 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.738 0.304 . . . . 6.72 110.527 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 pt -90.6 -31.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 6.54 110.933 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.356 -0.83 . . . . 7.43 110.586 -179.827 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.823 0.344 . . . . 16.5 110.822 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.63 141.94 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 13.22 110.583 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.02 149.81 15.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.414 -0.357 . . . . 12.19 110.975 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -103.98 152.37 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 11.64 111.156 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.76 101.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.772 -0.649 . . . . 6.66 109.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -89.43 133.56 34.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.182 0.438 . . . . 6.86 112.182 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -103.15 160.0 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 3.79 111.158 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.546 HD22 ' HE1' ' B' ' 43' ' ' TRP . 3.8 pp -64.78 -24.72 67.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.047 -0.524 . . . . 5.48 111.178 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.448 ' N ' HD12 ' A' ' 8' ' ' LEU . 77.1 p -67.79 -35.88 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.288 -0.415 . . . . 7.65 110.985 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.69 3.64 7.68 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.109 -0.567 . . . . 7.08 112.675 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -99.65 126.64 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.275 0.472 . . . . 6.58 112.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -101.07 133.67 45.24 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.712 -0.676 . . . . 6.95 109.467 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 13' ' ' ILE . 4.6 mp -117.59 142.03 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 5.97 111.68 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.717 -0.674 . . . . 8.28 110.029 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.465 HD11 HG12 ' A' ' 30' ' ' ILE . 35.9 mt -134.58 155.22 50.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.525 -0.307 . . . . 10.02 110.959 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -123.0 99.82 6.57 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.199 -0.455 . . . . 12.19 111.028 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 17' ' ' VAL . 11.2 p -153.04 115.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.542 -0.299 . . . . 14.73 111.731 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 43.6 mt-10 -51.46 168.77 0.25 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 113.867 1.062 . . . . 18.57 113.867 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 16.7 Cg_exo -69.39 -23.19 32.76 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.572 2.848 . . . . 19.89 113.344 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -84.12 28.96 0.58 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.673 0.273 . . . . 21.46 111.546 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -116.58 139.83 50.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.428 -0.351 . . . . 18.56 110.839 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 81.4 p -73.76 151.37 40.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 20.15 111.41 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.25 -36.54 69.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.352 -0.386 . . . . 16.47 110.384 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -43.15 99.53 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.4 -0.593 . . . . 19.99 109.4 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -60.62 -43.21 97.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.789 -0.641 . . . . 16.38 110.081 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 56' ' ' LEU . 93.3 t -62.57 -42.5 96.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.937 -0.574 . . . . 13.8 110.4 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.01 -28.7 69.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.125 -0.489 . . . . 13.67 110.421 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.89 71.68 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.59 -0.522 . . . . 14.55 109.59 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -62.93 -48.47 78.77 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.598 -0.728 . . . . 13.7 109.367 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.465 HG12 HD11 ' A' ' 15' ' ' LEU . 79.7 mt -61.1 -42.67 94.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.518 -0.764 . . . . 9.57 109.904 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -60.38 -28.41 68.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.602 -0.727 . . . . 15.04 110.833 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -75.74 -36.57 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 12.47 110.936 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.45 -64.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.05 -0.523 . . . . 9.23 112.035 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -78.49 -8.36 58.46 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.719 1.007 . . . . 9.6 113.719 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.66 26.96 67.45 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.388 -0.911 . . . . 12.2 113.416 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -98.27 118.59 63.31 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.799 0.299 . . . . 11.27 110.559 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.99 135.97 51.95 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.583 2.188 . . . . 14.23 112.219 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.79 -29.32 76.74 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.219 . . . . 14.34 112.046 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.1 -24.63 66.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.886 -0.597 . . . . 16.96 111.036 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -99.28 -16.3 18.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.025 -0.534 . . . . 14.45 110.979 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -80.03 123.8 28.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.005 0.431 . . . . 10.91 111.769 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.493 ' HB3' HG13 ' A' ' 70' ' ' VAL . 47.8 ttp180 -122.21 121.99 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.337 -0.986 . . . . 9.32 108.337 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 50' ' ' LEU . 92.2 mt -106.11 129.69 54.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.024 0.44 . . . . 10.56 112.031 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mt -116.17 121.03 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 9.75 110.52 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.689 ' HB3' HD21 ' A' ' 50' ' ' LEU . 72.2 t80 -128.05 117.29 21.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 15.27 110.57 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.58 22.14 10.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 14.76 111.392 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -10.25 67.47 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.01 -0.614 . . . . 12.99 112.767 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.07 -163.04 0.08 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.244 0.218 . . . . 17.08 111.124 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 -13.51 6.59 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.711 1.004 . . . . 14.97 113.711 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.689 HD21 ' HB3' ' A' ' 45' ' ' PHE . 2.2 mm? 58.5 106.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.788 0.328 . . . . 14.81 111.421 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -92.13 130.23 37.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.337 -0.392 . . . . 21.0 111.601 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -40.23 -60.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.82 -0.627 . . . . 18.5 111.35 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -50.75 -75.49 0.21 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.529 -0.843 . . . . 21.79 111.552 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' GLY . 32.4 mmt180 -27.53 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 24.16 113.479 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 6.3 t -111.72 164.04 13.47 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.154 -0.93 . . . . 21.36 111.093 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.3 mm? -51.72 -44.29 63.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.344 -0.389 . . . . 18.41 111.2 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 t -58.33 -29.37 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.14 -0.482 . . . . 21.76 111.602 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.85 -35.6 81.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 23.14 110.892 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -98.68 11.84 37.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 19.37 111.327 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 58.11 38.26 26.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.907 0.384 . . . . 22.24 111.317 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.32 115.96 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 17.93 110.864 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -109.35 -168.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.849 -0.614 . . . . 21.49 110.948 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.84 160.71 11.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 19.19 111.338 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 57.99 29.81 18.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.853 -0.612 . . . . 16.92 111.701 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.0 p -89.79 138.1 31.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 14.92 111.299 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.49 ' C ' HD12 ' A' ' 67' ' ' LEU . 76.0 p -99.94 127.25 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 11.29 110.797 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 66' ' ' THR . 8.2 mp -122.46 121.26 36.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.406 . . . . 10.94 110.884 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 8.09 110.941 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -94.9 113.89 25.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 6.7 110.244 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 7.13 110.993 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 . . . . . 0 C--O 1.232 0.165 0 N-CA-C 109.365 -0.606 . . . . 7.56 109.365 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.05 173.02 12.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 7.84 111.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.479 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 7.5 p -148.23 151.69 35.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.7 -0.682 . . . . 4.73 111.527 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -99.6 141.33 32.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.29 -0.414 . . . . 4.43 110.033 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 46.2 p -84.56 123.69 30.59 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.373 -0.376 . . . . 2.72 111.557 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.81 -21.03 23.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 3.78 110.514 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -148.53 156.25 42.08 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 4.88 110.703 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.04 143.62 36.51 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.608 2.205 . . . . 3.11 113.027 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' B' ' 15' ' ' TYR . 11.9 t80 -130.58 68.67 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 4.0 110.377 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.895 ' HA ' HG23 ' B' ' 24' ' ' THR . 90.1 m -53.92 115.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 3.82 110.707 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.61 140.01 47.16 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.772 -0.649 . . . . 3.22 112.181 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -102.68 -24.37 13.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.148 0.499 . . . . 4.64 110.925 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -119.11 165.14 14.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.491 -0.777 . . . . 4.05 110.324 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.33 -38.61 78.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 4.26 111.781 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.57 -6.01 43.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.884 0.373 . . . . 4.22 110.6 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.99 162.63 15.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.779 -0.646 . . . . 3.77 110.868 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 23' ' ' LEU . 36.3 mt -108.47 150.8 26.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.197 -0.668 . . . . 3.13 109.197 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.895 HG23 ' HA ' ' B' ' 16' ' ' THR . 32.1 m -114.15 127.41 55.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 2.46 110.155 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.558 ' CE1' HG12 ' B' ' 31' ' ' ILE . 50.3 m-85 -133.28 144.97 50.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.037 0.754 . . . . 2.49 113.037 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.492 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 11.1 ptp180 -109.42 176.49 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.698 -0.853 . . . . 6.21 108.698 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.27 126.41 31.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.65 0.738 . . . . 3.87 109.921 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 26.2 7.14 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.347 -1.297 . . . . 4.23 110.734 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 23.3 mm-40 -98.53 178.9 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.773 1.027 . . . . 4.19 113.773 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 mm -135.95 116.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.557 -1.656 . . . . 5.23 110.826 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.558 HG12 ' CE1' ' B' ' 25' ' ' PHE . 53.7 mt -108.36 132.21 56.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.044 -0.525 . . . . 4.64 111.446 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -91.67 125.53 36.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.029 -0.73 . . . . 7.14 109.029 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.82 100.67 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 6.33 110.966 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 45.4 mm -82.73 -58.31 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 6.97 110.972 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 66.8 m -157.18 105.89 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 7.03 111.656 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.437 ' NZ ' ' HB2' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -66.66 5.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 7.52 111.896 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -121.19 102.03 8.04 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 120.562 0.22 . . . . 8.93 110.459 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.443 HG22 ' HB2' ' B' ' 45' ' ' LYS . 42.9 p -110.71 -4.66 15.24 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.488 -0.323 . . . . 7.05 111.713 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.54 -1.2 71.89 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.967 -0.635 . . . . 8.42 112.446 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -129.45 120.54 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.189 -0.3 . . . . 7.96 110.189 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.03 132.74 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 8.2 111.108 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 1.57 81.79 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.688 -0.687 . . . . 6.68 112.394 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.622 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 53.6 m95 -120.78 123.15 41.94 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.937 0.398 . . . . 5.83 111.731 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' TRP . . . . . 0.414 ' NE1' ' HB2' ' B' ' 36' ' ' LYS . 3.7 m0 -112.93 161.43 17.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.062 -0.718 . . . . 5.87 109.062 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.443 ' HB2' HG22 ' B' ' 38' ' ' THR . 64.1 tttp -116.07 130.56 56.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.09 0.471 . . . . 5.33 111.216 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.54 175.45 21.22 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.407 -0.815 . . . . 4.14 111.562 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.1 132.66 53.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.223 0.535 . . . . 6.02 110.32 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.627 ' O ' ' N ' ' B' ' 50' ' ' GLY . 60.0 tp -124.87 169.22 12.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.219 -0.901 . . . . 4.21 110.224 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.519 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 62.5 m-20 -18.62 67.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.283 1.586 . . . . 5.39 115.283 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.98 -10.22 63.64 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.981 0.753 . . . . 5.53 114.981 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -110.38 155.11 22.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.92 0.86 . . . . 5.33 111.045 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' B' ' 52' ' ' GLU . 0.0 OUTLIER -127.58 140.29 52.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.909 -0.774 . . . . 5.79 108.909 178.256 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.8 -175.46 40.71 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.041 -1.076 . . . . 3.35 113.455 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.21 150.02 15.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.451 0.167 . . . . 4.3 111.076 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 50.6 p90 -134.97 140.45 35.06 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.049 0.452 . . . . 3.72 112.167 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.622 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.6 Cg_endo -95.09 174.61 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.458 3.439 . . . . 3.97 111.641 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.567 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 78.09 -12.83 1.03 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.255 1.576 . . . . 5.85 115.255 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 56.27 77.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.832 0.742 . . . . 5.67 109.103 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.9 m-85 -101.87 6.84 41.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.382 -0.826 . . . . 3.89 111.694 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.479 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -137.78 138.22 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.575 0.583 . . . . 3.89 112.575 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.69 130.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.866 -0.606 . . . . 4.64 111.77 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.405 HE22 ' C ' ' B' ' 64' ' ' SER . 0.0 OUTLIER -59.85 132.2 53.23 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.749 -0.463 . . . . 6.72 109.749 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 24.7 pt -139.31 37.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.924 0.392 . . . . 6.54 111.626 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' SER . . . . . 0.405 ' C ' HE22 ' B' ' 62' ' ' GLN . 30.4 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.23 -0.89 . . . . 7.43 110.85 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.605 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 95.2 mtp . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.836 0.35 . . . . 16.5 110.786 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -81.55 151.75 27.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.821 -0.627 . . . . 13.22 110.786 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -143.7 146.75 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 12.19 110.341 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -95.82 139.17 32.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 11.64 110.503 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.32 91.33 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.45 -0.574 . . . . 6.66 109.45 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.14 153.29 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.843 -0.617 . . . . 6.86 111.678 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 8' ' ' LEU . 24.6 m -133.6 159.82 39.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 3.79 109.398 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.819 ' H ' HD22 ' A' ' 8' ' ' LEU . 2.0 mm? -58.67 -37.95 77.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.944 0.402 . . . . 5.48 110.761 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.9 m -61.14 -22.35 64.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.812 -0.631 . . . . 7.65 111.262 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.36 17.66 21.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.079 -0.582 . . . . 7.08 112.141 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -99.38 110.37 22.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.299 . . . . 6.58 111.189 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -98.64 129.67 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 6.95 110.028 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 13' ' ' ILE . 4.4 mp -118.96 144.67 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.954 0.406 . . . . 5.97 111.285 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 p -96.6 136.54 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 8.28 110.867 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 tp -137.64 151.47 48.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.317 -0.401 . . . . 10.02 110.284 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.96 105.24 13.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.63 -0.259 . . . . 12.19 111.474 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -152.83 112.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.436 0.532 . . . . 14.73 112.436 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 1.5 mp0 -56.63 172.89 0.33 Allowed Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 112.881 0.696 . . . . 18.57 112.881 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 30.1 Cg_exo -63.99 -37.47 43.2 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.42 2.746 . . . . 19.89 112.73 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -63.67 -25.55 68.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 21.46 111.541 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.4 147.59 25.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.472 -0.331 . . . . 18.56 111.188 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -93.89 145.51 24.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.059 -0.519 . . . . 20.15 110.948 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 50' ' ' LEU . 24.8 mt -55.93 -31.8 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 16.47 111.505 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.28 -38.68 90.28 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.943 -0.391 . . . . 19.99 109.943 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -69.84 -40.72 75.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.966 -0.561 . . . . 16.38 109.95 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.28 -49.79 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 115.977 -0.556 . . . . 13.8 110.355 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HE2' HD13 ' A' ' 43' ' ' LEU . 97.7 mttt -59.07 -37.5 77.22 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.079 -0.509 . . . . 13.67 110.975 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.18 -38.28 87.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.294 -0.412 . . . . 14.55 110.944 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.59 -43.29 80.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.122 -0.49 . . . . 13.7 110.192 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.88 -36.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.143 -0.48 . . . . 9.57 109.772 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.432 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 59.0 tt0 -67.07 -29.17 68.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.898 -0.592 . . . . 15.04 111.164 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.3 -37.62 74.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 12.47 111.119 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -89.82 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.12 0.415 . . . . 9.23 112.12 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -83.15 -9.44 59.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.112 0.782 . . . . 9.6 113.112 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 62.54 25.02 66.64 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.427 -0.892 . . . . 12.2 113.208 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.1 mt -97.39 116.62 65.92 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.792 0.296 . . . . 11.27 110.829 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.95 138.71 70.07 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.698 2.266 . . . . 14.23 112.438 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.97 -22.7 55.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.585 2.19 . . . . 14.34 112.191 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.58 -25.28 66.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.535 . . . . 16.96 111.311 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -106.9 -5.48 18.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.368 -0.378 . . . . 14.45 111.572 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -88.95 127.0 35.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.948 0.404 . . . . 10.91 111.923 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 17.0 tpt180 -125.12 121.78 35.25 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.852 -0.796 . . . . 9.32 108.852 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.405 HD13 ' HE2' ' A' ' 27' ' ' LYS . 9.4 mp -102.8 126.55 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 10.56 111.186 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -112.65 129.76 67.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 9.75 110.406 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 50' ' ' LEU . 67.5 t80 -147.36 124.41 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 15.27 110.421 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.8 17.51 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 14.76 111.454 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.52 -3.62 81.79 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.786 -0.721 . . . . 12.99 112.593 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.22 150.32 32.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.778 0.323 . . . . 17.08 110.982 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -83.24 124.94 31.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 14.97 110.506 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 23' ' ' ILE . 48.9 mt -64.7 131.65 47.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 14.81 111.109 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.4 tp10 -90.31 127.29 36.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.996 -0.547 . . . . 21.0 110.917 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -41.45 34.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.599 -0.728 . . . . 18.5 112.301 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -0.12 83.79 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.982 -0.628 . . . . 21.79 114.208 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 51' ' ' GLU . 2.2 mpt_? -99.69 173.95 6.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.044 0.422 . . . . 24.16 110.961 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.2 p -119.19 158.21 26.43 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.22 -0.445 . . . . 21.36 111.04 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 8.4 mp -52.97 -28.91 26.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 18.41 111.826 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 p -72.78 -21.77 60.94 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.735 0.303 . . . . 21.76 111.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.58 -42.37 87.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.193 -0.458 . . . . 23.14 110.958 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.2 10.18 32.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.251 -0.431 . . . . 19.37 111.579 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.81 24.27 11.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.48 0.548 . . . . 22.24 112.48 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -57.56 155.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.721 -0.474 . . . . 17.93 109.721 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -149.59 165.63 31.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.737 -0.468 . . . . 21.49 109.737 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -52.4 146.98 8.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 19.19 111.506 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.56 30.04 10.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.869 -0.605 . . . . 16.92 111.776 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.1 p -86.72 160.9 18.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 14.92 110.898 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.6 m -115.48 124.74 51.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 11.29 110.635 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.4 mm? -113.39 122.45 47.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.23 -0.441 . . . . 10.94 110.294 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 23.4 t60 -85.94 112.82 21.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 8.09 111.078 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.56 118.12 31.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.009 -0.541 . . . . 6.7 110.737 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.622 HG22 HD21 ' A' ' 8' ' ' LEU . 39.5 t . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 7.13 110.881 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.231 0.107 0 N-CA-C 109.383 -0.599 . . . . 7.56 109.383 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -130.44 169.36 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.978 0.418 . . . . 7.84 111.622 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.581 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 9.5 p -149.02 151.86 35.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 4.73 111.114 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -99.22 143.38 29.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.211 -0.45 . . . . 4.43 110.835 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.453 HG21 ' HB3' ' B' ' 25' ' ' PHE . 41.7 p -84.7 125.23 32.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.165 -0.47 . . . . 2.72 111.84 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.54 -21.85 20.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.327 -0.397 . . . . 3.78 111.379 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.26 160.64 59.08 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 120.714 0.292 . . . . 4.88 111.622 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' ' 26' ' ' ARG . 92.6 Cg_endo -81.23 71.61 6.88 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.86 2.373 . . . . 3.11 113.619 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -64.58 127.65 32.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.042 -0.526 . . . . 4.0 111.309 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.54 ' HA ' HG23 ' B' ' 24' ' ' THR . 30.1 m -112.97 120.19 40.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.505 -0.316 . . . . 3.82 111.39 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.09 138.41 47.87 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.962 -0.637 . . . . 3.22 111.932 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.455 HG21 HG12 ' A' ' 44' ' ' ILE . 13.4 t -104.26 -24.58 13.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.936 0.398 . . . . 4.64 111.536 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -116.37 162.88 16.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.785 -0.643 . . . . 4.05 110.052 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.14 -41.05 86.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.211 -0.449 . . . . 4.26 111.044 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.48 -4.89 36.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.088 0.47 . . . . 4.22 109.961 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -83.34 156.87 22.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.53 -0.759 . . . . 3.77 110.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.758 HD13 ' H ' ' B' ' 24' ' ' THR . 0.4 OUTLIER -107.11 146.61 31.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.803 -1.184 . . . . 3.13 107.803 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.758 ' H ' HD13 ' B' ' 23' ' ' LEU . 53.3 m -111.83 128.08 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 2.46 110.352 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.6 ' CZ ' HD12 ' B' ' 23' ' ' LEU . 73.3 m-85 -128.02 128.62 45.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.323 0.49 . . . . 2.49 112.323 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.497 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 24.4 mmm180 -100.58 174.37 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.285 -0.635 . . . . 6.21 109.285 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.71 137.7 35.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.169 0.509 . . . . 3.87 110.229 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.24 21.65 51.21 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.704 -0.958 . . . . 4.23 110.704 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 21.6 mm-40 -99.36 -179.81 4.34 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.393 0.886 . . . . 4.19 113.393 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.2 mm -135.07 118.7 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.83 -1.532 . . . . 5.23 110.748 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.581 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 17.3 mt -112.23 136.74 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.911 -0.586 . . . . 4.64 112.1 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -95.06 125.8 39.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.901 -0.777 . . . . 7.14 108.901 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.466 ' C ' HD23 ' B' ' 33' ' ' LEU . 4.3 tt -74.34 105.89 5.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 6.33 111.622 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' B' ' 47' ' ' GLU . 75.5 mt -80.8 -65.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.577 -0.738 . . . . 6.97 110.793 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -153.08 129.65 10.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.86 -0.609 . . . . 7.03 111.929 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.403 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 48.9 mtpt -84.04 6.44 22.08 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.901 -0.591 . . . . 7.52 111.535 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 94.84 4.46 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.224 -0.287 . . . . 8.93 110.224 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 76.2 p -104.81 -1.96 25.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.413 -0.358 . . . . 7.05 111.706 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.3 -3.18 72.15 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.974 -0.632 . . . . 8.42 112.452 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -135.41 124.42 24.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.767 0.318 . . . . 7.96 110.49 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.07 57.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 8.2 110.881 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.59 2.38 82.2 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.639 -0.709 . . . . 6.68 112.404 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 69.5 m95 -119.12 121.64 40.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.901 0.381 . . . . 5.83 111.443 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' TRP . . . . . 0.403 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 36.5 m0 -113.07 168.57 9.59 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.813 -0.81 . . . . 5.87 108.813 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -125.11 129.65 50.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 5.33 110.704 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.11 174.69 21.79 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.812 -0.709 . . . . 4.14 112.316 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.493 ' HB2' HD11 ' B' ' 34' ' ' ILE . 34.0 tt0 -125.7 133.25 52.2 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.225 0.536 . . . . 6.02 110.728 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 50' ' ' GLY . 28.6 tp -127.93 171.18 12.04 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.184 -0.916 . . . . 4.21 109.889 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.461 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 79.4 m-20 -17.81 67.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.43 1.641 . . . . 5.39 115.43 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.6 -10.02 63.26 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 115.128 0.811 . . . . 5.53 115.128 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -109.94 154.41 23.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.15 0.975 . . . . 5.33 111.197 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.68 140.79 51.86 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.996 -0.742 . . . . 5.79 108.996 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.33 -176.03 42.38 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.012 -1.089 . . . . 3.35 113.358 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.82 152.72 15.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.432 0.158 . . . . 4.3 110.985 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 52.3 p90 -136.56 141.02 33.95 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.384 0.513 . . . . 3.72 112.384 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 95.2 Cg_endo -94.99 174.73 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.498 3.465 . . . . 3.97 111.275 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.566 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 24.2 m-20 75.43 -11.01 1.15 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.079 1.511 . . . . 5.85 115.079 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 56.33 76.63 0.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.829 -0.804 . . . . 5.67 108.829 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.1 m-85 -100.9 8.27 43.2 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.16 -0.927 . . . . 3.89 111.553 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.473 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -136.89 138.63 40.9 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.664 0.616 . . . . 3.89 112.664 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -113.42 127.17 70.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 4.64 111.296 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -54.47 108.23 0.36 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.851 0.358 . . . . 6.72 110.503 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.29 -36.37 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 6.54 110.934 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.38 -0.819 . . . . 7.43 110.746 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.01 0.433 . . . . 16.5 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -84.22 149.9 25.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.822 -0.626 . . . . 13.22 110.537 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -144.04 149.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 12.19 110.692 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.34 136.32 42.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 11.64 110.479 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 40.8 t -121.19 96.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.574 -0.528 . . . . 6.66 109.574 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 7' ' ' THR . 52.5 tttm -77.34 162.99 26.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.672 -0.694 . . . . 6.86 111.527 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.42 ' N ' ' CG ' ' A' ' 6' ' ' LYS . 56.8 p -142.16 160.99 39.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.467 -0.788 . . . . 3.79 110.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 8' ' ' LEU . 2.3 pt? -64.33 -22.76 67.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 5.48 111.175 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -81.82 -12.37 58.54 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.263 -0.426 . . . . 7.65 111.618 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 16.69 41.79 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.886 -0.673 . . . . 7.08 112.547 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -97.86 108.31 20.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.899 0.38 . . . . 6.58 111.354 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 p -100.06 126.01 46.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 6.95 110.256 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.427 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 36.1 pt -120.83 146.55 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.39 . . . . 5.97 111.253 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.5 p -97.06 140.46 31.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.87 -0.605 . . . . 8.28 111.123 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 29' ' ' LYS . 63.2 tp -138.4 149.7 45.79 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.247 -0.433 . . . . 10.02 110.258 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -109.46 103.79 12.75 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.872 0.323 . . . . 12.19 111.872 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -153.83 112.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.268 -0.424 . . . . 14.73 111.615 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.521 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 25.0 mt-10 -63.71 173.32 1.35 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.708 0.633 . . . . 18.57 112.708 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.588 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 50.7 Cg_exo -57.98 -42.35 59.08 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.333 2.688 . . . . 19.89 113.741 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.0 m -60.42 -23.99 64.83 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.039 0.385 . . . . 21.46 112.039 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.31 148.48 32.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.845 0.355 . . . . 18.56 111.276 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -92.74 145.87 24.08 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.107 -0.497 . . . . 20.15 111.14 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.42 HD13 ' O ' ' A' ' 54' ' ' ARG . 1.1 mp -55.82 -34.49 37.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 16.47 111.205 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.2 -41.07 98.02 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.894 -0.41 . . . . 19.99 109.894 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.22 -37.49 85.68 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.825 -0.625 . . . . 16.38 110.035 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 CA-C-N 116.152 -0.476 . . . . 13.8 110.037 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -58.61 -34.71 71.45 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.888 -0.597 . . . . 13.67 110.628 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 31' ' ' GLN . . . -68.23 -34.64 76.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 14.55 111.102 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HB3' HD11 ' A' ' 15' ' ' LEU . 79.7 mttt -73.71 -38.46 64.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 13.7 110.383 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.446 ' CG2' HD11 ' A' ' 36' ' ' ILE . 85.7 mt -65.01 -40.11 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 9.57 110.742 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 21.1 pt20 -69.72 -19.39 63.55 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.61 -0.268 . . . . 15.04 111.226 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -75.27 -35.33 61.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 12.47 110.467 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -93.1 -53.81 3.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.992 -0.549 . . . . 9.23 112.021 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.69 -11.62 55.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.842 0.682 . . . . 9.6 112.842 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 5.08 52.09 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.556 -0.83 . . . . 12.2 114.015 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.446 HD11 ' CG2' ' A' ' 30' ' ' ILE . 22.2 pt -79.82 128.91 72.67 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 117.355 0.578 . . . . 11.27 111.02 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.56 142.66 59.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.572 2.181 . . . . 14.23 112.738 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -24.66 64.74 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.881 2.387 . . . . 14.34 112.109 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.59 -24.9 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.894 -0.594 . . . . 16.96 111.142 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -108.59 -7.03 15.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.302 -0.408 . . . . 14.45 111.469 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -80.95 126.48 31.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 10.91 111.547 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -124.29 112.07 16.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 9.32 109.327 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.4 mp -98.06 124.59 42.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 10.56 111.16 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.523 HD12 HG21 ' B' ' 18' ' ' THR . 16.8 mm -113.71 131.52 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.833 -0.621 . . . . 9.75 110.646 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -147.53 119.22 8.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.616 . . . . 15.27 110.439 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.35 29.97 9.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.993 -0.549 . . . . 14.76 112.154 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.37 -3.69 76.48 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.426 -0.892 . . . . 12.99 113.239 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -114.84 146.84 40.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.803 0.335 . . . . 17.08 111.116 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -82.49 128.75 34.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 14.97 110.381 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.76 130.62 43.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 14.81 110.995 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.48 123.89 33.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.927 -0.578 . . . . 21.0 111.017 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -36.26 -57.18 0.74 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.992 -0.549 . . . . 18.5 111.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -52.93 -75.04 0.24 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.771 -0.728 . . . . 21.79 112.019 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.42 ' O ' HD13 ' A' ' 23' ' ' ILE . 29.5 mmt180 -29.17 158.11 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.911 1.078 . . . . 24.16 113.911 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -111.4 165.72 11.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.087 -0.96 . . . . 21.36 111.322 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.5 mm? -53.42 -32.48 49.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.189 -0.46 . . . . 18.41 111.86 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -70.05 -21.7 63.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.653 0.263 . . . . 21.76 111.5 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.97 -38.45 86.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 23.14 111.041 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -97.91 8.47 44.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 19.37 111.615 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 59.3 46.96 12.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.954 0.407 . . . . 22.24 111.137 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.03 107.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 17.93 110.912 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -91.66 -178.87 5.19 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.016 -0.538 . . . . 21.49 110.936 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.55 157.06 33.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.835 0.35 . . . . 19.19 111.124 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.2 24.95 14.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.809 -0.632 . . . . 16.92 111.684 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -85.78 161.18 19.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.712 0.292 . . . . 14.92 110.814 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.417 ' C ' HD12 ' A' ' 67' ' ' LEU . 4.5 t -116.73 126.85 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 11.29 110.84 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.6 mp -115.27 121.48 43.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 10.94 110.164 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -83.96 112.47 20.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.944 0.402 . . . . 8.09 111.778 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.403 HD21 HD12 ' A' ' 36' ' ' ILE . 65.4 tp -91.8 119.71 31.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 6.7 109.62 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 121.241 0.544 . . . . 7.13 112.346 -178.846 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.233 0.213 0 N-CA-C 108.834 -0.802 . . . . 7.56 108.834 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -124.76 159.92 29.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 7.84 111.828 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 16.8 m -141.14 146.35 36.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.186 -0.915 . . . . 4.73 110.569 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -100.47 133.23 45.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 4.43 110.199 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.3 m -73.85 127.13 32.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 2.72 110.913 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.8 mt -95.87 -22.1 17.66 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.144 0.424 . . . . 3.78 112.144 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -142.66 154.51 62.99 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 117.981 0.355 . . . . 4.88 111.614 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' B' ' 25' ' ' PHE . 74.2 Cg_endo -75.01 136.25 20.12 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.525 2.15 . . . . 3.11 112.913 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -139.16 129.12 25.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 4.0 109.883 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 31.8 m -110.84 121.35 45.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.85 0.357 . . . . 3.82 110.617 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.73 128.76 43.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.98 -0.629 . . . . 3.22 112.586 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.523 HG21 HD12 ' A' ' 44' ' ' ILE . 5.3 t -103.16 -23.07 13.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.182 0.515 . . . . 4.64 110.63 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -119.89 159.41 24.7 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.123 -0.944 . . . . 4.05 109.853 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.5 -29.13 69.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.386 0.513 . . . . 4.26 112.386 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -86.53 -2.64 58.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.945 -0.302 . . . . 4.22 111.682 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.55 160.17 16.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 3.77 111.281 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.602 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -117.24 165.46 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.246 -0.65 . . . . 3.13 109.246 178.004 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 61.7 m -115.42 128.65 56.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 2.46 110.187 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 10.8 m-85 -131.92 133.43 44.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.301 0.482 . . . . 2.49 112.301 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.53 176.26 5.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.826 -0.435 . . . . 6.21 109.826 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.21 136.68 35.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 3.87 110.323 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.79 55.42 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.571 -0.74 . . . . 4.23 111.318 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -100.13 179.72 4.4 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.877 1.066 . . . . 4.19 113.877 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.49 136.11 60.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.781 -1.554 . . . . 5.23 111.129 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.455 HD12 ' HB2' ' B' ' 60' ' ' ALA . 35.8 mt -132.86 133.09 59.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 4.64 111.207 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -90.21 126.49 35.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.58 -0.526 . . . . 7.14 109.58 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.531 ' C ' HD23 ' B' ' 33' ' ' LEU . 4.3 tt -73.47 102.08 3.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.995 0.426 . . . . 6.33 111.149 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 23.5 mm -84.08 -61.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.765 -0.652 . . . . 6.97 111.418 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.2 t -155.17 108.5 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.194 0.442 . . . . 7.03 112.194 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.475 ' HG3' HD21 ' B' ' 33' ' ' LEU . 38.3 mtmm -65.95 5.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.598 . . . . 7.52 111.722 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.44 101.07 7.39 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.535 0.207 . . . . 8.93 110.678 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.444 HG22 ' HB2' ' B' ' 45' ' ' LYS . 68.8 p -111.11 -4.38 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.449 -0.341 . . . . 7.05 111.184 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.18 -1.77 62.99 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.018 -0.611 . . . . 8.42 112.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.77 120.89 27.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.811 0.338 . . . . 7.96 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.79 56.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 8.2 110.962 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.63 1.56 85.41 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.826 -0.625 . . . . 6.68 112.421 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.408 ' HE1' ' HB3' ' A' ' 8' ' ' LEU . 83.6 m95 -123.31 120.39 32.95 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.289 0.544 . . . . 5.83 111.751 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' TRP . . . . . 0.565 ' HB2' ' CZ ' ' B' ' 55' ' ' PHE . 37.4 m0 -108.43 166.33 10.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.515 -0.766 . . . . 5.87 109.494 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.444 ' HB2' HG22 ' B' ' 38' ' ' THR . 45.4 tptt -117.28 131.64 56.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.959 0.409 . . . . 5.33 110.98 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.56 175.33 21.53 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.454 -0.794 . . . . 4.14 111.752 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.61 134.75 50.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.196 0.522 . . . . 6.02 110.629 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 50' ' ' GLY . 2.6 mt -130.9 171.73 12.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.105 -0.952 . . . . 4.21 110.159 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -17.35 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.127 1.529 . . . . 5.39 115.127 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.54 -12.79 50.3 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 114.319 0.488 . . . . 5.53 114.319 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.07 133.79 54.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.314 0.557 . . . . 5.33 111.337 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.545 ' C ' HD23 ' B' ' 23' ' ' LEU . 11.5 pt-20 -107.11 146.72 30.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.958 -0.565 . . . . 5.79 110.344 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.51 -177.85 38.73 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.663 -0.78 . . . . 3.35 112.855 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.406 ' CG1' HG21 ' B' ' 38' ' ' THR . 34.8 m -112.99 160.51 12.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.453 0.538 . . . . 4.3 112.453 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' B' ' 44' ' ' TRP . 3.0 p90 -124.79 157.49 65.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.375 -0.83 . . . . 3.72 110.807 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.03 123.02 2.65 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.69 2.26 . . . . 3.97 115.865 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p30 51.02 45.02 28.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.638 1.347 . . . . 5.85 114.638 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 62.7 88.64 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.772 1.027 . . . . 5.67 113.772 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.1 16.26 27.1 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.908 -0.775 . . . . 3.89 108.908 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 9' ' ' CYS . . . -142.64 138.49 30.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.81 0.3 . . . . 3.89 111.81 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.5 p -110.17 120.77 61.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 116.352 -0.385 . . . . 4.64 111.323 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.452 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 34.1 tt0 -51.51 150.86 3.43 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 121.023 0.44 . . . . 6.72 111.062 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.98 -37.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.671 . . . . 6.54 110.403 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.237 -0.887 . . . . 7.43 110.55 179.668 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttt . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.92 0.391 . . . . 16.5 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -82.93 152.7 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.587 . . . . 13.22 109.916 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 pt -145.32 150.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 12.19 110.249 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -102.73 135.15 44.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.189 -0.46 . . . . 11.64 110.691 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.37 99.4 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.327 -0.62 . . . . 6.66 109.327 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HG2' ' CG2' ' A' ' 12' ' ' THR . 6.7 tmtt? -86.81 111.78 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 6.86 111.663 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.2 p -84.83 -178.48 6.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 3.79 110.699 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 9' ' ' THR . 2.6 pp -85.93 -10.65 54.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.546 -0.297 . . . . 5.48 111.68 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.44 ' N ' HD12 ' A' ' 8' ' ' LEU . 8.8 t -97.29 21.06 10.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.928 0.394 . . . . 7.65 110.684 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.62 13.09 65.26 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.911 -0.662 . . . . 7.08 112.377 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -96.1 112.05 23.9 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.054 0.454 . . . . 6.58 111.933 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.418 ' CG2' ' HG2' ' A' ' 6' ' ' LYS . 31.4 p -104.28 122.39 45.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.647 -0.706 . . . . 6.95 110.012 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.1 pt -114.75 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.382 . . . . 5.97 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.5 p -87.72 135.31 33.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 8.28 110.36 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tp -134.67 146.45 49.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 10.02 110.556 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -102.67 130.92 49.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 12.19 110.498 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.76 -174.21 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.167 0.508 . . . . 14.73 111.575 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -138.97 145.95 47.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 18.57 109.044 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.09 -23.18 12.07 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.332 2.021 . . . . 19.89 112.709 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -87.85 -23.85 23.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 21.46 111.753 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.33 150.92 4.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.875 0.369 . . . . 18.56 111.656 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -96.49 140.71 30.73 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.931 -0.577 . . . . 20.15 111.259 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.4 HD12 HD13 ' A' ' 50' ' ' LEU . 50.7 mm -49.55 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.091 -0.504 . . . . 16.47 111.164 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.08 -41.06 78.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.87 0.367 . . . . 19.99 110.153 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -69.29 -35.55 76.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 16.38 110.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.05 -45.36 98.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.153 -0.476 . . . . 13.8 110.573 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -59.84 -37.19 78.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 13.67 110.826 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.01 66.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 14.55 110.82 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.21 -41.13 83.38 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.174 -0.676 . . . . 13.7 109.174 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.477 HD12 ' OE1' ' A' ' 41' ' ' GLN . 96.4 mt -67.25 -37.79 79.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.353 -0.84 . . . . 9.57 110.546 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 60.2 tt0 -61.63 -33.97 74.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.024 -0.535 . . . . 15.04 110.84 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -56.86 -27.11 59.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 12.47 110.074 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -99.85 -71.03 0.71 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.861 -0.609 . . . . 9.23 112.608 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.68 -10.98 60.25 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.537 0.569 . . . . 9.6 112.537 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 63.26 7.29 17.78 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.595 -0.812 . . . . 12.2 113.305 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 36' ' ' ILE . 23.5 pt -71.9 122.22 86.69 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.798 0.299 . . . . 11.27 111.017 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.56 142.76 70.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.405 2.07 . . . . 14.23 111.873 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.15 -25.32 43.55 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.712 2.275 . . . . 14.34 112.837 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.71 -23.62 66.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.918 0.71 . . . . 16.96 112.918 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -107.92 -5.62 17.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.612 . . . . 14.45 109.349 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.477 ' OE1' HD12 ' A' ' 30' ' ' ILE . 7.4 tt0 -83.14 100.93 10.85 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.247 -0.888 . . . . 10.91 110.888 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.455 ' HE ' ' N ' ' A' ' 43' ' ' LEU . 6.4 tpm_? -100.35 113.58 26.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.485 -0.932 . . . . 9.32 108.485 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.455 ' N ' ' HE ' ' A' ' 42' ' ' ARG . 61.9 mt -98.8 120.11 38.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.901 0.381 . . . . 10.56 110.887 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.666 HD12 HG21 ' B' ' 18' ' ' THR . 24.5 mm -109.43 137.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.681 -0.69 . . . . 9.75 110.367 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.502 ' HB3' HD21 ' A' ' 50' ' ' LEU . 62.5 t80 -156.47 132.34 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 15.27 111.182 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.72 6.23 2.58 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.837 -0.62 . . . . 14.76 111.87 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.41 -4.02 40.32 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.903 -0.665 . . . . 12.99 112.995 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' B' ' 18' ' ' THR . 55.0 tptt -122.01 152.16 40.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.747 0.308 . . . . 17.08 110.663 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -81.43 119.98 24.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 14.97 110.574 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 45' ' ' PHE . 84.1 mt -57.85 128.81 38.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.321 -0.4 . . . . 14.81 110.5 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 40.2 tt0 -81.08 124.97 29.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.323 -0.398 . . . . 21.0 109.986 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.47 -33.05 13.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.826 -0.624 . . . . 18.5 112.603 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -88.98 5.99 84.07 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.997 0.759 . . . . 21.79 114.997 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -105.55 173.04 6.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.672 0.736 . . . . 24.16 111.463 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -109.59 155.57 21.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.128 -0.487 . . . . 21.36 110.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.7 mt -53.97 -16.32 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 18.41 111.795 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -78.93 -26.01 43.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.647 0.26 . . . . 21.76 111.531 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.8 -36.98 84.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.39 -0.368 . . . . 23.14 110.765 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -99.44 12.23 36.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.155 -0.475 . . . . 19.37 111.878 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 m120 57.07 27.45 13.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.846 0.355 . . . . 22.24 111.416 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.453 HG12 ' CE2' ' A' ' 45' ' ' PHE . 98.1 mt -68.61 108.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.294 -0.412 . . . . 17.93 111.541 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.37 -179.54 4.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.207 -0.451 . . . . 21.49 111.108 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.37 156.77 28.17 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.949 0.404 . . . . 19.19 111.51 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 58.33 28.88 17.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.765 -0.652 . . . . 16.92 111.461 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 p -88.14 150.86 23.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 14.92 110.686 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.5 t -101.83 121.48 42.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 11.29 110.849 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.7 mp -110.82 117.17 32.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 10.94 109.864 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.413 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 17.6 m-70 -79.3 109.3 13.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 8.09 112.074 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -92.55 115.12 27.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.076 -0.511 . . . . 6.7 110.399 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 7.13 111.466 -179.347 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.232 0.177 0 N-CA-C 109.252 -0.648 . . . . 7.56 109.252 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -127.42 158.58 36.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.302 0.572 . . . . 7.84 112.063 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.533 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 24.0 p -145.22 145.78 31.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.023 -0.99 . . . . 4.73 110.581 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -101.76 137.15 40.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.824 0.345 . . . . 4.43 110.555 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -76.87 126.0 30.24 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.106 -0.497 . . . . 2.72 111.467 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 39.0 mt -88.73 -20.87 24.24 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.86 0.319 . . . . 3.78 111.86 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -147.37 156.73 45.97 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 121.052 -0.259 . . . . 4.88 111.399 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 138.47 29.24 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.48 2.12 . . . . 3.11 112.378 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 69.2 t80 -136.74 130.55 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.489 -0.778 . . . . 4.0 110.801 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.469 ' HA ' HG23 ' B' ' 24' ' ' THR . 34.2 m -111.83 119.56 38.99 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.884 0.373 . . . . 3.82 111.034 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.72 142.28 48.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.816 -0.629 . . . . 3.22 112.319 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.666 HG21 HD12 ' A' ' 44' ' ' ILE . 73.9 p -111.14 -22.24 11.53 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.95 0.405 . . . . 4.64 111.534 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -117.45 160.56 20.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.698 -0.683 . . . . 4.05 110.206 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -33.46 75.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 4.26 111.652 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -84.77 -4.26 58.97 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.834 0.35 . . . . 4.22 110.952 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -81.74 153.88 26.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.068 -0.515 . . . . 3.77 110.557 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' B' ' 48' ' ' LEU . 0.5 OUTLIER -104.43 144.05 32.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.961 -0.755 . . . . 3.13 108.961 178.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.469 HG23 ' HA ' ' B' ' 16' ' ' THR . 99.8 m -114.81 121.94 44.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.767 -0.651 . . . . 2.46 110.172 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' B' ' 15' ' ' TYR . 31.9 p90 -138.57 153.41 48.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.833 0.679 . . . . 2.49 112.833 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -109.52 -179.59 3.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.839 -0.43 . . . . 6.21 109.839 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.5 135.45 35.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.114 0.483 . . . . 3.87 109.842 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.03 31.97 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.524 -1.03 . . . . 4.23 110.524 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -96.79 178.69 5.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.793 0.806 . . . . 4.19 113.001 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.7 mm -135.76 114.16 15.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 113.763 -1.562 . . . . 5.23 111.245 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.07 139.58 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 4.64 110.861 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.68 128.81 37.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.456 -0.572 . . . . 7.14 109.456 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.443 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.9 tt -72.08 98.7 2.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 6.33 110.58 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.3 mm -79.54 -63.11 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 6.97 111.125 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -157.97 110.13 2.33 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.824 0.676 . . . . 7.03 112.824 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.438 ' O ' HG23 ' B' ' 38' ' ' THR . 58.6 mtmt -56.29 -69.81 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.999 -0.741 . . . . 7.52 108.999 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.51 98.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.426 -0.352 . . . . 8.93 111.394 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 36' ' ' LYS . 23.7 p -111.37 -5.3 14.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.34 -0.391 . . . . 7.05 111.104 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.27 -8.36 72.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.81 -0.71 . . . . 8.42 111.649 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.24 120.43 31.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.812 0.339 . . . . 7.96 110.656 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.31 55.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.496 . . . . 8.2 111.35 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 -0.7 83.72 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.807 -0.633 . . . . 6.68 112.675 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -121.63 127.37 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.333 0.566 . . . . 5.83 112.088 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' TRP . . . . . 0.57 ' HB2' ' CE2' ' B' ' 55' ' ' PHE . 23.2 m0 -113.88 162.15 16.72 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.285 -0.871 . . . . 5.87 109.201 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -114.19 131.25 56.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.086 0.469 . . . . 5.33 110.89 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.83 174.73 22.22 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.454 -0.794 . . . . 4.14 112.073 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.26 132.81 52.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.143 0.497 . . . . 6.02 110.272 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 50' ' ' GLY . 19.8 tp -129.81 170.28 14.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.192 -0.913 . . . . 4.21 109.755 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.471 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 67.7 m-20 -17.7 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.33 1.604 . . . . 5.39 115.33 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.4 -12.57 54.94 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.545 0.578 . . . . 5.53 114.545 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -119.5 134.36 55.25 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.461 0.63 . . . . 5.33 111.105 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.46 146.5 31.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.07 -0.514 . . . . 5.79 110.18 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.47 -177.48 41.93 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.541 -0.838 . . . . 3.35 112.55 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.98 160.99 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 112.126 0.417 . . . . 4.3 112.126 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' B' ' 44' ' ' TRP . 2.7 p90 -124.79 149.55 62.97 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.665 -0.698 . . . . 3.72 111.106 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.69 122.4 5.45 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.828 2.352 . . . . 3.97 115.171 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 51.26 43.76 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 114.171 1.174 . . . . 5.85 114.171 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.48 92.26 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.166 1.172 . . . . 5.67 114.166 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -102.84 17.52 23.72 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.425 -0.954 . . . . 3.89 108.425 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.533 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -146.26 138.2 24.96 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.591 0.219 . . . . 3.89 111.591 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 p -109.11 121.59 62.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.498 -0.319 . . . . 4.64 111.336 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.45 155.93 3.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.82 0.343 . . . . 6.72 110.594 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.87 -51.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 6.54 110.639 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.301 -0.856 . . . . 7.43 110.714 -179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.724 0.297 . . . . 16.5 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -84.58 148.03 26.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 13.22 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.4 pt -139.52 154.77 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.632 . . . . 12.19 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.87 134.57 53.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.023 -0.535 . . . . 11.64 110.376 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.8 t -118.16 100.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.376 -0.601 . . . . 6.66 109.376 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 14.5 tmtt? -88.82 131.2 35.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 6.86 112.155 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -106.08 163.17 12.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.252 -0.885 . . . . 3.79 110.841 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.74 -21.97 66.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.275 -0.421 . . . . 5.48 111.348 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 t -81.23 -8.51 59.76 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.382 -0.372 . . . . 7.65 111.18 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.1 54.99 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.179 -0.534 . . . . 7.08 112.965 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -97.0 108.58 21.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 6.58 111.337 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p -99.93 124.33 45.15 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.928 -0.578 . . . . 6.95 110.261 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.57 143.85 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.368 . . . . 5.97 111.185 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.1 m -98.13 135.66 39.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.865 -0.607 . . . . 8.28 110.786 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.89 152.95 52.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 10.02 110.985 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.48 121.01 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 12.19 109.753 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.444 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.5 m -140.12 -178.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.086 0.469 . . . . 14.73 111.446 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.44 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 38.8 tt0 -145.63 146.28 28.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.49 -0.777 . . . . 18.57 109.873 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 72.2 Cg_exo -50.47 -26.4 16.3 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 19.89 112.91 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 m -85.64 -23.85 27.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.323 -0.399 . . . . 21.46 111.28 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.6 148.96 8.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.381 . . . . 18.56 111.392 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 m -95.85 144.19 26.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.904 -0.589 . . . . 20.15 111.139 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.603 HD12 HD23 ' A' ' 50' ' ' LEU . 24.0 mm -51.86 -44.58 37.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.132 -0.485 . . . . 16.47 111.433 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.18 -38.06 67.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.853 0.359 . . . . 19.99 110.329 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -68.07 -38.84 82.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.556 . . . . 16.38 110.087 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -58.99 -48.57 86.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.144 -0.48 . . . . 13.8 110.416 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.75 -32.67 71.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.05 -0.523 . . . . 13.67 110.885 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.19 78.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.147 -0.479 . . . . 14.55 110.351 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' A' ' 17' ' ' VAL . 36.9 mtmm -70.09 -42.75 72.31 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 13.7 110.228 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.615 ' CG2' HD11 ' A' ' 36' ' ' ILE . 86.3 mt -61.05 -41.46 89.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.093 0.473 . . . . 9.57 109.985 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -32.87 74.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.819 -0.628 . . . . 15.04 110.989 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -66.12 -35.91 81.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 12.47 111.402 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.32 -59.25 2.13 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.399 0.518 . . . . 9.23 112.399 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.451 ' OE2' HD13 ' A' ' 36' ' ' ILE . 32.1 tt0 -81.66 -11.41 59.09 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.999 0.74 . . . . 9.6 112.999 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.83 -21.11 4.91 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.636 -0.792 . . . . 12.2 114.454 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.615 HD11 ' CG2' ' A' ' 30' ' ' ILE . 13.8 pt -54.54 135.49 62.92 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 117.469 0.634 . . . . 11.27 111.92 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 89.9 Cg_endo -78.98 135.41 12.4 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.819 2.346 . . . . 14.23 112.468 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.3 Cg_exo -54.33 -27.16 46.95 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.799 2.333 . . . . 14.34 112.965 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.51 -24.11 67.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.427 -0.351 . . . . 16.96 111.339 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -110.79 -5.16 15.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 14.45 111.363 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -80.93 128.09 33.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 10.91 111.495 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 42' ' ' ARG . 27.9 ttt-85 -125.18 114.21 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.18 -0.674 . . . . 9.32 109.18 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -101.94 126.54 48.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 10.56 110.858 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.85 134.39 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 9.75 110.893 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CB ' HD11 ' A' ' 50' ' ' LEU . 83.0 t80 -151.53 123.14 7.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.585 -0.734 . . . . 15.27 110.187 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 69.35 18.55 7.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.803 -0.635 . . . . 14.76 111.614 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.55 -12.07 70.63 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.704 -0.76 . . . . 12.99 112.678 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -107.72 148.49 29.36 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.05 0.452 . . . . 17.08 111.442 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -82.45 129.26 34.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.727 -0.669 . . . . 14.97 110.096 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.603 HD23 HD12 ' A' ' 23' ' ' ILE . 6.8 mp -67.97 130.87 44.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 14.81 111.225 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HB2' ' CG ' ' A' ' 54' ' ' ARG . 11.5 mm-40 -86.74 128.54 35.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 21.0 110.41 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.9 m-20 -52.03 -31.48 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.747 -0.66 . . . . 18.5 112.759 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.53 3.76 85.17 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.736 -0.745 . . . . 21.79 113.867 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' CG ' ' HB2' ' A' ' 51' ' ' GLU . 34.6 mmt180 -103.15 177.44 4.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.992 0.396 . . . . 24.16 110.829 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -123.16 160.5 26.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.364 . . . . 21.36 111.087 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -51.91 -31.01 26.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 18.41 111.753 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 p -71.04 -25.85 62.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.735 0.272 . . . . 21.76 111.735 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.81 -37.52 87.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.647 0.26 . . . . 23.14 111.059 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.91 7.46 46.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 19.37 111.829 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 m120 61.97 36.27 15.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.864 0.364 . . . . 22.24 111.54 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -78.65 107.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 17.93 111.272 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -95.21 -179.14 4.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.224 -0.444 . . . . 21.49 111.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.06 155.34 24.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.108 -0.496 . . . . 19.19 111.936 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 58.48 31.11 20.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.686 -0.688 . . . . 16.92 111.455 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -86.19 158.26 19.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 14.92 110.631 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 t -114.26 125.33 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 11.29 110.728 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -115.09 122.59 46.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.902 -0.59 . . . . 10.94 110.229 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.69 111.66 20.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.904 0.383 . . . . 8.09 111.611 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -92.34 115.0 27.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.032 -0.531 . . . . 6.7 109.807 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.332 -0.159 0 N-CA-C 112.271 0.471 . . . . 7.13 112.271 -178.998 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.444 -0.576 . . . . 7.56 109.444 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.9 160.05 33.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.327 0.584 . . . . 7.84 112.056 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.524 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 32.5 m -141.49 146.93 37.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.982 -1.008 . . . . 4.73 110.201 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -102.04 143.79 31.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.829 0.347 . . . . 4.43 111.078 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.5 m -82.01 123.64 29.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.999 -0.546 . . . . 2.72 111.515 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.37 -20.68 22.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.923 0.342 . . . . 3.78 111.923 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' B' ' 14' ' ' PRO . 30.6 t80 -154.94 144.64 15.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 117.921 0.328 . . . . 4.88 111.02 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' B' ' 13' ' ' PHE . 32.3 Cg_exo -59.45 138.46 84.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.416 2.077 . . . . 3.11 112.608 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.567 ' CZ ' ' HD3' ' B' ' 56' ' ' PRO . 29.2 t80 -133.72 131.1 39.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.687 -0.688 . . . . 4.0 110.839 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.614 ' HA ' HG23 ' B' ' 24' ' ' THR . 54.5 m -111.89 117.92 34.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.989 0.423 . . . . 3.82 111.049 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.45 138.01 47.19 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.973 -0.632 . . . . 3.22 112.366 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 15.7 m -104.51 -21.44 13.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.352 0.596 . . . . 4.64 110.241 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -118.46 156.06 29.69 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.948 -1.024 . . . . 4.05 109.861 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.72 -38.62 91.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 4.26 111.186 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.8 -3.21 33.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.809 0.338 . . . . 4.22 110.963 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -88.65 160.98 17.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 3.77 110.919 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' B' ' 48' ' ' LEU . 0.6 OUTLIER -103.87 140.66 37.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.542 -0.54 . . . . 3.13 109.542 178.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.614 HG23 ' HA ' ' B' ' 16' ' ' THR . 56.0 m -116.07 121.73 43.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.297 -0.865 . . . . 2.46 109.992 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.587 ' HB3' HD22 ' B' ' 48' ' ' LEU . 17.8 p90 -140.23 159.06 43.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.913 0.709 . . . . 2.49 112.913 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.558 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 81.4 mtt-85 -109.74 179.36 4.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.328 -0.249 . . . . 6.21 110.328 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -82.23 140.53 33.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.051 0.453 . . . . 3.87 110.048 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.61 21.87 49.23 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.602 -0.999 . . . . 4.23 110.602 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.558 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 5.3 mm-40 -97.96 179.45 4.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.471 0.915 . . . . 4.19 113.471 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -130.5 123.56 55.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.821 -1.536 . . . . 5.23 111.417 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -122.07 135.67 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.725 -0.671 . . . . 4.64 111.191 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.48 132.72 42.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.703 -0.481 . . . . 7.14 109.703 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.459 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.3 tt -72.98 100.46 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 6.33 110.798 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.18 -62.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.554 -0.748 . . . . 6.97 110.824 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.5 m -158.37 110.11 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.647 0.61 . . . . 7.03 112.647 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.712 ' O ' HG23 ' B' ' 38' ' ' THR . 35.0 mtmt -57.91 -71.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.383 -0.599 . . . . 7.52 109.383 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -45.72 94.43 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.325 -0.398 . . . . 8.93 111.502 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.712 HG23 ' O ' ' B' ' 36' ' ' LYS . 68.6 p -106.58 -9.02 16.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.241 -0.436 . . . . 7.05 111.051 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.29 -5.0 62.68 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.909 -0.662 . . . . 8.42 112.345 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -129.98 120.79 25.34 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.873 0.368 . . . . 7.96 110.554 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 133.3 55.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.57 . . . . 8.2 111.61 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 -0.64 85.48 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.586 -0.734 . . . . 6.68 112.699 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.412 ' CH2' ' HB3' ' B' ' 56' ' ' PRO . 79.6 m95 -121.86 123.6 42.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.324 0.562 . . . . 5.83 111.799 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' TRP . . . . . 0.558 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 21.8 m0 -110.32 172.11 7.06 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.504 -0.771 . . . . 5.87 109.322 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -125.39 130.61 52.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 5.33 110.905 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.2 176.31 21.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.488 -0.778 . . . . 4.14 111.77 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -124.7 133.79 53.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.303 0.573 . . . . 6.02 110.207 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.677 ' O ' ' N ' ' B' ' 50' ' ' GLY . 27.3 tp -129.56 170.1 14.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.098 -0.955 . . . . 4.21 109.778 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.507 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 31.5 p-10 -17.58 63.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.126 1.528 . . . . 5.39 115.126 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.61 -12.37 52.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 114.429 0.532 . . . . 5.53 114.429 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.32 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.545 0.672 . . . . 5.33 111.068 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' B' ' 52' ' ' GLU . 0.0 OUTLIER -112.27 146.18 38.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.07 -0.514 . . . . 5.79 110.506 179.618 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLY . . . . . 0.431 ' N ' ' HG ' ' B' ' 23' ' ' LEU . . . -174.74 -176.06 42.75 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.666 -0.778 . . . . 3.35 113.017 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -113.5 160.47 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 112.51 0.559 . . . . 4.3 112.51 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 6.2 p90 -125.19 148.49 60.79 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.563 -0.744 . . . . 3.72 110.976 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.567 ' HD3' ' CZ ' ' B' ' 15' ' ' TYR . 89.2 Cg_endo -79.05 123.24 5.59 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.035 2.49 . . . . 3.97 115.369 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 52.32 43.55 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.553 1.316 . . . . 5.85 114.553 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.52 93.55 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.692 1.367 . . . . 5.67 114.692 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.27 12.8 35.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.748 -0.834 . . . . 3.89 108.748 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.6 29.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 3.89 111.622 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.46 126.99 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.501 -0.318 . . . . 4.64 111.823 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.524 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 53.6 tt0 -59.37 140.69 55.87 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 110.167 -0.309 . . . . 6.72 110.167 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 56.3 mt -101.63 -60.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 6.54 110.705 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.149 -0.929 . . . . 7.43 110.76 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.877 0.37 . . . . 16.5 111.011 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -79.24 149.03 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.837 -0.62 . . . . 13.22 110.544 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.0 pt -142.94 147.88 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 12.19 110.678 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -97.55 137.24 36.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 11.64 110.597 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.41 91.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.573 -0.529 . . . . 6.66 109.573 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 7' ' ' THR . 61.7 tttm -77.03 164.29 25.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.916 -0.584 . . . . 6.86 111.425 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.427 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.8 m -143.57 159.43 42.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.427 -0.806 . . . . 3.79 110.041 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.418 ' N ' HG22 ' A' ' 7' ' ' THR . 3.4 pp -62.31 -22.37 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 5.48 111.37 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -81.75 -13.7 57.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.369 . . . . 7.65 111.272 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.98 47.63 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.057 -0.592 . . . . 7.08 112.468 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -93.59 111.31 22.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 6.58 111.492 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.03 125.0 44.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.759 -0.655 . . . . 6.95 110.134 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -117.01 142.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.384 . . . . 5.97 111.215 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.9 p -97.79 139.12 34.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 8.28 110.704 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 16' ' ' GLU . 59.3 tp -139.89 150.77 45.0 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.548 -0.296 . . . . 10.02 110.524 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.431 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -111.92 106.31 14.97 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.569 -0.287 . . . . 12.19 111.373 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.65 113.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.216 -0.447 . . . . 14.73 111.299 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 14.6 mp0 -60.78 172.15 0.91 Allowed Pre-proline 0 N--CA 1.467 0.408 0 N-CA-C 112.89 0.7 . . . . 18.57 112.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 41.2 Cg_exo -59.45 -39.74 73.33 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.32 2.68 . . . . 19.89 113.251 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.9 p -61.61 -26.2 67.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.38 -0.373 . . . . 21.46 111.759 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.04 151.26 9.23 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.921 0.391 . . . . 18.56 111.646 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -95.24 149.46 21.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.837 -0.62 . . . . 20.15 110.841 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 HD13 ' A' ' 50' ' ' LEU . 45.6 mm -58.62 -37.66 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 16.47 111.1 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.63 -40.48 92.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.902 0.382 . . . . 19.99 109.995 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.99 -41.8 95.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.935 -0.575 . . . . 16.38 110.013 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.65 -47.22 82.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.994 -0.548 . . . . 13.8 110.464 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -60.55 -36.37 78.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.922 -0.581 . . . . 13.67 110.541 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.86 84.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.03 -0.532 . . . . 14.55 110.375 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -65.44 -49.81 67.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.926 -0.579 . . . . 13.7 110.028 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.56 ' CG2' HD11 ' A' ' 36' ' ' ILE . 84.5 mt -57.55 -40.5 75.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.959 -0.564 . . . . 9.57 110.457 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -63.76 -30.09 71.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.037 -0.529 . . . . 15.04 111.025 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.59 -38.51 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 12.47 111.235 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -90.13 -59.93 2.06 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.087 0.403 . . . . 9.23 112.087 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HG3' HG23 ' A' ' 36' ' ' ILE . 9.3 tp10 -78.8 -11.93 60.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.022 0.749 . . . . 9.6 113.022 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.0 -17.71 4.51 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.537 -0.84 . . . . 12.2 114.213 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.56 HD11 ' CG2' ' A' ' 30' ' ' ILE . 16.5 pt -59.43 132.0 88.12 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 117.337 0.569 . . . . 11.27 112.043 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.79 144.38 38.94 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 14.23 112.231 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.88 -22.26 63.35 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.745 2.297 . . . . 14.34 112.374 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.59 -25.49 66.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 16.96 111.176 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -106.25 -13.11 15.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.358 -0.383 . . . . 14.45 111.42 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -73.59 132.8 43.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.12 0.486 . . . . 10.91 111.954 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 61.7 mtp180 -127.73 114.5 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.356 -0.838 . . . . 9.32 109.156 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB3' HD12 ' A' ' 50' ' ' LEU . 9.6 mp -101.3 122.16 43.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.836 0.351 . . . . 10.56 110.907 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 18.7 mm -113.3 133.17 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.899 -0.591 . . . . 9.75 110.442 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HB3' HD21 ' A' ' 50' ' ' LEU . 60.6 t80 -151.06 124.28 8.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 15.27 110.578 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.77 19.35 11.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 14.76 111.967 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.57 80.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.566 -0.826 . . . . 12.99 112.97 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.21 147.92 42.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.745 0.307 . . . . 17.08 110.729 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -81.88 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 14.97 110.3 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD13 HD12 ' A' ' 23' ' ' ILE . 68.3 mt -68.4 133.23 48.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 14.81 111.183 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.87 126.75 35.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 21.0 110.515 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.34 -35.03 25.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.921 -0.581 . . . . 18.5 112.351 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.7 1.87 88.02 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.954 -0.641 . . . . 21.79 114.273 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.78 177.64 4.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.172 0.486 . . . . 24.16 110.977 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -122.4 158.7 29.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.333 -0.394 . . . . 21.36 110.952 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.6 mm? -52.24 -24.29 7.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 18.41 111.744 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 m -75.04 -25.56 58.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.629 0.252 . . . . 21.76 111.515 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.18 -41.8 96.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 23.14 111.123 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -94.75 10.43 35.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.304 -0.407 . . . . 19.37 111.665 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 56.37 42.91 27.06 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.062 0.458 . . . . 22.24 111.207 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.4 HG12 ' CE2' ' A' ' 45' ' ' PHE . 73.9 mt -85.49 104.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 17.93 111.198 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -91.56 178.03 6.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.14 -0.482 . . . . 21.49 111.313 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -60.5 155.29 18.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.987 -0.552 . . . . 19.19 111.585 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 60.51 33.46 20.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.843 -0.617 . . . . 16.92 111.364 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 p -92.04 157.61 16.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 14.92 110.649 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.501 ' C ' HD12 ' A' ' 67' ' ' LEU . 5.1 t -113.74 124.4 52.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 11.29 110.712 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 66' ' ' THR . 8.1 mp -115.89 119.41 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 10.94 110.4 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 58.2 t-80 -77.99 120.87 23.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.381 -0.372 . . . . 8.09 111.148 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.51 109.75 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 6.7 111.273 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 19.4 t -92.44 123.72 44.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 7.13 109.962 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.9 mt -123.49 131.47 53.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 8.31 111.059 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 53.95 87.44 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.844 -0.616 . . . . 14.22 110.609 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.9 tp -87.03 87.2 7.4 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.155 -0.475 . . . . 13.68 110.722 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -81.55 -22.9 37.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 20.03 110.85 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.67 -110.91 0.56 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.898 -0.667 . . . . 17.34 112.118 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.418 -1.212 . . . . 17.6 112.414 179.707 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.854 0.359 . . . . 9.15 110.899 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -165.69 116.98 1.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.943 -0.572 . . . . 10.58 109.533 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -133.38 102.64 5.61 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.661 -0.699 . . . . 7.56 109.734 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' TYR . . . . . 0.427 ' H ' ' HB2' ' B' ' 64' ' ' SER . 20.0 m-85 -124.05 172.08 9.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 7.84 110.745 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.577 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 35.1 m -142.27 149.09 39.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 4.73 111.027 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -99.51 138.0 37.21 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.519 -0.309 . . . . 4.43 110.456 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -78.54 123.46 27.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.497 -0.32 . . . . 2.72 110.856 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.54 -21.31 19.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.331 0.493 . . . . 3.78 112.331 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' B' ' 14' ' ' PRO . 75.5 m-85 -145.84 155.01 52.11 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 117.954 0.343 . . . . 4.88 111.409 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 13' ' ' PHE . 6.8 Cg_exo -72.11 136.42 26.99 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.518 2.145 . . . . 3.11 112.728 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -137.96 127.68 25.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.889 -1.05 . . . . 4.0 109.539 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.2 m -112.06 121.67 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 3.82 111.322 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.85 143.71 48.74 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.744 -0.741 . . . . 3.22 111.926 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 44' ' ' ILE . 41.1 p -107.17 -18.63 13.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.519 . . . . 4.64 110.825 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -119.49 159.11 24.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 4.05 110.222 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.51 -30.65 71.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 4.26 111.357 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.31 -5.88 59.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 4.22 111.012 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -81.76 157.65 24.44 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.146 -0.479 . . . . 3.77 110.988 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.555 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 2.7 mt -110.59 151.61 27.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.626 -0.509 . . . . 3.13 109.626 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -115.72 129.23 56.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.328 -0.396 . . . . 2.46 110.468 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 29.9 m-85 -130.6 133.8 46.46 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.263 0.468 . . . . 2.49 112.263 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.531 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 97.7 mtt180 -104.04 175.24 5.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.763 -0.458 . . . . 6.21 109.763 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -81.5 134.44 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 3.87 110.006 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.17 50.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.925 -0.87 . . . . 4.23 110.925 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.2 mm-40 -98.42 179.42 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.423 0.898 . . . . 4.19 113.423 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -131.34 113.55 23.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.76 -1.564 . . . . 5.23 111.233 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' B' ' 60' ' ' ALA . 42.6 mt -106.89 129.41 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 4.64 110.677 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -89.96 127.27 36.0 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.894 -0.41 . . . . 7.14 109.894 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.28 128.04 34.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.044 0.45 . . . . 6.33 110.923 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.41 -48.97 6.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 6.97 110.785 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 79.3 p -167.06 113.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 7.03 111.983 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -69.32 5.11 1.39 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.907 -0.588 . . . . 7.52 111.32 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -121.85 101.89 7.85 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 116.63 -0.259 . . . . 8.93 110.305 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.476 HG22 ' HB2' ' B' ' 45' ' ' LYS . 30.5 p -112.33 -2.96 14.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.454 -0.339 . . . . 7.05 111.752 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.03 -5.14 78.68 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.685 . . . . 8.42 112.014 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -125.99 119.7 28.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 7.96 110.39 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.411 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -58.56 132.46 53.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 8.2 111.302 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.32 -0.46 85.53 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.9 -0.591 . . . . 6.68 112.704 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.492 ' CE3' HG23 ' B' ' 54' ' ' VAL . 77.6 m95 -122.92 123.74 41.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.454 0.627 . . . . 5.83 112.016 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' TRP . . . . . 0.555 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 19.4 m0 -109.66 165.15 11.9 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.477 -0.783 . . . . 5.87 109.428 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.476 ' HB2' HG22 ' B' ' 38' ' ' THR . 64.0 tttp -115.91 131.72 56.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.021 0.439 . . . . 5.33 110.965 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.7 174.82 21.86 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.411 -0.813 . . . . 4.14 111.717 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.05 133.36 52.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.291 0.567 . . . . 6.02 110.364 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' B' ' 50' ' ' GLY . 11.8 tp -130.06 170.99 13.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.929 -1.032 . . . . 4.21 109.675 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.475 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 60.3 m-20 -17.69 64.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.424 1.638 . . . . 5.39 115.424 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 82.97 -10.4 57.87 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 114.732 0.653 . . . . 5.53 114.732 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -118.93 143.39 47.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.544 0.672 . . . . 5.33 111.099 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.05 142.85 46.08 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.055 -0.52 . . . . 5.79 110.585 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLY . . . . . 0.478 ' H ' HD12 ' B' ' 23' ' ' LEU . . . -169.34 -179.19 41.1 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.943 -0.646 . . . . 3.35 112.481 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.492 HG23 ' CE3' ' B' ' 43' ' ' TRP . 33.7 m -113.44 163.36 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 112.441 0.534 . . . . 4.3 112.441 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 3.3 p90 -124.57 152.92 69.53 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.602 -0.726 . . . . 3.72 110.92 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.45 122.88 4.69 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.93 2.42 . . . . 3.97 115.683 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 50.95 44.51 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.983 1.105 . . . . 5.85 113.983 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 60.0 92.92 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.125 1.157 . . . . 5.67 114.125 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -103.38 15.97 27.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.723 -0.843 . . . . 3.89 108.723 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 31' ' ' ILE . . . -143.09 138.58 29.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.977 0.362 . . . . 3.89 111.977 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.59 119.43 59.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.366 -0.379 . . . . 4.64 111.445 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.577 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 63.5 tt0 -54.47 105.62 0.16 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.847 0.356 . . . . 6.72 110.611 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 33.0 pt -86.61 -30.12 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 6.54 110.733 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' SER . . . . . 0.427 ' HB2' ' H ' ' B' ' 8' ' ' TYR . 48.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.251 -0.88 . . . . 7.43 110.696 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 66.2 mtm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.716 0.293 . . . . 16.5 110.775 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.08 147.02 28.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 13.22 110.863 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.2 pt -146.53 156.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 12.19 110.765 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -108.74 147.13 32.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.854 -0.612 . . . . 11.64 110.424 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.25 103.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.009 -0.542 . . . . 6.66 110.587 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG2' ' N ' ' A' ' 7' ' ' THR . 85.6 tttt -78.33 164.51 24.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 6.86 111.077 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.464 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 8.4 m -139.91 147.09 40.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 3.79 109.823 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 71' ' ' LEU . 4.4 pp -60.67 -18.42 53.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.801 0.334 . . . . 5.48 111.401 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.447 ' N ' HD12 ' A' ' 8' ' ' LEU . 69.4 p -73.89 -35.7 64.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 7.65 110.531 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.43 -15.28 5.78 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.987 -0.552 . . . . 7.08 112.607 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -83.16 136.62 34.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.388 0.514 . . . . 6.58 112.388 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -115.68 124.53 51.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.283 -0.871 . . . . 6.95 109.332 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.13 144.01 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.02 0.438 . . . . 5.97 111.854 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -100.14 136.2 40.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.493 -0.776 . . . . 8.28 110.737 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.3 153.14 52.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.841 0.353 . . . . 10.02 110.84 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -120.5 102.91 8.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.009 -0.541 . . . . 12.19 111.391 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -153.89 116.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 14.73 110.711 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 167.21 1.19 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.753 1.02 . . . . 18.57 113.753 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.7 Cg_exo -60.12 -32.3 94.45 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.831 3.021 . . . . 19.89 114.08 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -77.87 31.18 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.762 0.315 . . . . 21.46 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -115.23 129.89 56.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.317 -0.401 . . . . 18.56 110.942 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 70.6 p -68.89 145.95 53.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 20.15 111.278 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 50' ' ' LEU . 1.1 mp -56.41 -35.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 16.47 110.755 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.48 -43.11 98.25 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 19.99 109.899 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -64.26 -39.63 94.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.973 -0.558 . . . . 16.38 109.931 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.105 -0.498 . . . . 13.8 110.036 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.94 -33.18 74.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.905 -0.588 . . . . 13.67 110.526 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.36 -34.1 76.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.066 -0.516 . . . . 14.55 110.217 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -71.36 -42.3 68.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 13.7 109.571 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.42 -47.97 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 115.866 -0.606 . . . . 9.57 109.741 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -58.42 -33.91 70.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 15.04 110.494 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.21 -33.71 76.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 12.47 110.931 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.11 -62.04 1.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 9.23 112.165 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.7 -13.74 59.66 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.449 0.907 . . . . 9.6 113.449 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 15.75 75.24 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.387 -0.911 . . . . 12.2 113.871 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -90.53 123.45 65.28 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 117.255 0.527 . . . . 11.27 110.932 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 48.3 Cg_exo -56.9 138.82 87.52 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.723 2.282 . . . . 14.23 112.348 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 33.5 Cg_exo -61.11 -30.29 88.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.521 2.147 . . . . 14.34 112.156 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.14 -20.61 66.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.779 -0.646 . . . . 16.96 111.074 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.61 -35.11 13.03 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.265 -0.425 . . . . 14.45 110.835 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -61.21 146.4 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 10.91 110.904 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 3.0 tpp180 -142.77 38.04 1.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 9.32 111.296 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 42' ' ' ARG . 69.5 mt -20.83 127.59 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.727 1.01 . . . . 10.56 113.727 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.567 HD12 HG21 ' B' ' 18' ' ' THR . 20.2 mm -114.95 136.33 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.183 -0.917 . . . . 9.75 109.734 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 81.7 t80 -138.7 123.75 19.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 15.27 111.276 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 13.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.545 0.572 . . . . 14.76 112.545 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.5 -29.34 9.16 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.829 -0.701 . . . . 12.99 113.191 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 14.6 ptpt -70.27 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.941 0.37 . . . . 17.08 111.02 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.509 ' N ' ' HG3' ' A' ' 48' ' ' LYS . 30.3 tt0 -148.53 107.65 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.93 -0.767 . . . . 14.97 108.93 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HB3' HG12 ' A' ' 23' ' ' ILE . 51.3 mt -57.75 127.22 30.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.875 0.695 . . . . 14.81 112.875 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.61 123.62 36.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.392 -0.822 . . . . 21.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -34.54 -61.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.713 -0.676 . . . . 18.5 112.168 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -47.96 -73.5 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 21.79 112.524 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.42 ' O ' HD13 ' A' ' 23' ' ' ILE . 31.0 mmt180 -34.24 163.2 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.366 0.876 . . . . 24.16 113.366 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 8.8 t -115.1 165.28 13.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.211 -0.904 . . . . 21.36 111.278 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 91.0 mt -55.69 -38.46 69.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 18.41 111.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.0 -26.57 68.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.366 . . . . 21.76 111.383 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.59 -29.07 69.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 23.14 110.992 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.11 16.57 24.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 19.37 111.125 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.55 39.62 31.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.083 -0.508 . . . . 22.24 111.306 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -87.74 113.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 17.93 111.094 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -105.47 -165.42 1.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 21.49 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 22.5 pttp -68.16 162.72 24.21 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 19.19 111.255 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 55.99 32.37 19.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.933 -0.576 . . . . 16.92 111.252 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -91.56 138.48 31.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 14.92 110.712 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -98.99 122.46 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 11.29 111.146 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.1 mt -116.71 117.95 31.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 10.94 110.173 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -88.66 114.12 24.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 8.09 111.831 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 45.8 mt -63.94 -172.13 0.06 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.958 -0.565 . . . . 6.7 109.903 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 90.4 t -162.94 106.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.763 -0.458 . . . . 7.13 109.763 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 71' ' ' LEU . 5.6 mp -112.41 76.42 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.216 0.532 . . . . 8.31 109.922 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -77.88 118.56 20.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.443 -0.799 . . . . 14.22 110.977 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 tp -111.0 -42.16 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.619 . . . . 13.68 110.348 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -116.03 -36.31 4.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 20.03 110.68 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.4 -59.52 0.02 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.931 -0.652 . . . . 17.34 112.81 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.456 -1.191 . . . . 17.6 112.71 -179.585 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.776 0.322 . . . . 9.15 111.21 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -169.37 117.18 0.62 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.165 0.507 . . . . 10.58 110.133 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -123.08 113.94 19.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.37 -0.832 . . . . 7.56 109.498 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -133.04 170.42 15.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.013 0.435 . . . . 7.84 112.039 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.518 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 13.7 p -153.45 150.23 28.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.656 -0.702 . . . . 4.73 111.036 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -102.5 138.2 39.73 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.384 -0.371 . . . . 4.43 110.245 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 35.9 p -80.47 125.64 30.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 2.72 111.825 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.1 -20.4 24.36 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.401 -0.363 . . . . 3.78 111.448 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' B' ' 14' ' ' PRO . 97.2 m-85 -149.26 158.0 38.87 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.739 0.304 . . . . 4.88 111.468 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' B' ' 13' ' ' PHE . 74.5 Cg_endo -75.21 140.34 24.77 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.736 2.291 . . . . 3.11 112.88 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -136.0 130.97 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.377 -0.829 . . . . 4.0 110.467 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.518 ' HA ' HG23 ' B' ' 24' ' ' THR . 88.0 m -111.54 118.21 35.11 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.942 0.401 . . . . 3.82 111.213 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.52 139.35 48.16 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.981 -0.628 . . . . 3.22 112.127 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.567 HG21 HD12 ' A' ' 44' ' ' ILE . 76.1 p -107.19 -21.47 12.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.199 0.523 . . . . 4.64 111.092 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -119.08 159.58 23.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.328 -0.851 . . . . 4.05 110.011 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -64.41 -36.09 83.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 4.26 111.505 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.75 -4.55 52.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 4.22 110.817 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 150.58 29.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.038 -0.528 . . . . 3.77 110.981 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.603 HD23 ' N ' ' B' ' 24' ' ' THR . 1.4 tt -100.07 137.48 38.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.526 -1.287 . . . . 3.13 107.526 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.603 ' N ' HD23 ' B' ' 23' ' ' LEU . 89.5 m -114.55 123.9 50.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.745 -0.661 . . . . 2.46 110.646 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -138.65 156.82 47.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.502 0.556 . . . . 2.49 112.502 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.455 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 34.0 mmt180 -111.55 179.45 4.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.176 -0.305 . . . . 6.21 110.176 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.93 143.55 31.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 3.87 110.43 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.57 19.96 67.33 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.088 -0.805 . . . . 4.23 111.088 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 19.3 mm-40 -98.15 179.11 4.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.517 0.932 . . . . 4.19 113.517 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -132.37 116.6 29.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 113.557 -1.656 . . . . 5.23 111.297 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.1 140.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 4.64 111.152 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -91.38 127.55 36.86 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.397 -0.594 . . . . 7.14 109.397 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tt -74.32 102.76 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 6.33 110.636 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 31.9 mm -80.72 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 6.97 111.243 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 89.1 p -157.86 120.28 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.098 0.777 . . . . 7.03 113.098 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.512 ' O ' HG23 ' B' ' 38' ' ' THR . 58.7 mttp -65.18 -72.2 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.987 -0.552 . . . . 7.52 109.911 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -44.8 100.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.099 -0.501 . . . . 8.93 111.732 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.512 HG23 ' O ' ' B' ' 36' ' ' LYS . 25.2 p -116.33 -3.69 11.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.964 -0.562 . . . . 7.05 110.881 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.86 -7.6 76.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.978 -0.629 . . . . 8.42 111.882 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -130.87 120.75 24.1 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.693 0.282 . . . . 7.96 110.483 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.51 137.55 58.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 8.2 110.878 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.808 -0.633 . . . . 6.68 112.614 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.595 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 64.1 m95 -120.79 117.41 27.35 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.831 0.348 . . . . 5.83 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -109.89 160.82 16.05 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.247 -0.649 . . . . 5.87 109.247 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -116.09 129.56 56.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.894 0.378 . . . . 5.33 110.389 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.37 175.63 22.24 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.731 -0.747 . . . . 4.14 112.179 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -126.51 135.42 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.499 . . . . 6.02 110.077 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.638 ' O ' ' N ' ' B' ' 50' ' ' GLY . 32.8 tp -128.53 170.16 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.31 -0.859 . . . . 4.21 110.242 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.433 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 20.9 m120 -18.3 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.403 1.631 . . . . 5.39 115.403 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.69 -11.48 61.73 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 114.894 0.717 . . . . 5.53 114.894 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -118.23 132.25 56.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.831 0.816 . . . . 5.33 111.29 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.01 152.25 24.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.46 -0.57 . . . . 5.79 109.46 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.11 -174.65 44.59 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.113 -1.041 . . . . 3.35 113.353 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.24 149.75 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 110.398 -0.223 . . . . 4.3 110.398 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.432 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 49.1 p90 -139.32 141.11 28.0 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.784 0.661 . . . . 3.72 112.784 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.595 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.3 Cg_endo -95.19 175.17 1.06 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.444 3.429 . . . . 3.97 111.511 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.419 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.1 m-20 79.57 -13.55 0.95 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.981 1.474 . . . . 5.85 114.981 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.22 76.6 0.28 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.873 -0.788 . . . . 5.67 108.873 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 13.1 m-85 -103.87 8.81 37.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.296 -0.865 . . . . 3.89 112.268 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.518 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -133.84 138.98 45.95 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.292 0.478 . . . . 3.89 112.292 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -113.53 136.16 50.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.882 -0.599 . . . . 4.64 111.366 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.08 144.48 28.97 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 120.742 0.306 . . . . 6.72 110.906 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 pt -137.9 -13.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.192 -0.458 . . . . 6.54 111.087 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.272 -0.871 . . . . 7.43 110.627 179.91 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 92.3 mtp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.853 0.359 . . . . 16.5 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -79.94 151.82 29.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 13.22 111.068 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.06 145.24 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.914 -0.585 . . . . 12.19 110.52 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -100.82 135.33 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 11.64 110.113 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 58.4 t -120.42 96.24 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.519 -0.549 . . . . 6.66 109.519 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 7' ' ' THR . 86.5 tttt -76.3 164.02 26.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.816 -0.629 . . . . 6.86 111.326 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.448 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 77.0 p -143.9 158.85 43.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 3.79 110.268 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.556 ' HB3' ' HE1' ' B' ' 43' ' ' TRP . 4.0 pp -61.91 -24.59 67.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.535 . . . . 5.48 111.219 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 p -78.59 -19.93 51.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.118 -0.492 . . . . 7.65 111.205 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.37 13.39 33.19 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.089 -0.577 . . . . 7.08 112.339 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.45 108.93 21.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.891 0.377 . . . . 6.58 111.407 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.38 125.69 45.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 6.95 110.128 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.446 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 31.2 pt -118.3 145.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.861 0.362 . . . . 5.97 111.027 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.641 ' C ' HD22 ' A' ' 15' ' ' LEU . 17.3 m -98.36 134.26 41.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 8.28 111.213 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.641 HD22 ' C ' ' A' ' 14' ' ' THR . 3.8 mm? -127.44 149.75 49.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.098 -0.501 . . . . 10.02 110.369 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.47 98.88 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.31 -0.405 . . . . 12.19 110.701 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.88 -172.74 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.099 0.476 . . . . 14.73 111.816 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -143.14 159.25 56.53 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 18.57 110.276 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 Cg_endo -59.93 -31.72 94.08 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.584 2.189 . . . . 19.89 112.212 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.3 t -82.36 -21.36 35.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 21.46 111.504 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.91 150.92 9.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.7 0.286 . . . . 18.56 111.125 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.3 p -97.35 141.7 30.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 20.15 111.073 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 50' ' ' LEU . 16.0 mt -53.73 -32.02 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 16.47 111.466 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.91 -42.47 99.8 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.615 -0.513 . . . . 19.99 109.615 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.06 -36.16 81.43 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.752 -0.658 . . . . 16.38 110.133 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.2 t -57.59 -46.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.378 -0.374 . . . . 13.8 110.197 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.39 -37.76 84.6 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.039 -0.528 . . . . 13.67 110.451 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.05 86.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 14.55 110.432 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 6.9 mmpt? -64.68 -49.2 71.86 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.033 -0.531 . . . . 13.7 109.956 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.69 -40.75 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 9.57 110.368 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -61.4 -34.78 75.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.018 -0.537 . . . . 15.04 110.816 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.96 -36.26 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 12.47 111.329 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.23 -63.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.234 -0.439 . . . . 9.23 112.025 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -78.4 -12.58 60.01 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.386 0.884 . . . . 9.6 113.386 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.14 -12.5 12.26 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.294 -0.955 . . . . 12.2 113.38 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.514 HD12 ' HD2' ' A' ' 37' ' ' PRO . 5.2 tp -60.52 128.07 87.68 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.856 0.328 . . . . 11.27 111.565 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 36' ' ' ILE . 59.8 Cg_endo -73.06 137.2 26.04 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.623 2.215 . . . . 14.23 112.622 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 53.2 Cg_exo -56.13 -29.0 73.15 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.026 2.484 . . . . 14.34 112.782 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.96 -24.85 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 16.96 111.271 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -108.54 -6.64 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 14.45 111.467 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.401 HE21 ' N ' ' A' ' 38' ' ' PRO . 46.4 mt-30 -81.17 127.19 32.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.066 0.46 . . . . 10.91 111.984 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -121.24 112.53 18.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.466 -0.788 . . . . 9.32 109.275 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.32 122.63 43.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.42 -0.355 . . . . 10.56 110.951 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.804 HD12 HG21 ' B' ' 18' ' ' THR . 34.3 mm -116.55 137.05 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.526 . . . . 9.75 110.983 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 50' ' ' LEU . 85.2 t80 -155.86 127.57 7.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.772 -0.649 . . . . 15.27 110.541 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.5 17.12 10.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.934 -0.575 . . . . 14.76 111.767 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.428 ' O ' HG22 ' B' ' 18' ' ' THR . . . 90.96 -2.41 79.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 12.99 112.964 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -117.82 148.56 41.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.749 0.309 . . . . 17.08 110.777 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -81.91 131.34 35.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 14.97 110.196 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.536 ' HB3' HD13 ' A' ' 23' ' ' ILE . 52.9 mt -69.74 130.13 41.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.95 0.405 . . . . 14.81 111.288 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -86.84 126.19 34.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.62 . . . . 21.0 110.174 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -48.58 -40.35 27.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.551 0.574 . . . . 18.5 112.551 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.408 ' H ' ' CD ' ' A' ' 51' ' ' GLU . . . -80.28 3.52 71.91 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.971 -0.633 . . . . 21.79 114.194 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 6.0 mmp_? -103.5 173.79 6.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.115 0.457 . . . . 24.16 110.881 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -118.99 160.84 21.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.872 0.368 . . . . 21.36 111.576 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.458 ' H ' HD22 ' A' ' 56' ' ' LEU . 3.6 mm? -51.78 -34.04 37.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.015 -0.538 . . . . 18.41 111.395 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -69.31 -24.97 64.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.485 -0.325 . . . . 21.76 111.303 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.412 . . . . 23.14 111.065 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -101.09 11.45 39.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.233 -0.44 . . . . 19.37 111.288 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 56.32 49.47 15.11 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.851 0.358 . . . . 22.24 111.184 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.404 HG12 ' CE2' ' A' ' 45' ' ' PHE . 79.8 mt -92.09 108.27 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 17.93 110.882 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -92.81 -177.98 4.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 21.49 110.899 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.97 158.88 24.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.337 -0.392 . . . . 19.19 111.125 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 59.46 29.05 18.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.946 -0.57 . . . . 16.92 111.509 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.5 t -89.1 153.19 21.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.308 -0.405 . . . . 14.92 110.843 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 t -110.9 126.02 54.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 11.29 111.124 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.1 mp -115.29 125.72 53.63 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.923 -0.58 . . . . 10.94 110.395 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -85.39 115.47 23.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.401 . . . . 8.09 111.589 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.7 tp -94.17 105.83 17.81 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.903 -0.59 . . . . 6.7 110.6 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -85.76 141.48 14.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.13 -0.486 . . . . 7.13 110.885 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.0 mt -129.0 141.55 51.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.091 -0.504 . . . . 8.31 111.006 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.47 ' N ' ' HE ' ' A' ' 72' ' ' ARG . 2.7 mmp_? 61.37 95.14 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.785 -0.643 . . . . 14.22 110.98 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.07 -27.84 64.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 13.68 110.988 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -63.46 112.26 2.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.222 -0.445 . . . . 20.03 110.165 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.98 -105.94 1.49 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.885 -0.674 . . . . 17.34 111.99 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.466 -1.186 . . . . 17.6 112.595 179.848 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.539 0.209 . . . . 9.15 110.93 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.02 175.26 5.51 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.182 0.515 . . . . 10.58 111.028 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -101.79 134.56 44.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.345 -0.843 . . . . 7.56 109.045 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.15 169.13 15.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.988 0.423 . . . . 7.84 111.9 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.627 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 6.7 p -152.63 147.69 26.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 4.73 110.478 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -100.19 141.3 33.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.434 -0.348 . . . . 4.43 110.684 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 54.4 p -80.25 124.78 29.12 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.271 -0.422 . . . . 2.72 111.743 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.24 -21.49 19.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.616 -0.265 . . . . 3.78 111.05 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -151.3 156.61 35.08 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.607 0.241 . . . . 4.88 110.83 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.68 140.58 29.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.549 2.166 . . . . 3.11 113.112 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -136.59 128.7 29.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.085 -0.961 . . . . 4.0 110.044 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.436 ' HA ' HG23 ' B' ' 24' ' ' THR . 88.3 m -112.2 120.4 41.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.8 0.333 . . . . 3.82 111.579 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.47 144.64 49.37 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.828 -0.701 . . . . 3.22 111.93 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.804 HG21 HD12 ' A' ' 44' ' ' ILE . 82.0 p -107.56 -22.19 12.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.057 0.456 . . . . 4.64 111.292 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.79 158.67 25.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.476 -0.784 . . . . 4.05 109.941 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.82 -35.91 82.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 4.26 111.438 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.3 -4.47 45.18 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.934 0.397 . . . . 4.22 110.535 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.91 156.58 22.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.762 -0.653 . . . . 3.77 110.44 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.513 HD23 ' HZ ' ' B' ' 25' ' ' PHE . 3.8 tp -107.14 146.33 31.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.354 -0.98 . . . . 3.13 108.354 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.436 HG23 ' HA ' ' B' ' 16' ' ' THR . 93.8 m -115.83 130.93 57.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.44 . . . . 2.46 111.099 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.513 ' HZ ' HD23 ' B' ' 23' ' ' LEU . 31.3 m-85 -131.56 139.02 49.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.169 0.433 . . . . 2.49 112.169 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.568 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 8.3 mpt_? -108.32 176.85 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.873 -0.418 . . . . 6.21 109.873 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -80.41 138.17 36.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 3.87 110.163 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.79 20.38 58.09 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.027 -0.829 . . . . 4.23 111.027 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.568 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 22.9 mm-40 -98.29 179.73 4.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.04 0.924 . . . . 4.19 113.391 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 mm -134.64 119.64 29.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 113.563 -1.653 . . . . 5.23 110.707 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.627 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 39.5 mt -114.18 133.73 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.007 -0.542 . . . . 4.64 111.591 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -93.43 126.68 38.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.384 -0.599 . . . . 7.14 109.384 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.47 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.9 tt -74.37 102.77 4.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 6.33 110.528 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mm -81.56 -64.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.498 -0.774 . . . . 6.97 111.197 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' B' ' 45' ' ' LYS . 69.1 m -154.47 112.3 3.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.683 0.623 . . . . 7.03 112.683 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.32 -72.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.979 -0.748 . . . . 7.52 108.979 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -45.04 96.05 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.096 -0.502 . . . . 8.93 111.381 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 4.5 t -112.08 -2.67 14.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.063 -0.517 . . . . 7.05 111.077 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.18 0.41 67.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.993 -0.622 . . . . 8.42 113.211 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -134.24 124.26 25.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.761 0.315 . . . . 7.96 111.205 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.11 131.9 50.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 8.2 111.035 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.16 -1.31 84.56 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.006 -0.616 . . . . 6.68 112.588 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.556 ' HE1' ' HB3' ' A' ' 8' ' ' LEU . 69.5 m95 -117.76 135.3 54.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.188 0.518 . . . . 5.83 111.543 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -123.51 155.42 37.58 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.086 -0.961 . . . . 5.87 109.033 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' B' ' 35' ' ' SER . 23.9 ttmm -113.45 130.35 56.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.908 0.385 . . . . 5.33 110.644 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.36 176.47 21.36 Favored Glycine 0 N--CA 1.453 -0.18 0 CA-C-N 115.73 -0.668 . . . . 4.14 112.056 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.39 135.02 51.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 6.02 110.414 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 50' ' ' GLY . 21.2 tp -130.12 170.02 14.58 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.332 -0.849 . . . . 4.21 110.109 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.53 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 25.3 m120 -17.88 65.19 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.401 1.63 . . . . 5.39 115.401 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.33 -12.95 57.3 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.776 0.67 . . . . 5.53 114.776 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -116.31 135.5 53.82 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.767 0.784 . . . . 5.33 111.19 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -108.81 152.95 24.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.117 -0.492 . . . . 5.79 109.853 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.18 -176.15 46.7 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.416 -0.897 . . . . 3.35 112.808 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.57 154.88 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.468 0.175 . . . . 4.3 110.571 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.475 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 46.5 p90 -141.49 140.18 20.05 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 112.755 0.65 . . . . 3.72 112.755 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 55' ' ' PHE . 96.7 Cg_endo -94.61 174.72 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.457 3.438 . . . . 3.97 110.637 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.472 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 79.75 -14.14 0.88 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.913 1.449 . . . . 5.85 114.913 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 58.5 t30 57.3 76.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.016 -0.735 . . . . 5.67 109.016 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 19.5 m-85 -101.66 6.46 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 3.89 111.948 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.1 139.01 40.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.466 0.543 . . . . 3.89 112.466 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.28 130.53 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 4.64 111.32 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -55.43 128.99 36.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.887 0.375 . . . . 6.72 111.092 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -88.4 -61.01 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.965 -0.561 . . . . 6.54 110.373 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.428 -0.796 . . . . 7.43 110.69 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' CA ' ' A' ' 63' ' ' LYS . 45.5 tpp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.829 0.347 . . . . 16.5 110.92 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -82.03 145.62 30.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 13.22 110.91 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -147.59 151.69 13.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 12.19 111.008 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.21 146.1 34.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 11.64 110.89 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 50.9 t -136.52 97.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 6.66 110.306 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.37 133.37 36.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 6.86 111.439 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.7 m -106.89 152.43 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 3.79 110.374 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.544 HD13 ' HE1' ' B' ' 43' ' ' TRP . 40.7 tp -56.45 -36.64 69.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 5.48 111.073 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -56.47 -36.11 68.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.056 -0.52 . . . . 7.65 111.209 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.29 8.62 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.068 -0.515 . . . . 7.08 112.351 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -100.16 124.79 45.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.942 0.401 . . . . 6.58 112.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -101.37 134.33 44.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.756 -0.656 . . . . 6.95 109.365 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.44 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 23.0 pt -119.72 143.67 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 5.97 111.623 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.6 p -101.32 137.62 39.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.484 -0.78 . . . . 8.28 110.952 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 mp -137.85 160.85 38.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.268 -0.423 . . . . 10.02 110.526 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.52 103.04 7.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 12.19 110.771 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.03 113.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.303 -0.408 . . . . 14.73 111.382 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.405 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 41.3 mt-10 -50.5 166.84 0.27 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.416 0.895 . . . . 18.57 113.416 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 28.7 Cg_exo -64.14 -33.62 60.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.442 2.761 . . . . 19.89 113.279 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -20.12 64.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.546 -0.297 . . . . 21.46 111.752 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.16 147.32 53.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 18.56 111.716 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 67.2 p -88.83 152.98 21.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.932 -0.576 . . . . 20.15 110.707 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.47 HD12 HD13 ' A' ' 50' ' ' LEU . 47.6 mm -57.07 -36.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.459 -0.337 . . . . 16.47 111.036 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -46.39 80.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 19.99 110.156 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -58.71 -42.84 89.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.863 -0.608 . . . . 16.38 110.303 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 56' ' ' LEU . 78.7 t -62.18 -41.64 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 13.8 110.524 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.52 -28.69 70.03 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.286 -0.415 . . . . 13.67 110.599 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.37 70.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 14.55 109.843 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -67.71 -46.24 72.78 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.831 -0.622 . . . . 13.7 109.48 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -61.49 -38.73 80.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.884 -0.598 . . . . 9.57 110.113 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -66.88 -32.28 73.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 15.04 110.697 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.99 -38.49 82.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 12.47 111.234 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -88.99 -51.18 5.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.265 0.469 . . . . 9.23 112.265 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.53 -10.87 47.41 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.487 0.921 . . . . 9.6 113.487 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.59 -37.39 2.06 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.533 -0.841 . . . . 12.2 114.3 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.522 HD12 HD21 ' A' ' 69' ' ' LEU . 8.4 pt -45.84 124.48 6.48 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 112.133 0.42 . . . . 11.27 112.133 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.68 144.48 89.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.969 2.446 . . . . 14.23 112.881 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.61 -28.31 82.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.84 2.36 . . . . 14.34 112.583 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.3 -27.51 68.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 16.96 111.359 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -100.3 -9.27 22.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.314 -0.403 . . . . 14.45 111.12 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -84.43 120.92 26.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 10.91 112.113 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -118.25 117.01 27.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.56 -0.746 . . . . 9.32 109.101 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.58 122.61 46.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.961 0.41 . . . . 10.56 111.963 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.741 ' HB ' HG21 ' B' ' 18' ' ' THR . 40.6 pt -111.03 127.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.639 -0.71 . . . . 9.75 110.439 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -129.48 120.52 25.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.489 -0.778 . . . . 15.27 110.795 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.35 19.69 9.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.615 . . . . 14.76 112.272 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.842 ' C ' HG22 ' B' ' 18' ' ' THR . . . 93.7 5.64 62.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.588 -0.815 . . . . 12.99 113.127 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 144.39 47.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.589 0.233 . . . . 17.08 110.491 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -79.14 140.46 37.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.235 -0.283 . . . . 14.97 110.235 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD13 HD12 ' A' ' 23' ' ' ILE . 90.8 mt -89.27 133.57 34.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.456 -0.338 . . . . 14.81 110.684 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.1 127.13 36.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 21.0 111.336 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -40.39 -51.38 2.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.793 -0.639 . . . . 18.5 111.373 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.71 -78.23 0.14 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.487 -0.863 . . . . 21.79 111.237 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -26.77 152.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.558 0.947 . . . . 24.16 113.558 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.4 p -107.05 164.09 12.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.194 -0.912 . . . . 21.36 111.256 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD11 HG21 ' A' ' 26' ' ' VAL . 11.2 mp -53.08 -39.19 63.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 18.41 111.241 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 m -61.63 -28.58 69.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 21.76 111.352 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.06 -38.31 90.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 23.14 111.055 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -96.05 12.54 30.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.443 . . . . 19.37 111.672 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.97 43.2 21.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.998 0.428 . . . . 22.24 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.7 mt -92.79 119.6 40.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.136 -0.484 . . . . 17.93 111.19 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -113.55 -170.43 1.69 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.256 -0.429 . . . . 21.49 111.491 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' CA ' ' SD ' ' A' ' 1' ' ' MET . 83.1 tttt -62.78 157.74 20.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.09 -0.505 . . . . 19.19 111.454 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 59.88 28.72 18.26 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.782 -0.645 . . . . 16.92 111.784 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -89.77 143.86 26.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.447 -0.342 . . . . 14.92 110.827 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -99.39 134.8 41.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 11.29 111.205 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.33 113.55 13.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.019 -0.537 . . . . 10.94 111.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.544 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 38.9 t-80 -83.62 119.32 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.999 0.428 . . . . 8.09 110.487 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.522 HD21 HD12 ' A' ' 36' ' ' ILE . 22.9 tp -95.25 121.3 36.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 6.7 110.777 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.451 ' C ' HD22 ' A' ' 71' ' ' LEU . 5.2 t -103.23 133.64 46.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.898 -0.592 . . . . 7.13 110.527 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 71' ' ' LEU . 2.9 mm? -122.48 125.14 45.18 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.495 -0.321 . . . . 8.31 111.378 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 50.31 100.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.979 -0.555 . . . . 14.22 112.072 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 73' ' ' LEU . 1.7 pt? -53.06 -51.67 61.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 13.68 111.059 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' N ' ' HG ' ' A' ' 73' ' ' LEU . 97.9 mtt180 54.19 20.52 2.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.507 -0.315 . . . . 20.03 111.165 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.53 9.38 10.28 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.049 -0.523 . . . . 17.34 111.927 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' B' ' 54' ' ' VAL . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.361 -1.244 . . . . 17.6 112.264 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.426 0.155 . . . . 9.15 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -112.67 175.63 5.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.102 0.477 . . . . 10.58 110.775 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -103.02 133.49 48.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.449 -0.796 . . . . 7.56 109.105 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -128.4 165.1 21.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.185 0.517 . . . . 7.84 111.91 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 26.2 p -145.77 148.15 32.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.187 -0.915 . . . . 4.73 110.762 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -99.13 143.12 29.76 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.391 -0.368 . . . . 4.43 110.684 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -86.66 124.18 32.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.083 -0.508 . . . . 2.72 111.33 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -94.73 -21.13 18.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.223 0.453 . . . . 3.78 112.223 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.445 ' HA ' ' HD3' ' B' ' 14' ' ' PRO . 79.6 t80 -145.68 140.9 16.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.886 0.328 . . . . 4.88 111.886 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 13' ' ' PHE . 36.7 Cg_exo -61.61 139.75 82.98 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.809 2.339 . . . . 3.11 112.488 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -138.69 133.64 32.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.72 -0.673 . . . . 4.0 111.288 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.43 ' HA ' HG23 ' B' ' 24' ' ' THR . 68.9 m -111.65 119.13 37.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.426 . . . . 3.82 110.754 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.82 139.08 48.61 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.887 -0.673 . . . . 3.22 112.553 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.842 HG22 ' C ' ' A' ' 47' ' ' GLY . 24.9 p -103.94 -23.46 13.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.181 0.515 . . . . 4.64 110.705 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -120.38 154.6 34.87 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.197 -0.91 . . . . 4.05 109.757 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.5 -39.66 92.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 4.26 111.458 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.13 -4.8 34.97 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.908 0.385 . . . . 4.22 110.589 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.2 158.82 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.973 -0.558 . . . . 3.77 110.949 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' B' ' 24' ' ' THR . 3.6 tt -102.62 139.99 37.49 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.812 -0.811 . . . . 3.13 108.812 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.754 ' N ' HD23 ' B' ' 23' ' ' LEU . 98.6 m -112.38 123.88 51.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.531 -0.759 . . . . 2.46 109.474 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' B' ' 55' ' ' PHE . 15.9 p90 -135.61 146.01 47.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.962 0.727 . . . . 2.49 112.962 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.501 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 31.9 mmt180 -109.56 178.29 4.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.116 -0.327 . . . . 6.21 110.116 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -81.35 142.77 32.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 3.87 110.328 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 20.23 61.72 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.878 -0.889 . . . . 4.23 110.878 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.6 mm-40 -98.53 178.81 4.9 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.343 0.868 . . . . 4.19 113.343 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 21.9 mm -136.05 116.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.648 -1.615 . . . . 5.23 110.943 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.443 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 55.2 mt -112.35 137.84 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 4.64 111.083 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' HIS . . . . . 0.488 ' O ' ' HA2' ' B' ' 46' ' ' GLY . 1.8 m-70 -92.51 128.19 38.27 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.326 -0.62 . . . . 7.14 109.326 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.533 ' C ' HD23 ' B' ' 33' ' ' LEU . 6.1 tt -73.81 102.26 3.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 6.33 111.113 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' B' ' 47' ' ' GLU . 55.1 mt -81.1 -64.61 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.666 -0.697 . . . . 6.97 111.098 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.0 t -154.12 116.7 4.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 7.03 112.286 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 52.3 mtpt -69.52 6.22 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.984 -0.553 . . . . 7.52 111.398 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -121.61 98.46 5.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.593 0.235 . . . . 8.93 110.64 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 45' ' ' LYS . 48.1 p -108.07 -1.4 20.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.544 -0.298 . . . . 7.05 111.423 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.83 -4.2 75.09 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.782 -0.723 . . . . 8.42 111.565 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -129.31 121.49 27.61 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.385 0.274 . . . . 7.96 110.65 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.425 ' O ' HD11 ' A' ' 8' ' ' LEU . . . -59.87 133.28 55.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 8.2 110.507 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.25 82.11 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.927 -0.654 . . . . 6.68 112.387 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.544 ' HE1' HD13 ' A' ' 8' ' ' LEU . 86.3 m95 -120.35 122.32 40.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.053 0.427 . . . . 5.83 111.443 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' TRP . . . . . 0.485 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 30.7 m0 -111.56 162.73 14.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.103 -0.703 . . . . 5.87 109.103 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' B' ' 38' ' ' THR . 63.6 tttm -115.58 129.98 56.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.795 0.331 . . . . 5.33 110.405 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' B' ' 32' ' ' HIS . . . -142.82 177.43 21.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.654 -0.784 . . . . 4.14 112.359 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' B' ' 34' ' ' ILE . 36.5 tt0 -125.13 133.55 52.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.294 0.568 . . . . 6.02 110.778 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.675 ' O ' ' N ' ' B' ' 50' ' ' GLY . 42.5 tp -127.45 169.96 13.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.987 -1.006 . . . . 4.21 109.269 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.456 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 58.2 m-20 -17.92 64.45 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.256 1.576 . . . . 5.39 115.256 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.71 -10.84 63.52 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 114.937 0.735 . . . . 5.53 114.937 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.45 152.62 24.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.162 0.981 . . . . 5.33 110.988 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 1.2 pm0 -125.73 142.15 51.65 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.948 -0.76 . . . . 5.79 108.948 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLY . . . . . 0.466 ' C ' ' HB2' ' B' ' 23' ' ' LEU . . . -179.84 -171.27 42.57 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 120.254 -0.974 . . . . 3.35 113.101 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.533 HG21 ' HA3' ' A' ' 76' ' ' GLY . 33.4 m -111.77 151.11 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 120.704 0.288 . . . . 4.3 111.055 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 38.4 p90 -131.34 139.52 35.68 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 112.219 0.451 . . . . 3.72 112.219 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 55' ' ' PHE . 94.4 Cg_endo -97.95 174.26 0.57 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.297 3.332 . . . . 3.97 111.546 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.503 ' HB2' ' CD2' ' B' ' 59' ' ' PHE . 16.6 m-20 78.78 -10.68 1.31 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.49 1.293 . . . . 5.85 114.49 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' B' ' 60' ' ' ALA . 15.8 m120 58.15 26.68 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 118.43 0.559 . . . . 5.67 110.201 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.503 ' CD2' ' HB2' ' B' ' 57' ' ' ASP . 9.3 m-85 -56.64 3.97 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.201 0.815 . . . . 3.89 113.201 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' B' ' 58' ' ' ASN . . . -129.47 138.87 51.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.225 0.454 . . . . 3.89 112.225 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 128.06 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 4.64 111.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -53.72 156.64 2.61 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 120.932 0.396 . . . . 6.72 110.746 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.46 -32.71 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 6.54 110.45 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 74.5 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.369 -0.824 . . . . 7.43 110.529 179.75 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 tpp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.678 0.275 . . . . 16.5 110.835 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -84.7 142.37 29.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 13.22 110.794 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -145.42 151.43 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 12.19 110.712 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -109.93 145.48 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 11.64 110.795 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 5' ' ' VAL . 31.3 m -136.27 106.4 5.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.184 0.516 . . . . 6.66 110.678 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 7' ' ' THR . 81.5 tttt -75.94 163.14 27.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 6.86 111.076 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.471 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.3 m -137.43 142.16 41.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.681 -0.69 . . . . 3.79 109.895 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 9' ' ' THR . 3.2 pp -55.31 -21.86 16.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.453 -0.34 . . . . 5.48 111.65 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.435 ' H ' HG22 ' A' ' 7' ' ' THR . 31.5 m -71.18 -39.37 71.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.397 -0.365 . . . . 7.65 110.575 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.78 -1.95 5.97 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.076 -0.583 . . . . 7.08 112.872 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -98.99 129.4 45.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.011 0.434 . . . . 6.58 112.073 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -104.57 136.15 44.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.577 -0.738 . . . . 6.95 109.448 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 13' ' ' ILE . 5.1 mp -118.0 152.72 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 5.97 111.471 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.404 ' N ' HG22 ' A' ' 13' ' ' ILE . 24.9 m -108.89 135.07 50.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 8.28 110.425 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.4 tp -135.53 154.14 51.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.491 -0.322 . . . . 10.02 110.728 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.64 99.74 6.71 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.306 -0.406 . . . . 12.19 111.278 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -149.95 111.81 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.532 -0.303 . . . . 14.73 111.54 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -52.14 166.18 0.43 Allowed Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 114.176 1.176 . . . . 18.57 114.176 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.9 Cg_exo -60.16 -30.66 91.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.715 2.943 . . . . 19.89 113.864 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 m -80.95 32.92 0.32 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 21.46 111.552 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -118.7 126.9 52.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 18.56 110.896 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 77.1 p -64.71 148.87 50.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 20.15 111.151 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.45 HD12 HD23 ' A' ' 50' ' ' LEU . 41.0 mm -58.51 -37.68 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 16.47 110.88 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 11.0 pt-20 -61.77 -40.52 95.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 19.99 110.091 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -64.16 -43.8 94.05 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.883 -0.599 . . . . 16.38 109.785 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.28 -41.07 88.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.884 -0.598 . . . . 13.8 110.434 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.89 -29.22 70.6 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.228 -0.442 . . . . 13.67 110.415 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.62 74.73 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.106 -0.497 . . . . 14.55 109.691 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -64.34 -47.62 78.67 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.586 -0.733 . . . . 13.7 109.559 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.46 -40.61 86.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 115.856 -0.611 . . . . 9.57 110.134 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -63.38 -30.38 71.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 15.04 110.909 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.19 -35.94 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 12.47 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -88.89 -58.97 2.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.114 -0.494 . . . . 9.23 112.003 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -82.5 -11.43 58.49 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.396 0.887 . . . . 9.6 113.396 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.36 -29.99 1.93 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.498 -0.858 . . . . 12.2 114.056 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 46.8 mm -50.09 124.72 17.69 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.994 0.397 . . . . 11.27 111.917 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 40.8 Cg_exo -58.86 151.97 60.99 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.774 2.316 . . . . 14.23 112.341 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.09 -32.82 16.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.688 2.259 . . . . 14.34 112.114 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.84 -22.98 67.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.061 -0.518 . . . . 16.96 111.077 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -97.2 -18.06 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 14.45 110.86 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -78.73 124.17 27.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.046 0.451 . . . . 10.91 112.036 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.466 HH21 HG21 ' A' ' 70' ' ' VAL . 37.6 ttp180 -121.23 118.89 30.74 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.459 -0.941 . . . . 9.32 108.459 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.56 127.96 50.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.142 0.496 . . . . 10.56 112.046 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.724 HG23 HG21 ' B' ' 18' ' ' THR . 39.5 mm -115.49 120.33 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.273 -0.876 . . . . 9.75 110.474 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CB ' HD11 ' A' ' 50' ' ' LEU . 60.3 t80 -130.12 119.46 23.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.031 -0.531 . . . . 15.27 111.028 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.95 18.33 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 14.76 112.097 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.689 ' O ' HG22 ' B' ' 18' ' ' THR . . . 94.7 1.84 63.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.603 -0.808 . . . . 12.99 112.989 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -117.36 143.49 45.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 17.08 110.893 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.83 131.83 35.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 14.97 110.719 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 50' ' ' LEU . 5.4 mp -80.22 134.72 36.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.921 0.391 . . . . 14.81 111.403 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 130.29 35.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.837 -0.62 . . . . 21.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 4.0 p30 -44.28 -49.34 9.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 18.5 111.214 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -58.79 -76.11 0.23 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.62 -0.8 . . . . 21.79 111.573 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' GLY . 60.7 mtp180 -28.55 156.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.584 0.957 . . . . 24.16 113.584 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 9.3 t -110.9 164.1 13.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.061 -0.972 . . . . 21.36 110.506 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 92.7 mt -53.73 -36.57 62.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 18.41 111.629 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.7 t -62.34 -29.69 70.64 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.749 0.278 . . . . 21.76 111.749 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.33 -34.83 79.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.677 0.275 . . . . 23.14 110.945 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -93.77 4.71 53.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.472 . . . . 19.37 111.275 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 64.03 33.02 12.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.001 0.429 . . . . 22.24 110.897 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.8 mt -80.93 116.93 26.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.53 . . . . 17.93 111.582 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -107.4 -170.82 1.76 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.72 -0.673 . . . . 21.49 110.46 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.38 160.7 21.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.467 -0.333 . . . . 19.19 111.01 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.6 26.8 15.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.172 -0.467 . . . . 16.92 111.744 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 t -87.47 139.13 30.86 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.761 0.315 . . . . 14.92 111.09 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -100.03 129.15 46.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 11.29 110.975 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -127.36 114.89 18.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.125 -0.489 . . . . 10.94 110.783 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.96 122.32 25.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 8.09 110.937 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.47 116.27 28.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.912 -0.585 . . . . 6.7 110.335 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.5 ' C ' HD12 ' A' ' 71' ' ' LEU . 38.2 t -107.49 139.24 30.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 7.13 111.735 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 70' ' ' VAL . 6.0 mp -122.14 110.79 16.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.476 -0.784 . . . . 8.31 110.037 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.411 ' HE ' ' NH1' ' A' ' 42' ' ' ARG . 35.8 mmt180 -96.6 112.75 24.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 14.22 110.82 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 73' ' ' LEU . 5.2 mp -102.18 -44.15 5.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.008 -0.542 . . . . 13.68 110.441 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -176.43 147.82 0.7 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.739 -0.664 . . . . 20.03 110.629 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.09 -30.63 5.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.923 -0.656 . . . . 17.34 112.918 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.374 -1.237 . . . . 17.6 112.659 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.757 0.313 . . . . 9.15 110.964 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -156.85 118.05 3.72 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.033 -0.531 . . . . 10.58 109.627 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -126.2 106.4 9.52 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.685 -0.688 . . . . 7.56 109.712 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.11 171.64 12.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.271 -0.422 . . . . 7.84 111.558 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 36.6 m -148.03 151.17 35.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.865 -0.607 . . . . 4.73 111.345 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -99.81 139.47 35.43 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.985 -0.376 . . . . 4.43 109.985 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 60.3 p -83.28 121.81 27.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.42 -0.355 . . . . 2.72 111.611 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.04 -20.85 23.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.552 -0.295 . . . . 3.78 111.309 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -147.57 157.46 44.64 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 4.88 111.13 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.76 140.77 26.57 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.665 2.243 . . . . 3.11 112.71 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.438 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 66.9 t80 -136.71 129.91 31.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 4.0 110.375 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.513 ' HA ' HG23 ' B' ' 24' ' ' THR . 7.4 t -113.0 121.33 44.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 3.82 111.52 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.29 145.61 49.73 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.822 -0.704 . . . . 3.22 111.865 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.724 HG21 HG23 ' A' ' 44' ' ' ILE . 57.9 p -107.98 -21.75 12.69 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.038 0.447 . . . . 4.64 111.255 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.61 162.35 18.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.539 -0.755 . . . . 4.05 110.516 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' B' ' 20' ' ' GLU . 1.8 mp0 -59.13 -27.94 66.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.897 -0.592 . . . . 4.26 112.544 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.73 -53.28 6.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.553 -0.459 . . . . 4.22 110.59 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -32.35 146.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.704 -0.68 . . . . 3.77 112.167 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' B' ' 24' ' ' THR . 3.2 tt -98.27 141.41 31.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.288 -1.005 . . . . 3.13 108.288 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.754 ' N ' HD23 ' B' ' 23' ' ' LEU . 95.9 m -113.96 122.9 48.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.84 -0.618 . . . . 2.46 110.374 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.482 ' CG ' HD11 ' B' ' 31' ' ' ILE . 37.1 p90 -138.54 155.27 48.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.614 0.598 . . . . 2.49 112.614 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.41 -179.86 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.222 -0.288 . . . . 6.21 110.222 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.18 141.49 32.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 3.87 110.177 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.87 58.94 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.736 -0.946 . . . . 4.23 110.736 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.497 ' HG2' ' H ' ' B' ' 30' ' ' ILE . 4.4 tt0 -99.29 179.28 4.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.23 0.826 . . . . 4.19 113.23 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.497 ' H ' ' HG2' ' B' ' 29' ' ' GLU . 30.3 mm -135.86 115.33 16.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.877 -1.51 . . . . 5.23 110.979 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.482 HD11 ' CG ' ' B' ' 25' ' ' PHE . 51.5 mt -114.49 145.88 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 4.64 111.166 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -97.43 129.22 44.67 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.514 -0.55 . . . . 7.14 109.514 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.404 ' C ' HD13 ' B' ' 33' ' ' LEU . 3.1 tm? -78.11 110.62 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 6.33 111.172 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -84.11 -58.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 6.97 111.264 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 70.6 m -158.92 121.43 3.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.32 0.489 . . . . 7.03 112.32 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.08 6.38 2.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.915 -0.584 . . . . 7.52 111.435 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.9 105.82 10.69 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.767 -0.197 . . . . 8.93 110.558 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.568 HG22 ' HB2' ' B' ' 45' ' ' LYS . 28.0 p -115.0 -3.3 12.65 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.806 0.299 . . . . 7.05 111.806 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.8 -9.04 77.69 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.759 -0.734 . . . . 8.42 112.233 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.73 118.69 30.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.698 0.285 . . . . 7.96 110.513 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.2 130.55 46.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 8.2 111.229 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 2.41 79.72 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.881 -0.599 . . . . 6.68 112.461 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 68.3 m95 -120.39 126.39 50.35 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.052 0.453 . . . . 5.83 112.023 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -110.85 165.08 12.14 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.589 -0.893 . . . . 5.87 108.589 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' B' ' 38' ' ' THR . 36.5 ttpt -119.86 129.95 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.956 0.408 . . . . 5.33 110.874 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.23 175.41 20.93 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.566 -0.743 . . . . 4.14 112.126 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -134.55 134.34 41.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 6.02 110.366 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 50' ' ' GLY . 52.5 tp -123.97 133.23 53.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 4.21 109.029 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -22.03 80.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.143 1.164 . . . . 5.39 114.143 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 125.24 -50.85 0.85 Allowed Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.57 -0.741 . . . . 5.53 114.753 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -112.06 153.87 26.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.998 0.899 . . . . 5.33 112.127 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.41 142.14 51.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.205 -0.907 . . . . 5.79 108.591 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.78 -176.08 41.96 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.086 -1.054 . . . . 3.35 113.245 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -112.85 152.91 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.576 0.227 . . . . 4.3 111.047 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 51.7 p90 -135.68 140.36 33.56 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.612 0.597 . . . . 3.72 112.612 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 64.6 Cg_endo -96.16 175.05 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.657 3.572 . . . . 3.97 110.976 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.537 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 3.2 m-20 77.34 -12.45 1.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.184 1.55 . . . . 5.85 115.184 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 58.19 75.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.424 -0.954 . . . . 5.67 108.424 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.537 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 17.3 m-85 -102.96 6.62 39.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.276 -0.874 . . . . 3.89 112.211 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.57 139.01 43.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.479 0.548 . . . . 3.89 112.479 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.84 130.0 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.942 -0.572 . . . . 4.64 111.561 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.466 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 8.9 tp-100 -54.19 112.68 1.02 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.738 0.304 . . . . 6.72 110.527 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 pt -90.6 -31.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 6.54 110.933 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.356 -0.83 . . . . 7.43 110.586 -179.827 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.823 0.344 . . . . 16.5 110.822 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.63 141.94 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 13.22 110.583 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.02 149.81 15.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.414 -0.357 . . . . 12.19 110.975 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -103.98 152.37 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 11.64 111.156 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.76 101.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.772 -0.649 . . . . 6.66 109.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -89.43 133.56 34.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.182 0.438 . . . . 6.86 112.182 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -103.15 160.0 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 3.79 111.158 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.546 HD22 ' HE1' ' B' ' 43' ' ' TRP . 3.8 pp -64.78 -24.72 67.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.047 -0.524 . . . . 5.48 111.178 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.448 ' N ' HD12 ' A' ' 8' ' ' LEU . 77.1 p -67.79 -35.88 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.288 -0.415 . . . . 7.65 110.985 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.69 3.64 7.68 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.109 -0.567 . . . . 7.08 112.675 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -99.65 126.64 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.275 0.472 . . . . 6.58 112.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -101.07 133.67 45.24 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.712 -0.676 . . . . 6.95 109.467 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 13' ' ' ILE . 4.6 mp -117.59 142.03 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 5.97 111.68 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.717 -0.674 . . . . 8.28 110.029 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.465 HD11 HG12 ' A' ' 30' ' ' ILE . 35.9 mt -134.58 155.22 50.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.525 -0.307 . . . . 10.02 110.959 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -123.0 99.82 6.57 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.199 -0.455 . . . . 12.19 111.028 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 17' ' ' VAL . 11.2 p -153.04 115.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.542 -0.299 . . . . 14.73 111.731 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 43.6 mt-10 -51.46 168.77 0.25 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 113.867 1.062 . . . . 18.57 113.867 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 16.7 Cg_exo -69.39 -23.19 32.76 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.572 2.848 . . . . 19.89 113.344 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -84.12 28.96 0.58 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.673 0.273 . . . . 21.46 111.546 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -116.58 139.83 50.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.428 -0.351 . . . . 18.56 110.839 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 81.4 p -73.76 151.37 40.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 20.15 111.41 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.25 -36.54 69.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.352 -0.386 . . . . 16.47 110.384 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -43.15 99.53 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.4 -0.593 . . . . 19.99 109.4 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -60.62 -43.21 97.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.789 -0.641 . . . . 16.38 110.081 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 56' ' ' LEU . 93.3 t -62.57 -42.5 96.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.937 -0.574 . . . . 13.8 110.4 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.01 -28.7 69.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.125 -0.489 . . . . 13.67 110.421 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.89 71.68 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.59 -0.522 . . . . 14.55 109.59 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -62.93 -48.47 78.77 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.598 -0.728 . . . . 13.7 109.367 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.465 HG12 HD11 ' A' ' 15' ' ' LEU . 79.7 mt -61.1 -42.67 94.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.518 -0.764 . . . . 9.57 109.904 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -60.38 -28.41 68.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.602 -0.727 . . . . 15.04 110.833 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -75.74 -36.57 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 12.47 110.936 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.45 -64.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.05 -0.523 . . . . 9.23 112.035 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -78.49 -8.36 58.46 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.719 1.007 . . . . 9.6 113.719 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.66 26.96 67.45 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.388 -0.911 . . . . 12.2 113.416 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -98.27 118.59 63.31 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.799 0.299 . . . . 11.27 110.559 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.99 135.97 51.95 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.583 2.188 . . . . 14.23 112.219 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.79 -29.32 76.74 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.219 . . . . 14.34 112.046 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.1 -24.63 66.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.886 -0.597 . . . . 16.96 111.036 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -99.28 -16.3 18.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.025 -0.534 . . . . 14.45 110.979 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -80.03 123.8 28.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.005 0.431 . . . . 10.91 111.769 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.493 ' HB3' HG13 ' A' ' 70' ' ' VAL . 47.8 ttp180 -122.21 121.99 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.337 -0.986 . . . . 9.32 108.337 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 50' ' ' LEU . 92.2 mt -106.11 129.69 54.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.024 0.44 . . . . 10.56 112.031 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mt -116.17 121.03 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 9.75 110.52 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.689 ' HB3' HD21 ' A' ' 50' ' ' LEU . 72.2 t80 -128.05 117.29 21.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 15.27 110.57 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.58 22.14 10.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 14.76 111.392 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -10.25 67.47 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.01 -0.614 . . . . 12.99 112.767 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.07 -163.04 0.08 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.244 0.218 . . . . 17.08 111.124 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 -13.51 6.59 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.711 1.004 . . . . 14.97 113.711 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.689 HD21 ' HB3' ' A' ' 45' ' ' PHE . 2.2 mm? 58.5 106.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.788 0.328 . . . . 14.81 111.421 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -92.13 130.23 37.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.337 -0.392 . . . . 21.0 111.601 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -40.23 -60.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.82 -0.627 . . . . 18.5 111.35 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -50.75 -75.49 0.21 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.529 -0.843 . . . . 21.79 111.552 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' GLY . 32.4 mmt180 -27.53 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 24.16 113.479 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 6.3 t -111.72 164.04 13.47 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.154 -0.93 . . . . 21.36 111.093 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.3 mm? -51.72 -44.29 63.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.344 -0.389 . . . . 18.41 111.2 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 t -58.33 -29.37 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.14 -0.482 . . . . 21.76 111.602 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.85 -35.6 81.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 23.14 110.892 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -98.68 11.84 37.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 19.37 111.327 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 58.11 38.26 26.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.907 0.384 . . . . 22.24 111.317 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.32 115.96 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 17.93 110.864 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -109.35 -168.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.849 -0.614 . . . . 21.49 110.948 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.84 160.71 11.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 19.19 111.338 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 57.99 29.81 18.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.853 -0.612 . . . . 16.92 111.701 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.0 p -89.79 138.1 31.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 14.92 111.299 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.49 ' C ' HD12 ' A' ' 67' ' ' LEU . 76.0 p -99.94 127.25 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 11.29 110.797 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 66' ' ' THR . 8.2 mp -122.46 121.26 36.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.406 . . . . 10.94 110.884 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 8.09 110.941 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -94.9 113.89 25.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 6.7 110.244 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -118.7 143.45 29.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 7.13 110.993 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 71' ' ' LEU . 2.2 mm? -105.0 148.15 27.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.919 -0.582 . . . . 8.31 110.3 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.421 ' HD3' ' CZ ' ' A' ' 42' ' ' ARG . 27.9 mmm180 -127.34 104.46 7.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 14.22 110.375 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 73' ' ' LEU . 2.0 pt? -144.94 -150.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 13.68 110.226 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -55.14 92.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.034 0.445 . . . . 20.03 110.285 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.9 -157.41 22.4 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.754 -0.657 . . . . 17.34 112.13 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.396 -1.224 . . . . 17.6 112.501 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.136 0.493 . . . . 9.15 110.951 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -171.2 124.98 0.63 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.375 -0.829 . . . . 10.58 109.863 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -127.95 104.55 7.86 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.763 -0.653 . . . . 7.56 109.365 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.05 173.02 12.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 7.84 111.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.479 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 7.5 p -148.23 151.69 35.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.7 -0.682 . . . . 4.73 111.527 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -99.6 141.33 32.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.29 -0.414 . . . . 4.43 110.033 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 46.2 p -84.56 123.69 30.59 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.373 -0.376 . . . . 2.72 111.557 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.81 -21.03 23.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 3.78 110.514 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -148.53 156.25 42.08 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 4.88 110.703 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.04 143.62 36.51 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.608 2.205 . . . . 3.11 113.027 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' B' ' 15' ' ' TYR . 11.9 t80 -130.58 68.67 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 4.0 110.377 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.895 ' HA ' HG23 ' B' ' 24' ' ' THR . 90.1 m -53.92 115.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 3.82 110.707 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.61 140.01 47.16 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.772 -0.649 . . . . 3.22 112.181 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -102.68 -24.37 13.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.148 0.499 . . . . 4.64 110.925 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -119.11 165.14 14.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.491 -0.777 . . . . 4.05 110.324 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.33 -38.61 78.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 4.26 111.781 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.57 -6.01 43.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.884 0.373 . . . . 4.22 110.6 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.99 162.63 15.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.779 -0.646 . . . . 3.77 110.868 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 23' ' ' LEU . 36.3 mt -108.47 150.8 26.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.197 -0.668 . . . . 3.13 109.197 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.895 HG23 ' HA ' ' B' ' 16' ' ' THR . 32.1 m -114.15 127.41 55.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 2.46 110.155 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.558 ' CE1' HG12 ' B' ' 31' ' ' ILE . 50.3 m-85 -133.28 144.97 50.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.037 0.754 . . . . 2.49 113.037 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.492 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 11.1 ptp180 -109.42 176.49 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.698 -0.853 . . . . 6.21 108.698 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.27 126.41 31.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.65 0.738 . . . . 3.87 109.921 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 26.2 7.14 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.347 -1.297 . . . . 4.23 110.734 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 23.3 mm-40 -98.53 178.9 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.773 1.027 . . . . 4.19 113.773 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 mm -135.95 116.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.557 -1.656 . . . . 5.23 110.826 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.558 HG12 ' CE1' ' B' ' 25' ' ' PHE . 53.7 mt -108.36 132.21 56.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.044 -0.525 . . . . 4.64 111.446 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -91.67 125.53 36.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.029 -0.73 . . . . 7.14 109.029 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.82 100.67 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 6.33 110.966 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 45.4 mm -82.73 -58.31 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 6.97 110.972 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 66.8 m -157.18 105.89 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 7.03 111.656 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.437 ' NZ ' ' HB2' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -66.66 5.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 7.52 111.896 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -121.19 102.03 8.04 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 120.562 0.22 . . . . 8.93 110.459 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.443 HG22 ' HB2' ' B' ' 45' ' ' LYS . 42.9 p -110.71 -4.66 15.24 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.488 -0.323 . . . . 7.05 111.713 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.54 -1.2 71.89 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.967 -0.635 . . . . 8.42 112.446 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -129.45 120.54 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.189 -0.3 . . . . 7.96 110.189 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.03 132.74 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 8.2 111.108 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 1.57 81.79 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.688 -0.687 . . . . 6.68 112.394 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.622 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 53.6 m95 -120.78 123.15 41.94 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.937 0.398 . . . . 5.83 111.731 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' TRP . . . . . 0.414 ' NE1' ' HB2' ' B' ' 36' ' ' LYS . 3.7 m0 -112.93 161.43 17.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.062 -0.718 . . . . 5.87 109.062 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.443 ' HB2' HG22 ' B' ' 38' ' ' THR . 64.1 tttp -116.07 130.56 56.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.09 0.471 . . . . 5.33 111.216 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.54 175.45 21.22 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.407 -0.815 . . . . 4.14 111.562 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.1 132.66 53.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.223 0.535 . . . . 6.02 110.32 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.627 ' O ' ' N ' ' B' ' 50' ' ' GLY . 60.0 tp -124.87 169.22 12.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.219 -0.901 . . . . 4.21 110.224 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.519 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 62.5 m-20 -18.62 67.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.283 1.586 . . . . 5.39 115.283 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.98 -10.22 63.64 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.981 0.753 . . . . 5.53 114.981 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -110.38 155.11 22.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.92 0.86 . . . . 5.33 111.045 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' B' ' 52' ' ' GLU . 0.0 OUTLIER -127.58 140.29 52.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.909 -0.774 . . . . 5.79 108.909 178.256 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.8 -175.46 40.71 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.041 -1.076 . . . . 3.35 113.455 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.21 150.02 15.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.451 0.167 . . . . 4.3 111.076 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 50.6 p90 -134.97 140.45 35.06 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.049 0.452 . . . . 3.72 112.167 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.622 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.6 Cg_endo -95.09 174.61 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.458 3.439 . . . . 3.97 111.641 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.567 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 78.09 -12.83 1.03 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.255 1.576 . . . . 5.85 115.255 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 56.27 77.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.832 0.742 . . . . 5.67 109.103 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.9 m-85 -101.87 6.84 41.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.382 -0.826 . . . . 3.89 111.694 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.479 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -137.78 138.22 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.575 0.583 . . . . 3.89 112.575 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.69 130.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.866 -0.606 . . . . 4.64 111.77 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.405 HE22 ' C ' ' B' ' 64' ' ' SER . 0.0 OUTLIER -59.85 132.2 53.23 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.749 -0.463 . . . . 6.72 109.749 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 24.7 pt -139.31 37.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.924 0.392 . . . . 6.54 111.626 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' SER . . . . . 0.405 ' C ' HE22 ' B' ' 62' ' ' GLN . 30.4 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.23 -0.89 . . . . 7.43 110.85 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.605 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 95.2 mtp . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.836 0.35 . . . . 16.5 110.786 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -81.55 151.75 27.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.821 -0.627 . . . . 13.22 110.786 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -143.7 146.75 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 12.19 110.341 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -95.82 139.17 32.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 11.64 110.503 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.32 91.33 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.45 -0.574 . . . . 6.66 109.45 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.14 153.29 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.843 -0.617 . . . . 6.86 111.678 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 8' ' ' LEU . 24.6 m -133.6 159.82 39.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 3.79 109.398 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.819 ' H ' HD22 ' A' ' 8' ' ' LEU . 2.0 mm? -58.67 -37.95 77.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.944 0.402 . . . . 5.48 110.761 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.9 m -61.14 -22.35 64.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.812 -0.631 . . . . 7.65 111.262 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.36 17.66 21.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.079 -0.582 . . . . 7.08 112.141 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -99.38 110.37 22.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.299 . . . . 6.58 111.189 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -98.64 129.67 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 6.95 110.028 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 13' ' ' ILE . 4.4 mp -118.96 144.67 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.954 0.406 . . . . 5.97 111.285 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 p -96.6 136.54 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 8.28 110.867 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 tp -137.64 151.47 48.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.317 -0.401 . . . . 10.02 110.284 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.96 105.24 13.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.63 -0.259 . . . . 12.19 111.474 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -152.83 112.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.436 0.532 . . . . 14.73 112.436 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 1.5 mp0 -56.63 172.89 0.33 Allowed Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 112.881 0.696 . . . . 18.57 112.881 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 30.1 Cg_exo -63.99 -37.47 43.2 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.42 2.746 . . . . 19.89 112.73 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -63.67 -25.55 68.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 21.46 111.541 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.4 147.59 25.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.472 -0.331 . . . . 18.56 111.188 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -93.89 145.51 24.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.059 -0.519 . . . . 20.15 110.948 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 50' ' ' LEU . 24.8 mt -55.93 -31.8 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 16.47 111.505 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.28 -38.68 90.28 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.943 -0.391 . . . . 19.99 109.943 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -69.84 -40.72 75.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.966 -0.561 . . . . 16.38 109.95 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.28 -49.79 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 115.977 -0.556 . . . . 13.8 110.355 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HE2' HD13 ' A' ' 43' ' ' LEU . 97.7 mttt -59.07 -37.5 77.22 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.079 -0.509 . . . . 13.67 110.975 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.18 -38.28 87.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.294 -0.412 . . . . 14.55 110.944 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.59 -43.29 80.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.122 -0.49 . . . . 13.7 110.192 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.88 -36.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.143 -0.48 . . . . 9.57 109.772 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.432 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 59.0 tt0 -67.07 -29.17 68.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.898 -0.592 . . . . 15.04 111.164 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.3 -37.62 74.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 12.47 111.119 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -89.82 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.12 0.415 . . . . 9.23 112.12 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -83.15 -9.44 59.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.112 0.782 . . . . 9.6 113.112 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 62.54 25.02 66.64 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.427 -0.892 . . . . 12.2 113.208 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.1 mt -97.39 116.62 65.92 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.792 0.296 . . . . 11.27 110.829 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.95 138.71 70.07 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.698 2.266 . . . . 14.23 112.438 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.97 -22.7 55.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.585 2.19 . . . . 14.34 112.191 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.58 -25.28 66.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.535 . . . . 16.96 111.311 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -106.9 -5.48 18.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.368 -0.378 . . . . 14.45 111.572 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -88.95 127.0 35.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.948 0.404 . . . . 10.91 111.923 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 17.0 tpt180 -125.12 121.78 35.25 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.852 -0.796 . . . . 9.32 108.852 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.405 HD13 ' HE2' ' A' ' 27' ' ' LYS . 9.4 mp -102.8 126.55 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 10.56 111.186 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -112.65 129.76 67.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 9.75 110.406 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 50' ' ' LEU . 67.5 t80 -147.36 124.41 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 15.27 110.421 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.8 17.51 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 14.76 111.454 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.52 -3.62 81.79 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.786 -0.721 . . . . 12.99 112.593 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.22 150.32 32.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.778 0.323 . . . . 17.08 110.982 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -83.24 124.94 31.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 14.97 110.506 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 23' ' ' ILE . 48.9 mt -64.7 131.65 47.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 14.81 111.109 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.4 tp10 -90.31 127.29 36.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.996 -0.547 . . . . 21.0 110.917 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -41.45 34.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.599 -0.728 . . . . 18.5 112.301 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -0.12 83.79 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.982 -0.628 . . . . 21.79 114.208 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 51' ' ' GLU . 2.2 mpt_? -99.69 173.95 6.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.044 0.422 . . . . 24.16 110.961 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.2 p -119.19 158.21 26.43 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.22 -0.445 . . . . 21.36 111.04 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 8.4 mp -52.97 -28.91 26.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 18.41 111.826 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 p -72.78 -21.77 60.94 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.735 0.303 . . . . 21.76 111.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.58 -42.37 87.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.193 -0.458 . . . . 23.14 110.958 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.2 10.18 32.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.251 -0.431 . . . . 19.37 111.579 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.81 24.27 11.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.48 0.548 . . . . 22.24 112.48 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -57.56 155.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.721 -0.474 . . . . 17.93 109.721 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -149.59 165.63 31.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.737 -0.468 . . . . 21.49 109.737 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -52.4 146.98 8.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 19.19 111.506 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.56 30.04 10.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.869 -0.605 . . . . 16.92 111.776 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.1 p -86.72 160.9 18.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 14.92 110.898 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.6 m -115.48 124.74 51.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 11.29 110.635 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.4 mm? -113.39 122.45 47.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.23 -0.441 . . . . 10.94 110.294 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 23.4 t60 -85.94 112.82 21.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 8.09 111.078 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.56 118.12 31.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.009 -0.541 . . . . 6.7 110.737 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.622 HG22 HD21 ' A' ' 8' ' ' LEU . 39.5 t -140.72 166.57 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 7.13 110.881 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.577 ' N ' HG12 ' A' ' 70' ' ' VAL . 6.9 mp -93.86 128.6 40.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.359 -0.382 . . . . 8.31 110.122 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -72.42 -146.03 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.56 -0.291 . . . . 14.22 110.257 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.9 mt -50.47 101.85 0.04 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.941 0.4 . . . . 13.68 110.444 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' C ' ' HD3' ' A' ' 74' ' ' ARG . 2.4 tmt_? -175.15 -48.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 20.03 109.866 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.83 -116.23 1.8 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.683 -0.689 . . . . 17.34 111.999 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.207 -1.33 . . . . 17.6 112.161 179.908 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.341 0.115 . . . . 9.15 110.967 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.429 ' HB2' ' CE2' ' B' ' 8' ' ' TYR . 74.6 mmtt -111.43 176.66 4.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.294 0.568 . . . . 10.58 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.55 129.2 55.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.233 -0.894 . . . . 7.56 109.383 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' TYR . . . . . 0.429 ' CE2' ' HB2' ' B' ' 6' ' ' LYS . 90.3 m-85 -130.44 169.36 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.978 0.418 . . . . 7.84 111.622 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.581 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 9.5 p -149.02 151.86 35.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 4.73 111.114 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -99.22 143.38 29.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.211 -0.45 . . . . 4.43 110.835 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.453 HG21 ' HB3' ' B' ' 25' ' ' PHE . 41.7 p -84.7 125.23 32.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.165 -0.47 . . . . 2.72 111.84 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.54 -21.85 20.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.327 -0.397 . . . . 3.78 111.379 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.26 160.64 59.08 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 120.714 0.292 . . . . 4.88 111.622 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' ' 26' ' ' ARG . 92.6 Cg_endo -81.23 71.61 6.88 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.86 2.373 . . . . 3.11 113.619 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -64.58 127.65 32.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.042 -0.526 . . . . 4.0 111.309 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.54 ' HA ' HG23 ' B' ' 24' ' ' THR . 30.1 m -112.97 120.19 40.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.505 -0.316 . . . . 3.82 111.39 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.09 138.41 47.87 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.962 -0.637 . . . . 3.22 111.932 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.515 HG23 ' ND2' ' B' ' 19' ' ' ASN . 13.4 t -104.26 -24.58 13.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.936 0.398 . . . . 4.64 111.536 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.515 ' ND2' HG23 ' B' ' 18' ' ' THR . 40.8 m-80 -116.37 162.88 16.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.785 -0.643 . . . . 4.05 110.052 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.14 -41.05 86.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.211 -0.449 . . . . 4.26 111.044 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.48 -4.89 36.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.088 0.47 . . . . 4.22 109.961 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -83.34 156.87 22.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.53 -0.759 . . . . 3.77 110.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.758 HD13 ' H ' ' B' ' 24' ' ' THR . 0.4 OUTLIER -107.11 146.61 31.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.803 -1.184 . . . . 3.13 107.803 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.758 ' H ' HD13 ' B' ' 23' ' ' LEU . 53.3 m -111.83 128.08 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 2.46 110.352 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.6 ' CZ ' HD12 ' B' ' 23' ' ' LEU . 73.3 m-85 -128.02 128.62 45.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.323 0.49 . . . . 2.49 112.323 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.497 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 24.4 mmm180 -100.58 174.37 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.285 -0.635 . . . . 6.21 109.285 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.71 137.7 35.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.169 0.509 . . . . 3.87 110.229 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.24 21.65 51.21 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.704 -0.958 . . . . 4.23 110.704 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 21.6 mm-40 -99.36 -179.81 4.34 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.393 0.886 . . . . 4.19 113.393 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.2 mm -135.07 118.7 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.83 -1.532 . . . . 5.23 110.748 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.581 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 17.3 mt -112.23 136.74 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.911 -0.586 . . . . 4.64 112.1 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -95.06 125.8 39.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.901 -0.777 . . . . 7.14 108.901 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.466 ' C ' HD23 ' B' ' 33' ' ' LEU . 4.3 tt -74.34 105.89 5.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 6.33 111.622 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' B' ' 47' ' ' GLU . 75.5 mt -80.8 -65.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.577 -0.738 . . . . 6.97 110.793 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -153.08 129.65 10.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.86 -0.609 . . . . 7.03 111.929 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.403 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 48.9 mtpt -84.04 6.44 22.08 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.901 -0.591 . . . . 7.52 111.535 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 94.84 4.46 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.224 -0.287 . . . . 8.93 110.224 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 76.2 p -104.81 -1.96 25.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.413 -0.358 . . . . 7.05 111.706 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.3 -3.18 72.15 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.974 -0.632 . . . . 8.42 112.452 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -135.41 124.42 24.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.767 0.318 . . . . 7.96 110.49 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.07 57.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 8.2 110.881 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.59 2.38 82.2 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.639 -0.709 . . . . 6.68 112.404 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 69.5 m95 -119.12 121.64 40.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.901 0.381 . . . . 5.83 111.443 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' TRP . . . . . 0.403 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 36.5 m0 -113.07 168.57 9.59 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.813 -0.81 . . . . 5.87 108.813 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -125.11 129.65 50.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 5.33 110.704 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.11 174.69 21.79 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.812 -0.709 . . . . 4.14 112.316 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.493 ' HB2' HD11 ' B' ' 34' ' ' ILE . 34.0 tt0 -125.7 133.25 52.2 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.225 0.536 . . . . 6.02 110.728 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 50' ' ' GLY . 28.6 tp -127.93 171.18 12.04 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.184 -0.916 . . . . 4.21 109.889 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.461 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 79.4 m-20 -17.81 67.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.43 1.641 . . . . 5.39 115.43 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.6 -10.02 63.26 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 115.128 0.811 . . . . 5.53 115.128 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -109.94 154.41 23.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.15 0.975 . . . . 5.33 111.197 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.68 140.79 51.86 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.996 -0.742 . . . . 5.79 108.996 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.33 -176.03 42.38 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.012 -1.089 . . . . 3.35 113.358 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.82 152.72 15.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.432 0.158 . . . . 4.3 110.985 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 52.3 p90 -136.56 141.02 33.95 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.384 0.513 . . . . 3.72 112.384 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 95.2 Cg_endo -94.99 174.73 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.498 3.465 . . . . 3.97 111.275 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.566 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 24.2 m-20 75.43 -11.01 1.15 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.079 1.511 . . . . 5.85 115.079 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 56.33 76.63 0.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.829 -0.804 . . . . 5.67 108.829 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.1 m-85 -100.9 8.27 43.2 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.16 -0.927 . . . . 3.89 111.553 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.473 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -136.89 138.63 40.9 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.664 0.616 . . . . 3.89 112.664 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -113.42 127.17 70.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 4.64 111.296 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -54.47 108.23 0.36 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.851 0.358 . . . . 6.72 110.503 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.29 -36.37 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 6.54 110.934 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.38 -0.819 . . . . 7.43 110.746 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.01 0.433 . . . . 16.5 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -84.22 149.9 25.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.822 -0.626 . . . . 13.22 110.537 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -144.04 149.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 12.19 110.692 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.34 136.32 42.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 11.64 110.479 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 40.8 t -121.19 96.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.574 -0.528 . . . . 6.66 109.574 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 7' ' ' THR . 52.5 tttm -77.34 162.99 26.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.672 -0.694 . . . . 6.86 111.527 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.42 ' N ' ' CG ' ' A' ' 6' ' ' LYS . 56.8 p -142.16 160.99 39.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.467 -0.788 . . . . 3.79 110.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 8' ' ' LEU . 2.3 pt? -64.33 -22.76 67.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 5.48 111.175 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -81.82 -12.37 58.54 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.263 -0.426 . . . . 7.65 111.618 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 16.69 41.79 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.886 -0.673 . . . . 7.08 112.547 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -97.86 108.31 20.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.899 0.38 . . . . 6.58 111.354 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 p -100.06 126.01 46.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 6.95 110.256 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.427 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 36.1 pt -120.83 146.55 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.39 . . . . 5.97 111.253 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.5 p -97.06 140.46 31.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.87 -0.605 . . . . 8.28 111.123 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 29' ' ' LYS . 63.2 tp -138.4 149.7 45.79 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.247 -0.433 . . . . 10.02 110.258 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -109.46 103.79 12.75 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.872 0.323 . . . . 12.19 111.872 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -153.83 112.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.268 -0.424 . . . . 14.73 111.615 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.521 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 25.0 mt-10 -63.71 173.32 1.35 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.708 0.633 . . . . 18.57 112.708 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.588 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 50.7 Cg_exo -57.98 -42.35 59.08 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.333 2.688 . . . . 19.89 113.741 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.0 m -60.42 -23.99 64.83 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.039 0.385 . . . . 21.46 112.039 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.31 148.48 32.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.845 0.355 . . . . 18.56 111.276 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -92.74 145.87 24.08 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.107 -0.497 . . . . 20.15 111.14 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.42 HD13 ' O ' ' A' ' 54' ' ' ARG . 1.1 mp -55.82 -34.49 37.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 16.47 111.205 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.2 -41.07 98.02 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.894 -0.41 . . . . 19.99 109.894 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.22 -37.49 85.68 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.825 -0.625 . . . . 16.38 110.035 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 CA-C-N 116.152 -0.476 . . . . 13.8 110.037 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -58.61 -34.71 71.45 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.888 -0.597 . . . . 13.67 110.628 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 31' ' ' GLN . . . -68.23 -34.64 76.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 14.55 111.102 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HB3' HD11 ' A' ' 15' ' ' LEU . 79.7 mttt -73.71 -38.46 64.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 13.7 110.383 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.446 ' CG2' HD11 ' A' ' 36' ' ' ILE . 85.7 mt -65.01 -40.11 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 9.57 110.742 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 21.1 pt20 -69.72 -19.39 63.55 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.61 -0.268 . . . . 15.04 111.226 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -75.27 -35.33 61.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 12.47 110.467 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -93.1 -53.81 3.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.992 -0.549 . . . . 9.23 112.021 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.69 -11.62 55.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.842 0.682 . . . . 9.6 112.842 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 5.08 52.09 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.556 -0.83 . . . . 12.2 114.015 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.446 HD11 ' CG2' ' A' ' 30' ' ' ILE . 22.2 pt -79.82 128.91 72.67 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 117.355 0.578 . . . . 11.27 111.02 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.56 142.66 59.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.572 2.181 . . . . 14.23 112.738 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -24.66 64.74 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.881 2.387 . . . . 14.34 112.109 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.59 -24.9 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.894 -0.594 . . . . 16.96 111.142 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -108.59 -7.03 15.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.302 -0.408 . . . . 14.45 111.469 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -80.95 126.48 31.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 10.91 111.547 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -124.29 112.07 16.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 9.32 109.327 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.4 mp -98.06 124.59 42.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 10.56 111.16 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.523 HD12 HG21 ' B' ' 18' ' ' THR . 16.8 mm -113.71 131.52 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.833 -0.621 . . . . 9.75 110.646 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -147.53 119.22 8.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.616 . . . . 15.27 110.439 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.35 29.97 9.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.993 -0.549 . . . . 14.76 112.154 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.37 -3.69 76.48 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.426 -0.892 . . . . 12.99 113.239 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -114.84 146.84 40.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.803 0.335 . . . . 17.08 111.116 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -82.49 128.75 34.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 14.97 110.381 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.76 130.62 43.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 14.81 110.995 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.48 123.89 33.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.927 -0.578 . . . . 21.0 111.017 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -36.26 -57.18 0.74 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.992 -0.549 . . . . 18.5 111.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -52.93 -75.04 0.24 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.771 -0.728 . . . . 21.79 112.019 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.42 ' O ' HD13 ' A' ' 23' ' ' ILE . 29.5 mmt180 -29.17 158.11 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.911 1.078 . . . . 24.16 113.911 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -111.4 165.72 11.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.087 -0.96 . . . . 21.36 111.322 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.5 mm? -53.42 -32.48 49.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.189 -0.46 . . . . 18.41 111.86 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -70.05 -21.7 63.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.653 0.263 . . . . 21.76 111.5 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.97 -38.45 86.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 23.14 111.041 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -97.91 8.47 44.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 19.37 111.615 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 59.3 46.96 12.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.954 0.407 . . . . 22.24 111.137 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.03 107.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 17.93 110.912 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -91.66 -178.87 5.19 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.016 -0.538 . . . . 21.49 110.936 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.55 157.06 33.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.835 0.35 . . . . 19.19 111.124 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.2 24.95 14.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.809 -0.632 . . . . 16.92 111.684 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -85.78 161.18 19.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.712 0.292 . . . . 14.92 110.814 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.417 ' C ' HD12 ' A' ' 67' ' ' LEU . 4.5 t -116.73 126.85 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 11.29 110.84 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.6 mp -115.27 121.48 43.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 10.94 110.164 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -83.96 112.47 20.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.944 0.402 . . . . 8.09 111.778 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.403 HD21 HD12 ' A' ' 36' ' ' ILE . 65.4 tp -91.8 119.71 31.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 6.7 109.62 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.4 ' C ' HD12 ' A' ' 71' ' ' LEU . 20.7 m -131.67 169.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.241 0.544 . . . . 7.13 112.346 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 71' ' ' LEU . 5.6 mp -126.65 134.47 50.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.277 -0.874 . . . . 8.31 110.219 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -76.27 78.2 3.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 14.22 111.073 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 75' ' ' GLY . 66.6 mt -121.81 68.86 0.92 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.112 -0.494 . . . . 13.68 110.77 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.477 ' NH1' HG22 ' B' ' 38' ' ' THR . 4.2 tmt_? 70.78 -18.06 0.27 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.912 -0.586 . . . . 20.03 111.6 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 73' ' ' LEU . . . -153.26 61.76 0.38 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.839 -0.696 . . . . 17.34 112.604 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.419 -1.212 . . . . 17.6 112.429 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.454 0.169 . . . . 9.15 111.061 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.84 173.26 6.42 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.067 0.46 . . . . 10.58 110.753 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -102.21 130.94 49.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.834 -0.802 . . . . 7.56 108.834 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -124.76 159.92 29.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 7.84 111.828 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 16.8 m -141.14 146.35 36.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.186 -0.915 . . . . 4.73 110.569 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -100.47 133.23 45.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 4.43 110.199 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.3 m -73.85 127.13 32.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 2.72 110.913 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.8 mt -95.87 -22.1 17.66 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.144 0.424 . . . . 3.78 112.144 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -142.66 154.51 62.99 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 117.981 0.355 . . . . 4.88 111.614 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' B' ' 25' ' ' PHE . 74.2 Cg_endo -75.01 136.25 20.12 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.525 2.15 . . . . 3.11 112.913 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -139.16 129.12 25.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 4.0 109.883 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 31.8 m -110.84 121.35 45.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.85 0.357 . . . . 3.82 110.617 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.73 128.76 43.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.98 -0.629 . . . . 3.22 112.586 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.523 HG21 HD12 ' A' ' 44' ' ' ILE . 5.3 t -103.16 -23.07 13.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.182 0.515 . . . . 4.64 110.63 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -119.89 159.41 24.7 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.123 -0.944 . . . . 4.05 109.853 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.5 -29.13 69.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.386 0.513 . . . . 4.26 112.386 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -86.53 -2.64 58.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.945 -0.302 . . . . 4.22 111.682 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.55 160.17 16.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 3.77 111.281 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.602 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -117.24 165.46 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.246 -0.65 . . . . 3.13 109.246 178.004 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 61.7 m -115.42 128.65 56.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 2.46 110.187 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 10.8 m-85 -131.92 133.43 44.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.301 0.482 . . . . 2.49 112.301 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.53 176.26 5.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.826 -0.435 . . . . 6.21 109.826 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.21 136.68 35.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 3.87 110.323 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.79 55.42 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.571 -0.74 . . . . 4.23 111.318 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -100.13 179.72 4.4 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.877 1.066 . . . . 4.19 113.877 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.49 136.11 60.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.781 -1.554 . . . . 5.23 111.129 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.455 HD12 ' HB2' ' B' ' 60' ' ' ALA . 35.8 mt -132.86 133.09 59.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 4.64 111.207 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -90.21 126.49 35.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.58 -0.526 . . . . 7.14 109.58 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.531 ' C ' HD23 ' B' ' 33' ' ' LEU . 4.3 tt -73.47 102.08 3.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.995 0.426 . . . . 6.33 111.149 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 23.5 mm -84.08 -61.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.765 -0.652 . . . . 6.97 111.418 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.2 t -155.17 108.5 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.194 0.442 . . . . 7.03 112.194 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.475 ' HG3' HD21 ' B' ' 33' ' ' LEU . 38.3 mtmm -65.95 5.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.598 . . . . 7.52 111.722 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.44 101.07 7.39 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.535 0.207 . . . . 8.93 110.678 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.477 HG22 ' NH1' ' A' ' 74' ' ' ARG . 68.8 p -111.11 -4.38 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.449 -0.341 . . . . 7.05 111.184 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.18 -1.77 62.99 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.018 -0.611 . . . . 8.42 112.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.77 120.89 27.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.811 0.338 . . . . 7.96 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.79 56.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 8.2 110.962 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.63 1.56 85.41 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.826 -0.625 . . . . 6.68 112.421 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.408 ' HE1' ' HB3' ' A' ' 8' ' ' LEU . 83.6 m95 -123.31 120.39 32.95 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.289 0.544 . . . . 5.83 111.751 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' TRP . . . . . 0.565 ' HB2' ' CZ ' ' B' ' 55' ' ' PHE . 37.4 m0 -108.43 166.33 10.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.515 -0.766 . . . . 5.87 109.494 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.444 ' HB2' HG22 ' B' ' 38' ' ' THR . 45.4 tptt -117.28 131.64 56.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.959 0.409 . . . . 5.33 110.98 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.56 175.33 21.53 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.454 -0.794 . . . . 4.14 111.752 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.61 134.75 50.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.196 0.522 . . . . 6.02 110.629 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 50' ' ' GLY . 2.6 mt -130.9 171.73 12.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.105 -0.952 . . . . 4.21 110.159 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -17.35 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.127 1.529 . . . . 5.39 115.127 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.54 -12.79 50.3 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 114.319 0.488 . . . . 5.53 114.319 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.07 133.79 54.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.314 0.557 . . . . 5.33 111.337 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.545 ' C ' HD23 ' B' ' 23' ' ' LEU . 11.5 pt-20 -107.11 146.72 30.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.958 -0.565 . . . . 5.79 110.344 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.51 -177.85 38.73 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.663 -0.78 . . . . 3.35 112.855 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.406 ' CG1' HG21 ' B' ' 38' ' ' THR . 34.8 m -112.99 160.51 12.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.453 0.538 . . . . 4.3 112.453 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' B' ' 44' ' ' TRP . 3.0 p90 -124.79 157.49 65.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.375 -0.83 . . . . 3.72 110.807 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.03 123.02 2.65 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.69 2.26 . . . . 3.97 115.865 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p30 51.02 45.02 28.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.638 1.347 . . . . 5.85 114.638 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 62.7 88.64 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.772 1.027 . . . . 5.67 113.772 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.1 16.26 27.1 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.908 -0.775 . . . . 3.89 108.908 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 9' ' ' CYS . . . -142.64 138.49 30.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.81 0.3 . . . . 3.89 111.81 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.5 p -110.17 120.77 61.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 116.352 -0.385 . . . . 4.64 111.323 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.452 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 34.1 tt0 -51.51 150.86 3.43 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 121.023 0.44 . . . . 6.72 111.062 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.98 -37.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.671 . . . . 6.54 110.403 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.237 -0.887 . . . . 7.43 110.55 179.668 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttt . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.92 0.391 . . . . 16.5 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -82.93 152.7 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.587 . . . . 13.22 109.916 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 pt -145.32 150.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 12.19 110.249 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -102.73 135.15 44.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.189 -0.46 . . . . 11.64 110.691 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.37 99.4 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.327 -0.62 . . . . 6.66 109.327 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HG2' ' CG2' ' A' ' 12' ' ' THR . 6.7 tmtt? -86.81 111.78 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 6.86 111.663 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.2 p -84.83 -178.48 6.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 3.79 110.699 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 9' ' ' THR . 2.6 pp -85.93 -10.65 54.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.546 -0.297 . . . . 5.48 111.68 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.44 ' N ' HD12 ' A' ' 8' ' ' LEU . 8.8 t -97.29 21.06 10.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.928 0.394 . . . . 7.65 110.684 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.62 13.09 65.26 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.911 -0.662 . . . . 7.08 112.377 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -96.1 112.05 23.9 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.054 0.454 . . . . 6.58 111.933 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.418 ' CG2' ' HG2' ' A' ' 6' ' ' LYS . 31.4 p -104.28 122.39 45.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.647 -0.706 . . . . 6.95 110.012 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.1 pt -114.75 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.382 . . . . 5.97 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.5 p -87.72 135.31 33.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 8.28 110.36 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tp -134.67 146.45 49.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 10.02 110.556 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -102.67 130.92 49.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 12.19 110.498 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.76 -174.21 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.167 0.508 . . . . 14.73 111.575 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -138.97 145.95 47.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 18.57 109.044 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.09 -23.18 12.07 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.332 2.021 . . . . 19.89 112.709 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -87.85 -23.85 23.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 21.46 111.753 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.33 150.92 4.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.875 0.369 . . . . 18.56 111.656 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -96.49 140.71 30.73 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.931 -0.577 . . . . 20.15 111.259 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.4 HD12 HD13 ' A' ' 50' ' ' LEU . 50.7 mm -49.55 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.091 -0.504 . . . . 16.47 111.164 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.08 -41.06 78.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.87 0.367 . . . . 19.99 110.153 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -69.29 -35.55 76.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 16.38 110.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.05 -45.36 98.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.153 -0.476 . . . . 13.8 110.573 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -59.84 -37.19 78.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 13.67 110.826 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.01 66.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 14.55 110.82 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.21 -41.13 83.38 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.174 -0.676 . . . . 13.7 109.174 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.477 HD12 ' OE1' ' A' ' 41' ' ' GLN . 96.4 mt -67.25 -37.79 79.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.353 -0.84 . . . . 9.57 110.546 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 60.2 tt0 -61.63 -33.97 74.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.024 -0.535 . . . . 15.04 110.84 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -56.86 -27.11 59.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 12.47 110.074 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -99.85 -71.03 0.71 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.861 -0.609 . . . . 9.23 112.608 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.68 -10.98 60.25 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.537 0.569 . . . . 9.6 112.537 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 63.26 7.29 17.78 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.595 -0.812 . . . . 12.2 113.305 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 36' ' ' ILE . 23.5 pt -71.9 122.22 86.69 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.798 0.299 . . . . 11.27 111.017 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.56 142.76 70.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.405 2.07 . . . . 14.23 111.873 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.15 -25.32 43.55 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.712 2.275 . . . . 14.34 112.837 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.71 -23.62 66.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.918 0.71 . . . . 16.96 112.918 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -107.92 -5.62 17.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.612 . . . . 14.45 109.349 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.477 ' OE1' HD12 ' A' ' 30' ' ' ILE . 7.4 tt0 -83.14 100.93 10.85 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.247 -0.888 . . . . 10.91 110.888 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' HE ' ' N ' ' A' ' 43' ' ' LEU . 6.4 tpm_? -100.35 113.58 26.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.485 -0.932 . . . . 9.32 108.485 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.455 ' N ' ' HE ' ' A' ' 42' ' ' ARG . 61.9 mt -98.8 120.11 38.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.901 0.381 . . . . 10.56 110.887 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.666 HD12 HG21 ' B' ' 18' ' ' THR . 24.5 mm -109.43 137.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.681 -0.69 . . . . 9.75 110.367 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.502 ' HB3' HD21 ' A' ' 50' ' ' LEU . 62.5 t80 -156.47 132.34 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 15.27 111.182 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.72 6.23 2.58 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.837 -0.62 . . . . 14.76 111.87 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.41 -4.02 40.32 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.903 -0.665 . . . . 12.99 112.995 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' B' ' 18' ' ' THR . 55.0 tptt -122.01 152.16 40.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.747 0.308 . . . . 17.08 110.663 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -81.43 119.98 24.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 14.97 110.574 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 45' ' ' PHE . 84.1 mt -57.85 128.81 38.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.321 -0.4 . . . . 14.81 110.5 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 40.2 tt0 -81.08 124.97 29.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.323 -0.398 . . . . 21.0 109.986 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.47 -33.05 13.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.826 -0.624 . . . . 18.5 112.603 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -88.98 5.99 84.07 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.997 0.759 . . . . 21.79 114.997 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -105.55 173.04 6.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.672 0.736 . . . . 24.16 111.463 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -109.59 155.57 21.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.128 -0.487 . . . . 21.36 110.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.7 mt -53.97 -16.32 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 18.41 111.795 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -78.93 -26.01 43.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.647 0.26 . . . . 21.76 111.531 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.8 -36.98 84.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.39 -0.368 . . . . 23.14 110.765 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -99.44 12.23 36.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.155 -0.475 . . . . 19.37 111.878 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 m120 57.07 27.45 13.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.846 0.355 . . . . 22.24 111.416 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.453 HG12 ' CE2' ' A' ' 45' ' ' PHE . 98.1 mt -68.61 108.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.294 -0.412 . . . . 17.93 111.541 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.37 -179.54 4.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.207 -0.451 . . . . 21.49 111.108 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.37 156.77 28.17 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.949 0.404 . . . . 19.19 111.51 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 58.33 28.88 17.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.765 -0.652 . . . . 16.92 111.461 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 p -88.14 150.86 23.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 14.92 110.686 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.5 t -101.83 121.48 42.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 11.29 110.849 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.7 mp -110.82 117.17 32.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 10.94 109.864 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.413 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 17.6 m-70 -79.3 109.3 13.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 8.09 112.074 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -92.55 115.12 27.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.076 -0.511 . . . . 6.7 110.399 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.4 171.22 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 7.13 111.466 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.4 tp -85.8 112.43 21.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 8.31 110.381 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -55.56 170.43 0.25 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.226 -0.443 . . . . 14.22 110.4 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' B' ' 19' ' ' ASN . 88.4 mt -39.03 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.448 -0.342 . . . . 13.68 110.735 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -172.0 -30.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.042 -0.526 . . . . 20.03 110.538 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.12 148.06 19.42 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.18 -0.533 . . . . 17.34 112.392 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.504 -1.164 . . . . 17.6 112.557 -179.871 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.594 0.235 . . . . 9.15 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.405 ' HB2' ' CZ ' ' B' ' 8' ' ' TYR . 56.4 mttm -110.81 173.82 6.15 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.095 0.474 . . . . 10.58 110.882 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.51 131.48 46.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.329 -0.851 . . . . 7.56 109.252 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' TYR . . . . . 0.405 ' CZ ' ' HB2' ' B' ' 6' ' ' LYS . 54.9 m-85 -127.42 158.58 36.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.302 0.572 . . . . 7.84 112.063 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.533 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 24.0 p -145.22 145.78 31.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.023 -0.99 . . . . 4.73 110.581 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -101.76 137.15 40.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.824 0.345 . . . . 4.43 110.555 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -76.87 126.0 30.24 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.106 -0.497 . . . . 2.72 111.467 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 39.0 mt -88.73 -20.87 24.24 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.86 0.319 . . . . 3.78 111.86 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -147.37 156.73 45.97 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 121.052 -0.259 . . . . 4.88 111.399 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 138.47 29.24 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.48 2.12 . . . . 3.11 112.378 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 69.2 t80 -136.74 130.55 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.489 -0.778 . . . . 4.0 110.801 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.469 ' HA ' HG23 ' B' ' 24' ' ' THR . 34.2 m -111.83 119.56 38.99 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.884 0.373 . . . . 3.82 111.034 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.72 142.28 48.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.816 -0.629 . . . . 3.22 112.319 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.666 HG21 HD12 ' A' ' 44' ' ' ILE . 73.9 p -111.14 -22.24 11.53 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.95 0.405 . . . . 4.64 111.534 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.42 ' HB3' HD21 ' A' ' 73' ' ' LEU . 93.3 m-20 -117.45 160.56 20.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.698 -0.683 . . . . 4.05 110.206 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -33.46 75.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 4.26 111.652 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -84.77 -4.26 58.97 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.834 0.35 . . . . 4.22 110.952 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -81.74 153.88 26.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.068 -0.515 . . . . 3.77 110.557 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' B' ' 48' ' ' LEU . 0.5 OUTLIER -104.43 144.05 32.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.961 -0.755 . . . . 3.13 108.961 178.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.469 HG23 ' HA ' ' B' ' 16' ' ' THR . 99.8 m -114.81 121.94 44.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.767 -0.651 . . . . 2.46 110.172 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' B' ' 15' ' ' TYR . 31.9 p90 -138.57 153.41 48.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.833 0.679 . . . . 2.49 112.833 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -109.52 -179.59 3.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.839 -0.43 . . . . 6.21 109.839 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.5 135.45 35.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.114 0.483 . . . . 3.87 109.842 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.03 31.97 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.524 -1.03 . . . . 4.23 110.524 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -96.79 178.69 5.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.793 0.806 . . . . 4.19 113.001 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.7 mm -135.76 114.16 15.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 113.763 -1.562 . . . . 5.23 111.245 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.07 139.58 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 4.64 110.861 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.68 128.81 37.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.456 -0.572 . . . . 7.14 109.456 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.443 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.9 tt -72.08 98.7 2.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 6.33 110.58 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.3 mm -79.54 -63.11 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 6.97 111.125 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -157.97 110.13 2.33 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.824 0.676 . . . . 7.03 112.824 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.438 ' O ' HG23 ' B' ' 38' ' ' THR . 58.6 mtmt -56.29 -69.81 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.999 -0.741 . . . . 7.52 108.999 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.51 98.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.426 -0.352 . . . . 8.93 111.394 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 36' ' ' LYS . 23.7 p -111.37 -5.3 14.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.34 -0.391 . . . . 7.05 111.104 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.27 -8.36 72.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.81 -0.71 . . . . 8.42 111.649 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.24 120.43 31.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.812 0.339 . . . . 7.96 110.656 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.31 55.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.496 . . . . 8.2 111.35 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 -0.7 83.72 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.807 -0.633 . . . . 6.68 112.675 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -121.63 127.37 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.333 0.566 . . . . 5.83 112.088 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' TRP . . . . . 0.57 ' HB2' ' CE2' ' B' ' 55' ' ' PHE . 23.2 m0 -113.88 162.15 16.72 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.285 -0.871 . . . . 5.87 109.201 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -114.19 131.25 56.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.086 0.469 . . . . 5.33 110.89 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.83 174.73 22.22 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.454 -0.794 . . . . 4.14 112.073 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.26 132.81 52.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.143 0.497 . . . . 6.02 110.272 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 50' ' ' GLY . 19.8 tp -129.81 170.28 14.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.192 -0.913 . . . . 4.21 109.755 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.471 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 67.7 m-20 -17.7 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.33 1.604 . . . . 5.39 115.33 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.4 -12.57 54.94 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.545 0.578 . . . . 5.53 114.545 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -119.5 134.36 55.25 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.461 0.63 . . . . 5.33 111.105 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.46 146.5 31.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.07 -0.514 . . . . 5.79 110.18 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.47 -177.48 41.93 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.541 -0.838 . . . . 3.35 112.55 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.98 160.99 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 112.126 0.417 . . . . 4.3 112.126 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' B' ' 44' ' ' TRP . 2.7 p90 -124.79 149.55 62.97 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.665 -0.698 . . . . 3.72 111.106 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.69 122.4 5.45 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.828 2.352 . . . . 3.97 115.171 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 51.26 43.76 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 114.171 1.174 . . . . 5.85 114.171 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.48 92.26 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.166 1.172 . . . . 5.67 114.166 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -102.84 17.52 23.72 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.425 -0.954 . . . . 3.89 108.425 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.533 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -146.26 138.2 24.96 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.591 0.219 . . . . 3.89 111.591 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 p -109.11 121.59 62.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.498 -0.319 . . . . 4.64 111.336 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.45 155.93 3.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.82 0.343 . . . . 6.72 110.594 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.87 -51.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 6.54 110.639 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.301 -0.856 . . . . 7.43 110.714 -179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.724 0.297 . . . . 16.5 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -84.58 148.03 26.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 13.22 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.4 pt -139.52 154.77 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.632 . . . . 12.19 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.87 134.57 53.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.023 -0.535 . . . . 11.64 110.376 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.8 t -118.16 100.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.376 -0.601 . . . . 6.66 109.376 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 14.5 tmtt? -88.82 131.2 35.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 6.86 112.155 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -106.08 163.17 12.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.252 -0.885 . . . . 3.79 110.841 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.74 -21.97 66.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.275 -0.421 . . . . 5.48 111.348 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 t -81.23 -8.51 59.76 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.382 -0.372 . . . . 7.65 111.18 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.1 54.99 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.179 -0.534 . . . . 7.08 112.965 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -97.0 108.58 21.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 6.58 111.337 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p -99.93 124.33 45.15 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.928 -0.578 . . . . 6.95 110.261 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.57 143.85 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.368 . . . . 5.97 111.185 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.1 m -98.13 135.66 39.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.865 -0.607 . . . . 8.28 110.786 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.89 152.95 52.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 10.02 110.985 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.48 121.01 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 12.19 109.753 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.444 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.5 m -140.12 -178.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.086 0.469 . . . . 14.73 111.446 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 38.8 tt0 -145.63 146.28 28.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.49 -0.777 . . . . 18.57 109.873 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 72.2 Cg_exo -50.47 -26.4 16.3 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 19.89 112.91 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 m -85.64 -23.85 27.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.323 -0.399 . . . . 21.46 111.28 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.6 148.96 8.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.381 . . . . 18.56 111.392 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 m -95.85 144.19 26.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.904 -0.589 . . . . 20.15 111.139 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.603 HD12 HD23 ' A' ' 50' ' ' LEU . 24.0 mm -51.86 -44.58 37.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.132 -0.485 . . . . 16.47 111.433 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.18 -38.06 67.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.853 0.359 . . . . 19.99 110.329 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -68.07 -38.84 82.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.556 . . . . 16.38 110.087 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -58.99 -48.57 86.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.144 -0.48 . . . . 13.8 110.416 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.75 -32.67 71.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.05 -0.523 . . . . 13.67 110.885 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.19 78.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.147 -0.479 . . . . 14.55 110.351 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' A' ' 17' ' ' VAL . 36.9 mtmm -70.09 -42.75 72.31 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 13.7 110.228 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.615 ' CG2' HD11 ' A' ' 36' ' ' ILE . 86.3 mt -61.05 -41.46 89.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.093 0.473 . . . . 9.57 109.985 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -32.87 74.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.819 -0.628 . . . . 15.04 110.989 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -66.12 -35.91 81.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 12.47 111.402 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.32 -59.25 2.13 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.399 0.518 . . . . 9.23 112.399 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.451 ' OE2' HD13 ' A' ' 36' ' ' ILE . 32.1 tt0 -81.66 -11.41 59.09 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.999 0.74 . . . . 9.6 112.999 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.83 -21.11 4.91 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.636 -0.792 . . . . 12.2 114.454 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.615 HD11 ' CG2' ' A' ' 30' ' ' ILE . 13.8 pt -54.54 135.49 62.92 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 117.469 0.634 . . . . 11.27 111.92 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 89.9 Cg_endo -78.98 135.41 12.4 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.819 2.346 . . . . 14.23 112.468 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.3 Cg_exo -54.33 -27.16 46.95 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.799 2.333 . . . . 14.34 112.965 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.51 -24.11 67.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.427 -0.351 . . . . 16.96 111.339 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -110.79 -5.16 15.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 14.45 111.363 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -80.93 128.09 33.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 10.91 111.495 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 42' ' ' ARG . 27.9 ttt-85 -125.18 114.21 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.18 -0.674 . . . . 9.32 109.18 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -101.94 126.54 48.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 10.56 110.858 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.85 134.39 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 9.75 110.893 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CB ' HD11 ' A' ' 50' ' ' LEU . 83.0 t80 -151.53 123.14 7.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.585 -0.734 . . . . 15.27 110.187 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 69.35 18.55 7.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.803 -0.635 . . . . 14.76 111.614 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.55 -12.07 70.63 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.704 -0.76 . . . . 12.99 112.678 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -107.72 148.49 29.36 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.05 0.452 . . . . 17.08 111.442 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -82.45 129.26 34.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.727 -0.669 . . . . 14.97 110.096 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.603 HD23 HD12 ' A' ' 23' ' ' ILE . 6.8 mp -67.97 130.87 44.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 14.81 111.225 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HB2' ' CG ' ' A' ' 54' ' ' ARG . 11.5 mm-40 -86.74 128.54 35.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 21.0 110.41 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.9 m-20 -52.03 -31.48 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.747 -0.66 . . . . 18.5 112.759 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.53 3.76 85.17 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.736 -0.745 . . . . 21.79 113.867 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' CG ' ' HB2' ' A' ' 51' ' ' GLU . 34.6 mmt180 -103.15 177.44 4.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.992 0.396 . . . . 24.16 110.829 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -123.16 160.5 26.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.364 . . . . 21.36 111.087 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -51.91 -31.01 26.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 18.41 111.753 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 p -71.04 -25.85 62.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.735 0.272 . . . . 21.76 111.735 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.81 -37.52 87.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.647 0.26 . . . . 23.14 111.059 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.91 7.46 46.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 19.37 111.829 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.6 m120 61.97 36.27 15.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.864 0.364 . . . . 22.24 111.54 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -78.65 107.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 17.93 111.272 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -95.21 -179.14 4.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.224 -0.444 . . . . 21.49 111.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.06 155.34 24.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.108 -0.496 . . . . 19.19 111.936 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 58.48 31.11 20.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.686 -0.688 . . . . 16.92 111.455 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -86.19 158.26 19.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 14.92 110.631 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 t -114.26 125.33 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 11.29 110.728 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -115.09 122.59 46.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.902 -0.59 . . . . 10.94 110.229 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.69 111.66 20.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.904 0.383 . . . . 8.09 111.611 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -92.34 115.0 27.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.032 -0.531 . . . . 6.7 109.807 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.5 -161.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.271 0.471 . . . . 7.13 112.271 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 tp -125.81 121.28 32.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.511 -0.768 . . . . 8.31 110.065 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -43.11 -70.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.083 -0.508 . . . . 14.22 111.909 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.7 tp -140.05 137.67 34.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.561 -0.291 . . . . 13.68 110.343 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? 179.8 -58.98 0.01 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.91 0.386 . . . . 20.03 110.403 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.17 35.94 0.36 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.042 -0.599 . . . . 17.34 112.413 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.377 -1.235 . . . . 17.6 112.417 179.663 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.496 0.188 . . . . 9.15 111.142 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -109.24 175.31 5.5 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.253 0.549 . . . . 10.58 110.954 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.59 132.39 49.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.27 -0.877 . . . . 7.56 109.444 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.9 160.05 33.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.327 0.584 . . . . 7.84 112.056 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.524 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 32.5 m -141.49 146.93 37.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.982 -1.008 . . . . 4.73 110.201 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -102.04 143.79 31.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.829 0.347 . . . . 4.43 111.078 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.5 m -82.01 123.64 29.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.999 -0.546 . . . . 2.72 111.515 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.37 -20.68 22.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.923 0.342 . . . . 3.78 111.923 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' B' ' 14' ' ' PRO . 30.6 t80 -154.94 144.64 15.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 117.921 0.328 . . . . 4.88 111.02 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' B' ' 13' ' ' PHE . 32.3 Cg_exo -59.45 138.46 84.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.416 2.077 . . . . 3.11 112.608 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.567 ' CZ ' ' HD3' ' B' ' 56' ' ' PRO . 29.2 t80 -133.72 131.1 39.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.687 -0.688 . . . . 4.0 110.839 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.614 ' HA ' HG23 ' B' ' 24' ' ' THR . 54.5 m -111.89 117.92 34.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.989 0.423 . . . . 3.82 111.049 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.45 138.01 47.19 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.973 -0.632 . . . . 3.22 112.366 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 15.7 m -104.51 -21.44 13.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.352 0.596 . . . . 4.64 110.241 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -118.46 156.06 29.69 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.948 -1.024 . . . . 4.05 109.861 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.72 -38.62 91.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 4.26 111.186 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.8 -3.21 33.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.809 0.338 . . . . 4.22 110.963 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -88.65 160.98 17.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 3.77 110.919 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' B' ' 48' ' ' LEU . 0.6 OUTLIER -103.87 140.66 37.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.542 -0.54 . . . . 3.13 109.542 178.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.614 HG23 ' HA ' ' B' ' 16' ' ' THR . 56.0 m -116.07 121.73 43.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.297 -0.865 . . . . 2.46 109.992 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.587 ' HB3' HD22 ' B' ' 48' ' ' LEU . 17.8 p90 -140.23 159.06 43.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.913 0.709 . . . . 2.49 112.913 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.558 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 81.4 mtt-85 -109.74 179.36 4.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.328 -0.249 . . . . 6.21 110.328 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -82.23 140.53 33.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.051 0.453 . . . . 3.87 110.048 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.61 21.87 49.23 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.602 -0.999 . . . . 4.23 110.602 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.558 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 5.3 mm-40 -97.96 179.45 4.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.471 0.915 . . . . 4.19 113.471 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -130.5 123.56 55.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.821 -1.536 . . . . 5.23 111.417 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -122.07 135.67 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.725 -0.671 . . . . 4.64 111.191 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.48 132.72 42.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.703 -0.481 . . . . 7.14 109.703 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.459 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.3 tt -72.98 100.46 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 6.33 110.798 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.18 -62.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.554 -0.748 . . . . 6.97 110.824 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.5 m -158.37 110.11 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.647 0.61 . . . . 7.03 112.647 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.712 ' O ' HG23 ' B' ' 38' ' ' THR . 35.0 mtmt -57.91 -71.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.383 -0.599 . . . . 7.52 109.383 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -45.72 94.43 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.325 -0.398 . . . . 8.93 111.502 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.712 HG23 ' O ' ' B' ' 36' ' ' LYS . 68.6 p -106.58 -9.02 16.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.241 -0.436 . . . . 7.05 111.051 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.29 -5.0 62.68 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.909 -0.662 . . . . 8.42 112.345 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -129.98 120.79 25.34 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.873 0.368 . . . . 7.96 110.554 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 133.3 55.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.57 . . . . 8.2 111.61 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 -0.64 85.48 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.586 -0.734 . . . . 6.68 112.699 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.412 ' CH2' ' HB3' ' B' ' 56' ' ' PRO . 79.6 m95 -121.86 123.6 42.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.324 0.562 . . . . 5.83 111.799 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' TRP . . . . . 0.558 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 21.8 m0 -110.32 172.11 7.06 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.504 -0.771 . . . . 5.87 109.322 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -125.39 130.61 52.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 5.33 110.905 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.2 176.31 21.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.488 -0.778 . . . . 4.14 111.77 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -124.7 133.79 53.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.303 0.573 . . . . 6.02 110.207 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.677 ' O ' ' N ' ' B' ' 50' ' ' GLY . 27.3 tp -129.56 170.1 14.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.098 -0.955 . . . . 4.21 109.778 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.507 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 31.5 p-10 -17.58 63.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.126 1.528 . . . . 5.39 115.126 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.61 -12.37 52.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 114.429 0.532 . . . . 5.53 114.429 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.32 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.545 0.672 . . . . 5.33 111.068 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' B' ' 52' ' ' GLU . 0.0 OUTLIER -112.27 146.18 38.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.07 -0.514 . . . . 5.79 110.506 179.618 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLY . . . . . 0.431 ' N ' ' HG ' ' B' ' 23' ' ' LEU . . . -174.74 -176.06 42.75 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.666 -0.778 . . . . 3.35 113.017 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -113.5 160.47 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 112.51 0.559 . . . . 4.3 112.51 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 6.2 p90 -125.19 148.49 60.79 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.563 -0.744 . . . . 3.72 110.976 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.567 ' HD3' ' CZ ' ' B' ' 15' ' ' TYR . 89.2 Cg_endo -79.05 123.24 5.59 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.035 2.49 . . . . 3.97 115.369 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 52.32 43.55 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.553 1.316 . . . . 5.85 114.553 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.52 93.55 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.692 1.367 . . . . 5.67 114.692 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.27 12.8 35.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.748 -0.834 . . . . 3.89 108.748 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.6 29.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 3.89 111.622 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.46 126.99 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.501 -0.318 . . . . 4.64 111.823 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.524 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 53.6 tt0 -59.37 140.69 55.87 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 110.167 -0.309 . . . . 6.72 110.167 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 56.3 mt -101.63 -60.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 6.54 110.705 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.149 -0.929 . . . . 7.43 110.76 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.877 0.37 . . . . 16.5 111.011 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -79.24 149.03 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.837 -0.62 . . . . 13.22 110.544 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.0 pt -142.94 147.88 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 12.19 110.678 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -97.55 137.24 36.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 11.64 110.597 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.41 91.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.573 -0.529 . . . . 6.66 109.573 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 7' ' ' THR . 61.7 tttm -77.03 164.29 25.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.916 -0.584 . . . . 6.86 111.425 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.427 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.8 m -143.57 159.43 42.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.427 -0.806 . . . . 3.79 110.041 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.418 ' N ' HG22 ' A' ' 7' ' ' THR . 3.4 pp -62.31 -22.37 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 5.48 111.37 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -81.75 -13.7 57.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.369 . . . . 7.65 111.272 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.98 47.63 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.057 -0.592 . . . . 7.08 112.468 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -93.59 111.31 22.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 6.58 111.492 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.03 125.0 44.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.759 -0.655 . . . . 6.95 110.134 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -117.01 142.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.384 . . . . 5.97 111.215 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.9 p -97.79 139.12 34.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 8.28 110.704 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 16' ' ' GLU . 59.3 tp -139.89 150.77 45.0 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.548 -0.296 . . . . 10.02 110.524 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.431 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -111.92 106.31 14.97 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.569 -0.287 . . . . 12.19 111.373 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.65 113.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.216 -0.447 . . . . 14.73 111.299 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 14.6 mp0 -60.78 172.15 0.91 Allowed Pre-proline 0 N--CA 1.467 0.408 0 N-CA-C 112.89 0.7 . . . . 18.57 112.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 41.2 Cg_exo -59.45 -39.74 73.33 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.32 2.68 . . . . 19.89 113.251 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.9 p -61.61 -26.2 67.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.38 -0.373 . . . . 21.46 111.759 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.04 151.26 9.23 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.921 0.391 . . . . 18.56 111.646 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -95.24 149.46 21.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.837 -0.62 . . . . 20.15 110.841 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 HD13 ' A' ' 50' ' ' LEU . 45.6 mm -58.62 -37.66 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 16.47 111.1 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.63 -40.48 92.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.902 0.382 . . . . 19.99 109.995 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.99 -41.8 95.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.935 -0.575 . . . . 16.38 110.013 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.65 -47.22 82.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.994 -0.548 . . . . 13.8 110.464 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -60.55 -36.37 78.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.922 -0.581 . . . . 13.67 110.541 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.86 84.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.03 -0.532 . . . . 14.55 110.375 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -65.44 -49.81 67.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.926 -0.579 . . . . 13.7 110.028 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.56 ' CG2' HD11 ' A' ' 36' ' ' ILE . 84.5 mt -57.55 -40.5 75.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.959 -0.564 . . . . 9.57 110.457 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -63.76 -30.09 71.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.037 -0.529 . . . . 15.04 111.025 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.59 -38.51 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 12.47 111.235 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -90.13 -59.93 2.06 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.087 0.403 . . . . 9.23 112.087 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HG3' HG23 ' A' ' 36' ' ' ILE . 9.3 tp10 -78.8 -11.93 60.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.022 0.749 . . . . 9.6 113.022 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.0 -17.71 4.51 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.537 -0.84 . . . . 12.2 114.213 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.56 HD11 ' CG2' ' A' ' 30' ' ' ILE . 16.5 pt -59.43 132.0 88.12 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 117.337 0.569 . . . . 11.27 112.043 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.79 144.38 38.94 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 14.23 112.231 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.88 -22.26 63.35 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.745 2.297 . . . . 14.34 112.374 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.59 -25.49 66.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 16.96 111.176 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -106.25 -13.11 15.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.358 -0.383 . . . . 14.45 111.42 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -73.59 132.8 43.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.12 0.486 . . . . 10.91 111.954 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 61.7 mtp180 -127.73 114.5 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.356 -0.838 . . . . 9.32 109.156 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB3' HD12 ' A' ' 50' ' ' LEU . 9.6 mp -101.3 122.16 43.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.836 0.351 . . . . 10.56 110.907 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 18.7 mm -113.3 133.17 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.899 -0.591 . . . . 9.75 110.442 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HB3' HD21 ' A' ' 50' ' ' LEU . 60.6 t80 -151.06 124.28 8.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 15.27 110.578 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.77 19.35 11.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 14.76 111.967 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.57 80.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.566 -0.826 . . . . 12.99 112.97 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.21 147.92 42.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.745 0.307 . . . . 17.08 110.729 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -81.88 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 14.97 110.3 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD13 HD12 ' A' ' 23' ' ' ILE . 68.3 mt -68.4 133.23 48.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 14.81 111.183 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.87 126.75 35.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 21.0 110.515 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.34 -35.03 25.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.921 -0.581 . . . . 18.5 112.351 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.7 1.87 88.02 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.954 -0.641 . . . . 21.79 114.273 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.78 177.64 4.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.172 0.486 . . . . 24.16 110.977 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -122.4 158.7 29.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.333 -0.394 . . . . 21.36 110.952 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.6 mm? -52.24 -24.29 7.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 18.41 111.744 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 m -75.04 -25.56 58.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.629 0.252 . . . . 21.76 111.515 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.18 -41.8 96.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 23.14 111.123 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -94.75 10.43 35.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.304 -0.407 . . . . 19.37 111.665 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 56.37 42.91 27.06 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.062 0.458 . . . . 22.24 111.207 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.4 HG12 ' CE2' ' A' ' 45' ' ' PHE . 73.9 mt -85.49 104.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 17.93 111.198 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -91.56 178.03 6.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.14 -0.482 . . . . 21.49 111.313 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -60.5 155.29 18.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.987 -0.552 . . . . 19.19 111.585 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 60.51 33.46 20.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.843 -0.617 . . . . 16.92 111.364 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 p -92.04 157.61 16.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 14.92 110.649 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.501 ' C ' HD12 ' A' ' 67' ' ' LEU . 5.1 t -113.74 124.4 52.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 11.29 110.712 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 66' ' ' THR . 8.1 mp -115.89 119.41 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 10.94 110.4 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 58.2 t-80 -77.99 120.87 23.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.381 -0.372 . . . . 8.09 111.148 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.51 109.75 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 6.7 111.273 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 19.4 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 7.13 109.962 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 C--O 1.232 0.164 0 N-CA-C 109.734 -0.469 . . . . 7.56 109.734 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . 0.427 ' H ' ' HB2' ' B' ' 64' ' ' SER . 20.0 m-85 -124.05 172.08 9.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 7.84 110.745 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.577 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 35.1 m -142.27 149.09 39.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 4.73 111.027 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -99.51 138.0 37.21 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.519 -0.309 . . . . 4.43 110.456 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -78.54 123.46 27.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.497 -0.32 . . . . 2.72 110.856 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.54 -21.31 19.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.331 0.493 . . . . 3.78 112.331 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' B' ' 14' ' ' PRO . 75.5 m-85 -145.84 155.01 52.11 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 117.954 0.343 . . . . 4.88 111.409 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 13' ' ' PHE . 6.8 Cg_exo -72.11 136.42 26.99 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.518 2.145 . . . . 3.11 112.728 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -137.96 127.68 25.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.889 -1.05 . . . . 4.0 109.539 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.2 m -112.06 121.67 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 3.82 111.322 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.85 143.71 48.74 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.744 -0.741 . . . . 3.22 111.926 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 44' ' ' ILE . 41.1 p -107.17 -18.63 13.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.519 . . . . 4.64 110.825 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -119.49 159.11 24.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 4.05 110.222 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.51 -30.65 71.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 4.26 111.357 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.31 -5.88 59.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 4.22 111.012 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -81.76 157.65 24.44 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.146 -0.479 . . . . 3.77 110.988 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.555 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 2.7 mt -110.59 151.61 27.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.626 -0.509 . . . . 3.13 109.626 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -115.72 129.23 56.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.328 -0.396 . . . . 2.46 110.468 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 29.9 m-85 -130.6 133.8 46.46 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.263 0.468 . . . . 2.49 112.263 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.531 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 97.7 mtt180 -104.04 175.24 5.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.763 -0.458 . . . . 6.21 109.763 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -81.5 134.44 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 3.87 110.006 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.17 50.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.925 -0.87 . . . . 4.23 110.925 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.2 mm-40 -98.42 179.42 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.423 0.898 . . . . 4.19 113.423 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -131.34 113.55 23.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.76 -1.564 . . . . 5.23 111.233 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' B' ' 60' ' ' ALA . 42.6 mt -106.89 129.41 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 4.64 110.677 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -89.96 127.27 36.0 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.894 -0.41 . . . . 7.14 109.894 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.28 128.04 34.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.044 0.45 . . . . 6.33 110.923 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.41 -48.97 6.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 6.97 110.785 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 79.3 p -167.06 113.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 7.03 111.983 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -69.32 5.11 1.39 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.907 -0.588 . . . . 7.52 111.32 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -121.85 101.89 7.85 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 116.63 -0.259 . . . . 8.93 110.305 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.476 HG22 ' HB2' ' B' ' 45' ' ' LYS . 30.5 p -112.33 -2.96 14.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.454 -0.339 . . . . 7.05 111.752 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.03 -5.14 78.68 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.685 . . . . 8.42 112.014 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -125.99 119.7 28.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 7.96 110.39 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.411 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -58.56 132.46 53.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 8.2 111.302 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.32 -0.46 85.53 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.9 -0.591 . . . . 6.68 112.704 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.492 ' CE3' HG23 ' B' ' 54' ' ' VAL . 77.6 m95 -122.92 123.74 41.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.454 0.627 . . . . 5.83 112.016 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' TRP . . . . . 0.555 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 19.4 m0 -109.66 165.15 11.9 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.477 -0.783 . . . . 5.87 109.428 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.476 ' HB2' HG22 ' B' ' 38' ' ' THR . 64.0 tttp -115.91 131.72 56.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.021 0.439 . . . . 5.33 110.965 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.7 174.82 21.86 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.411 -0.813 . . . . 4.14 111.717 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.05 133.36 52.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.291 0.567 . . . . 6.02 110.364 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' B' ' 50' ' ' GLY . 11.8 tp -130.06 170.99 13.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.929 -1.032 . . . . 4.21 109.675 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.475 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 60.3 m-20 -17.69 64.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.424 1.638 . . . . 5.39 115.424 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 82.97 -10.4 57.87 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 114.732 0.653 . . . . 5.53 114.732 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -118.93 143.39 47.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.544 0.672 . . . . 5.33 111.099 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.05 142.85 46.08 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.055 -0.52 . . . . 5.79 110.585 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . 0.478 ' H ' HD12 ' B' ' 23' ' ' LEU . . . -169.34 -179.19 41.1 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.943 -0.646 . . . . 3.35 112.481 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.492 HG23 ' CE3' ' B' ' 43' ' ' TRP . 33.7 m -113.44 163.36 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 112.441 0.534 . . . . 4.3 112.441 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 3.3 p90 -124.57 152.92 69.53 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.602 -0.726 . . . . 3.72 110.92 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.45 122.88 4.69 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.93 2.42 . . . . 3.97 115.683 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 50.95 44.51 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.983 1.105 . . . . 5.85 113.983 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 60.0 92.92 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.125 1.157 . . . . 5.67 114.125 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -103.38 15.97 27.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.723 -0.843 . . . . 3.89 108.723 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 31' ' ' ILE . . . -143.09 138.58 29.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.977 0.362 . . . . 3.89 111.977 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.59 119.43 59.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.366 -0.379 . . . . 4.64 111.445 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.577 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 63.5 tt0 -54.47 105.62 0.16 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.847 0.356 . . . . 6.72 110.611 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 33.0 pt -86.61 -30.12 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 6.54 110.733 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . 0.427 ' HB2' ' H ' ' B' ' 8' ' ' TYR . 48.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.251 -0.88 . . . . 7.43 110.696 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 66.2 mtm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.716 0.293 . . . . 16.5 110.775 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.08 147.02 28.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 13.22 110.863 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.2 pt -146.53 156.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 12.19 110.765 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -108.74 147.13 32.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.854 -0.612 . . . . 11.64 110.424 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.25 103.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.009 -0.542 . . . . 6.66 110.587 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG2' ' N ' ' A' ' 7' ' ' THR . 85.6 tttt -78.33 164.51 24.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 6.86 111.077 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.464 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 8.4 m -139.91 147.09 40.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 3.79 109.823 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 9' ' ' THR . 4.4 pp -60.67 -18.42 53.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.801 0.334 . . . . 5.48 111.401 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.447 ' N ' HD12 ' A' ' 8' ' ' LEU . 69.4 p -73.89 -35.7 64.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 7.65 110.531 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.43 -15.28 5.78 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.987 -0.552 . . . . 7.08 112.607 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -83.16 136.62 34.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.388 0.514 . . . . 6.58 112.388 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -115.68 124.53 51.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.283 -0.871 . . . . 6.95 109.332 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.13 144.01 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.02 0.438 . . . . 5.97 111.854 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -100.14 136.2 40.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.493 -0.776 . . . . 8.28 110.737 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.3 153.14 52.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.841 0.353 . . . . 10.02 110.84 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -120.5 102.91 8.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.009 -0.541 . . . . 12.19 111.391 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -153.89 116.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 14.73 110.711 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 167.21 1.19 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.753 1.02 . . . . 18.57 113.753 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.7 Cg_exo -60.12 -32.3 94.45 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.831 3.021 . . . . 19.89 114.08 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -77.87 31.18 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.762 0.315 . . . . 21.46 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -115.23 129.89 56.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.317 -0.401 . . . . 18.56 110.942 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 70.6 p -68.89 145.95 53.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 20.15 111.278 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 50' ' ' LEU . 1.1 mp -56.41 -35.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 16.47 110.755 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.48 -43.11 98.25 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 19.99 109.899 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -64.26 -39.63 94.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.973 -0.558 . . . . 16.38 109.931 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.105 -0.498 . . . . 13.8 110.036 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.94 -33.18 74.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.905 -0.588 . . . . 13.67 110.526 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.36 -34.1 76.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.066 -0.516 . . . . 14.55 110.217 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -71.36 -42.3 68.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 13.7 109.571 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.42 -47.97 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 115.866 -0.606 . . . . 9.57 109.741 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -58.42 -33.91 70.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 15.04 110.494 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.21 -33.71 76.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 12.47 110.931 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.11 -62.04 1.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 9.23 112.165 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.7 -13.74 59.66 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.449 0.907 . . . . 9.6 113.449 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 15.75 75.24 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.387 -0.911 . . . . 12.2 113.871 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -90.53 123.45 65.28 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 117.255 0.527 . . . . 11.27 110.932 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 48.3 Cg_exo -56.9 138.82 87.52 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.723 2.282 . . . . 14.23 112.348 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 33.5 Cg_exo -61.11 -30.29 88.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.521 2.147 . . . . 14.34 112.156 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.14 -20.61 66.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.779 -0.646 . . . . 16.96 111.074 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.61 -35.11 13.03 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.265 -0.425 . . . . 14.45 110.835 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -61.21 146.4 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 10.91 110.904 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 3.0 tpp180 -142.77 38.04 1.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 9.32 111.296 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 42' ' ' ARG . 69.5 mt -20.83 127.59 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.727 1.01 . . . . 10.56 113.727 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.567 HD12 HG21 ' B' ' 18' ' ' THR . 20.2 mm -114.95 136.33 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.183 -0.917 . . . . 9.75 109.734 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 81.7 t80 -138.7 123.75 19.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 15.27 111.276 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 13.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.545 0.572 . . . . 14.76 112.545 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.5 -29.34 9.16 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.829 -0.701 . . . . 12.99 113.191 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 14.6 ptpt -70.27 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.941 0.37 . . . . 17.08 111.02 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.509 ' N ' ' HG3' ' A' ' 48' ' ' LYS . 30.3 tt0 -148.53 107.65 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.93 -0.767 . . . . 14.97 108.93 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HB3' HG12 ' A' ' 23' ' ' ILE . 51.3 mt -57.75 127.22 30.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.875 0.695 . . . . 14.81 112.875 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.61 123.62 36.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.392 -0.822 . . . . 21.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -34.54 -61.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.713 -0.676 . . . . 18.5 112.168 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -47.96 -73.5 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 21.79 112.524 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.42 ' O ' HD13 ' A' ' 23' ' ' ILE . 31.0 mmt180 -34.24 163.2 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.366 0.876 . . . . 24.16 113.366 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 8.8 t -115.1 165.28 13.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.211 -0.904 . . . . 21.36 111.278 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 91.0 mt -55.69 -38.46 69.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 18.41 111.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.0 -26.57 68.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.366 . . . . 21.76 111.383 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.59 -29.07 69.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 23.14 110.992 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.11 16.57 24.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 19.37 111.125 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.55 39.62 31.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.083 -0.508 . . . . 22.24 111.306 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -87.74 113.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 17.93 111.094 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -105.47 -165.42 1.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 21.49 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 22.5 pttp -68.16 162.72 24.21 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 19.19 111.255 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 55.99 32.37 19.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.933 -0.576 . . . . 16.92 111.252 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -91.56 138.48 31.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 14.92 110.712 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -98.99 122.46 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 11.29 111.146 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.1 mt -116.71 117.95 31.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 10.94 110.173 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -88.66 114.12 24.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 8.09 111.831 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.419 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 45.8 mt -63.94 -172.13 0.06 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.958 -0.565 . . . . 6.7 109.903 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 90.4 t . . . . . 0 C--N 1.33 -0.272 0 N-CA-C 109.763 -0.458 . . . . 7.13 109.763 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 . . . . . 0 C--O 1.231 0.083 0 N-CA-C 109.498 -0.556 . . . . 7.56 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -133.04 170.42 15.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.013 0.435 . . . . 7.84 112.039 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.518 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 13.7 p -153.45 150.23 28.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.656 -0.702 . . . . 4.73 111.036 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -102.5 138.2 39.73 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.384 -0.371 . . . . 4.43 110.245 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 35.9 p -80.47 125.64 30.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 2.72 111.825 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.1 -20.4 24.36 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.401 -0.363 . . . . 3.78 111.448 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' B' ' 14' ' ' PRO . 97.2 m-85 -149.26 158.0 38.87 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.739 0.304 . . . . 4.88 111.468 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' B' ' 13' ' ' PHE . 74.5 Cg_endo -75.21 140.34 24.77 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.736 2.291 . . . . 3.11 112.88 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -136.0 130.97 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.377 -0.829 . . . . 4.0 110.467 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.518 ' HA ' HG23 ' B' ' 24' ' ' THR . 88.0 m -111.54 118.21 35.11 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.942 0.401 . . . . 3.82 111.213 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.52 139.35 48.16 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.981 -0.628 . . . . 3.22 112.127 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.567 HG21 HD12 ' A' ' 44' ' ' ILE . 76.1 p -107.19 -21.47 12.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.199 0.523 . . . . 4.64 111.092 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -119.08 159.58 23.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.328 -0.851 . . . . 4.05 110.011 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -64.41 -36.09 83.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 4.26 111.505 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.75 -4.55 52.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 4.22 110.817 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 150.58 29.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.038 -0.528 . . . . 3.77 110.981 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.603 HD23 ' N ' ' B' ' 24' ' ' THR . 1.4 tt -100.07 137.48 38.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.526 -1.287 . . . . 3.13 107.526 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.603 ' N ' HD23 ' B' ' 23' ' ' LEU . 89.5 m -114.55 123.9 50.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.745 -0.661 . . . . 2.46 110.646 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -138.65 156.82 47.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.502 0.556 . . . . 2.49 112.502 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.455 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 34.0 mmt180 -111.55 179.45 4.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.176 -0.305 . . . . 6.21 110.176 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.93 143.55 31.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 3.87 110.43 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.57 19.96 67.33 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.088 -0.805 . . . . 4.23 111.088 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 19.3 mm-40 -98.15 179.11 4.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.517 0.932 . . . . 4.19 113.517 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -132.37 116.6 29.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 113.557 -1.656 . . . . 5.23 111.297 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.1 140.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 4.64 111.152 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -91.38 127.55 36.86 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.397 -0.594 . . . . 7.14 109.397 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tt -74.32 102.76 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 6.33 110.636 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 31.9 mm -80.72 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 6.97 111.243 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 89.1 p -157.86 120.28 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.098 0.777 . . . . 7.03 113.098 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.512 ' O ' HG23 ' B' ' 38' ' ' THR . 58.7 mttp -65.18 -72.2 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.987 -0.552 . . . . 7.52 109.911 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -44.8 100.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.099 -0.501 . . . . 8.93 111.732 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.512 HG23 ' O ' ' B' ' 36' ' ' LYS . 25.2 p -116.33 -3.69 11.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.964 -0.562 . . . . 7.05 110.881 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.86 -7.6 76.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.978 -0.629 . . . . 8.42 111.882 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -130.87 120.75 24.1 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.693 0.282 . . . . 7.96 110.483 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.51 137.55 58.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 8.2 110.878 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.808 -0.633 . . . . 6.68 112.614 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.595 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 64.1 m95 -120.79 117.41 27.35 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.831 0.348 . . . . 5.83 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -109.89 160.82 16.05 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.247 -0.649 . . . . 5.87 109.247 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -116.09 129.56 56.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.894 0.378 . . . . 5.33 110.389 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.37 175.63 22.24 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.731 -0.747 . . . . 4.14 112.179 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -126.51 135.42 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.499 . . . . 6.02 110.077 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.638 ' O ' ' N ' ' B' ' 50' ' ' GLY . 32.8 tp -128.53 170.16 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.31 -0.859 . . . . 4.21 110.242 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.433 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 50.9 m-80 -18.3 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.403 1.631 . . . . 5.39 115.403 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.69 -11.48 61.73 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 114.894 0.717 . . . . 5.53 114.894 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -118.23 132.25 56.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.831 0.816 . . . . 5.33 111.29 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.01 152.25 24.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.46 -0.57 . . . . 5.79 109.46 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.11 -174.65 44.59 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.113 -1.041 . . . . 3.35 113.353 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.24 149.75 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 110.398 -0.223 . . . . 4.3 110.398 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.432 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 49.1 p90 -139.32 141.11 28.0 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.784 0.661 . . . . 3.72 112.784 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.595 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.3 Cg_endo -95.19 175.17 1.06 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.444 3.429 . . . . 3.97 111.511 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.419 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.1 m-20 79.57 -13.55 0.95 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.981 1.474 . . . . 5.85 114.981 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.22 76.6 0.28 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.873 -0.788 . . . . 5.67 108.873 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 13.1 m-85 -103.87 8.81 37.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.296 -0.865 . . . . 3.89 112.268 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.518 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -133.84 138.98 45.95 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.292 0.478 . . . . 3.89 112.292 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -113.53 136.16 50.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.882 -0.599 . . . . 4.64 111.366 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.08 144.48 28.97 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 120.742 0.306 . . . . 6.72 110.906 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 pt -137.9 -13.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.192 -0.458 . . . . 6.54 111.087 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.272 -0.871 . . . . 7.43 110.627 179.91 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 92.3 mtp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.853 0.359 . . . . 16.5 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -79.94 151.82 29.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 13.22 111.068 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.06 145.24 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.914 -0.585 . . . . 12.19 110.52 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -100.82 135.33 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 11.64 110.113 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 58.4 t -120.42 96.24 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.519 -0.549 . . . . 6.66 109.519 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 7' ' ' THR . 86.5 tttt -76.3 164.02 26.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.816 -0.629 . . . . 6.86 111.326 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.448 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 77.0 p -143.9 158.85 43.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 3.79 110.268 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.556 ' HB3' ' HE1' ' B' ' 43' ' ' TRP . 4.0 pp -61.91 -24.59 67.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.535 . . . . 5.48 111.219 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 p -78.59 -19.93 51.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.118 -0.492 . . . . 7.65 111.205 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.37 13.39 33.19 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.089 -0.577 . . . . 7.08 112.339 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.45 108.93 21.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.891 0.377 . . . . 6.58 111.407 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.38 125.69 45.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 6.95 110.128 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.446 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 31.2 pt -118.3 145.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.861 0.362 . . . . 5.97 111.027 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.641 ' C ' HD22 ' A' ' 15' ' ' LEU . 17.3 m -98.36 134.26 41.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 8.28 111.213 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.641 HD22 ' C ' ' A' ' 14' ' ' THR . 3.8 mm? -127.44 149.75 49.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.098 -0.501 . . . . 10.02 110.369 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.47 98.88 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.31 -0.405 . . . . 12.19 110.701 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.88 -172.74 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.099 0.476 . . . . 14.73 111.816 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -143.14 159.25 56.53 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 18.57 110.276 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 Cg_endo -59.93 -31.72 94.08 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.584 2.189 . . . . 19.89 112.212 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.3 t -82.36 -21.36 35.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 21.46 111.504 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.91 150.92 9.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.7 0.286 . . . . 18.56 111.125 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.3 p -97.35 141.7 30.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 20.15 111.073 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 50' ' ' LEU . 16.0 mt -53.73 -32.02 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 16.47 111.466 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.91 -42.47 99.8 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.615 -0.513 . . . . 19.99 109.615 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -67.06 -36.16 81.43 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.752 -0.658 . . . . 16.38 110.133 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.2 t -57.59 -46.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.378 -0.374 . . . . 13.8 110.197 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.39 -37.76 84.6 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.039 -0.528 . . . . 13.67 110.451 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.05 86.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 14.55 110.432 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 6.9 mmpt? -64.68 -49.2 71.86 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.033 -0.531 . . . . 13.7 109.956 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.69 -40.75 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 9.57 110.368 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -61.4 -34.78 75.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.018 -0.537 . . . . 15.04 110.816 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.96 -36.26 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 12.47 111.329 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.23 -63.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.234 -0.439 . . . . 9.23 112.025 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -78.4 -12.58 60.01 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.386 0.884 . . . . 9.6 113.386 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.14 -12.5 12.26 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.294 -0.955 . . . . 12.2 113.38 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.514 HD12 ' HD2' ' A' ' 37' ' ' PRO . 5.2 tp -60.52 128.07 87.68 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.856 0.328 . . . . 11.27 111.565 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 36' ' ' ILE . 59.8 Cg_endo -73.06 137.2 26.04 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.623 2.215 . . . . 14.23 112.622 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 53.2 Cg_exo -56.13 -29.0 73.15 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.026 2.484 . . . . 14.34 112.782 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.96 -24.85 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 16.96 111.271 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -108.54 -6.64 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 14.45 111.467 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.401 HE21 ' N ' ' A' ' 38' ' ' PRO . 46.4 mt-30 -81.17 127.19 32.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.066 0.46 . . . . 10.91 111.984 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -121.24 112.53 18.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.466 -0.788 . . . . 9.32 109.275 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.32 122.63 43.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.42 -0.355 . . . . 10.56 110.951 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.804 HD12 HG21 ' B' ' 18' ' ' THR . 34.3 mm -116.55 137.05 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.526 . . . . 9.75 110.983 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 50' ' ' LEU . 85.2 t80 -155.86 127.57 7.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.772 -0.649 . . . . 15.27 110.541 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.5 17.12 10.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.934 -0.575 . . . . 14.76 111.767 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.428 ' O ' HG22 ' B' ' 18' ' ' THR . . . 90.96 -2.41 79.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 12.99 112.964 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -117.82 148.56 41.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.749 0.309 . . . . 17.08 110.777 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -81.91 131.34 35.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 14.97 110.196 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.536 ' HB3' HD13 ' A' ' 23' ' ' ILE . 52.9 mt -69.74 130.13 41.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.95 0.405 . . . . 14.81 111.288 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -86.84 126.19 34.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.62 . . . . 21.0 110.174 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -48.58 -40.35 27.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.551 0.574 . . . . 18.5 112.551 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.408 ' H ' ' CD ' ' A' ' 51' ' ' GLU . . . -80.28 3.52 71.91 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.971 -0.633 . . . . 21.79 114.194 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 6.0 mmp_? -103.5 173.79 6.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.115 0.457 . . . . 24.16 110.881 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -118.99 160.84 21.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.872 0.368 . . . . 21.36 111.576 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.458 ' H ' HD22 ' A' ' 56' ' ' LEU . 3.6 mm? -51.78 -34.04 37.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.015 -0.538 . . . . 18.41 111.395 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -69.31 -24.97 64.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.485 -0.325 . . . . 21.76 111.303 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.412 . . . . 23.14 111.065 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -101.09 11.45 39.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.233 -0.44 . . . . 19.37 111.288 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 56.32 49.47 15.11 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.851 0.358 . . . . 22.24 111.184 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.404 HG12 ' CE2' ' A' ' 45' ' ' PHE . 79.8 mt -92.09 108.27 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 17.93 110.882 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -92.81 -177.98 4.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 21.49 110.899 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.97 158.88 24.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.337 -0.392 . . . . 19.19 111.125 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 59.46 29.05 18.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.946 -0.57 . . . . 16.92 111.509 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.5 t -89.1 153.19 21.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.308 -0.405 . . . . 14.92 110.843 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 t -110.9 126.02 54.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 11.29 111.124 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.1 mp -115.29 125.72 53.63 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.923 -0.58 . . . . 10.94 110.395 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -85.39 115.47 23.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.401 . . . . 8.09 111.589 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.7 tp -94.17 105.83 17.81 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.903 -0.59 . . . . 6.7 110.6 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.13 -0.486 . . . . 7.13 110.885 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 . . . . . 0 C--O 1.231 0.111 0 N-CA-C 109.045 -0.724 . . . . 7.56 109.045 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.15 169.13 15.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.988 0.423 . . . . 7.84 111.9 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.627 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 6.7 p -152.63 147.69 26.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 4.73 110.478 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -100.19 141.3 33.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.434 -0.348 . . . . 4.43 110.684 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 54.4 p -80.25 124.78 29.12 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.271 -0.422 . . . . 2.72 111.743 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.24 -21.49 19.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.616 -0.265 . . . . 3.78 111.05 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -151.3 156.61 35.08 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.607 0.241 . . . . 4.88 110.83 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.68 140.58 29.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.549 2.166 . . . . 3.11 113.112 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -136.59 128.7 29.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.085 -0.961 . . . . 4.0 110.044 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.436 ' HA ' HG23 ' B' ' 24' ' ' THR . 88.3 m -112.2 120.4 41.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.8 0.333 . . . . 3.82 111.579 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.47 144.64 49.37 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.828 -0.701 . . . . 3.22 111.93 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.804 HG21 HD12 ' A' ' 44' ' ' ILE . 82.0 p -107.56 -22.19 12.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.057 0.456 . . . . 4.64 111.292 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.79 158.67 25.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.476 -0.784 . . . . 4.05 109.941 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.82 -35.91 82.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 4.26 111.438 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.3 -4.47 45.18 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.934 0.397 . . . . 4.22 110.535 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.91 156.58 22.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.762 -0.653 . . . . 3.77 110.44 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.513 HD23 ' HZ ' ' B' ' 25' ' ' PHE . 3.8 tp -107.14 146.33 31.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.354 -0.98 . . . . 3.13 108.354 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.436 HG23 ' HA ' ' B' ' 16' ' ' THR . 93.8 m -115.83 130.93 57.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.44 . . . . 2.46 111.099 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.513 ' HZ ' HD23 ' B' ' 23' ' ' LEU . 31.3 m-85 -131.56 139.02 49.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.169 0.433 . . . . 2.49 112.169 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.568 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 8.3 mpt_? -108.32 176.85 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.873 -0.418 . . . . 6.21 109.873 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -80.41 138.17 36.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 3.87 110.163 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.79 20.38 58.09 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.027 -0.829 . . . . 4.23 111.027 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.568 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 22.9 mm-40 -98.29 179.73 4.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.04 0.924 . . . . 4.19 113.391 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 mm -134.64 119.64 29.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 113.563 -1.653 . . . . 5.23 110.707 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.627 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 39.5 mt -114.18 133.73 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.007 -0.542 . . . . 4.64 111.591 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -93.43 126.68 38.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.384 -0.599 . . . . 7.14 109.384 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.47 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.9 tt -74.37 102.77 4.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 6.33 110.528 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mm -81.56 -64.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.498 -0.774 . . . . 6.97 111.197 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' B' ' 45' ' ' LYS . 69.1 m -154.47 112.3 3.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.683 0.623 . . . . 7.03 112.683 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.32 -72.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.979 -0.748 . . . . 7.52 108.979 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -45.04 96.05 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.096 -0.502 . . . . 8.93 111.381 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 4.5 t -112.08 -2.67 14.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.063 -0.517 . . . . 7.05 111.077 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.18 0.41 67.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.993 -0.622 . . . . 8.42 113.211 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -134.24 124.26 25.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.761 0.315 . . . . 7.96 111.205 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.11 131.9 50.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 8.2 111.035 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.16 -1.31 84.56 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.006 -0.616 . . . . 6.68 112.588 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.556 ' HE1' ' HB3' ' A' ' 8' ' ' LEU . 69.5 m95 -117.76 135.3 54.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.188 0.518 . . . . 5.83 111.543 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -123.51 155.42 37.58 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.086 -0.961 . . . . 5.87 109.033 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' B' ' 35' ' ' SER . 23.9 ttmm -113.45 130.35 56.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.908 0.385 . . . . 5.33 110.644 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.36 176.47 21.36 Favored Glycine 0 N--CA 1.453 -0.18 0 CA-C-N 115.73 -0.668 . . . . 4.14 112.056 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.39 135.02 51.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 6.02 110.414 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 50' ' ' GLY . 21.2 tp -130.12 170.02 14.58 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.332 -0.849 . . . . 4.21 110.109 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.53 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 55.9 m-80 -17.88 65.19 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.401 1.63 . . . . 5.39 115.401 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.33 -12.95 57.3 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.776 0.67 . . . . 5.53 114.776 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -116.31 135.5 53.82 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.767 0.784 . . . . 5.33 111.19 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -108.81 152.95 24.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.117 -0.492 . . . . 5.79 109.853 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.18 -176.15 46.7 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.416 -0.897 . . . . 3.35 112.808 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.57 154.88 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.468 0.175 . . . . 4.3 110.571 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.475 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 46.5 p90 -141.49 140.18 20.05 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 112.755 0.65 . . . . 3.72 112.755 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 55' ' ' PHE . 96.7 Cg_endo -94.61 174.72 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.457 3.438 . . . . 3.97 110.637 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.472 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 79.75 -14.14 0.88 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.913 1.449 . . . . 5.85 114.913 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 57.3 76.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.016 -0.735 . . . . 5.67 109.016 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 19.5 m-85 -101.66 6.46 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 3.89 111.948 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.1 139.01 40.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.466 0.543 . . . . 3.89 112.466 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.28 130.53 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 4.64 111.32 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -55.43 128.99 36.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.887 0.375 . . . . 6.72 111.092 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -88.4 -61.01 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.965 -0.561 . . . . 6.54 110.373 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.428 -0.796 . . . . 7.43 110.69 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' CA ' ' A' ' 63' ' ' LYS . 45.5 tpp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.829 0.347 . . . . 16.5 110.92 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -82.03 145.62 30.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 13.22 110.91 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -147.59 151.69 13.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 12.19 111.008 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.21 146.1 34.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 11.64 110.89 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 50.9 t -136.52 97.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 6.66 110.306 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.37 133.37 36.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 6.86 111.439 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.7 m -106.89 152.43 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 3.79 110.374 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.544 HD13 ' HE1' ' B' ' 43' ' ' TRP . 40.7 tp -56.45 -36.64 69.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 5.48 111.073 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -56.47 -36.11 68.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.056 -0.52 . . . . 7.65 111.209 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.29 8.62 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.068 -0.515 . . . . 7.08 112.351 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -100.16 124.79 45.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.942 0.401 . . . . 6.58 112.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -101.37 134.33 44.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.756 -0.656 . . . . 6.95 109.365 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.44 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 23.0 pt -119.72 143.67 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 5.97 111.623 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.6 p -101.32 137.62 39.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.484 -0.78 . . . . 8.28 110.952 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 mp -137.85 160.85 38.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.268 -0.423 . . . . 10.02 110.526 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.52 103.04 7.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 12.19 110.771 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.03 113.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.303 -0.408 . . . . 14.73 111.382 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.405 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 41.3 mt-10 -50.5 166.84 0.27 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.416 0.895 . . . . 18.57 113.416 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 28.7 Cg_exo -64.14 -33.62 60.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.442 2.761 . . . . 19.89 113.279 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -20.12 64.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.546 -0.297 . . . . 21.46 111.752 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.16 147.32 53.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 18.56 111.716 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 67.2 p -88.83 152.98 21.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.932 -0.576 . . . . 20.15 110.707 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.47 HD12 HD13 ' A' ' 50' ' ' LEU . 47.6 mm -57.07 -36.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.459 -0.337 . . . . 16.47 111.036 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -46.39 80.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 19.99 110.156 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -58.71 -42.84 89.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.863 -0.608 . . . . 16.38 110.303 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 56' ' ' LEU . 78.7 t -62.18 -41.64 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 13.8 110.524 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.52 -28.69 70.03 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.286 -0.415 . . . . 13.67 110.599 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.37 70.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 14.55 109.843 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -67.71 -46.24 72.78 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.831 -0.622 . . . . 13.7 109.48 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -61.49 -38.73 80.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.884 -0.598 . . . . 9.57 110.113 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -66.88 -32.28 73.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 15.04 110.697 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.99 -38.49 82.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 12.47 111.234 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -88.99 -51.18 5.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.265 0.469 . . . . 9.23 112.265 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.53 -10.87 47.41 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.487 0.921 . . . . 9.6 113.487 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.59 -37.39 2.06 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.533 -0.841 . . . . 12.2 114.3 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.522 HD12 HD21 ' A' ' 69' ' ' LEU . 8.4 pt -45.84 124.48 6.48 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 112.133 0.42 . . . . 11.27 112.133 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.68 144.48 89.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.969 2.446 . . . . 14.23 112.881 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.61 -28.31 82.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.84 2.36 . . . . 14.34 112.583 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.3 -27.51 68.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 16.96 111.359 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -100.3 -9.27 22.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.314 -0.403 . . . . 14.45 111.12 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -84.43 120.92 26.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 10.91 112.113 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -118.25 117.01 27.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.56 -0.746 . . . . 9.32 109.101 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.58 122.61 46.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.961 0.41 . . . . 10.56 111.963 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.741 ' HB ' HG21 ' B' ' 18' ' ' THR . 40.6 pt -111.03 127.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.639 -0.71 . . . . 9.75 110.439 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -129.48 120.52 25.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.489 -0.778 . . . . 15.27 110.795 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.35 19.69 9.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.615 . . . . 14.76 112.272 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.842 ' C ' HG22 ' B' ' 18' ' ' THR . . . 93.7 5.64 62.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.588 -0.815 . . . . 12.99 113.127 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 144.39 47.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.589 0.233 . . . . 17.08 110.491 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.14 140.46 37.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.235 -0.283 . . . . 14.97 110.235 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD13 HD12 ' A' ' 23' ' ' ILE . 90.8 mt -89.27 133.57 34.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.456 -0.338 . . . . 14.81 110.684 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.1 127.13 36.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 21.0 111.336 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -40.39 -51.38 2.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.793 -0.639 . . . . 18.5 111.373 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.71 -78.23 0.14 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.487 -0.863 . . . . 21.79 111.237 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -26.77 152.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.558 0.947 . . . . 24.16 113.558 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.4 p -107.05 164.09 12.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.194 -0.912 . . . . 21.36 111.256 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD11 HG21 ' A' ' 26' ' ' VAL . 11.2 mp -53.08 -39.19 63.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 18.41 111.241 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 m -61.63 -28.58 69.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 21.76 111.352 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.06 -38.31 90.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 23.14 111.055 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -96.05 12.54 30.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.443 . . . . 19.37 111.672 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 57.97 43.2 21.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.998 0.428 . . . . 22.24 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.7 mt -92.79 119.6 40.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.136 -0.484 . . . . 17.93 111.19 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -113.55 -170.43 1.69 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.256 -0.429 . . . . 21.49 111.491 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' CA ' ' SD ' ' A' ' 1' ' ' MET . 83.1 tttt -62.78 157.74 20.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.09 -0.505 . . . . 19.19 111.454 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 59.88 28.72 18.26 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.782 -0.645 . . . . 16.92 111.784 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -89.77 143.86 26.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.447 -0.342 . . . . 14.92 110.827 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -99.39 134.8 41.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 11.29 111.205 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.33 113.55 13.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.019 -0.537 . . . . 10.94 111.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.544 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 38.9 t-80 -83.62 119.32 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.999 0.428 . . . . 8.09 110.487 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.522 HD21 HD12 ' A' ' 36' ' ' ILE . 22.9 tp -95.25 121.3 36.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 6.7 110.777 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.898 -0.592 . . . . 7.13 110.527 -179.82 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 C--O 1.231 0.124 0 N-CA-C 109.105 -0.702 . . . . 7.56 109.105 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -128.4 165.1 21.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.185 0.517 . . . . 7.84 111.91 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 26.2 p -145.77 148.15 32.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.187 -0.915 . . . . 4.73 110.762 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -99.13 143.12 29.76 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.391 -0.368 . . . . 4.43 110.684 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -86.66 124.18 32.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.083 -0.508 . . . . 2.72 111.33 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -94.73 -21.13 18.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.223 0.453 . . . . 3.78 112.223 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.445 ' HA ' ' HD3' ' B' ' 14' ' ' PRO . 79.6 t80 -145.68 140.9 16.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.886 0.328 . . . . 4.88 111.886 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 13' ' ' PHE . 36.7 Cg_exo -61.61 139.75 82.98 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.809 2.339 . . . . 3.11 112.488 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -138.69 133.64 32.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.72 -0.673 . . . . 4.0 111.288 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.43 ' HA ' HG23 ' B' ' 24' ' ' THR . 68.9 m -111.65 119.13 37.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.426 . . . . 3.82 110.754 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.82 139.08 48.61 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.887 -0.673 . . . . 3.22 112.553 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.842 HG22 ' C ' ' A' ' 47' ' ' GLY . 24.9 p -103.94 -23.46 13.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.181 0.515 . . . . 4.64 110.705 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -120.38 154.6 34.87 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.197 -0.91 . . . . 4.05 109.757 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.5 -39.66 92.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 4.26 111.458 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.13 -4.8 34.97 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.908 0.385 . . . . 4.22 110.589 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.2 158.82 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.973 -0.558 . . . . 3.77 110.949 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' B' ' 24' ' ' THR . 3.6 tt -102.62 139.99 37.49 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.812 -0.811 . . . . 3.13 108.812 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.754 ' N ' HD23 ' B' ' 23' ' ' LEU . 98.6 m -112.38 123.88 51.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.531 -0.759 . . . . 2.46 109.474 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' B' ' 55' ' ' PHE . 15.9 p90 -135.61 146.01 47.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.962 0.727 . . . . 2.49 112.962 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.501 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 31.9 mmt180 -109.56 178.29 4.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.116 -0.327 . . . . 6.21 110.116 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -81.35 142.77 32.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 3.87 110.328 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 20.23 61.72 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.878 -0.889 . . . . 4.23 110.878 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.6 mm-40 -98.53 178.81 4.9 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.343 0.868 . . . . 4.19 113.343 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 21.9 mm -136.05 116.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.648 -1.615 . . . . 5.23 110.943 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.443 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 55.2 mt -112.35 137.84 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 4.64 111.083 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' HIS . . . . . 0.488 ' O ' ' HA2' ' B' ' 46' ' ' GLY . 1.8 m-70 -92.51 128.19 38.27 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.326 -0.62 . . . . 7.14 109.326 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.533 ' C ' HD23 ' B' ' 33' ' ' LEU . 6.1 tt -73.81 102.26 3.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 6.33 111.113 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' B' ' 47' ' ' GLU . 55.1 mt -81.1 -64.61 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.666 -0.697 . . . . 6.97 111.098 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.0 t -154.12 116.7 4.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 7.03 112.286 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 52.3 mtpt -69.52 6.22 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.984 -0.553 . . . . 7.52 111.398 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -121.61 98.46 5.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.593 0.235 . . . . 8.93 110.64 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 45' ' ' LYS . 48.1 p -108.07 -1.4 20.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.544 -0.298 . . . . 7.05 111.423 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.83 -4.2 75.09 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.782 -0.723 . . . . 8.42 111.565 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -129.31 121.49 27.61 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.385 0.274 . . . . 7.96 110.65 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.425 ' O ' HD11 ' A' ' 8' ' ' LEU . . . -59.87 133.28 55.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 8.2 110.507 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.25 82.11 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.927 -0.654 . . . . 6.68 112.387 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.544 ' HE1' HD13 ' A' ' 8' ' ' LEU . 86.3 m95 -120.35 122.32 40.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.053 0.427 . . . . 5.83 111.443 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' TRP . . . . . 0.485 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 30.7 m0 -111.56 162.73 14.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.103 -0.703 . . . . 5.87 109.103 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' B' ' 38' ' ' THR . 63.6 tttm -115.58 129.98 56.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.795 0.331 . . . . 5.33 110.405 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' B' ' 32' ' ' HIS . . . -142.82 177.43 21.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.654 -0.784 . . . . 4.14 112.359 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' B' ' 34' ' ' ILE . 36.5 tt0 -125.13 133.55 52.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.294 0.568 . . . . 6.02 110.778 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.675 ' O ' ' N ' ' B' ' 50' ' ' GLY . 42.5 tp -127.45 169.96 13.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.987 -1.006 . . . . 4.21 109.269 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.456 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 58.2 m-20 -17.92 64.45 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.256 1.576 . . . . 5.39 115.256 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.71 -10.84 63.52 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 114.937 0.735 . . . . 5.53 114.937 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.45 152.62 24.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.162 0.981 . . . . 5.33 110.988 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 1.2 pm0 -125.73 142.15 51.65 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.948 -0.76 . . . . 5.79 108.948 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . 0.466 ' C ' ' HB2' ' B' ' 23' ' ' LEU . . . -179.84 -171.27 42.57 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 120.254 -0.974 . . . . 3.35 113.101 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 33.4 m -111.77 151.11 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 120.704 0.288 . . . . 4.3 111.055 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 38.4 p90 -131.34 139.52 35.68 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 112.219 0.451 . . . . 3.72 112.219 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 55' ' ' PHE . 94.4 Cg_endo -97.95 174.26 0.57 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.297 3.332 . . . . 3.97 111.546 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.503 ' HB2' ' CD2' ' B' ' 59' ' ' PHE . 16.6 m-20 78.78 -10.68 1.31 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.49 1.293 . . . . 5.85 114.49 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' B' ' 60' ' ' ALA . 15.8 m120 58.15 26.68 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 118.43 0.559 . . . . 5.67 110.201 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.503 ' CD2' ' HB2' ' B' ' 57' ' ' ASP . 9.3 m-85 -56.64 3.97 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.201 0.815 . . . . 3.89 113.201 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' B' ' 58' ' ' ASN . . . -129.47 138.87 51.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.225 0.454 . . . . 3.89 112.225 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 128.06 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 4.64 111.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -53.72 156.64 2.61 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 120.932 0.396 . . . . 6.72 110.746 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.46 -32.71 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 6.54 110.45 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 74.5 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.369 -0.824 . . . . 7.43 110.529 179.75 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 tpp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.678 0.275 . . . . 16.5 110.835 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -84.7 142.37 29.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 13.22 110.794 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -145.42 151.43 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 12.19 110.712 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -109.93 145.48 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 11.64 110.795 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 5' ' ' VAL . 31.3 m -136.27 106.4 5.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.184 0.516 . . . . 6.66 110.678 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 7' ' ' THR . 81.5 tttt -75.94 163.14 27.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 6.86 111.076 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.471 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.3 m -137.43 142.16 41.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.681 -0.69 . . . . 3.79 109.895 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 9' ' ' THR . 3.2 pp -55.31 -21.86 16.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.453 -0.34 . . . . 5.48 111.65 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.435 ' H ' HG22 ' A' ' 7' ' ' THR . 31.5 m -71.18 -39.37 71.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.397 -0.365 . . . . 7.65 110.575 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.78 -1.95 5.97 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.076 -0.583 . . . . 7.08 112.872 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -98.99 129.4 45.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.011 0.434 . . . . 6.58 112.073 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -104.57 136.15 44.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.577 -0.738 . . . . 6.95 109.448 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 13' ' ' ILE . 5.1 mp -118.0 152.72 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 5.97 111.471 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.404 ' N ' HG22 ' A' ' 13' ' ' ILE . 24.9 m -108.89 135.07 50.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 8.28 110.425 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.4 tp -135.53 154.14 51.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.491 -0.322 . . . . 10.02 110.728 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.64 99.74 6.71 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.306 -0.406 . . . . 12.19 111.278 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -149.95 111.81 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.532 -0.303 . . . . 14.73 111.54 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -52.14 166.18 0.43 Allowed Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 114.176 1.176 . . . . 18.57 114.176 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.9 Cg_exo -60.16 -30.66 91.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.715 2.943 . . . . 19.89 113.864 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 m -80.95 32.92 0.32 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 21.46 111.552 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -118.7 126.9 52.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 18.56 110.896 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 77.1 p -64.71 148.87 50.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 20.15 111.151 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.45 HD12 HD23 ' A' ' 50' ' ' LEU . 41.0 mm -58.51 -37.68 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 16.47 110.88 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 11.0 pt-20 -61.77 -40.52 95.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 19.99 110.091 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -64.16 -43.8 94.05 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.883 -0.599 . . . . 16.38 109.785 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.28 -41.07 88.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.884 -0.598 . . . . 13.8 110.434 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.89 -29.22 70.6 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.228 -0.442 . . . . 13.67 110.415 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.62 74.73 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.106 -0.497 . . . . 14.55 109.691 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -64.34 -47.62 78.67 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.586 -0.733 . . . . 13.7 109.559 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.46 -40.61 86.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 115.856 -0.611 . . . . 9.57 110.134 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -63.38 -30.38 71.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 15.04 110.909 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.19 -35.94 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 12.47 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -88.89 -58.97 2.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.114 -0.494 . . . . 9.23 112.003 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -82.5 -11.43 58.49 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.396 0.887 . . . . 9.6 113.396 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.36 -29.99 1.93 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.498 -0.858 . . . . 12.2 114.056 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 46.8 mm -50.09 124.72 17.69 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.994 0.397 . . . . 11.27 111.917 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 40.8 Cg_exo -58.86 151.97 60.99 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.774 2.316 . . . . 14.23 112.341 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.09 -32.82 16.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.688 2.259 . . . . 14.34 112.114 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.84 -22.98 67.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.061 -0.518 . . . . 16.96 111.077 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -97.2 -18.06 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 14.45 110.86 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -78.73 124.17 27.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.046 0.451 . . . . 10.91 112.036 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.466 HH21 HG21 ' A' ' 70' ' ' VAL . 37.6 ttp180 -121.23 118.89 30.74 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.459 -0.941 . . . . 9.32 108.459 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.56 127.96 50.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.142 0.496 . . . . 10.56 112.046 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.724 HG23 HG21 ' B' ' 18' ' ' THR . 39.5 mm -115.49 120.33 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.273 -0.876 . . . . 9.75 110.474 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CB ' HD11 ' A' ' 50' ' ' LEU . 60.3 t80 -130.12 119.46 23.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.031 -0.531 . . . . 15.27 111.028 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.95 18.33 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 14.76 112.097 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.689 ' O ' HG22 ' B' ' 18' ' ' THR . . . 94.7 1.84 63.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.603 -0.808 . . . . 12.99 112.989 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -117.36 143.49 45.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 17.08 110.893 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.83 131.83 35.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 14.97 110.719 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 50' ' ' LEU . 5.4 mp -80.22 134.72 36.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.921 0.391 . . . . 14.81 111.403 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 130.29 35.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.837 -0.62 . . . . 21.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 4.0 p30 -44.28 -49.34 9.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 18.5 111.214 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -58.79 -76.11 0.23 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.62 -0.8 . . . . 21.79 111.573 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' GLY . 60.7 mtp180 -28.55 156.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.584 0.957 . . . . 24.16 113.584 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 9.3 t -110.9 164.1 13.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.061 -0.972 . . . . 21.36 110.506 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 92.7 mt -53.73 -36.57 62.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 18.41 111.629 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.7 t -62.34 -29.69 70.64 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.749 0.278 . . . . 21.76 111.749 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.33 -34.83 79.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.677 0.275 . . . . 23.14 110.945 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -93.77 4.71 53.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.472 . . . . 19.37 111.275 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 64.03 33.02 12.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.001 0.429 . . . . 22.24 110.897 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.8 mt -80.93 116.93 26.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.53 . . . . 17.93 111.582 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -107.4 -170.82 1.76 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.72 -0.673 . . . . 21.49 110.46 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.38 160.7 21.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.467 -0.333 . . . . 19.19 111.01 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.6 26.8 15.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.172 -0.467 . . . . 16.92 111.744 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 t -87.47 139.13 30.86 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.761 0.315 . . . . 14.92 111.09 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -100.03 129.15 46.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 11.29 110.975 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -127.36 114.89 18.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.125 -0.489 . . . . 10.94 110.783 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.96 122.32 25.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 8.09 110.937 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.47 116.27 28.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.912 -0.585 . . . . 6.7 110.335 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.466 HG21 HH21 ' A' ' 42' ' ' ARG . 38.2 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 7.13 111.735 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 . . . . . 0 C--O 1.232 0.171 0 N-CA-C 109.712 -0.477 . . . . 7.56 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.11 171.64 12.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.271 -0.422 . . . . 7.84 111.558 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 36.6 m -148.03 151.17 35.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.865 -0.607 . . . . 4.73 111.345 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -99.81 139.47 35.43 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.985 -0.376 . . . . 4.43 109.985 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 60.3 p -83.28 121.81 27.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.42 -0.355 . . . . 2.72 111.611 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.04 -20.85 23.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.552 -0.295 . . . . 3.78 111.309 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -147.57 157.46 44.64 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 4.88 111.13 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.76 140.77 26.57 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.665 2.243 . . . . 3.11 112.71 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.438 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 66.9 t80 -136.71 129.91 31.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 4.0 110.375 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.513 ' HA ' HG23 ' B' ' 24' ' ' THR . 7.4 t -113.0 121.33 44.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 3.82 111.52 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.29 145.61 49.73 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.822 -0.704 . . . . 3.22 111.865 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.724 HG21 HG23 ' A' ' 44' ' ' ILE . 57.9 p -107.98 -21.75 12.69 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.038 0.447 . . . . 4.64 111.255 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -118.61 162.35 18.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.539 -0.755 . . . . 4.05 110.516 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' B' ' 20' ' ' GLU . 1.8 mp0 -59.13 -27.94 66.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.897 -0.592 . . . . 4.26 112.544 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.73 -53.28 6.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.553 -0.459 . . . . 4.22 110.59 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -32.35 146.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.704 -0.68 . . . . 3.77 112.167 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' B' ' 24' ' ' THR . 3.2 tt -98.27 141.41 31.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.288 -1.005 . . . . 3.13 108.288 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.754 ' N ' HD23 ' B' ' 23' ' ' LEU . 95.9 m -113.96 122.9 48.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.84 -0.618 . . . . 2.46 110.374 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.482 ' CG ' HD11 ' B' ' 31' ' ' ILE . 37.1 p90 -138.54 155.27 48.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.614 0.598 . . . . 2.49 112.614 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.41 -179.86 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.222 -0.288 . . . . 6.21 110.222 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.18 141.49 32.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 3.87 110.177 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.87 58.94 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.736 -0.946 . . . . 4.23 110.736 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.497 ' HG2' ' H ' ' B' ' 30' ' ' ILE . 4.4 tt0 -99.29 179.28 4.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.23 0.826 . . . . 4.19 113.23 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.497 ' H ' ' HG2' ' B' ' 29' ' ' GLU . 30.3 mm -135.86 115.33 16.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.877 -1.51 . . . . 5.23 110.979 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.482 HD11 ' CG ' ' B' ' 25' ' ' PHE . 51.5 mt -114.49 145.88 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 4.64 111.166 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -97.43 129.22 44.67 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.514 -0.55 . . . . 7.14 109.514 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.404 ' C ' HD13 ' B' ' 33' ' ' LEU . 3.1 tm? -78.11 110.62 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 6.33 111.172 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -84.11 -58.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 6.97 111.264 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 70.6 m -158.92 121.43 3.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.32 0.489 . . . . 7.03 112.32 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.08 6.38 2.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.915 -0.584 . . . . 7.52 111.435 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.9 105.82 10.69 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.767 -0.197 . . . . 8.93 110.558 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.568 HG22 ' HB2' ' B' ' 45' ' ' LYS . 28.0 p -115.0 -3.3 12.65 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.806 0.299 . . . . 7.05 111.806 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.8 -9.04 77.69 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.759 -0.734 . . . . 8.42 112.233 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.73 118.69 30.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.698 0.285 . . . . 7.96 110.513 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.2 130.55 46.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 8.2 111.229 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 2.41 79.72 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.881 -0.599 . . . . 6.68 112.461 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 68.3 m95 -120.39 126.39 50.35 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.052 0.453 . . . . 5.83 112.023 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -110.85 165.08 12.14 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.589 -0.893 . . . . 5.87 108.589 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' B' ' 38' ' ' THR . 36.5 ttpt -119.86 129.95 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.956 0.408 . . . . 5.33 110.874 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.23 175.41 20.93 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.566 -0.743 . . . . 4.14 112.126 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -134.55 134.34 41.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 6.02 110.366 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 50' ' ' GLY . 52.5 tp -123.97 133.23 53.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 4.21 109.029 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -22.03 80.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.143 1.164 . . . . 5.39 114.143 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 125.24 -50.85 0.85 Allowed Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.57 -0.741 . . . . 5.53 114.753 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -112.06 153.87 26.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.998 0.899 . . . . 5.33 112.127 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.41 142.14 51.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.205 -0.907 . . . . 5.79 108.591 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.78 -176.08 41.96 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.086 -1.054 . . . . 3.35 113.245 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -112.85 152.91 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.576 0.227 . . . . 4.3 111.047 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 51.7 p90 -135.68 140.36 33.56 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.612 0.597 . . . . 3.72 112.612 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 64.6 Cg_endo -96.16 175.05 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.657 3.572 . . . . 3.97 110.976 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.537 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 3.2 m-20 77.34 -12.45 1.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.184 1.55 . . . . 5.85 115.184 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . 0.444 ' C ' HD22 ' B' ' 58' ' ' ASN . 0.2 OUTLIER 58.19 75.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.424 -0.954 . . . . 5.67 108.424 -177.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.537 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 17.3 m-85 -102.96 6.62 39.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.276 -0.874 . . . . 3.89 112.211 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.57 139.01 43.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.479 0.548 . . . . 3.89 112.479 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.84 130.0 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.942 -0.572 . . . . 4.64 111.561 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.466 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 8.9 tp-100 -54.19 112.68 1.02 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.738 0.304 . . . . 6.72 110.527 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 pt -90.6 -31.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 6.54 110.933 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.356 -0.83 . . . . 7.43 110.586 -179.827 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.823 0.344 . . . . 16.5 110.822 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.63 141.94 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 13.22 110.583 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.02 149.81 15.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.414 -0.357 . . . . 12.19 110.975 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -103.98 152.37 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 11.64 111.156 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.76 101.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.772 -0.649 . . . . 6.66 109.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -89.43 133.56 34.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.182 0.438 . . . . 6.86 112.182 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -103.15 160.0 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 3.79 111.158 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.546 HD22 ' HE1' ' B' ' 43' ' ' TRP . 3.8 pp -64.78 -24.72 67.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.047 -0.524 . . . . 5.48 111.178 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.448 ' N ' HD12 ' A' ' 8' ' ' LEU . 77.1 p -67.79 -35.88 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.288 -0.415 . . . . 7.65 110.985 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.69 3.64 7.68 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.109 -0.567 . . . . 7.08 112.675 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -99.65 126.64 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.275 0.472 . . . . 6.58 112.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -101.07 133.67 45.24 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.712 -0.676 . . . . 6.95 109.467 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 13' ' ' ILE . 4.6 mp -117.59 142.03 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 5.97 111.68 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.717 -0.674 . . . . 8.28 110.029 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.465 HD11 HG12 ' A' ' 30' ' ' ILE . 35.9 mt -134.58 155.22 50.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.525 -0.307 . . . . 10.02 110.959 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -123.0 99.82 6.57 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.199 -0.455 . . . . 12.19 111.028 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 17' ' ' VAL . 11.2 p -153.04 115.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.542 -0.299 . . . . 14.73 111.731 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 43.6 mt-10 -51.46 168.77 0.25 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 113.867 1.062 . . . . 18.57 113.867 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 16.7 Cg_exo -69.39 -23.19 32.76 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.572 2.848 . . . . 19.89 113.344 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -84.12 28.96 0.58 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.673 0.273 . . . . 21.46 111.546 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -116.58 139.83 50.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.428 -0.351 . . . . 18.56 110.839 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 81.4 p -73.76 151.37 40.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 20.15 111.41 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.25 -36.54 69.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.352 -0.386 . . . . 16.47 110.384 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -43.15 99.53 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.4 -0.593 . . . . 19.99 109.4 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -60.62 -43.21 97.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.789 -0.641 . . . . 16.38 110.081 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 56' ' ' LEU . 93.3 t -62.57 -42.5 96.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.937 -0.574 . . . . 13.8 110.4 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.01 -28.7 69.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.125 -0.489 . . . . 13.67 110.421 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.89 71.68 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.59 -0.522 . . . . 14.55 109.59 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -62.93 -48.47 78.77 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.598 -0.728 . . . . 13.7 109.367 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.465 HG12 HD11 ' A' ' 15' ' ' LEU . 79.7 mt -61.1 -42.67 94.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.518 -0.764 . . . . 9.57 109.904 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -60.38 -28.41 68.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.602 -0.727 . . . . 15.04 110.833 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -75.74 -36.57 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 12.47 110.936 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.45 -64.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.05 -0.523 . . . . 9.23 112.035 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -78.49 -8.36 58.46 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.719 1.007 . . . . 9.6 113.719 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.66 26.96 67.45 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.388 -0.911 . . . . 12.2 113.416 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -98.27 118.59 63.31 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.799 0.299 . . . . 11.27 110.559 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.99 135.97 51.95 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.583 2.188 . . . . 14.23 112.219 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.79 -29.32 76.74 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.219 . . . . 14.34 112.046 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.1 -24.63 66.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.886 -0.597 . . . . 16.96 111.036 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -99.28 -16.3 18.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.025 -0.534 . . . . 14.45 110.979 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -80.03 123.8 28.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.005 0.431 . . . . 10.91 111.769 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.493 ' HB3' HG13 ' A' ' 70' ' ' VAL . 47.8 ttp180 -122.21 121.99 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.337 -0.986 . . . . 9.32 108.337 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 50' ' ' LEU . 92.2 mt -106.11 129.69 54.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.024 0.44 . . . . 10.56 112.031 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mt -116.17 121.03 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 9.75 110.52 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.689 ' HB3' HD21 ' A' ' 50' ' ' LEU . 72.2 t80 -128.05 117.29 21.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 15.27 110.57 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.58 22.14 10.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 14.76 111.392 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -10.25 67.47 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.01 -0.614 . . . . 12.99 112.767 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.07 -163.04 0.08 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.244 0.218 . . . . 17.08 111.124 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 -13.51 6.59 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.711 1.004 . . . . 14.97 113.711 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.689 HD21 ' HB3' ' A' ' 45' ' ' PHE . 2.2 mm? 58.5 106.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.788 0.328 . . . . 14.81 111.421 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -92.13 130.23 37.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.337 -0.392 . . . . 21.0 111.601 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -40.23 -60.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.82 -0.627 . . . . 18.5 111.35 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -50.75 -75.49 0.21 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.529 -0.843 . . . . 21.79 111.552 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' GLY . 32.4 mmt180 -27.53 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 24.16 113.479 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 6.3 t -111.72 164.04 13.47 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.154 -0.93 . . . . 21.36 111.093 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.3 mm? -51.72 -44.29 63.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.344 -0.389 . . . . 18.41 111.2 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 t -58.33 -29.37 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.14 -0.482 . . . . 21.76 111.602 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.85 -35.6 81.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 23.14 110.892 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -98.68 11.84 37.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 19.37 111.327 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 58.11 38.26 26.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.907 0.384 . . . . 22.24 111.317 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.32 115.96 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 17.93 110.864 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -109.35 -168.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.849 -0.614 . . . . 21.49 110.948 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.84 160.71 11.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 19.19 111.338 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 57.99 29.81 18.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.853 -0.612 . . . . 16.92 111.701 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.0 p -89.79 138.1 31.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 14.92 111.299 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.49 ' C ' HD12 ' A' ' 67' ' ' LEU . 76.0 p -99.94 127.25 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 11.29 110.797 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 66' ' ' THR . 8.2 mp -122.46 121.26 36.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.406 . . . . 10.94 110.884 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 8.09 110.941 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -94.9 113.89 25.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 6.7 110.244 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 7.13 110.993 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 . . . . . 0 C--O 1.232 0.165 0 N-CA-C 109.365 -0.606 . . . . 7.56 109.365 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.05 173.02 12.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 7.84 111.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.479 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 7.5 p -148.23 151.69 35.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.7 -0.682 . . . . 4.73 111.527 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -99.6 141.33 32.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.29 -0.414 . . . . 4.43 110.033 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 46.2 p -84.56 123.69 30.59 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.373 -0.376 . . . . 2.72 111.557 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.81 -21.03 23.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 3.78 110.514 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -148.53 156.25 42.08 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 4.88 110.703 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.04 143.62 36.51 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.608 2.205 . . . . 3.11 113.027 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' B' ' 15' ' ' TYR . 11.9 t80 -130.58 68.67 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 4.0 110.377 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.895 ' HA ' HG23 ' B' ' 24' ' ' THR . 90.1 m -53.92 115.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 3.82 110.707 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.61 140.01 47.16 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.772 -0.649 . . . . 3.22 112.181 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -102.68 -24.37 13.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.148 0.499 . . . . 4.64 110.925 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -119.11 165.14 14.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.491 -0.777 . . . . 4.05 110.324 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.33 -38.61 78.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 4.26 111.781 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.57 -6.01 43.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.884 0.373 . . . . 4.22 110.6 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.99 162.63 15.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.779 -0.646 . . . . 3.77 110.868 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 23' ' ' LEU . 36.3 mt -108.47 150.8 26.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.197 -0.668 . . . . 3.13 109.197 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.895 HG23 ' HA ' ' B' ' 16' ' ' THR . 32.1 m -114.15 127.41 55.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 2.46 110.155 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.558 ' CE1' HG12 ' B' ' 31' ' ' ILE . 50.3 m-85 -133.28 144.97 50.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.037 0.754 . . . . 2.49 113.037 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.492 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 11.1 ptp180 -109.42 176.49 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.698 -0.853 . . . . 6.21 108.698 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.27 126.41 31.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.65 0.738 . . . . 3.87 109.921 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 26.2 7.14 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.347 -1.297 . . . . 4.23 110.734 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 23.3 mm-40 -98.53 178.9 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.773 1.027 . . . . 4.19 113.773 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 mm -135.95 116.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.557 -1.656 . . . . 5.23 110.826 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.558 HG12 ' CE1' ' B' ' 25' ' ' PHE . 53.7 mt -108.36 132.21 56.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.044 -0.525 . . . . 4.64 111.446 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -91.67 125.53 36.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.029 -0.73 . . . . 7.14 109.029 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.82 100.67 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 6.33 110.966 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 45.4 mm -82.73 -58.31 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 6.97 110.972 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 66.8 m -157.18 105.89 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 7.03 111.656 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.437 ' NZ ' ' HB2' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -66.66 5.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 7.52 111.896 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -121.19 102.03 8.04 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 120.562 0.22 . . . . 8.93 110.459 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.443 HG22 ' HB2' ' B' ' 45' ' ' LYS . 42.9 p -110.71 -4.66 15.24 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.488 -0.323 . . . . 7.05 111.713 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.54 -1.2 71.89 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.967 -0.635 . . . . 8.42 112.446 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -129.45 120.54 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.189 -0.3 . . . . 7.96 110.189 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.03 132.74 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 8.2 111.108 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 1.57 81.79 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.688 -0.687 . . . . 6.68 112.394 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.622 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 53.6 m95 -120.78 123.15 41.94 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.937 0.398 . . . . 5.83 111.731 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' TRP . . . . . 0.414 ' NE1' ' HB2' ' B' ' 36' ' ' LYS . 3.7 m0 -112.93 161.43 17.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.062 -0.718 . . . . 5.87 109.062 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.443 ' HB2' HG22 ' B' ' 38' ' ' THR . 64.1 tttp -116.07 130.56 56.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.09 0.471 . . . . 5.33 111.216 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.54 175.45 21.22 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.407 -0.815 . . . . 4.14 111.562 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.1 132.66 53.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.223 0.535 . . . . 6.02 110.32 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.627 ' O ' ' N ' ' B' ' 50' ' ' GLY . 60.0 tp -124.87 169.22 12.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.219 -0.901 . . . . 4.21 110.224 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.519 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 62.5 m-20 -18.62 67.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.283 1.586 . . . . 5.39 115.283 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.98 -10.22 63.64 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.981 0.753 . . . . 5.53 114.981 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -110.38 155.11 22.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.92 0.86 . . . . 5.33 111.045 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' B' ' 52' ' ' GLU . 0.0 OUTLIER -127.58 140.29 52.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.909 -0.774 . . . . 5.79 108.909 178.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.8 -175.46 40.71 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.041 -1.076 . . . . 3.35 113.455 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.21 150.02 15.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.451 0.167 . . . . 4.3 111.076 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 50.6 p90 -134.97 140.45 35.06 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.049 0.452 . . . . 3.72 112.167 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.622 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.6 Cg_endo -95.09 174.61 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.458 3.439 . . . . 3.97 111.641 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.567 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 78.09 -12.83 1.03 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.255 1.576 . . . . 5.85 115.255 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 14.9 m120 56.27 77.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.832 0.742 . . . . 5.67 109.103 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.9 m-85 -101.87 6.84 41.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.382 -0.826 . . . . 3.89 111.694 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.479 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -137.78 138.22 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.575 0.583 . . . . 3.89 112.575 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.69 130.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.866 -0.606 . . . . 4.64 111.77 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.405 HE22 ' C ' ' B' ' 64' ' ' SER . 0.0 OUTLIER -59.85 132.2 53.23 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.749 -0.463 . . . . 6.72 109.749 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 24.7 pt -139.31 37.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.924 0.392 . . . . 6.54 111.626 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . 0.405 ' C ' HE22 ' B' ' 62' ' ' GLN . 30.4 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.23 -0.89 . . . . 7.43 110.85 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.605 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 95.2 mtp . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.836 0.35 . . . . 16.5 110.786 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -81.55 151.75 27.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.821 -0.627 . . . . 13.22 110.786 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -143.7 146.75 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 12.19 110.341 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -95.82 139.17 32.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 11.64 110.503 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.32 91.33 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.45 -0.574 . . . . 6.66 109.45 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.14 153.29 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.843 -0.617 . . . . 6.86 111.678 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 8' ' ' LEU . 24.6 m -133.6 159.82 39.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 3.79 109.398 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.819 ' H ' HD22 ' A' ' 8' ' ' LEU . 2.0 mm? -58.67 -37.95 77.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.944 0.402 . . . . 5.48 110.761 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.9 m -61.14 -22.35 64.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.812 -0.631 . . . . 7.65 111.262 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.36 17.66 21.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.079 -0.582 . . . . 7.08 112.141 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -99.38 110.37 22.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.299 . . . . 6.58 111.189 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -98.64 129.67 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 6.95 110.028 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 13' ' ' ILE . 4.4 mp -118.96 144.67 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.954 0.406 . . . . 5.97 111.285 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 p -96.6 136.54 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 8.28 110.867 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 tp -137.64 151.47 48.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.317 -0.401 . . . . 10.02 110.284 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.96 105.24 13.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.63 -0.259 . . . . 12.19 111.474 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -152.83 112.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.436 0.532 . . . . 14.73 112.436 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 1.5 mp0 -56.63 172.89 0.33 Allowed Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 112.881 0.696 . . . . 18.57 112.881 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 30.1 Cg_exo -63.99 -37.47 43.2 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.42 2.746 . . . . 19.89 112.73 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -63.67 -25.55 68.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 21.46 111.541 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.4 147.59 25.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.472 -0.331 . . . . 18.56 111.188 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -93.89 145.51 24.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.059 -0.519 . . . . 20.15 110.948 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 50' ' ' LEU . 24.8 mt -55.93 -31.8 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 16.47 111.505 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.28 -38.68 90.28 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.943 -0.391 . . . . 19.99 109.943 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -69.84 -40.72 75.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.966 -0.561 . . . . 16.38 109.95 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.28 -49.79 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 115.977 -0.556 . . . . 13.8 110.355 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HE2' HD13 ' A' ' 43' ' ' LEU . 97.7 mttt -59.07 -37.5 77.22 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.079 -0.509 . . . . 13.67 110.975 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.18 -38.28 87.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.294 -0.412 . . . . 14.55 110.944 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.59 -43.29 80.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.122 -0.49 . . . . 13.7 110.192 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.88 -36.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.143 -0.48 . . . . 9.57 109.772 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.432 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 59.0 tt0 -67.07 -29.17 68.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.898 -0.592 . . . . 15.04 111.164 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.3 -37.62 74.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 12.47 111.119 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -89.82 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.12 0.415 . . . . 9.23 112.12 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -83.15 -9.44 59.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.112 0.782 . . . . 9.6 113.112 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 62.54 25.02 66.64 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.427 -0.892 . . . . 12.2 113.208 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.1 mt -97.39 116.62 65.92 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.792 0.296 . . . . 11.27 110.829 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.95 138.71 70.07 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.698 2.266 . . . . 14.23 112.438 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.97 -22.7 55.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.585 2.19 . . . . 14.34 112.191 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.58 -25.28 66.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.535 . . . . 16.96 111.311 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -106.9 -5.48 18.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.368 -0.378 . . . . 14.45 111.572 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -88.95 127.0 35.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.948 0.404 . . . . 10.91 111.923 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 17.0 tpt180 -125.12 121.78 35.25 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.852 -0.796 . . . . 9.32 108.852 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.405 HD13 ' HE2' ' A' ' 27' ' ' LYS . 9.4 mp -102.8 126.55 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 10.56 111.186 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -112.65 129.76 67.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 9.75 110.406 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 50' ' ' LEU . 67.5 t80 -147.36 124.41 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 15.27 110.421 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.8 17.51 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 14.76 111.454 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.52 -3.62 81.79 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.786 -0.721 . . . . 12.99 112.593 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.22 150.32 32.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.778 0.323 . . . . 17.08 110.982 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -83.24 124.94 31.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 14.97 110.506 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 23' ' ' ILE . 48.9 mt -64.7 131.65 47.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 14.81 111.109 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.4 tp10 -90.31 127.29 36.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.996 -0.547 . . . . 21.0 110.917 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -41.45 34.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.599 -0.728 . . . . 18.5 112.301 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -0.12 83.79 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.982 -0.628 . . . . 21.79 114.208 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 51' ' ' GLU . 2.2 mpt_? -99.69 173.95 6.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.044 0.422 . . . . 24.16 110.961 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.2 p -119.19 158.21 26.43 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.22 -0.445 . . . . 21.36 111.04 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 8.4 mp -52.97 -28.91 26.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 18.41 111.826 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 p -72.78 -21.77 60.94 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.735 0.303 . . . . 21.76 111.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.58 -42.37 87.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.193 -0.458 . . . . 23.14 110.958 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.2 10.18 32.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.251 -0.431 . . . . 19.37 111.579 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.81 24.27 11.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.48 0.548 . . . . 22.24 112.48 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -57.56 155.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.721 -0.474 . . . . 17.93 109.721 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -149.59 165.63 31.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.737 -0.468 . . . . 21.49 109.737 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -52.4 146.98 8.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 19.19 111.506 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.56 30.04 10.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.869 -0.605 . . . . 16.92 111.776 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.1 p -86.72 160.9 18.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 14.92 110.898 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.6 m -115.48 124.74 51.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 11.29 110.635 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.4 mm? -113.39 122.45 47.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.23 -0.441 . . . . 10.94 110.294 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 23.4 t60 -85.94 112.82 21.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 8.09 111.078 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.56 118.12 31.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.009 -0.541 . . . . 6.7 110.737 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.622 HG22 HD21 ' A' ' 8' ' ' LEU . 39.5 t . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 7.13 110.881 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.231 0.107 0 N-CA-C 109.383 -0.599 . . . . 7.56 109.383 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -130.44 169.36 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.978 0.418 . . . . 7.84 111.622 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.581 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 9.5 p -149.02 151.86 35.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 4.73 111.114 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -99.22 143.38 29.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.211 -0.45 . . . . 4.43 110.835 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.453 HG21 ' HB3' ' B' ' 25' ' ' PHE . 41.7 p -84.7 125.23 32.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.165 -0.47 . . . . 2.72 111.84 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.54 -21.85 20.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.327 -0.397 . . . . 3.78 111.379 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.26 160.64 59.08 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 120.714 0.292 . . . . 4.88 111.622 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' ' 26' ' ' ARG . 92.6 Cg_endo -81.23 71.61 6.88 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.86 2.373 . . . . 3.11 113.619 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -64.58 127.65 32.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.042 -0.526 . . . . 4.0 111.309 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.54 ' HA ' HG23 ' B' ' 24' ' ' THR . 30.1 m -112.97 120.19 40.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.505 -0.316 . . . . 3.82 111.39 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.09 138.41 47.87 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.962 -0.637 . . . . 3.22 111.932 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.515 HG23 ' ND2' ' B' ' 19' ' ' ASN . 13.4 t -104.26 -24.58 13.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.936 0.398 . . . . 4.64 111.536 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.515 ' ND2' HG23 ' B' ' 18' ' ' THR . 40.8 m-80 -116.37 162.88 16.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.785 -0.643 . . . . 4.05 110.052 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.14 -41.05 86.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.211 -0.449 . . . . 4.26 111.044 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.48 -4.89 36.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.088 0.47 . . . . 4.22 109.961 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -83.34 156.87 22.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.53 -0.759 . . . . 3.77 110.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.758 HD13 ' H ' ' B' ' 24' ' ' THR . 0.4 OUTLIER -107.11 146.61 31.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.803 -1.184 . . . . 3.13 107.803 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.758 ' H ' HD13 ' B' ' 23' ' ' LEU . 53.3 m -111.83 128.08 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 2.46 110.352 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.6 ' CZ ' HD12 ' B' ' 23' ' ' LEU . 73.3 m-85 -128.02 128.62 45.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.323 0.49 . . . . 2.49 112.323 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.497 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 24.4 mmm180 -100.58 174.37 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.285 -0.635 . . . . 6.21 109.285 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.71 137.7 35.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.169 0.509 . . . . 3.87 110.229 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.24 21.65 51.21 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.704 -0.958 . . . . 4.23 110.704 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 21.6 mm-40 -99.36 -179.81 4.34 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.393 0.886 . . . . 4.19 113.393 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.2 mm -135.07 118.7 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.83 -1.532 . . . . 5.23 110.748 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.581 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 17.3 mt -112.23 136.74 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.911 -0.586 . . . . 4.64 112.1 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -95.06 125.8 39.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.901 -0.777 . . . . 7.14 108.901 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.466 ' C ' HD23 ' B' ' 33' ' ' LEU . 4.3 tt -74.34 105.89 5.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 6.33 111.622 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' B' ' 47' ' ' GLU . 75.5 mt -80.8 -65.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.577 -0.738 . . . . 6.97 110.793 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -153.08 129.65 10.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.86 -0.609 . . . . 7.03 111.929 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.403 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 48.9 mtpt -84.04 6.44 22.08 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.901 -0.591 . . . . 7.52 111.535 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 94.84 4.46 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.224 -0.287 . . . . 8.93 110.224 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 76.2 p -104.81 -1.96 25.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.413 -0.358 . . . . 7.05 111.706 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.3 -3.18 72.15 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.974 -0.632 . . . . 8.42 112.452 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -135.41 124.42 24.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.767 0.318 . . . . 7.96 110.49 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.07 57.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 8.2 110.881 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.59 2.38 82.2 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.639 -0.709 . . . . 6.68 112.404 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 69.5 m95 -119.12 121.64 40.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.901 0.381 . . . . 5.83 111.443 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' TRP . . . . . 0.403 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 36.5 m0 -113.07 168.57 9.59 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.813 -0.81 . . . . 5.87 108.813 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -125.11 129.65 50.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 5.33 110.704 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.11 174.69 21.79 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.812 -0.709 . . . . 4.14 112.316 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.493 ' HB2' HD11 ' B' ' 34' ' ' ILE . 34.0 tt0 -125.7 133.25 52.2 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.225 0.536 . . . . 6.02 110.728 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 50' ' ' GLY . 28.6 tp -127.93 171.18 12.04 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.184 -0.916 . . . . 4.21 109.889 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.461 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 14.2 m120 -17.81 67.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.43 1.641 . . . . 5.39 115.43 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.6 -10.02 63.26 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 115.128 0.811 . . . . 5.53 115.128 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -109.94 154.41 23.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.15 0.975 . . . . 5.33 111.197 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.68 140.79 51.86 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.996 -0.742 . . . . 5.79 108.996 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.33 -176.03 42.38 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.012 -1.089 . . . . 3.35 113.358 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.82 152.72 15.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.432 0.158 . . . . 4.3 110.985 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 52.3 p90 -136.56 141.02 33.95 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.384 0.513 . . . . 3.72 112.384 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 95.2 Cg_endo -94.99 174.73 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.498 3.465 . . . . 3.97 111.275 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.566 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 24.2 m-20 75.43 -11.01 1.15 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.079 1.511 . . . . 5.85 115.079 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 56.33 76.63 0.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.829 -0.804 . . . . 5.67 108.829 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.1 m-85 -100.9 8.27 43.2 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.16 -0.927 . . . . 3.89 111.553 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.473 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -136.89 138.63 40.9 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.664 0.616 . . . . 3.89 112.664 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -113.42 127.17 70.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 4.64 111.296 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -54.47 108.23 0.36 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.851 0.358 . . . . 6.72 110.503 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.29 -36.37 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 6.54 110.934 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.38 -0.819 . . . . 7.43 110.746 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.01 0.433 . . . . 16.5 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -84.22 149.9 25.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.822 -0.626 . . . . 13.22 110.537 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -144.04 149.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 12.19 110.692 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.34 136.32 42.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 11.64 110.479 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 40.8 t -121.19 96.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.574 -0.528 . . . . 6.66 109.574 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 7' ' ' THR . 52.5 tttm -77.34 162.99 26.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.672 -0.694 . . . . 6.86 111.527 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.42 ' N ' ' CG ' ' A' ' 6' ' ' LYS . 56.8 p -142.16 160.99 39.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.467 -0.788 . . . . 3.79 110.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 8' ' ' LEU . 2.3 pt? -64.33 -22.76 67.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 5.48 111.175 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -81.82 -12.37 58.54 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.263 -0.426 . . . . 7.65 111.618 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 16.69 41.79 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.886 -0.673 . . . . 7.08 112.547 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -97.86 108.31 20.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.899 0.38 . . . . 6.58 111.354 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 p -100.06 126.01 46.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 6.95 110.256 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.427 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 36.1 pt -120.83 146.55 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.39 . . . . 5.97 111.253 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.5 p -97.06 140.46 31.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.87 -0.605 . . . . 8.28 111.123 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 29' ' ' LYS . 63.2 tp -138.4 149.7 45.79 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.247 -0.433 . . . . 10.02 110.258 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -109.46 103.79 12.75 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.872 0.323 . . . . 12.19 111.872 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -153.83 112.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.268 -0.424 . . . . 14.73 111.615 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.521 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 25.0 mt-10 -63.71 173.32 1.35 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.708 0.633 . . . . 18.57 112.708 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.588 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 50.7 Cg_exo -57.98 -42.35 59.08 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.333 2.688 . . . . 19.89 113.741 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.0 m -60.42 -23.99 64.83 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.039 0.385 . . . . 21.46 112.039 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.31 148.48 32.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.845 0.355 . . . . 18.56 111.276 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -92.74 145.87 24.08 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.107 -0.497 . . . . 20.15 111.14 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.42 HD13 ' O ' ' A' ' 54' ' ' ARG . 1.1 mp -55.82 -34.49 37.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 16.47 111.205 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.2 -41.07 98.02 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.894 -0.41 . . . . 19.99 109.894 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.22 -37.49 85.68 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.825 -0.625 . . . . 16.38 110.035 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 CA-C-N 116.152 -0.476 . . . . 13.8 110.037 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -58.61 -34.71 71.45 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.888 -0.597 . . . . 13.67 110.628 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 31' ' ' GLN . . . -68.23 -34.64 76.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 14.55 111.102 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HB3' HD11 ' A' ' 15' ' ' LEU . 79.7 mttt -73.71 -38.46 64.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 13.7 110.383 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.446 ' CG2' HD11 ' A' ' 36' ' ' ILE . 85.7 mt -65.01 -40.11 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 9.57 110.742 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 21.1 pt20 -69.72 -19.39 63.55 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.61 -0.268 . . . . 15.04 111.226 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -75.27 -35.33 61.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 12.47 110.467 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -93.1 -53.81 3.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.992 -0.549 . . . . 9.23 112.021 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.69 -11.62 55.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.842 0.682 . . . . 9.6 112.842 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 5.08 52.09 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.556 -0.83 . . . . 12.2 114.015 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.446 HD11 ' CG2' ' A' ' 30' ' ' ILE . 22.2 pt -79.82 128.91 72.67 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 117.355 0.578 . . . . 11.27 111.02 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.56 142.66 59.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.572 2.181 . . . . 14.23 112.738 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -24.66 64.74 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.881 2.387 . . . . 14.34 112.109 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.59 -24.9 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.894 -0.594 . . . . 16.96 111.142 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -108.59 -7.03 15.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.302 -0.408 . . . . 14.45 111.469 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -80.95 126.48 31.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 10.91 111.547 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -124.29 112.07 16.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 9.32 109.327 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.4 mp -98.06 124.59 42.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 10.56 111.16 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.523 HD12 HG21 ' B' ' 18' ' ' THR . 16.8 mm -113.71 131.52 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.833 -0.621 . . . . 9.75 110.646 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -147.53 119.22 8.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.616 . . . . 15.27 110.439 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.35 29.97 9.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.993 -0.549 . . . . 14.76 112.154 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.37 -3.69 76.48 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.426 -0.892 . . . . 12.99 113.239 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -114.84 146.84 40.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.803 0.335 . . . . 17.08 111.116 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -82.49 128.75 34.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 14.97 110.381 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.76 130.62 43.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 14.81 110.995 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.48 123.89 33.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.927 -0.578 . . . . 21.0 111.017 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -36.26 -57.18 0.74 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.992 -0.549 . . . . 18.5 111.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -52.93 -75.04 0.24 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.771 -0.728 . . . . 21.79 112.019 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.42 ' O ' HD13 ' A' ' 23' ' ' ILE . 29.5 mmt180 -29.17 158.11 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.911 1.078 . . . . 24.16 113.911 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -111.4 165.72 11.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.087 -0.96 . . . . 21.36 111.322 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.5 mm? -53.42 -32.48 49.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.189 -0.46 . . . . 18.41 111.86 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -70.05 -21.7 63.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.653 0.263 . . . . 21.76 111.5 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.97 -38.45 86.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 23.14 111.041 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -97.91 8.47 44.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 19.37 111.615 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 59.3 46.96 12.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.954 0.407 . . . . 22.24 111.137 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.03 107.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 17.93 110.912 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.66 -178.87 5.19 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.016 -0.538 . . . . 21.49 110.936 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.55 157.06 33.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.835 0.35 . . . . 19.19 111.124 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.2 24.95 14.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.809 -0.632 . . . . 16.92 111.684 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -85.78 161.18 19.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.712 0.292 . . . . 14.92 110.814 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.417 ' C ' HD12 ' A' ' 67' ' ' LEU . 4.5 t -116.73 126.85 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 11.29 110.84 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.6 mp -115.27 121.48 43.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 10.94 110.164 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -83.96 112.47 20.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.944 0.402 . . . . 8.09 111.778 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.403 HD21 HD12 ' A' ' 36' ' ' ILE . 65.4 tp -91.8 119.71 31.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 6.7 109.62 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 121.241 0.544 . . . . 7.13 112.346 -178.846 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.233 0.213 0 N-CA-C 108.834 -0.802 . . . . 7.56 108.834 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -124.76 159.92 29.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 7.84 111.828 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 16.8 m -141.14 146.35 36.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.186 -0.915 . . . . 4.73 110.569 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -100.47 133.23 45.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 4.43 110.199 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.3 m -73.85 127.13 32.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 2.72 110.913 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.8 mt -95.87 -22.1 17.66 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.144 0.424 . . . . 3.78 112.144 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -142.66 154.51 62.99 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 117.981 0.355 . . . . 4.88 111.614 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' B' ' 25' ' ' PHE . 74.2 Cg_endo -75.01 136.25 20.12 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.525 2.15 . . . . 3.11 112.913 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -139.16 129.12 25.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 4.0 109.883 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 31.8 m -110.84 121.35 45.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.85 0.357 . . . . 3.82 110.617 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.73 128.76 43.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.98 -0.629 . . . . 3.22 112.586 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.523 HG21 HD12 ' A' ' 44' ' ' ILE . 5.3 t -103.16 -23.07 13.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.182 0.515 . . . . 4.64 110.63 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -119.89 159.41 24.7 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.123 -0.944 . . . . 4.05 109.853 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.5 -29.13 69.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.386 0.513 . . . . 4.26 112.386 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -86.53 -2.64 58.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.945 -0.302 . . . . 4.22 111.682 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.55 160.17 16.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 3.77 111.281 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.602 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -117.24 165.46 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.246 -0.65 . . . . 3.13 109.246 178.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 61.7 m -115.42 128.65 56.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 2.46 110.187 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 10.8 m-85 -131.92 133.43 44.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.301 0.482 . . . . 2.49 112.301 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.53 176.26 5.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.826 -0.435 . . . . 6.21 109.826 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.21 136.68 35.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 3.87 110.323 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.79 55.42 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.571 -0.74 . . . . 4.23 111.318 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -100.13 179.72 4.4 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.877 1.066 . . . . 4.19 113.877 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.49 136.11 60.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.781 -1.554 . . . . 5.23 111.129 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.455 HD12 ' HB2' ' B' ' 60' ' ' ALA . 35.8 mt -132.86 133.09 59.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 4.64 111.207 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -90.21 126.49 35.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.58 -0.526 . . . . 7.14 109.58 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.531 ' C ' HD23 ' B' ' 33' ' ' LEU . 4.3 tt -73.47 102.08 3.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.995 0.426 . . . . 6.33 111.149 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 23.5 mm -84.08 -61.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.765 -0.652 . . . . 6.97 111.418 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.2 t -155.17 108.5 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.194 0.442 . . . . 7.03 112.194 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.475 ' HG3' HD21 ' B' ' 33' ' ' LEU . 38.3 mtmm -65.95 5.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.598 . . . . 7.52 111.722 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.44 101.07 7.39 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.535 0.207 . . . . 8.93 110.678 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.444 HG22 ' HB2' ' B' ' 45' ' ' LYS . 68.8 p -111.11 -4.38 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.449 -0.341 . . . . 7.05 111.184 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.18 -1.77 62.99 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.018 -0.611 . . . . 8.42 112.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.77 120.89 27.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.811 0.338 . . . . 7.96 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.79 56.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 8.2 110.962 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.63 1.56 85.41 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.826 -0.625 . . . . 6.68 112.421 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.408 ' HE1' ' HB3' ' A' ' 8' ' ' LEU . 83.6 m95 -123.31 120.39 32.95 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.289 0.544 . . . . 5.83 111.751 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' TRP . . . . . 0.565 ' HB2' ' CZ ' ' B' ' 55' ' ' PHE . 37.4 m0 -108.43 166.33 10.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.515 -0.766 . . . . 5.87 109.494 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.444 ' HB2' HG22 ' B' ' 38' ' ' THR . 45.4 tptt -117.28 131.64 56.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.959 0.409 . . . . 5.33 110.98 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.56 175.33 21.53 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.454 -0.794 . . . . 4.14 111.752 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.61 134.75 50.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.196 0.522 . . . . 6.02 110.629 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 50' ' ' GLY . 2.6 mt -130.9 171.73 12.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.105 -0.952 . . . . 4.21 110.159 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.446 ' ND2' HD22 ' B' ' 48' ' ' LEU . 11.8 m-80 -17.35 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.127 1.529 . . . . 5.39 115.127 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.54 -12.79 50.3 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 114.319 0.488 . . . . 5.53 114.319 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.07 133.79 54.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.314 0.557 . . . . 5.33 111.337 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.545 ' C ' HD23 ' B' ' 23' ' ' LEU . 11.5 pt-20 -107.11 146.72 30.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.958 -0.565 . . . . 5.79 110.344 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.51 -177.85 38.73 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.663 -0.78 . . . . 3.35 112.855 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.406 ' CG1' HG21 ' B' ' 38' ' ' THR . 34.8 m -112.99 160.51 12.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.453 0.538 . . . . 4.3 112.453 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' B' ' 44' ' ' TRP . 3.0 p90 -124.79 157.49 65.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.375 -0.83 . . . . 3.72 110.807 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.03 123.02 2.65 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.69 2.26 . . . . 3.97 115.865 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p30 51.02 45.02 28.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.638 1.347 . . . . 5.85 114.638 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 m120 62.7 88.64 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.772 1.027 . . . . 5.67 113.772 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.1 16.26 27.1 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.908 -0.775 . . . . 3.89 108.908 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 9' ' ' CYS . . . -142.64 138.49 30.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.81 0.3 . . . . 3.89 111.81 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.5 p -110.17 120.77 61.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 116.352 -0.385 . . . . 4.64 111.323 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.452 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 34.1 tt0 -51.51 150.86 3.43 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 121.023 0.44 . . . . 6.72 111.062 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.98 -37.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.671 . . . . 6.54 110.403 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.237 -0.887 . . . . 7.43 110.55 179.668 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttt . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.92 0.391 . . . . 16.5 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -82.93 152.7 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.587 . . . . 13.22 109.916 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 pt -145.32 150.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 12.19 110.249 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -102.73 135.15 44.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.189 -0.46 . . . . 11.64 110.691 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.37 99.4 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.327 -0.62 . . . . 6.66 109.327 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HG2' ' CG2' ' A' ' 12' ' ' THR . 6.7 tmtt? -86.81 111.78 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 6.86 111.663 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.2 p -84.83 -178.48 6.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 3.79 110.699 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 9' ' ' THR . 2.6 pp -85.93 -10.65 54.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.546 -0.297 . . . . 5.48 111.68 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.44 ' N ' HD12 ' A' ' 8' ' ' LEU . 8.8 t -97.29 21.06 10.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.928 0.394 . . . . 7.65 110.684 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.62 13.09 65.26 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.911 -0.662 . . . . 7.08 112.377 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -96.1 112.05 23.9 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.054 0.454 . . . . 6.58 111.933 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.418 ' CG2' ' HG2' ' A' ' 6' ' ' LYS . 31.4 p -104.28 122.39 45.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.647 -0.706 . . . . 6.95 110.012 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.1 pt -114.75 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.382 . . . . 5.97 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.5 p -87.72 135.31 33.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 8.28 110.36 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tp -134.67 146.45 49.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 10.02 110.556 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -102.67 130.92 49.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 12.19 110.498 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.76 -174.21 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.167 0.508 . . . . 14.73 111.575 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -138.97 145.95 47.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 18.57 109.044 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.09 -23.18 12.07 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.332 2.021 . . . . 19.89 112.709 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -87.85 -23.85 23.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 21.46 111.753 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.33 150.92 4.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.875 0.369 . . . . 18.56 111.656 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -96.49 140.71 30.73 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.931 -0.577 . . . . 20.15 111.259 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.4 HD12 HD13 ' A' ' 50' ' ' LEU . 50.7 mm -49.55 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.091 -0.504 . . . . 16.47 111.164 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.08 -41.06 78.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.87 0.367 . . . . 19.99 110.153 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -69.29 -35.55 76.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 16.38 110.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.05 -45.36 98.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.153 -0.476 . . . . 13.8 110.573 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -59.84 -37.19 78.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 13.67 110.826 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.01 66.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 14.55 110.82 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.21 -41.13 83.38 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.174 -0.676 . . . . 13.7 109.174 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.477 HD12 ' OE1' ' A' ' 41' ' ' GLN . 96.4 mt -67.25 -37.79 79.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.353 -0.84 . . . . 9.57 110.546 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 60.2 tt0 -61.63 -33.97 74.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.024 -0.535 . . . . 15.04 110.84 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -56.86 -27.11 59.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 12.47 110.074 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -99.85 -71.03 0.71 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.861 -0.609 . . . . 9.23 112.608 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.68 -10.98 60.25 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.537 0.569 . . . . 9.6 112.537 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 63.26 7.29 17.78 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.595 -0.812 . . . . 12.2 113.305 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 36' ' ' ILE . 23.5 pt -71.9 122.22 86.69 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.798 0.299 . . . . 11.27 111.017 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.56 142.76 70.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.405 2.07 . . . . 14.23 111.873 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.15 -25.32 43.55 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.712 2.275 . . . . 14.34 112.837 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.71 -23.62 66.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.918 0.71 . . . . 16.96 112.918 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -107.92 -5.62 17.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.612 . . . . 14.45 109.349 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.477 ' OE1' HD12 ' A' ' 30' ' ' ILE . 7.4 tt0 -83.14 100.93 10.85 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.247 -0.888 . . . . 10.91 110.888 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.455 ' HE ' ' N ' ' A' ' 43' ' ' LEU . 6.4 tpm_? -100.35 113.58 26.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.485 -0.932 . . . . 9.32 108.485 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.455 ' N ' ' HE ' ' A' ' 42' ' ' ARG . 61.9 mt -98.8 120.11 38.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.901 0.381 . . . . 10.56 110.887 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.666 HD12 HG21 ' B' ' 18' ' ' THR . 24.5 mm -109.43 137.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.681 -0.69 . . . . 9.75 110.367 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.502 ' HB3' HD21 ' A' ' 50' ' ' LEU . 62.5 t80 -156.47 132.34 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 15.27 111.182 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.72 6.23 2.58 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.837 -0.62 . . . . 14.76 111.87 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.41 -4.02 40.32 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.903 -0.665 . . . . 12.99 112.995 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' B' ' 18' ' ' THR . 55.0 tptt -122.01 152.16 40.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.747 0.308 . . . . 17.08 110.663 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -81.43 119.98 24.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 14.97 110.574 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 45' ' ' PHE . 84.1 mt -57.85 128.81 38.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.321 -0.4 . . . . 14.81 110.5 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 40.2 tt0 -81.08 124.97 29.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.323 -0.398 . . . . 21.0 109.986 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.47 -33.05 13.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.826 -0.624 . . . . 18.5 112.603 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -88.98 5.99 84.07 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.997 0.759 . . . . 21.79 114.997 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -105.55 173.04 6.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.672 0.736 . . . . 24.16 111.463 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -109.59 155.57 21.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.128 -0.487 . . . . 21.36 110.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.7 mt -53.97 -16.32 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 18.41 111.795 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -78.93 -26.01 43.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.647 0.26 . . . . 21.76 111.531 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.8 -36.98 84.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.39 -0.368 . . . . 23.14 110.765 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -99.44 12.23 36.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.155 -0.475 . . . . 19.37 111.878 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 m120 57.07 27.45 13.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.846 0.355 . . . . 22.24 111.416 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.453 HG12 ' CE2' ' A' ' 45' ' ' PHE . 98.1 mt -68.61 108.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.294 -0.412 . . . . 17.93 111.541 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.37 -179.54 4.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.207 -0.451 . . . . 21.49 111.108 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.37 156.77 28.17 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.949 0.404 . . . . 19.19 111.51 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 58.33 28.88 17.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.765 -0.652 . . . . 16.92 111.461 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 p -88.14 150.86 23.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 14.92 110.686 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.5 t -101.83 121.48 42.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 11.29 110.849 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.7 mp -110.82 117.17 32.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 10.94 109.864 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.413 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 17.6 m-70 -79.3 109.3 13.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 8.09 112.074 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -92.55 115.12 27.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.076 -0.511 . . . . 6.7 110.399 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 7.13 111.466 -179.347 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.232 0.177 0 N-CA-C 109.252 -0.648 . . . . 7.56 109.252 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -127.42 158.58 36.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.302 0.572 . . . . 7.84 112.063 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.533 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 24.0 p -145.22 145.78 31.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.023 -0.99 . . . . 4.73 110.581 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -101.76 137.15 40.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.824 0.345 . . . . 4.43 110.555 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -76.87 126.0 30.24 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.106 -0.497 . . . . 2.72 111.467 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 39.0 mt -88.73 -20.87 24.24 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.86 0.319 . . . . 3.78 111.86 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -147.37 156.73 45.97 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 121.052 -0.259 . . . . 4.88 111.399 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 138.47 29.24 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.48 2.12 . . . . 3.11 112.378 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 69.2 t80 -136.74 130.55 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.489 -0.778 . . . . 4.0 110.801 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.469 ' HA ' HG23 ' B' ' 24' ' ' THR . 34.2 m -111.83 119.56 38.99 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.884 0.373 . . . . 3.82 111.034 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.72 142.28 48.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.816 -0.629 . . . . 3.22 112.319 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.666 HG21 HD12 ' A' ' 44' ' ' ILE . 73.9 p -111.14 -22.24 11.53 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.95 0.405 . . . . 4.64 111.534 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -117.45 160.56 20.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.698 -0.683 . . . . 4.05 110.206 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -33.46 75.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 4.26 111.652 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -84.77 -4.26 58.97 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.834 0.35 . . . . 4.22 110.952 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -81.74 153.88 26.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.068 -0.515 . . . . 3.77 110.557 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' B' ' 48' ' ' LEU . 0.5 OUTLIER -104.43 144.05 32.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.961 -0.755 . . . . 3.13 108.961 178.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.469 HG23 ' HA ' ' B' ' 16' ' ' THR . 99.8 m -114.81 121.94 44.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.767 -0.651 . . . . 2.46 110.172 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' B' ' 15' ' ' TYR . 31.9 p90 -138.57 153.41 48.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.833 0.679 . . . . 2.49 112.833 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -109.52 -179.59 3.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.839 -0.43 . . . . 6.21 109.839 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.5 135.45 35.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.114 0.483 . . . . 3.87 109.842 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.03 31.97 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.524 -1.03 . . . . 4.23 110.524 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -96.79 178.69 5.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.793 0.806 . . . . 4.19 113.001 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.7 mm -135.76 114.16 15.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 113.763 -1.562 . . . . 5.23 111.245 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.07 139.58 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 4.64 110.861 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' B' ' 32' ' ' HIS . 7.2 m170 -91.68 128.81 37.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.456 -0.572 . . . . 7.14 109.456 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.443 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.9 tt -72.08 98.7 2.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 6.33 110.58 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.3 mm -79.54 -63.11 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 6.97 111.125 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -157.97 110.13 2.33 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.824 0.676 . . . . 7.03 112.824 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.438 ' O ' HG23 ' B' ' 38' ' ' THR . 58.6 mtmt -56.29 -69.81 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.999 -0.741 . . . . 7.52 108.999 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.51 98.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.426 -0.352 . . . . 8.93 111.394 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 36' ' ' LYS . 23.7 p -111.37 -5.3 14.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.34 -0.391 . . . . 7.05 111.104 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.27 -8.36 72.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.81 -0.71 . . . . 8.42 111.649 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.24 120.43 31.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.812 0.339 . . . . 7.96 110.656 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.31 55.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.496 . . . . 8.2 111.35 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 -0.7 83.72 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.807 -0.633 . . . . 6.68 112.675 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -121.63 127.37 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.333 0.566 . . . . 5.83 112.088 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' TRP . . . . . 0.57 ' HB2' ' CE2' ' B' ' 55' ' ' PHE . 23.2 m0 -113.88 162.15 16.72 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.285 -0.871 . . . . 5.87 109.201 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -114.19 131.25 56.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.086 0.469 . . . . 5.33 110.89 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.83 174.73 22.22 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.454 -0.794 . . . . 4.14 112.073 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.26 132.81 52.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.143 0.497 . . . . 6.02 110.272 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 50' ' ' GLY . 19.8 tp -129.81 170.28 14.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.192 -0.913 . . . . 4.21 109.755 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.471 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 67.7 m-20 -17.7 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.33 1.604 . . . . 5.39 115.33 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.4 -12.57 54.94 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.545 0.578 . . . . 5.53 114.545 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -119.5 134.36 55.25 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.461 0.63 . . . . 5.33 111.105 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.46 146.5 31.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.07 -0.514 . . . . 5.79 110.18 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.47 -177.48 41.93 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.541 -0.838 . . . . 3.35 112.55 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.98 160.99 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 112.126 0.417 . . . . 4.3 112.126 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' B' ' 44' ' ' TRP . 2.7 p90 -124.79 149.55 62.97 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.665 -0.698 . . . . 3.72 111.106 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.69 122.4 5.45 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.828 2.352 . . . . 3.97 115.171 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 51.26 43.76 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 114.171 1.174 . . . . 5.85 114.171 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.48 92.26 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.166 1.172 . . . . 5.67 114.166 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -102.84 17.52 23.72 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.425 -0.954 . . . . 3.89 108.425 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.533 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -146.26 138.2 24.96 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.591 0.219 . . . . 3.89 111.591 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 p -109.11 121.59 62.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.498 -0.319 . . . . 4.64 111.336 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.45 155.93 3.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.82 0.343 . . . . 6.72 110.594 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.87 -51.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 6.54 110.639 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.301 -0.856 . . . . 7.43 110.714 -179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.724 0.297 . . . . 16.5 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -84.58 148.03 26.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 13.22 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.4 pt -139.52 154.77 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.632 . . . . 12.19 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.87 134.57 53.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.023 -0.535 . . . . 11.64 110.376 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.8 t -118.16 100.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.376 -0.601 . . . . 6.66 109.376 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 14.5 tmtt? -88.82 131.2 35.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 6.86 112.155 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -106.08 163.17 12.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.252 -0.885 . . . . 3.79 110.841 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.74 -21.97 66.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.275 -0.421 . . . . 5.48 111.348 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 t -81.23 -8.51 59.76 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.382 -0.372 . . . . 7.65 111.18 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.1 54.99 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.179 -0.534 . . . . 7.08 112.965 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -97.0 108.58 21.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 6.58 111.337 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p -99.93 124.33 45.15 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.928 -0.578 . . . . 6.95 110.261 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.57 143.85 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.368 . . . . 5.97 111.185 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.1 m -98.13 135.66 39.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.865 -0.607 . . . . 8.28 110.786 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.89 152.95 52.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 10.02 110.985 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.48 121.01 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 12.19 109.753 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.444 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.5 m -140.12 -178.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.086 0.469 . . . . 14.73 111.446 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.44 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 38.8 tt0 -145.63 146.28 28.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.49 -0.777 . . . . 18.57 109.873 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 72.2 Cg_exo -50.47 -26.4 16.3 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 19.89 112.91 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 m -85.64 -23.85 27.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.323 -0.399 . . . . 21.46 111.28 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.6 148.96 8.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.381 . . . . 18.56 111.392 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 m -95.85 144.19 26.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.904 -0.589 . . . . 20.15 111.139 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.603 HD12 HD23 ' A' ' 50' ' ' LEU . 24.0 mm -51.86 -44.58 37.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.132 -0.485 . . . . 16.47 111.433 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.18 -38.06 67.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.853 0.359 . . . . 19.99 110.329 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -68.07 -38.84 82.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.556 . . . . 16.38 110.087 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -58.99 -48.57 86.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.144 -0.48 . . . . 13.8 110.416 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.75 -32.67 71.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.05 -0.523 . . . . 13.67 110.885 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.19 78.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.147 -0.479 . . . . 14.55 110.351 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' A' ' 17' ' ' VAL . 36.9 mtmm -70.09 -42.75 72.31 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 13.7 110.228 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.615 ' CG2' HD11 ' A' ' 36' ' ' ILE . 86.3 mt -61.05 -41.46 89.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.093 0.473 . . . . 9.57 109.985 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -32.87 74.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.819 -0.628 . . . . 15.04 110.989 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -66.12 -35.91 81.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 12.47 111.402 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.32 -59.25 2.13 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.399 0.518 . . . . 9.23 112.399 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.451 ' OE2' HD13 ' A' ' 36' ' ' ILE . 32.1 tt0 -81.66 -11.41 59.09 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.999 0.74 . . . . 9.6 112.999 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.83 -21.11 4.91 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.636 -0.792 . . . . 12.2 114.454 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.615 HD11 ' CG2' ' A' ' 30' ' ' ILE . 13.8 pt -54.54 135.49 62.92 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 117.469 0.634 . . . . 11.27 111.92 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 89.9 Cg_endo -78.98 135.41 12.4 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.819 2.346 . . . . 14.23 112.468 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.3 Cg_exo -54.33 -27.16 46.95 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.799 2.333 . . . . 14.34 112.965 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.51 -24.11 67.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.427 -0.351 . . . . 16.96 111.339 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -110.79 -5.16 15.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 14.45 111.363 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -80.93 128.09 33.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 10.91 111.495 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 42' ' ' ARG . 27.9 ttt-85 -125.18 114.21 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.18 -0.674 . . . . 9.32 109.18 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -101.94 126.54 48.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 10.56 110.858 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.85 134.39 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 9.75 110.893 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CB ' HD11 ' A' ' 50' ' ' LEU . 83.0 t80 -151.53 123.14 7.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.585 -0.734 . . . . 15.27 110.187 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 69.35 18.55 7.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.803 -0.635 . . . . 14.76 111.614 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.55 -12.07 70.63 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.704 -0.76 . . . . 12.99 112.678 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -107.72 148.49 29.36 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.05 0.452 . . . . 17.08 111.442 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -82.45 129.26 34.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.727 -0.669 . . . . 14.97 110.096 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.603 HD23 HD12 ' A' ' 23' ' ' ILE . 6.8 mp -67.97 130.87 44.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 14.81 111.225 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HB2' ' CG ' ' A' ' 54' ' ' ARG . 11.5 mm-40 -86.74 128.54 35.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 21.0 110.41 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.9 m-20 -52.03 -31.48 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.747 -0.66 . . . . 18.5 112.759 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.53 3.76 85.17 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.736 -0.745 . . . . 21.79 113.867 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' CG ' ' HB2' ' A' ' 51' ' ' GLU . 34.6 mmt180 -103.15 177.44 4.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.992 0.396 . . . . 24.16 110.829 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -123.16 160.5 26.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.364 . . . . 21.36 111.087 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -51.91 -31.01 26.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 18.41 111.753 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 p -71.04 -25.85 62.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.735 0.272 . . . . 21.76 111.735 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.81 -37.52 87.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.647 0.26 . . . . 23.14 111.059 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.91 7.46 46.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 19.37 111.829 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 61.97 36.27 15.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.864 0.364 . . . . 22.24 111.54 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -78.65 107.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 17.93 111.272 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -95.21 -179.14 4.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.224 -0.444 . . . . 21.49 111.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.06 155.34 24.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.108 -0.496 . . . . 19.19 111.936 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 58.48 31.11 20.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.686 -0.688 . . . . 16.92 111.455 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -86.19 158.26 19.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 14.92 110.631 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 t -114.26 125.33 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 11.29 110.728 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -115.09 122.59 46.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.902 -0.59 . . . . 10.94 110.229 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.69 111.66 20.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.904 0.383 . . . . 8.09 111.611 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -92.34 115.0 27.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.032 -0.531 . . . . 6.7 109.807 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.332 -0.159 0 N-CA-C 112.271 0.471 . . . . 7.13 112.271 -178.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.444 -0.576 . . . . 7.56 109.444 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.9 160.05 33.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.327 0.584 . . . . 7.84 112.056 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.524 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 32.5 m -141.49 146.93 37.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.982 -1.008 . . . . 4.73 110.201 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -102.04 143.79 31.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.829 0.347 . . . . 4.43 111.078 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.5 m -82.01 123.64 29.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.999 -0.546 . . . . 2.72 111.515 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.37 -20.68 22.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.923 0.342 . . . . 3.78 111.923 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' B' ' 14' ' ' PRO . 30.6 t80 -154.94 144.64 15.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 117.921 0.328 . . . . 4.88 111.02 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' B' ' 13' ' ' PHE . 32.3 Cg_exo -59.45 138.46 84.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.416 2.077 . . . . 3.11 112.608 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.567 ' CZ ' ' HD3' ' B' ' 56' ' ' PRO . 29.2 t80 -133.72 131.1 39.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.687 -0.688 . . . . 4.0 110.839 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.614 ' HA ' HG23 ' B' ' 24' ' ' THR . 54.5 m -111.89 117.92 34.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.989 0.423 . . . . 3.82 111.049 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.45 138.01 47.19 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.973 -0.632 . . . . 3.22 112.366 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 15.7 m -104.51 -21.44 13.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.352 0.596 . . . . 4.64 110.241 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -118.46 156.06 29.69 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.948 -1.024 . . . . 4.05 109.861 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.72 -38.62 91.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 4.26 111.186 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.8 -3.21 33.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.809 0.338 . . . . 4.22 110.963 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -88.65 160.98 17.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 3.77 110.919 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' B' ' 48' ' ' LEU . 0.6 OUTLIER -103.87 140.66 37.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.542 -0.54 . . . . 3.13 109.542 178.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.614 HG23 ' HA ' ' B' ' 16' ' ' THR . 56.0 m -116.07 121.73 43.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.297 -0.865 . . . . 2.46 109.992 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.587 ' HB3' HD22 ' B' ' 48' ' ' LEU . 17.8 p90 -140.23 159.06 43.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.913 0.709 . . . . 2.49 112.913 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.558 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 81.4 mtt-85 -109.74 179.36 4.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.328 -0.249 . . . . 6.21 110.328 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -82.23 140.53 33.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.051 0.453 . . . . 3.87 110.048 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.61 21.87 49.23 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.602 -0.999 . . . . 4.23 110.602 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.558 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 5.3 mm-40 -97.96 179.45 4.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.471 0.915 . . . . 4.19 113.471 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -130.5 123.56 55.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.821 -1.536 . . . . 5.23 111.417 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -122.07 135.67 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.725 -0.671 . . . . 4.64 111.191 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.48 132.72 42.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.703 -0.481 . . . . 7.14 109.703 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.459 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.3 tt -72.98 100.46 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 6.33 110.798 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.18 -62.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.554 -0.748 . . . . 6.97 110.824 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.5 m -158.37 110.11 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.647 0.61 . . . . 7.03 112.647 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.712 ' O ' HG23 ' B' ' 38' ' ' THR . 35.0 mtmt -57.91 -71.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.383 -0.599 . . . . 7.52 109.383 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -45.72 94.43 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.325 -0.398 . . . . 8.93 111.502 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.712 HG23 ' O ' ' B' ' 36' ' ' LYS . 68.6 p -106.58 -9.02 16.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.241 -0.436 . . . . 7.05 111.051 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.29 -5.0 62.68 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.909 -0.662 . . . . 8.42 112.345 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -129.98 120.79 25.34 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.873 0.368 . . . . 7.96 110.554 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 133.3 55.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.57 . . . . 8.2 111.61 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 -0.64 85.48 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.586 -0.734 . . . . 6.68 112.699 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.412 ' CH2' ' HB3' ' B' ' 56' ' ' PRO . 79.6 m95 -121.86 123.6 42.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.324 0.562 . . . . 5.83 111.799 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' TRP . . . . . 0.558 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 21.8 m0 -110.32 172.11 7.06 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.504 -0.771 . . . . 5.87 109.322 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -125.39 130.61 52.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 5.33 110.905 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.2 176.31 21.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.488 -0.778 . . . . 4.14 111.77 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -124.7 133.79 53.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.303 0.573 . . . . 6.02 110.207 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.677 ' O ' ' N ' ' B' ' 50' ' ' GLY . 27.3 tp -129.56 170.1 14.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.098 -0.955 . . . . 4.21 109.778 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.507 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 31.5 p-10 -17.58 63.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.126 1.528 . . . . 5.39 115.126 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.61 -12.37 52.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 114.429 0.532 . . . . 5.53 114.429 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.32 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.545 0.672 . . . . 5.33 111.068 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' B' ' 52' ' ' GLU . 0.0 OUTLIER -112.27 146.18 38.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.07 -0.514 . . . . 5.79 110.506 179.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . 0.431 ' N ' ' HG ' ' B' ' 23' ' ' LEU . . . -174.74 -176.06 42.75 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.666 -0.778 . . . . 3.35 113.017 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -113.5 160.47 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 112.51 0.559 . . . . 4.3 112.51 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 6.2 p90 -125.19 148.49 60.79 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.563 -0.744 . . . . 3.72 110.976 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.567 ' HD3' ' CZ ' ' B' ' 15' ' ' TYR . 89.2 Cg_endo -79.05 123.24 5.59 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.035 2.49 . . . . 3.97 115.369 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 52.32 43.55 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.553 1.316 . . . . 5.85 114.553 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ASN . . . . . 0.613 HD22 ' N ' ' B' ' 58' ' ' ASN . 0.8 OUTLIER 60.52 93.55 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.692 1.367 . . . . 5.67 114.692 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.27 12.8 35.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.748 -0.834 . . . . 3.89 108.748 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.6 29.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 3.89 111.622 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.46 126.99 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.501 -0.318 . . . . 4.64 111.823 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.524 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 53.6 tt0 -59.37 140.69 55.87 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 110.167 -0.309 . . . . 6.72 110.167 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 56.3 mt -101.63 -60.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 6.54 110.705 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.149 -0.929 . . . . 7.43 110.76 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.877 0.37 . . . . 16.5 111.011 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -79.24 149.03 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.837 -0.62 . . . . 13.22 110.544 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.0 pt -142.94 147.88 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 12.19 110.678 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -97.55 137.24 36.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 11.64 110.597 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.41 91.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.573 -0.529 . . . . 6.66 109.573 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 7' ' ' THR . 61.7 tttm -77.03 164.29 25.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.916 -0.584 . . . . 6.86 111.425 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.427 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.8 m -143.57 159.43 42.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.427 -0.806 . . . . 3.79 110.041 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.418 ' N ' HG22 ' A' ' 7' ' ' THR . 3.4 pp -62.31 -22.37 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 5.48 111.37 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -81.75 -13.7 57.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.369 . . . . 7.65 111.272 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.98 47.63 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.057 -0.592 . . . . 7.08 112.468 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -93.59 111.31 22.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 6.58 111.492 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.03 125.0 44.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.759 -0.655 . . . . 6.95 110.134 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -117.01 142.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.384 . . . . 5.97 111.215 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.9 p -97.79 139.12 34.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 8.28 110.704 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 16' ' ' GLU . 59.3 tp -139.89 150.77 45.0 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.548 -0.296 . . . . 10.02 110.524 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.431 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -111.92 106.31 14.97 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.569 -0.287 . . . . 12.19 111.373 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.65 113.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.216 -0.447 . . . . 14.73 111.299 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 14.6 mp0 -60.78 172.15 0.91 Allowed Pre-proline 0 N--CA 1.467 0.408 0 N-CA-C 112.89 0.7 . . . . 18.57 112.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 41.2 Cg_exo -59.45 -39.74 73.33 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.32 2.68 . . . . 19.89 113.251 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.9 p -61.61 -26.2 67.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.38 -0.373 . . . . 21.46 111.759 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.04 151.26 9.23 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.921 0.391 . . . . 18.56 111.646 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -95.24 149.46 21.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.837 -0.62 . . . . 20.15 110.841 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 HD13 ' A' ' 50' ' ' LEU . 45.6 mm -58.62 -37.66 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 16.47 111.1 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.63 -40.48 92.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.902 0.382 . . . . 19.99 109.995 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.99 -41.8 95.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.935 -0.575 . . . . 16.38 110.013 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.65 -47.22 82.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.994 -0.548 . . . . 13.8 110.464 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -60.55 -36.37 78.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.922 -0.581 . . . . 13.67 110.541 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.86 84.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.03 -0.532 . . . . 14.55 110.375 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -65.44 -49.81 67.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.926 -0.579 . . . . 13.7 110.028 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.56 ' CG2' HD11 ' A' ' 36' ' ' ILE . 84.5 mt -57.55 -40.5 75.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.959 -0.564 . . . . 9.57 110.457 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -63.76 -30.09 71.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.037 -0.529 . . . . 15.04 111.025 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.59 -38.51 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 12.47 111.235 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -90.13 -59.93 2.06 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.087 0.403 . . . . 9.23 112.087 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HG3' HG23 ' A' ' 36' ' ' ILE . 9.3 tp10 -78.8 -11.93 60.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.022 0.749 . . . . 9.6 113.022 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.0 -17.71 4.51 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.537 -0.84 . . . . 12.2 114.213 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.56 HD11 ' CG2' ' A' ' 30' ' ' ILE . 16.5 pt -59.43 132.0 88.12 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 117.337 0.569 . . . . 11.27 112.043 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.79 144.38 38.94 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 14.23 112.231 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.88 -22.26 63.35 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.745 2.297 . . . . 14.34 112.374 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.59 -25.49 66.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 16.96 111.176 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -106.25 -13.11 15.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.358 -0.383 . . . . 14.45 111.42 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -73.59 132.8 43.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.12 0.486 . . . . 10.91 111.954 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 61.7 mtp180 -127.73 114.5 17.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.356 -0.838 . . . . 9.32 109.156 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB3' HD12 ' A' ' 50' ' ' LEU . 9.6 mp -101.3 122.16 43.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.836 0.351 . . . . 10.56 110.907 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 18.7 mm -113.3 133.17 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.899 -0.591 . . . . 9.75 110.442 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HB3' HD21 ' A' ' 50' ' ' LEU . 60.6 t80 -151.06 124.28 8.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 15.27 110.578 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.77 19.35 11.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 14.76 111.967 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.57 80.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.566 -0.826 . . . . 12.99 112.97 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.21 147.92 42.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.745 0.307 . . . . 17.08 110.729 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -81.88 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 14.97 110.3 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD13 HD12 ' A' ' 23' ' ' ILE . 68.3 mt -68.4 133.23 48.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 14.81 111.183 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.87 126.75 35.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.833 -0.621 . . . . 21.0 110.515 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.34 -35.03 25.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.921 -0.581 . . . . 18.5 112.351 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.7 1.87 88.02 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.954 -0.641 . . . . 21.79 114.273 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.78 177.64 4.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.172 0.486 . . . . 24.16 110.977 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -122.4 158.7 29.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.333 -0.394 . . . . 21.36 110.952 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.6 mm? -52.24 -24.29 7.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 18.41 111.744 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.7 m -75.04 -25.56 58.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.629 0.252 . . . . 21.76 111.515 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.18 -41.8 96.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 23.14 111.123 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -94.75 10.43 35.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.304 -0.407 . . . . 19.37 111.665 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 56.37 42.91 27.06 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.062 0.458 . . . . 22.24 111.207 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.4 HG12 ' CE2' ' A' ' 45' ' ' PHE . 73.9 mt -85.49 104.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 17.93 111.198 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -91.56 178.03 6.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.14 -0.482 . . . . 21.49 111.313 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -60.5 155.29 18.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.987 -0.552 . . . . 19.19 111.585 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 60.51 33.46 20.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.843 -0.617 . . . . 16.92 111.364 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 p -92.04 157.61 16.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 14.92 110.649 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.501 ' C ' HD12 ' A' ' 67' ' ' LEU . 5.1 t -113.74 124.4 52.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 11.29 110.712 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 66' ' ' THR . 8.1 mp -115.89 119.41 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 10.94 110.4 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 58.2 t-80 -77.99 120.87 23.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.381 -0.372 . . . . 8.09 111.148 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.51 109.75 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 6.7 111.273 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 19.4 t -92.44 123.72 44.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 7.13 109.962 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.9 mt -123.49 131.47 53.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 8.31 111.059 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 53.95 87.44 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.844 -0.616 . . . . 14.22 110.609 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.9 tp -87.03 87.2 7.4 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.155 -0.475 . . . . 13.68 110.722 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -81.55 -22.9 37.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 20.03 110.85 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.67 -110.91 0.56 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.898 -0.667 . . . . 17.34 112.118 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.418 -1.212 . . . . 17.6 112.414 179.707 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.854 0.359 . . . . 9.15 110.899 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -165.69 116.98 1.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.943 -0.572 . . . . 10.58 109.533 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -133.38 102.64 5.61 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.661 -0.699 . . . . 7.56 109.734 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . 0.427 ' H ' ' HB2' ' B' ' 64' ' ' SER . 20.0 m-85 -124.05 172.08 9.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.07 -0.513 . . . . 7.84 110.745 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.577 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 35.1 m -142.27 149.09 39.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 4.73 111.027 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -99.51 138.0 37.21 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.519 -0.309 . . . . 4.43 110.456 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -78.54 123.46 27.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.497 -0.32 . . . . 2.72 110.856 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.54 -21.31 19.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.331 0.493 . . . . 3.78 112.331 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' B' ' 14' ' ' PRO . 75.5 m-85 -145.84 155.01 52.11 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 117.954 0.343 . . . . 4.88 111.409 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 13' ' ' PHE . 6.8 Cg_exo -72.11 136.42 26.99 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.518 2.145 . . . . 3.11 112.728 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -137.96 127.68 25.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.889 -1.05 . . . . 4.0 109.539 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.2 m -112.06 121.67 45.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 3.82 111.322 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.85 143.71 48.74 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.744 -0.741 . . . . 3.22 111.926 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 44' ' ' ILE . 41.1 p -107.17 -18.63 13.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.519 . . . . 4.64 110.825 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -119.49 159.11 24.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 4.05 110.222 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.51 -30.65 71.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 4.26 111.357 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.31 -5.88 59.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 4.22 111.012 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -81.76 157.65 24.44 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.146 -0.479 . . . . 3.77 110.988 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.555 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 2.7 mt -110.59 151.61 27.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.626 -0.509 . . . . 3.13 109.626 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -115.72 129.23 56.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.328 -0.396 . . . . 2.46 110.468 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 29.9 m-85 -130.6 133.8 46.46 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.263 0.468 . . . . 2.49 112.263 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.531 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 97.7 mtt180 -104.04 175.24 5.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.763 -0.458 . . . . 6.21 109.763 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -81.5 134.44 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 3.87 110.006 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.01 20.17 50.77 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 110.925 -0.87 . . . . 4.23 110.925 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.2 mm-40 -98.42 179.42 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.423 0.898 . . . . 4.19 113.423 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 mm -131.34 113.55 23.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.76 -1.564 . . . . 5.23 111.233 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' B' ' 60' ' ' ALA . 42.6 mt -106.89 129.41 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 4.64 110.677 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -89.96 127.27 36.0 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.894 -0.41 . . . . 7.14 109.894 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.28 128.04 34.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.044 0.45 . . . . 6.33 110.923 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.41 -48.97 6.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 6.97 110.785 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 79.3 p -167.06 113.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 7.03 111.983 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -69.32 5.11 1.39 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.907 -0.588 . . . . 7.52 111.32 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -121.85 101.89 7.85 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 116.63 -0.259 . . . . 8.93 110.305 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.476 HG22 ' HB2' ' B' ' 45' ' ' LYS . 30.5 p -112.33 -2.96 14.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.454 -0.339 . . . . 7.05 111.752 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.03 -5.14 78.68 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.685 . . . . 8.42 112.014 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -125.99 119.7 28.38 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 7.96 110.39 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.411 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -58.56 132.46 53.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 8.2 111.302 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.32 -0.46 85.53 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.9 -0.591 . . . . 6.68 112.704 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.492 ' CE3' HG23 ' B' ' 54' ' ' VAL . 77.6 m95 -122.92 123.74 41.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.454 0.627 . . . . 5.83 112.016 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' TRP . . . . . 0.555 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 19.4 m0 -109.66 165.15 11.9 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.477 -0.783 . . . . 5.87 109.428 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.476 ' HB2' HG22 ' B' ' 38' ' ' THR . 64.0 tttp -115.91 131.72 56.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.021 0.439 . . . . 5.33 110.965 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.7 174.82 21.86 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.411 -0.813 . . . . 4.14 111.717 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.05 133.36 52.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.291 0.567 . . . . 6.02 110.364 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' B' ' 50' ' ' GLY . 11.8 tp -130.06 170.99 13.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.929 -1.032 . . . . 4.21 109.675 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.475 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 60.3 m-20 -17.69 64.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.424 1.638 . . . . 5.39 115.424 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 82.97 -10.4 57.87 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 114.732 0.653 . . . . 5.53 114.732 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -118.93 143.39 47.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.544 0.672 . . . . 5.33 111.099 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.05 142.85 46.08 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.055 -0.52 . . . . 5.79 110.585 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . 0.478 ' H ' HD12 ' B' ' 23' ' ' LEU . . . -169.34 -179.19 41.1 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.943 -0.646 . . . . 3.35 112.481 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.492 HG23 ' CE3' ' B' ' 43' ' ' TRP . 33.7 m -113.44 163.36 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 112.441 0.534 . . . . 4.3 112.441 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 3.3 p90 -124.57 152.92 69.53 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.602 -0.726 . . . . 3.72 110.92 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.45 122.88 4.69 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.93 2.42 . . . . 3.97 115.683 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 50.95 44.51 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.983 1.105 . . . . 5.85 113.983 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 60.0 92.92 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.125 1.157 . . . . 5.67 114.125 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -103.38 15.97 27.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.723 -0.843 . . . . 3.89 108.723 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 31' ' ' ILE . . . -143.09 138.58 29.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.977 0.362 . . . . 3.89 111.977 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.59 119.43 59.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.366 -0.379 . . . . 4.64 111.445 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.577 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 63.5 tt0 -54.47 105.62 0.16 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.847 0.356 . . . . 6.72 110.611 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 33.0 pt -86.61 -30.12 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.035 -0.53 . . . . 6.54 110.733 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . 0.427 ' HB2' ' H ' ' B' ' 8' ' ' TYR . 48.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.251 -0.88 . . . . 7.43 110.696 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 66.2 mtm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.716 0.293 . . . . 16.5 110.775 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.08 147.02 28.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 13.22 110.863 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.2 pt -146.53 156.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 12.19 110.765 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -108.74 147.13 32.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.854 -0.612 . . . . 11.64 110.424 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.25 103.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.009 -0.542 . . . . 6.66 110.587 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG2' ' N ' ' A' ' 7' ' ' THR . 85.6 tttt -78.33 164.51 24.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 6.86 111.077 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.464 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 8.4 m -139.91 147.09 40.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.752 -0.658 . . . . 3.79 109.823 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 71' ' ' LEU . 4.4 pp -60.67 -18.42 53.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.801 0.334 . . . . 5.48 111.401 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.447 ' N ' HD12 ' A' ' 8' ' ' LEU . 69.4 p -73.89 -35.7 64.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 7.65 110.531 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.43 -15.28 5.78 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.987 -0.552 . . . . 7.08 112.607 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -83.16 136.62 34.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.388 0.514 . . . . 6.58 112.388 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -115.68 124.53 51.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.283 -0.871 . . . . 6.95 109.332 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.13 144.01 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.02 0.438 . . . . 5.97 111.854 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -100.14 136.2 40.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.493 -0.776 . . . . 8.28 110.737 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.3 153.14 52.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.841 0.353 . . . . 10.02 110.84 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -120.5 102.91 8.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.009 -0.541 . . . . 12.19 111.391 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -153.89 116.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 14.73 110.711 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 167.21 1.19 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.753 1.02 . . . . 18.57 113.753 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.7 Cg_exo -60.12 -32.3 94.45 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.831 3.021 . . . . 19.89 114.08 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -77.87 31.18 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.762 0.315 . . . . 21.46 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -115.23 129.89 56.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.317 -0.401 . . . . 18.56 110.942 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 70.6 p -68.89 145.95 53.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 20.15 111.278 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 50' ' ' LEU . 1.1 mp -56.41 -35.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 16.47 110.755 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.48 -43.11 98.25 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 19.99 109.899 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -64.26 -39.63 94.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.973 -0.558 . . . . 16.38 109.931 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.105 -0.498 . . . . 13.8 110.036 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -62.94 -33.18 74.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.905 -0.588 . . . . 13.67 110.526 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.36 -34.1 76.59 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.066 -0.516 . . . . 14.55 110.217 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -71.36 -42.3 68.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 13.7 109.571 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.42 -47.97 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 115.866 -0.606 . . . . 9.57 109.741 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -58.42 -33.91 70.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 15.04 110.494 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.21 -33.71 76.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.766 -0.652 . . . . 12.47 110.931 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.11 -62.04 1.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 9.23 112.165 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.7 -13.74 59.66 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.449 0.907 . . . . 9.6 113.449 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 15.75 75.24 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.387 -0.911 . . . . 12.2 113.871 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -90.53 123.45 65.28 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 117.255 0.527 . . . . 11.27 110.932 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 48.3 Cg_exo -56.9 138.82 87.52 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.723 2.282 . . . . 14.23 112.348 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 33.5 Cg_exo -61.11 -30.29 88.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.521 2.147 . . . . 14.34 112.156 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.14 -20.61 66.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.779 -0.646 . . . . 16.96 111.074 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.61 -35.11 13.03 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.265 -0.425 . . . . 14.45 110.835 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -61.21 146.4 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 10.91 110.904 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 3.0 tpp180 -142.77 38.04 1.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.9 0.381 . . . . 9.32 111.296 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 42' ' ' ARG . 69.5 mt -20.83 127.59 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.727 1.01 . . . . 10.56 113.727 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.567 HD12 HG21 ' B' ' 18' ' ' THR . 20.2 mm -114.95 136.33 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.183 -0.917 . . . . 9.75 109.734 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 81.7 t80 -138.7 123.75 19.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 15.27 111.276 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 13.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.545 0.572 . . . . 14.76 112.545 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.5 -29.34 9.16 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.829 -0.701 . . . . 12.99 113.191 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 14.6 ptpt -70.27 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.941 0.37 . . . . 17.08 111.02 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.509 ' N ' ' HG3' ' A' ' 48' ' ' LYS . 30.3 tt0 -148.53 107.65 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.93 -0.767 . . . . 14.97 108.93 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HB3' HG12 ' A' ' 23' ' ' ILE . 51.3 mt -57.75 127.22 30.94 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.875 0.695 . . . . 14.81 112.875 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.61 123.62 36.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.392 -0.822 . . . . 21.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -34.54 -61.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.713 -0.676 . . . . 18.5 112.168 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -47.96 -73.5 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 21.79 112.524 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.42 ' O ' HD13 ' A' ' 23' ' ' ILE . 31.0 mmt180 -34.24 163.2 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.366 0.876 . . . . 24.16 113.366 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 8.8 t -115.1 165.28 13.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.211 -0.904 . . . . 21.36 111.278 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 91.0 mt -55.69 -38.46 69.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 18.41 111.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.0 -26.57 68.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.366 . . . . 21.76 111.383 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.59 -29.07 69.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 23.14 110.992 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.11 16.57 24.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 19.37 111.125 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.55 39.62 31.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.083 -0.508 . . . . 22.24 111.306 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.9 mt -87.74 113.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 17.93 111.094 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -105.47 -165.42 1.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 21.49 110.88 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 22.5 pttp -68.16 162.72 24.21 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 19.19 111.255 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 55.99 32.37 19.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.933 -0.576 . . . . 16.92 111.252 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -91.56 138.48 31.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 14.92 110.712 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -98.99 122.46 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 11.29 111.146 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.1 mt -116.71 117.95 31.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 10.94 110.173 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -88.66 114.12 24.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 8.09 111.831 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 45.8 mt -63.94 -172.13 0.06 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.958 -0.565 . . . . 6.7 109.903 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 90.4 t -162.94 106.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.763 -0.458 . . . . 7.13 109.763 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 71' ' ' LEU . 5.6 mp -112.41 76.42 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.216 0.532 . . . . 8.31 109.922 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -77.88 118.56 20.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.443 -0.799 . . . . 14.22 110.977 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 tp -111.0 -42.16 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.837 -0.619 . . . . 13.68 110.348 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -116.03 -36.31 4.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 20.03 110.68 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.4 -59.52 0.02 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.931 -0.652 . . . . 17.34 112.81 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.456 -1.191 . . . . 17.6 112.71 -179.585 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.776 0.322 . . . . 9.15 111.21 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -169.37 117.18 0.62 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.165 0.507 . . . . 10.58 110.133 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -123.08 113.94 19.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.37 -0.832 . . . . 7.56 109.498 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -133.04 170.42 15.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.013 0.435 . . . . 7.84 112.039 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.518 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 13.7 p -153.45 150.23 28.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.656 -0.702 . . . . 4.73 111.036 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -102.5 138.2 39.73 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.384 -0.371 . . . . 4.43 110.245 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 35.9 p -80.47 125.64 30.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 2.72 111.825 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.1 -20.4 24.36 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.401 -0.363 . . . . 3.78 111.448 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' B' ' 14' ' ' PRO . 97.2 m-85 -149.26 158.0 38.87 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.739 0.304 . . . . 4.88 111.468 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' B' ' 13' ' ' PHE . 74.5 Cg_endo -75.21 140.34 24.77 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.736 2.291 . . . . 3.11 112.88 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -136.0 130.97 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.377 -0.829 . . . . 4.0 110.467 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.518 ' HA ' HG23 ' B' ' 24' ' ' THR . 88.0 m -111.54 118.21 35.11 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.942 0.401 . . . . 3.82 111.213 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.52 139.35 48.16 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.981 -0.628 . . . . 3.22 112.127 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.567 HG21 HD12 ' A' ' 44' ' ' ILE . 76.1 p -107.19 -21.47 12.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.199 0.523 . . . . 4.64 111.092 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -119.08 159.58 23.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.328 -0.851 . . . . 4.05 110.011 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -64.41 -36.09 83.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 4.26 111.505 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.75 -4.55 52.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 4.22 110.817 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 150.58 29.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.038 -0.528 . . . . 3.77 110.981 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.603 HD23 ' N ' ' B' ' 24' ' ' THR . 1.4 tt -100.07 137.48 38.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.526 -1.287 . . . . 3.13 107.526 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.603 ' N ' HD23 ' B' ' 23' ' ' LEU . 89.5 m -114.55 123.9 50.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.745 -0.661 . . . . 2.46 110.646 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -138.65 156.82 47.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.502 0.556 . . . . 2.49 112.502 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.455 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 34.0 mmt180 -111.55 179.45 4.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.176 -0.305 . . . . 6.21 110.176 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.93 143.55 31.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 3.87 110.43 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.57 19.96 67.33 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.088 -0.805 . . . . 4.23 111.088 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 19.3 mm-40 -98.15 179.11 4.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.517 0.932 . . . . 4.19 113.517 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -132.37 116.6 29.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 113.557 -1.656 . . . . 5.23 111.297 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.1 140.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 4.64 111.152 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -91.38 127.55 36.86 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.397 -0.594 . . . . 7.14 109.397 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tt -74.32 102.76 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 6.33 110.636 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 31.9 mm -80.72 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 6.97 111.243 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 89.1 p -157.86 120.28 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.098 0.777 . . . . 7.03 113.098 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.512 ' O ' HG23 ' B' ' 38' ' ' THR . 58.7 mttp -65.18 -72.2 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.987 -0.552 . . . . 7.52 109.911 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -44.8 100.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.099 -0.501 . . . . 8.93 111.732 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.512 HG23 ' O ' ' B' ' 36' ' ' LYS . 25.2 p -116.33 -3.69 11.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.964 -0.562 . . . . 7.05 110.881 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.86 -7.6 76.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.978 -0.629 . . . . 8.42 111.882 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -130.87 120.75 24.1 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.693 0.282 . . . . 7.96 110.483 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.51 137.55 58.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 8.2 110.878 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.808 -0.633 . . . . 6.68 112.614 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.595 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 64.1 m95 -120.79 117.41 27.35 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.831 0.348 . . . . 5.83 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -109.89 160.82 16.05 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.247 -0.649 . . . . 5.87 109.247 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -116.09 129.56 56.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.894 0.378 . . . . 5.33 110.389 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.37 175.63 22.24 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.731 -0.747 . . . . 4.14 112.179 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -126.51 135.42 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.499 . . . . 6.02 110.077 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.638 ' O ' ' N ' ' B' ' 50' ' ' GLY . 32.8 tp -128.53 170.16 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.31 -0.859 . . . . 4.21 110.242 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.433 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 50.9 m-80 -18.3 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.403 1.631 . . . . 5.39 115.403 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.69 -11.48 61.73 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 114.894 0.717 . . . . 5.53 114.894 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -118.23 132.25 56.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.831 0.816 . . . . 5.33 111.29 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.01 152.25 24.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.46 -0.57 . . . . 5.79 109.46 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.11 -174.65 44.59 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.113 -1.041 . . . . 3.35 113.353 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.24 149.75 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 110.398 -0.223 . . . . 4.3 110.398 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.432 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 49.1 p90 -139.32 141.11 28.0 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.784 0.661 . . . . 3.72 112.784 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.595 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.3 Cg_endo -95.19 175.17 1.06 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.444 3.429 . . . . 3.97 111.511 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.419 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.1 m-20 79.57 -13.55 0.95 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.981 1.474 . . . . 5.85 114.981 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.22 76.6 0.28 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.873 -0.788 . . . . 5.67 108.873 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 13.1 m-85 -103.87 8.81 37.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.296 -0.865 . . . . 3.89 112.268 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.518 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -133.84 138.98 45.95 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.292 0.478 . . . . 3.89 112.292 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -113.53 136.16 50.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.882 -0.599 . . . . 4.64 111.366 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.08 144.48 28.97 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 120.742 0.306 . . . . 6.72 110.906 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 pt -137.9 -13.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.192 -0.458 . . . . 6.54 111.087 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.272 -0.871 . . . . 7.43 110.627 179.91 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 92.3 mtp . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.853 0.359 . . . . 16.5 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -79.94 151.82 29.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 13.22 111.068 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.06 145.24 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.914 -0.585 . . . . 12.19 110.52 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -100.82 135.33 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 11.64 110.113 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 58.4 t -120.42 96.24 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.519 -0.549 . . . . 6.66 109.519 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 7' ' ' THR . 86.5 tttt -76.3 164.02 26.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.816 -0.629 . . . . 6.86 111.326 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.448 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 77.0 p -143.9 158.85 43.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 3.79 110.268 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.556 ' HB3' ' HE1' ' B' ' 43' ' ' TRP . 4.0 pp -61.91 -24.59 67.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.535 . . . . 5.48 111.219 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 p -78.59 -19.93 51.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.118 -0.492 . . . . 7.65 111.205 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.37 13.39 33.19 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.089 -0.577 . . . . 7.08 112.339 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.45 108.93 21.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.891 0.377 . . . . 6.58 111.407 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -99.38 125.69 45.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 6.95 110.128 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.446 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 31.2 pt -118.3 145.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.861 0.362 . . . . 5.97 111.027 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.641 ' C ' HD22 ' A' ' 15' ' ' LEU . 17.3 m -98.36 134.26 41.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 8.28 111.213 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.641 HD22 ' C ' ' A' ' 14' ' ' THR . 3.8 mm? -127.44 149.75 49.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.098 -0.501 . . . . 10.02 110.369 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.47 98.88 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.31 -0.405 . . . . 12.19 110.701 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.88 -172.74 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.099 0.476 . . . . 14.73 111.816 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -143.14 159.25 56.53 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 18.57 110.276 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 Cg_endo -59.93 -31.72 94.08 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.584 2.189 . . . . 19.89 112.212 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.3 t -82.36 -21.36 35.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 21.46 111.504 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.91 150.92 9.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.7 0.286 . . . . 18.56 111.125 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.3 p -97.35 141.7 30.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 20.15 111.073 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 50' ' ' LEU . 16.0 mt -53.73 -32.02 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 16.47 111.466 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.91 -42.47 99.8 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.615 -0.513 . . . . 19.99 109.615 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -67.06 -36.16 81.43 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.752 -0.658 . . . . 16.38 110.133 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.2 t -57.59 -46.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.378 -0.374 . . . . 13.8 110.197 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.39 -37.76 84.6 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.039 -0.528 . . . . 13.67 110.451 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.05 86.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 14.55 110.432 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 6.9 mmpt? -64.68 -49.2 71.86 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.033 -0.531 . . . . 13.7 109.956 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.69 -40.75 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 9.57 110.368 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -61.4 -34.78 75.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.018 -0.537 . . . . 15.04 110.816 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.96 -36.26 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 12.47 111.329 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.23 -63.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.234 -0.439 . . . . 9.23 112.025 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -78.4 -12.58 60.01 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.386 0.884 . . . . 9.6 113.386 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.14 -12.5 12.26 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.294 -0.955 . . . . 12.2 113.38 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.514 HD12 ' HD2' ' A' ' 37' ' ' PRO . 5.2 tp -60.52 128.07 87.68 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.856 0.328 . . . . 11.27 111.565 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 36' ' ' ILE . 59.8 Cg_endo -73.06 137.2 26.04 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.623 2.215 . . . . 14.23 112.622 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 53.2 Cg_exo -56.13 -29.0 73.15 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.026 2.484 . . . . 14.34 112.782 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.96 -24.85 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 16.96 111.271 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -108.54 -6.64 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 14.45 111.467 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.401 HE21 ' N ' ' A' ' 38' ' ' PRO . 46.4 mt-30 -81.17 127.19 32.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.066 0.46 . . . . 10.91 111.984 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -121.24 112.53 18.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.466 -0.788 . . . . 9.32 109.275 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.32 122.63 43.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.42 -0.355 . . . . 10.56 110.951 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.804 HD12 HG21 ' B' ' 18' ' ' THR . 34.3 mm -116.55 137.05 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.526 . . . . 9.75 110.983 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 50' ' ' LEU . 85.2 t80 -155.86 127.57 7.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.772 -0.649 . . . . 15.27 110.541 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.5 17.12 10.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.934 -0.575 . . . . 14.76 111.767 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.428 ' O ' HG22 ' B' ' 18' ' ' THR . . . 90.96 -2.41 79.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 12.99 112.964 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -117.82 148.56 41.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.749 0.309 . . . . 17.08 110.777 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -81.91 131.34 35.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 14.97 110.196 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.536 ' HB3' HD13 ' A' ' 23' ' ' ILE . 52.9 mt -69.74 130.13 41.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.95 0.405 . . . . 14.81 111.288 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -86.84 126.19 34.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.62 . . . . 21.0 110.174 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -48.58 -40.35 27.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.551 0.574 . . . . 18.5 112.551 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.408 ' H ' ' CD ' ' A' ' 51' ' ' GLU . . . -80.28 3.52 71.91 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.971 -0.633 . . . . 21.79 114.194 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 6.0 mmp_? -103.5 173.79 6.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.115 0.457 . . . . 24.16 110.881 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -118.99 160.84 21.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.872 0.368 . . . . 21.36 111.576 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.458 ' H ' HD22 ' A' ' 56' ' ' LEU . 3.6 mm? -51.78 -34.04 37.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.015 -0.538 . . . . 18.41 111.395 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -69.31 -24.97 64.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.485 -0.325 . . . . 21.76 111.303 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.412 . . . . 23.14 111.065 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -101.09 11.45 39.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.233 -0.44 . . . . 19.37 111.288 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 56.32 49.47 15.11 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.851 0.358 . . . . 22.24 111.184 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.404 HG12 ' CE2' ' A' ' 45' ' ' PHE . 79.8 mt -92.09 108.27 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 17.93 110.882 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -92.81 -177.98 4.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 21.49 110.899 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.97 158.88 24.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.337 -0.392 . . . . 19.19 111.125 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 59.46 29.05 18.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.946 -0.57 . . . . 16.92 111.509 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.5 t -89.1 153.19 21.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.308 -0.405 . . . . 14.92 110.843 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 t -110.9 126.02 54.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 11.29 111.124 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.1 mp -115.29 125.72 53.63 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.923 -0.58 . . . . 10.94 110.395 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -85.39 115.47 23.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.401 . . . . 8.09 111.589 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.7 tp -94.17 105.83 17.81 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.903 -0.59 . . . . 6.7 110.6 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -85.76 141.48 14.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.13 -0.486 . . . . 7.13 110.885 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.0 mt -129.0 141.55 51.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.091 -0.504 . . . . 8.31 111.006 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.47 ' N ' ' HE ' ' A' ' 72' ' ' ARG . 2.7 mmp_? 61.37 95.14 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.785 -0.643 . . . . 14.22 110.98 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.07 -27.84 64.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 13.68 110.988 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -63.46 112.26 2.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.222 -0.445 . . . . 20.03 110.165 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.98 -105.94 1.49 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.885 -0.674 . . . . 17.34 111.99 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.466 -1.186 . . . . 17.6 112.595 179.848 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.539 0.209 . . . . 9.15 110.93 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.02 175.26 5.51 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.182 0.515 . . . . 10.58 111.028 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -101.79 134.56 44.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.345 -0.843 . . . . 7.56 109.045 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.15 169.13 15.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.988 0.423 . . . . 7.84 111.9 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.627 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 6.7 p -152.63 147.69 26.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 4.73 110.478 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -100.19 141.3 33.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.434 -0.348 . . . . 4.43 110.684 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 54.4 p -80.25 124.78 29.12 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.271 -0.422 . . . . 2.72 111.743 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.24 -21.49 19.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.616 -0.265 . . . . 3.78 111.05 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -151.3 156.61 35.08 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-O 120.607 0.241 . . . . 4.88 110.83 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.68 140.58 29.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.549 2.166 . . . . 3.11 113.112 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -136.59 128.7 29.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.085 -0.961 . . . . 4.0 110.044 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.436 ' HA ' HG23 ' B' ' 24' ' ' THR . 88.3 m -112.2 120.4 41.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.8 0.333 . . . . 3.82 111.579 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.47 144.64 49.37 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.828 -0.701 . . . . 3.22 111.93 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.804 HG21 HD12 ' A' ' 44' ' ' ILE . 82.0 p -107.56 -22.19 12.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.057 0.456 . . . . 4.64 111.292 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.79 158.67 25.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.476 -0.784 . . . . 4.05 109.941 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.82 -35.91 82.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 4.26 111.438 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.3 -4.47 45.18 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.934 0.397 . . . . 4.22 110.535 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.91 156.58 22.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.762 -0.653 . . . . 3.77 110.44 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.513 HD23 ' HZ ' ' B' ' 25' ' ' PHE . 3.8 tp -107.14 146.33 31.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.354 -0.98 . . . . 3.13 108.354 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.436 HG23 ' HA ' ' B' ' 16' ' ' THR . 93.8 m -115.83 130.93 57.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.231 -0.44 . . . . 2.46 111.099 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.513 ' HZ ' HD23 ' B' ' 23' ' ' LEU . 31.3 m-85 -131.56 139.02 49.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.169 0.433 . . . . 2.49 112.169 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.568 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 8.3 mpt_? -108.32 176.85 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.873 -0.418 . . . . 6.21 109.873 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -80.41 138.17 36.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 3.87 110.163 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.79 20.38 58.09 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.027 -0.829 . . . . 4.23 111.027 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.568 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 22.9 mm-40 -98.29 179.73 4.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.04 0.924 . . . . 4.19 113.391 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.8 mm -134.64 119.64 29.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 113.563 -1.653 . . . . 5.23 110.707 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.627 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 39.5 mt -114.18 133.73 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.007 -0.542 . . . . 4.64 111.591 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -93.43 126.68 38.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.384 -0.599 . . . . 7.14 109.384 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.47 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.9 tt -74.37 102.77 4.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 6.33 110.528 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mm -81.56 -64.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.498 -0.774 . . . . 6.97 111.197 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' B' ' 45' ' ' LYS . 69.1 m -154.47 112.3 3.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.683 0.623 . . . . 7.03 112.683 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.32 -72.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.979 -0.748 . . . . 7.52 108.979 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -45.04 96.05 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.096 -0.502 . . . . 8.93 111.381 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 4.5 t -112.08 -2.67 14.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.063 -0.517 . . . . 7.05 111.077 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.18 0.41 67.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.993 -0.622 . . . . 8.42 113.211 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -134.24 124.26 25.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.761 0.315 . . . . 7.96 111.205 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.11 131.9 50.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 8.2 111.035 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.16 -1.31 84.56 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.006 -0.616 . . . . 6.68 112.588 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.556 ' HE1' ' HB3' ' A' ' 8' ' ' LEU . 69.5 m95 -117.76 135.3 54.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.188 0.518 . . . . 5.83 111.543 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -123.51 155.42 37.58 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.086 -0.961 . . . . 5.87 109.033 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' B' ' 35' ' ' SER . 23.9 ttmm -113.45 130.35 56.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.908 0.385 . . . . 5.33 110.644 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.36 176.47 21.36 Favored Glycine 0 N--CA 1.453 -0.18 0 CA-C-N 115.73 -0.668 . . . . 4.14 112.056 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.39 135.02 51.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 6.02 110.414 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 50' ' ' GLY . 21.2 tp -130.12 170.02 14.58 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.332 -0.849 . . . . 4.21 110.109 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.53 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 55.9 m-80 -17.88 65.19 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.401 1.63 . . . . 5.39 115.401 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.33 -12.95 57.3 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.776 0.67 . . . . 5.53 114.776 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -116.31 135.5 53.82 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.767 0.784 . . . . 5.33 111.19 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -108.81 152.95 24.18 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.117 -0.492 . . . . 5.79 109.853 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.18 -176.15 46.7 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.416 -0.897 . . . . 3.35 112.808 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.57 154.88 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.468 0.175 . . . . 4.3 110.571 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.475 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 46.5 p90 -141.49 140.18 20.05 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 112.755 0.65 . . . . 3.72 112.755 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 55' ' ' PHE . 96.7 Cg_endo -94.61 174.72 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.457 3.438 . . . . 3.97 110.637 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.472 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 79.75 -14.14 0.88 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 114.913 1.449 . . . . 5.85 114.913 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 57.3 76.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.016 -0.735 . . . . 5.67 109.016 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 19.5 m-85 -101.66 6.46 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.35 -0.841 . . . . 3.89 111.948 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.1 139.01 40.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.466 0.543 . . . . 3.89 112.466 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.28 130.53 68.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.843 -0.617 . . . . 4.64 111.32 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -55.43 128.99 36.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.887 0.375 . . . . 6.72 111.092 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -88.4 -61.01 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.965 -0.561 . . . . 6.54 110.373 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.428 -0.796 . . . . 7.43 110.69 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' CA ' ' A' ' 63' ' ' LYS . 45.5 tpp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.829 0.347 . . . . 16.5 110.92 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -82.03 145.62 30.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 13.22 110.91 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -147.59 151.69 13.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 12.19 111.008 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.21 146.1 34.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.898 -0.592 . . . . 11.64 110.89 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 50.9 t -136.52 97.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 6.66 110.306 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.37 133.37 36.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 6.86 111.439 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.7 m -106.89 152.43 23.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 3.79 110.374 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.544 HD13 ' HE1' ' B' ' 43' ' ' TRP . 40.7 tp -56.45 -36.64 69.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.917 -0.583 . . . . 5.48 111.073 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -56.47 -36.11 68.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.056 -0.52 . . . . 7.65 111.209 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.29 8.62 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.068 -0.515 . . . . 7.08 112.351 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -100.16 124.79 45.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.942 0.401 . . . . 6.58 112.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -101.37 134.33 44.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.756 -0.656 . . . . 6.95 109.365 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.44 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 23.0 pt -119.72 143.67 30.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 5.97 111.623 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.6 p -101.32 137.62 39.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.484 -0.78 . . . . 8.28 110.952 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 mp -137.85 160.85 38.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.268 -0.423 . . . . 10.02 110.526 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.52 103.04 7.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 12.19 110.771 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.03 113.67 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.303 -0.408 . . . . 14.73 111.382 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.405 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 41.3 mt-10 -50.5 166.84 0.27 Allowed Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 113.416 0.895 . . . . 18.57 113.416 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 28.7 Cg_exo -64.14 -33.62 60.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.442 2.761 . . . . 19.89 113.279 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -20.12 64.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.546 -0.297 . . . . 21.46 111.752 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.16 147.32 53.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.368 . . . . 18.56 111.716 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 67.2 p -88.83 152.98 21.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.932 -0.576 . . . . 20.15 110.707 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.47 HD12 HD13 ' A' ' 50' ' ' LEU . 47.6 mm -57.07 -36.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.459 -0.337 . . . . 16.47 111.036 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -46.39 80.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 19.99 110.156 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -58.71 -42.84 89.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.863 -0.608 . . . . 16.38 110.303 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 56' ' ' LEU . 78.7 t -62.18 -41.64 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 13.8 110.524 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.52 -28.69 70.03 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.286 -0.415 . . . . 13.67 110.599 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.37 70.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 14.55 109.843 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -67.71 -46.24 72.78 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.831 -0.622 . . . . 13.7 109.48 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -61.49 -38.73 80.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.884 -0.598 . . . . 9.57 110.113 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -66.88 -32.28 73.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 15.04 110.697 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.99 -38.49 82.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 12.47 111.234 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -88.99 -51.18 5.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.265 0.469 . . . . 9.23 112.265 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.53 -10.87 47.41 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.487 0.921 . . . . 9.6 113.487 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.59 -37.39 2.06 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.533 -0.841 . . . . 12.2 114.3 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.522 HD12 HD21 ' A' ' 69' ' ' LEU . 8.4 pt -45.84 124.48 6.48 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 112.133 0.42 . . . . 11.27 112.133 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.68 144.48 89.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.969 2.446 . . . . 14.23 112.881 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.61 -28.31 82.61 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.84 2.36 . . . . 14.34 112.583 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.3 -27.51 68.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 16.96 111.359 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -100.3 -9.27 22.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.314 -0.403 . . . . 14.45 111.12 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -84.43 120.92 26.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 10.91 112.113 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -118.25 117.01 27.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.56 -0.746 . . . . 9.32 109.101 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.58 122.61 46.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.961 0.41 . . . . 10.56 111.963 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.741 ' HB ' HG21 ' B' ' 18' ' ' THR . 40.6 pt -111.03 127.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.639 -0.71 . . . . 9.75 110.439 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -129.48 120.52 25.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.489 -0.778 . . . . 15.27 110.795 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.35 19.69 9.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.846 -0.615 . . . . 14.76 112.272 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.842 ' C ' HG22 ' B' ' 18' ' ' THR . . . 93.7 5.64 62.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.588 -0.815 . . . . 12.99 113.127 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 144.39 47.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.589 0.233 . . . . 17.08 110.491 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.14 140.46 37.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.235 -0.283 . . . . 14.97 110.235 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD13 HD12 ' A' ' 23' ' ' ILE . 90.8 mt -89.27 133.57 34.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.456 -0.338 . . . . 14.81 110.684 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.1 127.13 36.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 21.0 111.336 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -40.39 -51.38 2.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.793 -0.639 . . . . 18.5 111.373 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.71 -78.23 0.14 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.487 -0.863 . . . . 21.79 111.237 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -26.77 152.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.558 0.947 . . . . 24.16 113.558 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.4 p -107.05 164.09 12.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.194 -0.912 . . . . 21.36 111.256 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD11 HG21 ' A' ' 26' ' ' VAL . 11.2 mp -53.08 -39.19 63.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 18.41 111.241 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 m -61.63 -28.58 69.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 21.76 111.352 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.06 -38.31 90.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 23.14 111.055 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -96.05 12.54 30.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.443 . . . . 19.37 111.672 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 57.97 43.2 21.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.998 0.428 . . . . 22.24 110.844 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.7 mt -92.79 119.6 40.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.136 -0.484 . . . . 17.93 111.19 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -113.55 -170.43 1.69 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.256 -0.429 . . . . 21.49 111.491 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' CA ' ' SD ' ' A' ' 1' ' ' MET . 83.1 tttt -62.78 157.74 20.45 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.09 -0.505 . . . . 19.19 111.454 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 59.88 28.72 18.26 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.782 -0.645 . . . . 16.92 111.784 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -89.77 143.86 26.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.447 -0.342 . . . . 14.92 110.827 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -99.39 134.8 41.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 11.29 111.205 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.33 113.55 13.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.019 -0.537 . . . . 10.94 111.222 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.544 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 38.9 t-80 -83.62 119.32 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.999 0.428 . . . . 8.09 110.487 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.522 HD21 HD12 ' A' ' 36' ' ' ILE . 22.9 tp -95.25 121.3 36.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 6.7 110.777 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.451 ' C ' HD22 ' A' ' 71' ' ' LEU . 5.2 t -103.23 133.64 46.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.898 -0.592 . . . . 7.13 110.527 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 71' ' ' LEU . 2.9 mm? -122.48 125.14 45.18 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.495 -0.321 . . . . 8.31 111.378 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 50.31 100.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.979 -0.555 . . . . 14.22 112.072 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 73' ' ' LEU . 1.7 pt? -53.06 -51.67 61.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 13.68 111.059 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' N ' ' HG ' ' A' ' 73' ' ' LEU . 97.9 mtt180 54.19 20.52 2.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.507 -0.315 . . . . 20.03 111.165 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.53 9.38 10.28 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.049 -0.523 . . . . 17.34 111.927 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' B' ' 54' ' ' VAL . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.361 -1.244 . . . . 17.6 112.264 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.426 0.155 . . . . 9.15 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -112.67 175.63 5.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.102 0.477 . . . . 10.58 110.775 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -103.02 133.49 48.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.449 -0.796 . . . . 7.56 109.105 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -128.4 165.1 21.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.185 0.517 . . . . 7.84 111.91 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 26.2 p -145.77 148.15 32.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.187 -0.915 . . . . 4.73 110.762 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -99.13 143.12 29.76 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.391 -0.368 . . . . 4.43 110.684 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -86.66 124.18 32.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.083 -0.508 . . . . 2.72 111.33 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -94.73 -21.13 18.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.223 0.453 . . . . 3.78 112.223 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.445 ' HA ' ' HD3' ' B' ' 14' ' ' PRO . 79.6 t80 -145.68 140.9 16.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.886 0.328 . . . . 4.88 111.886 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 13' ' ' PHE . 36.7 Cg_exo -61.61 139.75 82.98 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.809 2.339 . . . . 3.11 112.488 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -138.69 133.64 32.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.72 -0.673 . . . . 4.0 111.288 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.43 ' HA ' HG23 ' B' ' 24' ' ' THR . 68.9 m -111.65 119.13 37.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.426 . . . . 3.82 110.754 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.82 139.08 48.61 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.887 -0.673 . . . . 3.22 112.553 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.842 HG22 ' C ' ' A' ' 47' ' ' GLY . 24.9 p -103.94 -23.46 13.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.181 0.515 . . . . 4.64 110.705 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -120.38 154.6 34.87 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.197 -0.91 . . . . 4.05 109.757 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.5 -39.66 92.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 4.26 111.458 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.13 -4.8 34.97 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.908 0.385 . . . . 4.22 110.589 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.2 158.82 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.973 -0.558 . . . . 3.77 110.949 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' B' ' 24' ' ' THR . 3.6 tt -102.62 139.99 37.49 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.812 -0.811 . . . . 3.13 108.812 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.754 ' N ' HD23 ' B' ' 23' ' ' LEU . 98.6 m -112.38 123.88 51.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.531 -0.759 . . . . 2.46 109.474 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' B' ' 55' ' ' PHE . 15.9 p90 -135.61 146.01 47.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.962 0.727 . . . . 2.49 112.962 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.501 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 31.9 mmt180 -109.56 178.29 4.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.116 -0.327 . . . . 6.21 110.116 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -81.35 142.77 32.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 3.87 110.328 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 20.23 61.72 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.878 -0.889 . . . . 4.23 110.878 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 24.6 mm-40 -98.53 178.81 4.9 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.343 0.868 . . . . 4.19 113.343 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 21.9 mm -136.05 116.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.648 -1.615 . . . . 5.23 110.943 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.443 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 55.2 mt -112.35 137.84 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 4.64 111.083 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' HIS . . . . . 0.488 ' O ' ' HA2' ' B' ' 46' ' ' GLY . 1.8 m-70 -92.51 128.19 38.27 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.326 -0.62 . . . . 7.14 109.326 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.533 ' C ' HD23 ' B' ' 33' ' ' LEU . 6.1 tt -73.81 102.26 3.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 6.33 111.113 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' B' ' 47' ' ' GLU . 55.1 mt -81.1 -64.61 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.666 -0.697 . . . . 6.97 111.098 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.0 t -154.12 116.7 4.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 7.03 112.286 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 52.3 mtpt -69.52 6.22 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.984 -0.553 . . . . 7.52 111.398 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -121.61 98.46 5.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.593 0.235 . . . . 8.93 110.64 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 45' ' ' LYS . 48.1 p -108.07 -1.4 20.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.544 -0.298 . . . . 7.05 111.423 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.83 -4.2 75.09 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.782 -0.723 . . . . 8.42 111.565 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -129.31 121.49 27.61 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.385 0.274 . . . . 7.96 110.65 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.425 ' O ' HD11 ' A' ' 8' ' ' LEU . . . -59.87 133.28 55.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 8.2 110.507 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.25 82.11 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.927 -0.654 . . . . 6.68 112.387 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.544 ' HE1' HD13 ' A' ' 8' ' ' LEU . 86.3 m95 -120.35 122.32 40.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.053 0.427 . . . . 5.83 111.443 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' TRP . . . . . 0.485 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 30.7 m0 -111.56 162.73 14.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.103 -0.703 . . . . 5.87 109.103 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' B' ' 38' ' ' THR . 63.6 tttm -115.58 129.98 56.71 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.795 0.331 . . . . 5.33 110.405 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' B' ' 32' ' ' HIS . . . -142.82 177.43 21.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.654 -0.784 . . . . 4.14 112.359 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' B' ' 34' ' ' ILE . 36.5 tt0 -125.13 133.55 52.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.294 0.568 . . . . 6.02 110.778 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.675 ' O ' ' N ' ' B' ' 50' ' ' GLY . 42.5 tp -127.45 169.96 13.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.987 -1.006 . . . . 4.21 109.269 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.456 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 58.2 m-20 -17.92 64.45 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.256 1.576 . . . . 5.39 115.256 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 85.71 -10.84 63.52 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 114.937 0.735 . . . . 5.53 114.937 177.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.45 152.62 24.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.162 0.981 . . . . 5.33 110.988 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 1.2 pm0 -125.73 142.15 51.65 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.948 -0.76 . . . . 5.79 108.948 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . 0.466 ' C ' ' HB2' ' B' ' 23' ' ' LEU . . . -179.84 -171.27 42.57 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 120.254 -0.974 . . . . 3.35 113.101 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.533 HG21 ' HA3' ' A' ' 76' ' ' GLY . 33.4 m -111.77 151.11 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 120.704 0.288 . . . . 4.3 111.055 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 38.4 p90 -131.34 139.52 35.68 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 112.219 0.451 . . . . 3.72 112.219 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 55' ' ' PHE . 94.4 Cg_endo -97.95 174.26 0.57 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.297 3.332 . . . . 3.97 111.546 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.503 ' HB2' ' CD2' ' B' ' 59' ' ' PHE . 16.6 m-20 78.78 -10.68 1.31 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.49 1.293 . . . . 5.85 114.49 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' B' ' 60' ' ' ALA . 15.8 m120 58.15 26.68 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 118.43 0.559 . . . . 5.67 110.201 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.503 ' CD2' ' HB2' ' B' ' 57' ' ' ASP . 9.3 m-85 -56.64 3.97 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.201 0.815 . . . . 3.89 113.201 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' B' ' 58' ' ' ASN . . . -129.47 138.87 51.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.225 0.454 . . . . 3.89 112.225 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 128.06 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 4.64 111.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -53.72 156.64 2.61 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 120.932 0.396 . . . . 6.72 110.746 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.46 -32.71 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 6.54 110.45 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 74.5 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.369 -0.824 . . . . 7.43 110.529 179.75 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 tpp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.678 0.275 . . . . 16.5 110.835 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -84.7 142.37 29.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 13.22 110.794 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.6 pt -145.42 151.43 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 12.19 110.712 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -109.93 145.48 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.947 -0.569 . . . . 11.64 110.795 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 5' ' ' VAL . 31.3 m -136.27 106.4 5.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.184 0.516 . . . . 6.66 110.678 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 7' ' ' THR . 81.5 tttt -75.94 163.14 27.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 6.86 111.076 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.471 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 17.3 m -137.43 142.16 41.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.681 -0.69 . . . . 3.79 109.895 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 9' ' ' THR . 3.2 pp -55.31 -21.86 16.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.453 -0.34 . . . . 5.48 111.65 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.435 ' H ' HG22 ' A' ' 7' ' ' THR . 31.5 m -71.18 -39.37 71.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.397 -0.365 . . . . 7.65 110.575 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.78 -1.95 5.97 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.076 -0.583 . . . . 7.08 112.872 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -98.99 129.4 45.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.011 0.434 . . . . 6.58 112.073 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -104.57 136.15 44.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.577 -0.738 . . . . 6.95 109.448 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 13' ' ' ILE . 5.1 mp -118.0 152.72 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 5.97 111.471 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.404 ' N ' HG22 ' A' ' 13' ' ' ILE . 24.9 m -108.89 135.07 50.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 8.28 110.425 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.4 tp -135.53 154.14 51.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.491 -0.322 . . . . 10.02 110.728 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.64 99.74 6.71 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.306 -0.406 . . . . 12.19 111.278 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -149.95 111.81 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.532 -0.303 . . . . 14.73 111.54 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -52.14 166.18 0.43 Allowed Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 114.176 1.176 . . . . 18.57 114.176 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.9 Cg_exo -60.16 -30.66 91.83 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.715 2.943 . . . . 19.89 113.864 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 m -80.95 32.92 0.32 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 21.46 111.552 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -118.7 126.9 52.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 18.56 110.896 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 77.1 p -64.71 148.87 50.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 20.15 111.151 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.45 HD12 HD23 ' A' ' 50' ' ' LEU . 41.0 mm -58.51 -37.68 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.263 -0.426 . . . . 16.47 110.88 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 11.0 pt-20 -61.77 -40.52 95.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 19.99 110.091 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -64.16 -43.8 94.05 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.883 -0.599 . . . . 16.38 109.785 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.28 -41.07 88.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.884 -0.598 . . . . 13.8 110.434 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.89 -29.22 70.6 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.228 -0.442 . . . . 13.67 110.415 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.62 74.73 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.106 -0.497 . . . . 14.55 109.691 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -64.34 -47.62 78.67 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.586 -0.733 . . . . 13.7 109.559 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.6 mt -61.46 -40.61 86.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-N 115.856 -0.611 . . . . 9.57 110.134 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -63.38 -30.38 71.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.319 -0.4 . . . . 15.04 110.909 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.19 -35.94 71.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 12.47 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -88.89 -58.97 2.36 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.114 -0.494 . . . . 9.23 112.003 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -82.5 -11.43 58.49 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.396 0.887 . . . . 9.6 113.396 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.36 -29.99 1.93 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.498 -0.858 . . . . 12.2 114.056 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 46.8 mm -50.09 124.72 17.69 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.994 0.397 . . . . 11.27 111.917 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 40.8 Cg_exo -58.86 151.97 60.99 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.774 2.316 . . . . 14.23 112.341 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.09 -32.82 16.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.688 2.259 . . . . 14.34 112.114 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.84 -22.98 67.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.061 -0.518 . . . . 16.96 111.077 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -97.2 -18.06 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 14.45 110.86 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -78.73 124.17 27.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.046 0.451 . . . . 10.91 112.036 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.466 HH21 HG21 ' A' ' 70' ' ' VAL . 37.6 ttp180 -121.23 118.89 30.74 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.459 -0.941 . . . . 9.32 108.459 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.56 127.96 50.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.142 0.496 . . . . 10.56 112.046 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.724 HG23 HG21 ' B' ' 18' ' ' THR . 39.5 mm -115.49 120.33 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.273 -0.876 . . . . 9.75 110.474 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CB ' HD11 ' A' ' 50' ' ' LEU . 60.3 t80 -130.12 119.46 23.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.031 -0.531 . . . . 15.27 111.028 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.95 18.33 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 14.76 112.097 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.689 ' O ' HG22 ' B' ' 18' ' ' THR . . . 94.7 1.84 63.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.603 -0.808 . . . . 12.99 112.989 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -117.36 143.49 45.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 17.08 110.893 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.83 131.83 35.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 14.97 110.719 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 50' ' ' LEU . 5.4 mp -80.22 134.72 36.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.921 0.391 . . . . 14.81 111.403 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.02 130.29 35.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.837 -0.62 . . . . 21.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 4.0 p30 -44.28 -49.34 9.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 18.5 111.214 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -58.79 -76.11 0.23 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.62 -0.8 . . . . 21.79 111.573 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' GLY . 60.7 mtp180 -28.55 156.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.584 0.957 . . . . 24.16 113.584 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 9.3 t -110.9 164.1 13.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.061 -0.972 . . . . 21.36 110.506 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 92.7 mt -53.73 -36.57 62.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 18.41 111.629 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.7 t -62.34 -29.69 70.64 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.749 0.278 . . . . 21.76 111.749 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.33 -34.83 79.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.677 0.275 . . . . 23.14 110.945 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -93.77 4.71 53.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.472 . . . . 19.37 111.275 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 64.03 33.02 12.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.001 0.429 . . . . 22.24 110.897 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.8 mt -80.93 116.93 26.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.035 -0.53 . . . . 17.93 111.582 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -107.4 -170.82 1.76 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.72 -0.673 . . . . 21.49 110.46 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.38 160.7 21.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.467 -0.333 . . . . 19.19 111.01 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 59.6 26.8 15.89 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.172 -0.467 . . . . 16.92 111.744 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 t -87.47 139.13 30.86 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.761 0.315 . . . . 14.92 111.09 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -100.03 129.15 46.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 11.29 110.975 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -127.36 114.89 18.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.125 -0.489 . . . . 10.94 110.783 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.96 122.32 25.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 8.09 110.937 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.47 116.27 28.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.912 -0.585 . . . . 6.7 110.335 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.5 ' C ' HD12 ' A' ' 71' ' ' LEU . 38.2 t -107.49 139.24 30.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 7.13 111.735 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 70' ' ' VAL . 6.0 mp -122.14 110.79 16.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.476 -0.784 . . . . 8.31 110.037 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.411 ' HE ' ' NH1' ' A' ' 42' ' ' ARG . 35.8 mmt180 -96.6 112.75 24.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 14.22 110.82 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 73' ' ' LEU . 5.2 mp -102.18 -44.15 5.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.008 -0.542 . . . . 13.68 110.441 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -176.43 147.82 0.7 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.739 -0.664 . . . . 20.03 110.629 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.09 -30.63 5.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.923 -0.656 . . . . 17.34 112.918 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.374 -1.237 . . . . 17.6 112.659 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.757 0.313 . . . . 9.15 110.964 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -156.85 118.05 3.72 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.033 -0.531 . . . . 10.58 109.627 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -126.2 106.4 9.52 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.685 -0.688 . . . . 7.56 109.712 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.11 171.64 12.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.271 -0.422 . . . . 7.84 111.558 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 36.6 m -148.03 151.17 35.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.865 -0.607 . . . . 4.73 111.345 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -99.81 139.47 35.43 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.985 -0.376 . . . . 4.43 109.985 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 60.3 p -83.28 121.81 27.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.42 -0.355 . . . . 2.72 111.611 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.04 -20.85 23.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.552 -0.295 . . . . 3.78 111.309 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -147.57 157.46 44.64 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 4.88 111.13 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.76 140.77 26.57 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.665 2.243 . . . . 3.11 112.71 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.438 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 66.9 t80 -136.71 129.91 31.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.368 -0.833 . . . . 4.0 110.375 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.513 ' HA ' HG23 ' B' ' 24' ' ' THR . 7.4 t -113.0 121.33 44.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 3.82 111.52 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.29 145.61 49.73 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.822 -0.704 . . . . 3.22 111.865 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.724 HG21 HG23 ' A' ' 44' ' ' ILE . 57.9 p -107.98 -21.75 12.69 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.038 0.447 . . . . 4.64 111.255 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -118.61 162.35 18.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.539 -0.755 . . . . 4.05 110.516 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' B' ' 20' ' ' GLU . 1.8 mp0 -59.13 -27.94 66.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.897 -0.592 . . . . 4.26 112.544 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.73 -53.28 6.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.553 -0.459 . . . . 4.22 110.59 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -32.35 146.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.704 -0.68 . . . . 3.77 112.167 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' B' ' 24' ' ' THR . 3.2 tt -98.27 141.41 31.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.288 -1.005 . . . . 3.13 108.288 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.754 ' N ' HD23 ' B' ' 23' ' ' LEU . 95.9 m -113.96 122.9 48.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.84 -0.618 . . . . 2.46 110.374 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.482 ' CG ' HD11 ' B' ' 31' ' ' ILE . 37.1 p90 -138.54 155.27 48.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.614 0.598 . . . . 2.49 112.614 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.41 -179.86 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.222 -0.288 . . . . 6.21 110.222 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.18 141.49 32.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 3.87 110.177 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.75 20.87 58.94 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.736 -0.946 . . . . 4.23 110.736 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.497 ' HG2' ' H ' ' B' ' 30' ' ' ILE . 4.4 tt0 -99.29 179.28 4.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.23 0.826 . . . . 4.19 113.23 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.497 ' H ' ' HG2' ' B' ' 29' ' ' GLU . 30.3 mm -135.86 115.33 16.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.877 -1.51 . . . . 5.23 110.979 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.482 HD11 ' CG ' ' B' ' 25' ' ' PHE . 51.5 mt -114.49 145.88 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 4.64 111.166 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -97.43 129.22 44.67 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.514 -0.55 . . . . 7.14 109.514 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.404 ' C ' HD13 ' B' ' 33' ' ' LEU . 3.1 tm? -78.11 110.62 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 6.33 111.172 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -84.11 -58.77 3.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 6.97 111.264 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 70.6 m -158.92 121.43 3.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.32 0.489 . . . . 7.03 112.32 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.08 6.38 2.19 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.915 -0.584 . . . . 7.52 111.435 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.9 105.82 10.69 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.767 -0.197 . . . . 8.93 110.558 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.568 HG22 ' HB2' ' B' ' 45' ' ' LYS . 28.0 p -115.0 -3.3 12.65 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 111.806 0.299 . . . . 7.05 111.806 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.8 -9.04 77.69 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.759 -0.734 . . . . 8.42 112.233 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.73 118.69 30.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.698 0.285 . . . . 7.96 110.513 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.2 130.55 46.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 8.2 111.229 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.42 2.41 79.72 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.881 -0.599 . . . . 6.68 112.461 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 68.3 m95 -120.39 126.39 50.35 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.052 0.453 . . . . 5.83 112.023 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -110.85 165.08 12.14 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.589 -0.893 . . . . 5.87 108.589 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' B' ' 38' ' ' THR . 36.5 ttpt -119.86 129.95 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.956 0.408 . . . . 5.33 110.874 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.23 175.41 20.93 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.566 -0.743 . . . . 4.14 112.126 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -134.55 134.34 41.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 6.02 110.366 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 50' ' ' GLY . 52.5 tp -123.97 133.23 53.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 4.21 109.029 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -22.03 80.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.143 1.164 . . . . 5.39 114.143 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 125.24 -50.85 0.85 Allowed Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.57 -0.741 . . . . 5.53 114.753 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -112.06 153.87 26.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.998 0.899 . . . . 5.33 112.127 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.41 142.14 51.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.205 -0.907 . . . . 5.79 108.591 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.78 -176.08 41.96 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.086 -1.054 . . . . 3.35 113.245 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -112.85 152.91 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.576 0.227 . . . . 4.3 111.047 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 51.7 p90 -135.68 140.36 33.56 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.612 0.597 . . . . 3.72 112.612 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 64.6 Cg_endo -96.16 175.05 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.657 3.572 . . . . 3.97 110.976 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.537 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 3.2 m-20 77.34 -12.45 1.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.184 1.55 . . . . 5.85 115.184 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . 0.444 ' C ' HD22 ' B' ' 58' ' ' ASN . 0.2 OUTLIER 58.19 75.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.424 -0.954 . . . . 5.67 108.424 -177.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.537 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 17.3 m-85 -102.96 6.62 39.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.276 -0.874 . . . . 3.89 112.211 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.57 139.01 43.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.479 0.548 . . . . 3.89 112.479 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.84 130.0 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.942 -0.572 . . . . 4.64 111.561 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.466 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 8.9 tp-100 -54.19 112.68 1.02 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.738 0.304 . . . . 6.72 110.527 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 pt -90.6 -31.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 6.54 110.933 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.356 -0.83 . . . . 7.43 110.586 -179.827 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.823 0.344 . . . . 16.5 110.822 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.63 141.94 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 13.22 110.583 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.02 149.81 15.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.414 -0.357 . . . . 12.19 110.975 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -103.98 152.37 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 11.64 111.156 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.76 101.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.772 -0.649 . . . . 6.66 109.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -89.43 133.56 34.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.182 0.438 . . . . 6.86 112.182 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -103.15 160.0 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.786 -0.643 . . . . 3.79 111.158 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.546 HD22 ' HE1' ' B' ' 43' ' ' TRP . 3.8 pp -64.78 -24.72 67.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.047 -0.524 . . . . 5.48 111.178 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.448 ' N ' HD12 ' A' ' 8' ' ' LEU . 77.1 p -67.79 -35.88 79.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.288 -0.415 . . . . 7.65 110.985 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.69 3.64 7.68 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.109 -0.567 . . . . 7.08 112.675 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -99.65 126.64 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.275 0.472 . . . . 6.58 112.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.8 m -101.07 133.67 45.24 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.712 -0.676 . . . . 6.95 109.467 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 13' ' ' ILE . 4.6 mp -117.59 142.03 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 5.97 111.68 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -100.21 135.87 40.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.717 -0.674 . . . . 8.28 110.029 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.465 HD11 HG12 ' A' ' 30' ' ' ILE . 35.9 mt -134.58 155.22 50.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.525 -0.307 . . . . 10.02 110.959 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -123.0 99.82 6.57 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.199 -0.455 . . . . 12.19 111.028 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 17' ' ' VAL . 11.2 p -153.04 115.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.542 -0.299 . . . . 14.73 111.731 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 43.6 mt-10 -51.46 168.77 0.25 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 113.867 1.062 . . . . 18.57 113.867 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 16.7 Cg_exo -69.39 -23.19 32.76 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.572 2.848 . . . . 19.89 113.344 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -84.12 28.96 0.58 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.673 0.273 . . . . 21.46 111.546 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -116.58 139.83 50.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.428 -0.351 . . . . 18.56 110.839 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 81.4 p -73.76 151.37 40.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 20.15 111.41 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.25 -36.54 69.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.352 -0.386 . . . . 16.47 110.384 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -43.15 99.53 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.4 -0.593 . . . . 19.99 109.4 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -60.62 -43.21 97.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.789 -0.641 . . . . 16.38 110.081 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 56' ' ' LEU . 93.3 t -62.57 -42.5 96.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.937 -0.574 . . . . 13.8 110.4 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.01 -28.7 69.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.125 -0.489 . . . . 13.67 110.421 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.32 -38.89 71.68 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.59 -0.522 . . . . 14.55 109.59 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -62.93 -48.47 78.77 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.598 -0.728 . . . . 13.7 109.367 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.465 HG12 HD11 ' A' ' 15' ' ' LEU . 79.7 mt -61.1 -42.67 94.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.518 -0.764 . . . . 9.57 109.904 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -60.38 -28.41 68.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.602 -0.727 . . . . 15.04 110.833 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -75.74 -36.57 59.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 12.47 110.936 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.45 -64.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.05 -0.523 . . . . 9.23 112.035 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -78.49 -8.36 58.46 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.719 1.007 . . . . 9.6 113.719 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.66 26.96 67.45 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.388 -0.911 . . . . 12.2 113.416 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.8 mt -98.27 118.59 63.31 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.799 0.299 . . . . 11.27 110.559 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.99 135.97 51.95 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.583 2.188 . . . . 14.23 112.219 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.79 -29.32 76.74 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.219 . . . . 14.34 112.046 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.1 -24.63 66.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.886 -0.597 . . . . 16.96 111.036 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -99.28 -16.3 18.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.025 -0.534 . . . . 14.45 110.979 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -80.03 123.8 28.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.005 0.431 . . . . 10.91 111.769 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.493 ' HB3' HG13 ' A' ' 70' ' ' VAL . 47.8 ttp180 -122.21 121.99 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.337 -0.986 . . . . 9.32 108.337 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 50' ' ' LEU . 92.2 mt -106.11 129.69 54.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.024 0.44 . . . . 10.56 112.031 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mt -116.17 121.03 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 9.75 110.52 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.689 ' HB3' HD21 ' A' ' 50' ' ' LEU . 72.2 t80 -128.05 117.29 21.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 15.27 110.57 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.58 22.14 10.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 14.76 111.392 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -10.25 67.47 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.01 -0.614 . . . . 12.99 112.767 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.07 -163.04 0.08 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.244 0.218 . . . . 17.08 111.124 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.42 -13.51 6.59 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.711 1.004 . . . . 14.97 113.711 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.689 HD21 ' HB3' ' A' ' 45' ' ' PHE . 2.2 mm? 58.5 106.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.788 0.328 . . . . 14.81 111.421 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -92.13 130.23 37.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.337 -0.392 . . . . 21.0 111.601 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -40.23 -60.37 1.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.82 -0.627 . . . . 18.5 111.35 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -50.75 -75.49 0.21 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.529 -0.843 . . . . 21.79 111.552 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' GLY . 32.4 mmt180 -27.53 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.479 0.918 . . . . 24.16 113.479 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 6.3 t -111.72 164.04 13.47 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.154 -0.93 . . . . 21.36 111.093 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.3 mm? -51.72 -44.29 63.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.344 -0.389 . . . . 18.41 111.2 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 t -58.33 -29.37 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.14 -0.482 . . . . 21.76 111.602 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.85 -35.6 81.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.33 . . . . 23.14 110.892 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -98.68 11.84 37.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 19.37 111.327 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 58.11 38.26 26.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.907 0.384 . . . . 22.24 111.317 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.32 115.96 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 17.93 110.864 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -109.35 -168.68 1.36 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.849 -0.614 . . . . 21.49 110.948 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -61.84 160.71 11.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 19.19 111.338 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 57.99 29.81 18.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.853 -0.612 . . . . 16.92 111.701 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.0 p -89.79 138.1 31.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 14.92 111.299 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.49 ' C ' HD12 ' A' ' 67' ' ' LEU . 76.0 p -99.94 127.25 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 11.29 110.797 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 66' ' ' THR . 8.2 mp -122.46 121.26 36.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.406 . . . . 10.94 110.884 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 8.09 110.941 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -94.9 113.89 25.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 6.7 110.244 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -118.7 143.45 29.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 7.13 110.993 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 71' ' ' LEU . 2.2 mm? -105.0 148.15 27.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.919 -0.582 . . . . 8.31 110.3 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.421 ' HD3' ' CZ ' ' A' ' 42' ' ' ARG . 27.9 mmm180 -127.34 104.46 7.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 14.22 110.375 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 73' ' ' LEU . 2.0 pt? -144.94 -150.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 13.68 110.226 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -55.14 92.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.034 0.445 . . . . 20.03 110.285 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.9 -157.41 22.4 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.754 -0.657 . . . . 17.34 112.13 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.396 -1.224 . . . . 17.6 112.501 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.136 0.493 . . . . 9.15 110.951 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -171.2 124.98 0.63 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.375 -0.829 . . . . 10.58 109.863 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -127.95 104.55 7.86 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.763 -0.653 . . . . 7.56 109.365 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.05 173.02 12.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 7.84 111.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.479 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 7.5 p -148.23 151.69 35.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.7 -0.682 . . . . 4.73 111.527 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -99.6 141.33 32.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.29 -0.414 . . . . 4.43 110.033 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 46.2 p -84.56 123.69 30.59 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.373 -0.376 . . . . 2.72 111.557 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 31.9 mt -88.81 -21.03 23.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 3.78 110.514 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -148.53 156.25 42.08 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 4.88 110.703 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.04 143.62 36.51 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.608 2.205 . . . . 3.11 113.027 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' B' ' 15' ' ' TYR . 11.9 t80 -130.58 68.67 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 4.0 110.377 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.895 ' HA ' HG23 ' B' ' 24' ' ' THR . 90.1 m -53.92 115.4 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 3.82 110.707 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.61 140.01 47.16 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.772 -0.649 . . . . 3.22 112.181 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -102.68 -24.37 13.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.148 0.499 . . . . 4.64 110.925 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -119.11 165.14 14.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.491 -0.777 . . . . 4.05 110.324 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.33 -38.61 78.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.492 . . . . 4.26 111.781 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.57 -6.01 43.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.884 0.373 . . . . 4.22 110.6 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.99 162.63 15.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.779 -0.646 . . . . 3.77 110.868 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 23' ' ' LEU . 36.3 mt -108.47 150.8 26.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.197 -0.668 . . . . 3.13 109.197 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.895 HG23 ' HA ' ' B' ' 16' ' ' THR . 32.1 m -114.15 127.41 55.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 2.46 110.155 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.558 ' CE1' HG12 ' B' ' 31' ' ' ILE . 50.3 m-85 -133.28 144.97 50.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.037 0.754 . . . . 2.49 113.037 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.492 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 11.1 ptp180 -109.42 176.49 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.698 -0.853 . . . . 6.21 108.698 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.27 126.41 31.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.65 0.738 . . . . 3.87 109.921 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 26.2 7.14 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.347 -1.297 . . . . 4.23 110.734 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 23.3 mm-40 -98.53 178.9 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.773 1.027 . . . . 4.19 113.773 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 mm -135.95 116.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.557 -1.656 . . . . 5.23 110.826 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.558 HG12 ' CE1' ' B' ' 25' ' ' PHE . 53.7 mt -108.36 132.21 56.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.044 -0.525 . . . . 4.64 111.446 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -91.67 125.53 36.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.029 -0.73 . . . . 7.14 109.029 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.82 100.67 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 6.33 110.966 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 45.4 mm -82.73 -58.31 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 6.97 110.972 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 66.8 m -157.18 105.89 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 7.03 111.656 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.437 ' NZ ' ' HB2' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -66.66 5.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 7.52 111.896 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -121.19 102.03 8.04 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 120.562 0.22 . . . . 8.93 110.459 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.443 HG22 ' HB2' ' B' ' 45' ' ' LYS . 42.9 p -110.71 -4.66 15.24 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.488 -0.323 . . . . 7.05 111.713 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.54 -1.2 71.89 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.967 -0.635 . . . . 8.42 112.446 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -129.45 120.54 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.189 -0.3 . . . . 7.96 110.189 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.03 132.74 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 8.2 111.108 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 1.57 81.79 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.688 -0.687 . . . . 6.68 112.394 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.622 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 53.6 m95 -120.78 123.15 41.94 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.937 0.398 . . . . 5.83 111.731 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' TRP . . . . . 0.414 ' NE1' ' HB2' ' B' ' 36' ' ' LYS . 3.7 m0 -112.93 161.43 17.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.062 -0.718 . . . . 5.87 109.062 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.443 ' HB2' HG22 ' B' ' 38' ' ' THR . 64.1 tttp -116.07 130.56 56.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.09 0.471 . . . . 5.33 111.216 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.54 175.45 21.22 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.407 -0.815 . . . . 4.14 111.562 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -125.1 132.66 53.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.223 0.535 . . . . 6.02 110.32 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.627 ' O ' ' N ' ' B' ' 50' ' ' GLY . 60.0 tp -124.87 169.22 12.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.219 -0.901 . . . . 4.21 110.224 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.519 ' N ' ' HG ' ' B' ' 48' ' ' LEU . 62.5 m-20 -18.62 67.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.283 1.586 . . . . 5.39 115.283 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.98 -10.22 63.64 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.981 0.753 . . . . 5.53 114.981 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -110.38 155.11 22.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.92 0.86 . . . . 5.33 111.045 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' B' ' 52' ' ' GLU . 0.0 OUTLIER -127.58 140.29 52.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.909 -0.774 . . . . 5.79 108.909 178.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.8 -175.46 40.71 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.041 -1.076 . . . . 3.35 113.455 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.21 150.02 15.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.451 0.167 . . . . 4.3 111.076 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 50.6 p90 -134.97 140.45 35.06 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.049 0.452 . . . . 3.72 112.167 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.622 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 87.6 Cg_endo -95.09 174.61 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.458 3.439 . . . . 3.97 111.641 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.567 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 18.6 m-20 78.09 -12.83 1.03 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.255 1.576 . . . . 5.85 115.255 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 14.9 m120 56.27 77.57 0.24 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.832 0.742 . . . . 5.67 109.103 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.9 m-85 -101.87 6.84 41.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.382 -0.826 . . . . 3.89 111.694 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.479 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -137.78 138.22 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.575 0.583 . . . . 3.89 112.575 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.69 130.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.866 -0.606 . . . . 4.64 111.77 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.405 HE22 ' C ' ' B' ' 64' ' ' SER . 0.0 OUTLIER -59.85 132.2 53.23 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.749 -0.463 . . . . 6.72 109.749 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 24.7 pt -139.31 37.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.924 0.392 . . . . 6.54 111.626 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . 0.405 ' C ' HE22 ' B' ' 62' ' ' GLN . 30.4 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.23 -0.89 . . . . 7.43 110.85 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.605 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 95.2 mtp . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.836 0.35 . . . . 16.5 110.786 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -81.55 151.75 27.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.821 -0.627 . . . . 13.22 110.786 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 pt -143.7 146.75 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 12.19 110.341 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -95.82 139.17 32.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 11.64 110.503 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.32 91.33 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.45 -0.574 . . . . 6.66 109.45 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -79.14 153.29 30.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.843 -0.617 . . . . 6.86 111.678 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 8' ' ' LEU . 24.6 m -133.6 159.82 39.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 3.79 109.398 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.819 ' H ' HD22 ' A' ' 8' ' ' LEU . 2.0 mm? -58.67 -37.95 77.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.944 0.402 . . . . 5.48 110.761 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.9 m -61.14 -22.35 64.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.812 -0.631 . . . . 7.65 111.262 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.36 17.66 21.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.079 -0.582 . . . . 7.08 112.141 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -99.38 110.37 22.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.299 . . . . 6.58 111.189 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -98.64 129.67 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 6.95 110.028 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 13' ' ' ILE . 4.4 mp -118.96 144.67 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.954 0.406 . . . . 5.97 111.285 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.5 p -96.6 136.54 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 8.28 110.867 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.1 tp -137.64 151.47 48.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.317 -0.401 . . . . 10.02 110.284 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.96 105.24 13.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.63 -0.259 . . . . 12.19 111.474 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -152.83 112.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.436 0.532 . . . . 14.73 112.436 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 1.5 mp0 -56.63 172.89 0.33 Allowed Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 112.881 0.696 . . . . 18.57 112.881 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 30.1 Cg_exo -63.99 -37.47 43.2 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.42 2.746 . . . . 19.89 112.73 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -63.67 -25.55 68.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 21.46 111.541 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.4 147.59 25.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.472 -0.331 . . . . 18.56 111.188 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -93.89 145.51 24.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.059 -0.519 . . . . 20.15 110.948 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 50' ' ' LEU . 24.8 mt -55.93 -31.8 31.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 16.47 111.505 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.28 -38.68 90.28 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.943 -0.391 . . . . 19.99 109.943 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -69.84 -40.72 75.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.966 -0.561 . . . . 16.38 109.95 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -54.28 -49.79 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 115.977 -0.556 . . . . 13.8 110.355 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HE2' HD13 ' A' ' 43' ' ' LEU . 97.7 mttt -59.07 -37.5 77.22 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.079 -0.509 . . . . 13.67 110.975 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.18 -38.28 87.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.294 -0.412 . . . . 14.55 110.944 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.59 -43.29 80.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.122 -0.49 . . . . 13.7 110.192 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.88 -36.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.143 -0.48 . . . . 9.57 109.772 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.432 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 59.0 tt0 -67.07 -29.17 68.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.898 -0.592 . . . . 15.04 111.164 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.3 -37.62 74.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.631 0.253 . . . . 12.47 111.119 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -89.82 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.12 0.415 . . . . 9.23 112.12 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -83.15 -9.44 59.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.112 0.782 . . . . 9.6 113.112 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 62.54 25.02 66.64 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.427 -0.892 . . . . 12.2 113.208 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.1 mt -97.39 116.62 65.92 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.792 0.296 . . . . 11.27 110.829 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.95 138.71 70.07 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.698 2.266 . . . . 14.23 112.438 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.97 -22.7 55.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.585 2.19 . . . . 14.34 112.191 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.58 -25.28 66.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.535 . . . . 16.96 111.311 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -106.9 -5.48 18.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.368 -0.378 . . . . 14.45 111.572 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -88.95 127.0 35.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.948 0.404 . . . . 10.91 111.923 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 17.0 tpt180 -125.12 121.78 35.25 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.852 -0.796 . . . . 9.32 108.852 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.405 HD13 ' HE2' ' A' ' 27' ' ' LYS . 9.4 mp -102.8 126.55 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 10.56 111.186 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -112.65 129.76 67.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 9.75 110.406 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 50' ' ' LEU . 67.5 t80 -147.36 124.41 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.901 -0.591 . . . . 15.27 110.421 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.8 17.51 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 14.76 111.454 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.52 -3.62 81.79 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.786 -0.721 . . . . 12.99 112.593 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -113.22 150.32 32.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.778 0.323 . . . . 17.08 110.982 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -83.24 124.94 31.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 14.97 110.506 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 23' ' ' ILE . 48.9 mt -64.7 131.65 47.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 14.81 111.109 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.4 tp10 -90.31 127.29 36.12 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.996 -0.547 . . . . 21.0 110.917 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -41.45 34.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.599 -0.728 . . . . 18.5 112.301 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -0.12 83.79 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.982 -0.628 . . . . 21.79 114.208 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 51' ' ' GLU . 2.2 mpt_? -99.69 173.95 6.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.044 0.422 . . . . 24.16 110.961 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.2 p -119.19 158.21 26.43 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.22 -0.445 . . . . 21.36 111.04 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 8.4 mp -52.97 -28.91 26.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 18.41 111.826 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 p -72.78 -21.77 60.94 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.735 0.303 . . . . 21.76 111.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.58 -42.37 87.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.193 -0.458 . . . . 23.14 110.958 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.2 10.18 32.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.251 -0.431 . . . . 19.37 111.579 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.81 24.27 11.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.48 0.548 . . . . 22.24 112.48 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -57.56 155.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.721 -0.474 . . . . 17.93 109.721 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -149.59 165.63 31.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.737 -0.468 . . . . 21.49 109.737 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -52.4 146.98 8.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 19.19 111.506 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.56 30.04 10.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.869 -0.605 . . . . 16.92 111.776 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.1 p -86.72 160.9 18.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 14.92 110.898 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.6 m -115.48 124.74 51.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 11.29 110.635 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.4 mm? -113.39 122.45 47.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.23 -0.441 . . . . 10.94 110.294 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 23.4 t60 -85.94 112.82 21.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 8.09 111.078 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.4 tp -94.56 118.12 31.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.009 -0.541 . . . . 6.7 110.737 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.622 HG22 HD21 ' A' ' 8' ' ' LEU . 39.5 t -140.72 166.57 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 7.13 110.881 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.577 ' N ' HG12 ' A' ' 70' ' ' VAL . 6.9 mp -93.86 128.6 40.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.359 -0.382 . . . . 8.31 110.122 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -72.42 -146.03 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.56 -0.291 . . . . 14.22 110.257 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.9 mt -50.47 101.85 0.04 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.941 0.4 . . . . 13.68 110.444 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' C ' ' HD3' ' A' ' 74' ' ' ARG . 2.4 tmt_? -175.15 -48.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 20.03 109.866 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.83 -116.23 1.8 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.683 -0.689 . . . . 17.34 111.999 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.207 -1.33 . . . . 17.6 112.161 179.908 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.341 0.115 . . . . 9.15 110.967 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.429 ' HB2' ' CE2' ' B' ' 8' ' ' TYR . 74.6 mmtt -111.43 176.66 4.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.294 0.568 . . . . 10.58 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.55 129.2 55.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.233 -0.894 . . . . 7.56 109.383 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . 0.429 ' CE2' ' HB2' ' B' ' 6' ' ' LYS . 90.3 m-85 -130.44 169.36 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.978 0.418 . . . . 7.84 111.622 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.581 ' SG ' ' HB ' ' B' ' 31' ' ' ILE . 9.5 p -149.02 151.86 35.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 4.73 111.114 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -99.22 143.38 29.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.211 -0.45 . . . . 4.43 110.835 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.453 HG21 ' HB3' ' B' ' 25' ' ' PHE . 41.7 p -84.7 125.23 32.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.165 -0.47 . . . . 2.72 111.84 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.54 -21.85 20.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.327 -0.397 . . . . 3.78 111.379 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -140.26 160.64 59.08 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 120.714 0.292 . . . . 4.88 111.622 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' ' 26' ' ' ARG . 92.6 Cg_endo -81.23 71.61 6.88 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.86 2.373 . . . . 3.11 113.619 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -64.58 127.65 32.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.042 -0.526 . . . . 4.0 111.309 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.54 ' HA ' HG23 ' B' ' 24' ' ' THR . 30.1 m -112.97 120.19 40.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.505 -0.316 . . . . 3.82 111.39 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.09 138.41 47.87 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.962 -0.637 . . . . 3.22 111.932 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.515 HG23 ' ND2' ' B' ' 19' ' ' ASN . 13.4 t -104.26 -24.58 13.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.936 0.398 . . . . 4.64 111.536 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.515 ' ND2' HG23 ' B' ' 18' ' ' THR . 40.8 m-80 -116.37 162.88 16.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.785 -0.643 . . . . 4.05 110.052 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.14 -41.05 86.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.211 -0.449 . . . . 4.26 111.044 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.48 -4.89 36.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.088 0.47 . . . . 4.22 109.961 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -83.34 156.87 22.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.53 -0.759 . . . . 3.77 110.62 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.758 HD13 ' H ' ' B' ' 24' ' ' THR . 0.4 OUTLIER -107.11 146.61 31.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.803 -1.184 . . . . 3.13 107.803 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.758 ' H ' HD13 ' B' ' 23' ' ' LEU . 53.3 m -111.83 128.08 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 2.46 110.352 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.6 ' CZ ' HD12 ' B' ' 23' ' ' LEU . 73.3 m-85 -128.02 128.62 45.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.323 0.49 . . . . 2.49 112.323 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.497 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 24.4 mmm180 -100.58 174.37 6.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.285 -0.635 . . . . 6.21 109.285 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -81.71 137.7 35.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.169 0.509 . . . . 3.87 110.229 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.24 21.65 51.21 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.704 -0.958 . . . . 4.23 110.704 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 21.6 mm-40 -99.36 -179.81 4.34 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.393 0.886 . . . . 4.19 113.393 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 25.2 mm -135.07 118.7 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.83 -1.532 . . . . 5.23 110.748 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.581 ' HB ' ' SG ' ' B' ' 9' ' ' CYS . 17.3 mt -112.23 136.74 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.911 -0.586 . . . . 4.64 112.1 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -95.06 125.8 39.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.901 -0.777 . . . . 7.14 108.901 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.466 ' C ' HD23 ' B' ' 33' ' ' LEU . 4.3 tt -74.34 105.89 5.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 6.33 111.622 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' B' ' 47' ' ' GLU . 75.5 mt -80.8 -65.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.577 -0.738 . . . . 6.97 110.793 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.9 m -153.08 129.65 10.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.86 -0.609 . . . . 7.03 111.929 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.403 ' HE3' ' CZ2' ' B' ' 44' ' ' TRP . 48.9 mtpt -84.04 6.44 22.08 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.901 -0.591 . . . . 7.52 111.535 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 94.84 4.46 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.224 -0.287 . . . . 8.93 110.224 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 76.2 p -104.81 -1.96 25.41 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.413 -0.358 . . . . 7.05 111.706 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.3 -3.18 72.15 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.974 -0.632 . . . . 8.42 112.452 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -135.41 124.42 24.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.767 0.318 . . . . 7.96 110.49 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.07 57.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 8.2 110.881 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.59 2.38 82.2 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.639 -0.709 . . . . 6.68 112.404 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' B' ' 56' ' ' PRO . 69.5 m95 -119.12 121.64 40.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.901 0.381 . . . . 5.83 111.443 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' TRP . . . . . 0.403 ' CZ2' ' HE3' ' B' ' 36' ' ' LYS . 36.5 m0 -113.07 168.57 9.59 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.813 -0.81 . . . . 5.87 108.813 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -125.11 129.65 50.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.783 0.325 . . . . 5.33 110.704 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.11 174.69 21.79 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.812 -0.709 . . . . 4.14 112.316 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.493 ' HB2' HD11 ' B' ' 34' ' ' ILE . 34.0 tt0 -125.7 133.25 52.2 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.225 0.536 . . . . 6.02 110.728 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 50' ' ' GLY . 28.6 tp -127.93 171.18 12.04 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.184 -0.916 . . . . 4.21 109.889 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.461 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 14.2 m120 -17.81 67.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.43 1.641 . . . . 5.39 115.43 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.6 -10.02 63.26 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 115.128 0.811 . . . . 5.53 115.128 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -109.94 154.41 23.16 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.15 0.975 . . . . 5.33 111.197 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.68 140.79 51.86 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.996 -0.742 . . . . 5.79 108.996 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.33 -176.03 42.38 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.012 -1.089 . . . . 3.35 113.358 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.82 152.72 15.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.432 0.158 . . . . 4.3 110.985 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' B' ' 56' ' ' PRO . 52.3 p90 -136.56 141.02 33.95 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.384 0.513 . . . . 3.72 112.384 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' B' ' 57' ' ' ASP . 95.2 Cg_endo -94.99 174.73 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.498 3.465 . . . . 3.97 111.275 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.566 ' HB2' ' CE2' ' B' ' 59' ' ' PHE . 24.2 m-20 75.43 -11.01 1.15 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.079 1.511 . . . . 5.85 115.079 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 56.33 76.63 0.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.829 -0.804 . . . . 5.67 108.829 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' B' ' 57' ' ' ASP . 28.1 m-85 -100.9 8.27 43.2 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.16 -0.927 . . . . 3.89 111.553 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.473 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -136.89 138.63 40.9 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.664 0.616 . . . . 3.89 112.664 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -113.42 127.17 70.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 4.64 111.296 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -54.47 108.23 0.36 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.851 0.358 . . . . 6.72 110.503 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 22.8 pt -88.29 -36.37 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 6.54 110.934 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.38 -0.819 . . . . 7.43 110.746 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.01 0.433 . . . . 16.5 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -84.22 149.9 25.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.822 -0.626 . . . . 13.22 110.537 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -144.04 149.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 12.19 110.692 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.34 136.32 42.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 11.64 110.479 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 40.8 t -121.19 96.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.574 -0.528 . . . . 6.66 109.574 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 7' ' ' THR . 52.5 tttm -77.34 162.99 26.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.672 -0.694 . . . . 6.86 111.527 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.42 ' N ' ' CG ' ' A' ' 6' ' ' LYS . 56.8 p -142.16 160.99 39.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.467 -0.788 . . . . 3.79 110.175 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 8' ' ' LEU . 2.3 pt? -64.33 -22.76 67.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 5.48 111.175 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -81.82 -12.37 58.54 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.263 -0.426 . . . . 7.65 111.618 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 16.69 41.79 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.886 -0.673 . . . . 7.08 112.547 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -97.86 108.31 20.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.899 0.38 . . . . 6.58 111.354 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 p -100.06 126.01 46.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 6.95 110.256 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.427 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 36.1 pt -120.83 146.55 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.39 . . . . 5.97 111.253 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.5 p -97.06 140.46 31.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.87 -0.605 . . . . 8.28 111.123 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 29' ' ' LYS . 63.2 tp -138.4 149.7 45.79 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.247 -0.433 . . . . 10.02 110.258 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -109.46 103.79 12.75 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.872 0.323 . . . . 12.19 111.872 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -153.83 112.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.268 -0.424 . . . . 14.73 111.615 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.521 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . 25.0 mt-10 -63.71 173.32 1.35 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.708 0.633 . . . . 18.57 112.708 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.588 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 50.7 Cg_exo -57.98 -42.35 59.08 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 123.333 2.688 . . . . 19.89 113.741 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.0 m -60.42 -23.99 64.83 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.039 0.385 . . . . 21.46 112.039 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.31 148.48 32.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.845 0.355 . . . . 18.56 111.276 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -92.74 145.87 24.08 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.107 -0.497 . . . . 20.15 111.14 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.42 HD13 ' O ' ' A' ' 54' ' ' ARG . 1.1 mp -55.82 -34.49 37.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 16.47 111.205 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.2 -41.07 98.02 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.894 -0.41 . . . . 19.99 109.894 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.22 -37.49 85.68 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.825 -0.625 . . . . 16.38 110.035 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.8 t -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 CA-C-N 116.152 -0.476 . . . . 13.8 110.037 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -58.61 -34.71 71.45 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.888 -0.597 . . . . 13.67 110.628 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 31' ' ' GLN . . . -68.23 -34.64 76.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 14.55 111.102 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HB3' HD11 ' A' ' 15' ' ' LEU . 79.7 mttt -73.71 -38.46 64.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 13.7 110.383 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.446 ' CG2' HD11 ' A' ' 36' ' ' ILE . 85.7 mt -65.01 -40.11 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 9.57 110.742 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 21.1 pt20 -69.72 -19.39 63.55 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.61 -0.268 . . . . 15.04 111.226 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -75.27 -35.33 61.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 12.47 110.467 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -93.1 -53.81 3.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.992 -0.549 . . . . 9.23 112.021 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.69 -11.62 55.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.842 0.682 . . . . 9.6 112.842 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 5.08 52.09 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.556 -0.83 . . . . 12.2 114.015 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.446 HD11 ' CG2' ' A' ' 30' ' ' ILE . 22.2 pt -79.82 128.91 72.67 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 117.355 0.578 . . . . 11.27 111.02 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.56 142.66 59.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.572 2.181 . . . . 14.23 112.738 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.31 -24.66 64.74 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.881 2.387 . . . . 14.34 112.109 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.59 -24.9 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.894 -0.594 . . . . 16.96 111.142 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -108.59 -7.03 15.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.302 -0.408 . . . . 14.45 111.469 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -80.95 126.48 31.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 10.91 111.547 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -124.29 112.07 16.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 9.32 109.327 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.4 mp -98.06 124.59 42.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 10.56 111.16 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.523 HD12 HG21 ' B' ' 18' ' ' THR . 16.8 mm -113.71 131.52 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.833 -0.621 . . . . 9.75 110.646 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -147.53 119.22 8.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.846 -0.616 . . . . 15.27 110.439 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.35 29.97 9.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.993 -0.549 . . . . 14.76 112.154 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.37 -3.69 76.48 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.426 -0.892 . . . . 12.99 113.239 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -114.84 146.84 40.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.803 0.335 . . . . 17.08 111.116 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -82.49 128.75 34.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 14.97 110.381 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.76 130.62 43.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 14.81 110.995 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.48 123.89 33.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.927 -0.578 . . . . 21.0 111.017 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -36.26 -57.18 0.74 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.992 -0.549 . . . . 18.5 111.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . -52.93 -75.04 0.24 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.771 -0.728 . . . . 21.79 112.019 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.42 ' O ' HD13 ' A' ' 23' ' ' ILE . 29.5 mmt180 -29.17 158.11 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.911 1.078 . . . . 24.16 113.911 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.8 p -111.4 165.72 11.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.087 -0.96 . . . . 21.36 111.322 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.5 mm? -53.42 -32.48 49.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.189 -0.46 . . . . 18.41 111.86 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -70.05 -21.7 63.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.653 0.263 . . . . 21.76 111.5 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.97 -38.45 86.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 23.14 111.041 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -97.91 8.47 44.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 19.37 111.615 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 59.3 46.96 12.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.954 0.407 . . . . 22.24 111.137 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.03 107.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 17.93 110.912 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.66 -178.87 5.19 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.016 -0.538 . . . . 21.49 110.936 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.55 157.06 33.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.835 0.35 . . . . 19.19 111.124 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 63.2 24.95 14.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.809 -0.632 . . . . 16.92 111.684 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -85.78 161.18 19.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.712 0.292 . . . . 14.92 110.814 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.417 ' C ' HD12 ' A' ' 67' ' ' LEU . 4.5 t -116.73 126.85 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 11.29 110.84 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.6 mp -115.27 121.48 43.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 10.94 110.164 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -83.96 112.47 20.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.944 0.402 . . . . 8.09 111.778 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.403 HD21 HD12 ' A' ' 36' ' ' ILE . 65.4 tp -91.8 119.71 31.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 6.7 109.62 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.4 ' C ' HD12 ' A' ' 71' ' ' LEU . 20.7 m -131.67 169.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.241 0.544 . . . . 7.13 112.346 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 71' ' ' LEU . 5.6 mp -126.65 134.47 50.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.277 -0.874 . . . . 8.31 110.219 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -76.27 78.2 3.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 14.22 111.073 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 75' ' ' GLY . 66.6 mt -121.81 68.86 0.92 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.112 -0.494 . . . . 13.68 110.77 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.477 ' NH1' HG22 ' B' ' 38' ' ' THR . 4.2 tmt_? 70.78 -18.06 0.27 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.912 -0.586 . . . . 20.03 111.6 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 73' ' ' LEU . . . -153.26 61.76 0.38 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.839 -0.696 . . . . 17.34 112.604 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.419 -1.212 . . . . 17.6 112.429 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.454 0.169 . . . . 9.15 111.061 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.84 173.26 6.42 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.067 0.46 . . . . 10.58 110.753 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -102.21 130.94 49.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.834 -0.802 . . . . 7.56 108.834 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -124.76 159.92 29.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.234 0.54 . . . . 7.84 111.828 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' HB1' ' B' ' 60' ' ' ALA . 16.8 m -141.14 146.35 36.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.186 -0.915 . . . . 4.73 110.569 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -100.47 133.23 45.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 4.43 110.199 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.3 m -73.85 127.13 32.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.332 -0.394 . . . . 2.72 110.913 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.8 mt -95.87 -22.1 17.66 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.144 0.424 . . . . 3.78 112.144 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -142.66 154.51 62.99 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 117.981 0.355 . . . . 4.88 111.614 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' B' ' 25' ' ' PHE . 74.2 Cg_endo -75.01 136.25 20.12 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.525 2.15 . . . . 3.11 112.913 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -139.16 129.12 25.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 4.0 109.883 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 31.8 m -110.84 121.35 45.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.85 0.357 . . . . 3.82 110.617 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.73 128.76 43.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.98 -0.629 . . . . 3.22 112.586 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.523 HG21 HD12 ' A' ' 44' ' ' ILE . 5.3 t -103.16 -23.07 13.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.182 0.515 . . . . 4.64 110.63 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -119.89 159.41 24.7 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.123 -0.944 . . . . 4.05 109.853 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -61.5 -29.13 69.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.386 0.513 . . . . 4.26 112.386 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -86.53 -2.64 58.64 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.945 -0.302 . . . . 4.22 111.682 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.55 160.17 16.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.359 . . . . 3.77 111.281 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.602 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -117.24 165.46 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.246 -0.65 . . . . 3.13 109.246 178.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 61.7 m -115.42 128.65 56.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 2.46 110.187 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 23' ' ' LEU . 10.8 m-85 -131.92 133.43 44.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.301 0.482 . . . . 2.49 112.301 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.53 176.26 5.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.826 -0.435 . . . . 6.21 109.826 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.21 136.68 35.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 3.87 110.323 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.79 55.42 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.571 -0.74 . . . . 4.23 111.318 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -100.13 179.72 4.4 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.877 1.066 . . . . 4.19 113.877 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.49 136.11 60.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 113.781 -1.554 . . . . 5.23 111.129 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.455 HD12 ' HB2' ' B' ' 60' ' ' ALA . 35.8 mt -132.86 133.09 59.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 4.64 111.207 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -90.21 126.49 35.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.58 -0.526 . . . . 7.14 109.58 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.531 ' C ' HD23 ' B' ' 33' ' ' LEU . 4.3 tt -73.47 102.08 3.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.995 0.426 . . . . 6.33 111.149 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 23.5 mm -84.08 -61.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.765 -0.652 . . . . 6.97 111.418 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 48.2 t -155.17 108.5 2.81 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.194 0.442 . . . . 7.03 112.194 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.475 ' HG3' HD21 ' B' ' 33' ' ' LEU . 38.3 mtmm -65.95 5.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.598 . . . . 7.52 111.722 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.44 101.07 7.39 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 120.535 0.207 . . . . 8.93 110.678 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.477 HG22 ' NH1' ' A' ' 74' ' ' ARG . 68.8 p -111.11 -4.38 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.449 -0.341 . . . . 7.05 111.184 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.18 -1.77 62.99 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.018 -0.611 . . . . 8.42 112.014 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.77 120.89 27.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.811 0.338 . . . . 7.96 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.79 56.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 8.2 110.962 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.63 1.56 85.41 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.826 -0.625 . . . . 6.68 112.421 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.408 ' HE1' ' HB3' ' A' ' 8' ' ' LEU . 83.6 m95 -123.31 120.39 32.95 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.289 0.544 . . . . 5.83 111.751 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' TRP . . . . . 0.565 ' HB2' ' CZ ' ' B' ' 55' ' ' PHE . 37.4 m0 -108.43 166.33 10.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.515 -0.766 . . . . 5.87 109.494 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.444 ' HB2' HG22 ' B' ' 38' ' ' THR . 45.4 tptt -117.28 131.64 56.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.959 0.409 . . . . 5.33 110.98 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.56 175.33 21.53 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.454 -0.794 . . . . 4.14 111.752 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.61 134.75 50.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.196 0.522 . . . . 6.02 110.629 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 50' ' ' GLY . 2.6 mt -130.9 171.73 12.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.105 -0.952 . . . . 4.21 110.159 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.446 ' ND2' HD22 ' B' ' 48' ' ' LEU . 11.8 m-80 -17.35 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.127 1.529 . . . . 5.39 115.127 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.54 -12.79 50.3 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 114.319 0.488 . . . . 5.53 114.319 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.07 133.79 54.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.314 0.557 . . . . 5.33 111.337 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.545 ' C ' HD23 ' B' ' 23' ' ' LEU . 11.5 pt-20 -107.11 146.72 30.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.958 -0.565 . . . . 5.79 110.344 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.51 -177.85 38.73 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.663 -0.78 . . . . 3.35 112.855 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.406 ' CG1' HG21 ' B' ' 38' ' ' THR . 34.8 m -112.99 160.51 12.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.453 0.538 . . . . 4.3 112.453 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' B' ' 44' ' ' TRP . 3.0 p90 -124.79 157.49 65.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.375 -0.83 . . . . 3.72 110.807 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.03 123.02 2.65 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.69 2.26 . . . . 3.97 115.865 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p30 51.02 45.02 28.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.638 1.347 . . . . 5.85 114.638 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 m120 62.7 88.64 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.772 1.027 . . . . 5.67 113.772 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.1 16.26 27.1 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.908 -0.775 . . . . 3.89 108.908 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 9' ' ' CYS . . . -142.64 138.49 30.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.81 0.3 . . . . 3.89 111.81 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.5 p -110.17 120.77 61.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 116.352 -0.385 . . . . 4.64 111.323 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.452 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 34.1 tt0 -51.51 150.86 3.43 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 121.023 0.44 . . . . 6.72 111.062 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.98 -37.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.671 . . . . 6.54 110.403 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.237 -0.887 . . . . 7.43 110.55 179.668 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttt . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.92 0.391 . . . . 16.5 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -82.93 152.7 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.587 . . . . 13.22 109.916 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 pt -145.32 150.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 12.19 110.249 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -102.73 135.15 44.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.189 -0.46 . . . . 11.64 110.691 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.37 99.4 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.327 -0.62 . . . . 6.66 109.327 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HG2' ' CG2' ' A' ' 12' ' ' THR . 6.7 tmtt? -86.81 111.78 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 6.86 111.663 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.2 p -84.83 -178.48 6.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 3.79 110.699 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 9' ' ' THR . 2.6 pp -85.93 -10.65 54.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.546 -0.297 . . . . 5.48 111.68 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.44 ' N ' HD12 ' A' ' 8' ' ' LEU . 8.8 t -97.29 21.06 10.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.928 0.394 . . . . 7.65 110.684 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.62 13.09 65.26 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.911 -0.662 . . . . 7.08 112.377 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -96.1 112.05 23.9 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.054 0.454 . . . . 6.58 111.933 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.418 ' CG2' ' HG2' ' A' ' 6' ' ' LYS . 31.4 p -104.28 122.39 45.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.647 -0.706 . . . . 6.95 110.012 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.1 pt -114.75 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.382 . . . . 5.97 111.114 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.5 p -87.72 135.31 33.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 8.28 110.36 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tp -134.67 146.45 49.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 10.02 110.556 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -102.67 130.92 49.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 12.19 110.498 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.76 -174.21 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.167 0.508 . . . . 14.73 111.575 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -138.97 145.95 47.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.585 -0.734 . . . . 18.57 109.044 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.09 -23.18 12.07 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.332 2.021 . . . . 19.89 112.709 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -87.85 -23.85 23.87 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 21.46 111.753 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.33 150.92 4.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.875 0.369 . . . . 18.56 111.656 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -96.49 140.71 30.73 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.931 -0.577 . . . . 20.15 111.259 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.4 HD12 HD13 ' A' ' 50' ' ' LEU . 50.7 mm -49.55 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.091 -0.504 . . . . 16.47 111.164 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.08 -41.06 78.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.87 0.367 . . . . 19.99 110.153 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -69.29 -35.55 76.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 16.38 110.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.05 -45.36 98.72 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.153 -0.476 . . . . 13.8 110.573 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -59.84 -37.19 78.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 13.67 110.826 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.01 66.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 14.55 110.82 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.21 -41.13 83.38 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.174 -0.676 . . . . 13.7 109.174 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.477 HD12 ' OE1' ' A' ' 41' ' ' GLN . 96.4 mt -67.25 -37.79 79.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.353 -0.84 . . . . 9.57 110.546 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 60.2 tt0 -61.63 -33.97 74.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.024 -0.535 . . . . 15.04 110.84 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -56.86 -27.11 59.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 12.47 110.074 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -99.85 -71.03 0.71 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.861 -0.609 . . . . 9.23 112.608 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.68 -10.98 60.25 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.537 0.569 . . . . 9.6 112.537 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 63.26 7.29 17.78 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.595 -0.812 . . . . 12.2 113.305 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 36' ' ' ILE . 23.5 pt -71.9 122.22 86.69 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.798 0.299 . . . . 11.27 111.017 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.56 142.76 70.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.405 2.07 . . . . 14.23 111.873 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.15 -25.32 43.55 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.712 2.275 . . . . 14.34 112.837 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.71 -23.62 66.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.918 0.71 . . . . 16.96 112.918 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -107.92 -5.62 17.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.349 -0.612 . . . . 14.45 109.349 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.477 ' OE1' HD12 ' A' ' 30' ' ' ILE . 7.4 tt0 -83.14 100.93 10.85 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.247 -0.888 . . . . 10.91 110.888 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' HE ' ' N ' ' A' ' 43' ' ' LEU . 6.4 tpm_? -100.35 113.58 26.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.485 -0.932 . . . . 9.32 108.485 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.455 ' N ' ' HE ' ' A' ' 42' ' ' ARG . 61.9 mt -98.8 120.11 38.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.901 0.381 . . . . 10.56 110.887 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.666 HD12 HG21 ' B' ' 18' ' ' THR . 24.5 mm -109.43 137.43 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.681 -0.69 . . . . 9.75 110.367 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.502 ' HB3' HD21 ' A' ' 50' ' ' LEU . 62.5 t80 -156.47 132.34 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 15.27 111.182 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.72 6.23 2.58 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.837 -0.62 . . . . 14.76 111.87 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.41 -4.02 40.32 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.903 -0.665 . . . . 12.99 112.995 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' B' ' 18' ' ' THR . 55.0 tptt -122.01 152.16 40.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.747 0.308 . . . . 17.08 110.663 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -81.43 119.98 24.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 14.97 110.574 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 45' ' ' PHE . 84.1 mt -57.85 128.81 38.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.321 -0.4 . . . . 14.81 110.5 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 40.2 tt0 -81.08 124.97 29.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.323 -0.398 . . . . 21.0 109.986 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.47 -33.05 13.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.826 -0.624 . . . . 18.5 112.603 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -88.98 5.99 84.07 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.997 0.759 . . . . 21.79 114.997 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -105.55 173.04 6.48 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.672 0.736 . . . . 24.16 111.463 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -109.59 155.57 21.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.128 -0.487 . . . . 21.36 110.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.7 mt -53.97 -16.32 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 18.41 111.795 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -78.93 -26.01 43.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.647 0.26 . . . . 21.76 111.531 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.8 -36.98 84.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.39 -0.368 . . . . 23.14 110.765 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -99.44 12.23 36.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.155 -0.475 . . . . 19.37 111.878 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.4 m120 57.07 27.45 13.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.846 0.355 . . . . 22.24 111.416 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.453 HG12 ' CE2' ' A' ' 45' ' ' PHE . 98.1 mt -68.61 108.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.294 -0.412 . . . . 17.93 111.541 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -94.37 -179.54 4.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.207 -0.451 . . . . 21.49 111.108 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.37 156.77 28.17 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.949 0.404 . . . . 19.19 111.51 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 58.33 28.88 17.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.765 -0.652 . . . . 16.92 111.461 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 p -88.14 150.86 23.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 14.92 110.686 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.5 t -101.83 121.48 42.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.191 -0.459 . . . . 11.29 110.849 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.7 mp -110.82 117.17 32.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 10.94 109.864 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.413 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 17.6 m-70 -79.3 109.3 13.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 8.09 112.074 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -92.55 115.12 27.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.076 -0.511 . . . . 6.7 110.399 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.4 171.22 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 7.13 111.466 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.4 tp -85.8 112.43 21.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 8.31 110.381 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -55.56 170.43 0.25 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.226 -0.443 . . . . 14.22 110.4 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' B' ' 19' ' ' ASN . 88.4 mt -39.03 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.448 -0.342 . . . . 13.68 110.735 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -172.0 -30.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.042 -0.526 . . . . 20.03 110.538 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.12 148.06 19.42 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.18 -0.533 . . . . 17.34 112.392 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.504 -1.164 . . . . 17.6 112.557 -179.871 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.594 0.235 . . . . 9.15 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.405 ' HB2' ' CZ ' ' B' ' 8' ' ' TYR . 56.4 mttm -110.81 173.82 6.15 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.095 0.474 . . . . 10.58 110.882 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.51 131.48 46.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.329 -0.851 . . . . 7.56 109.252 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . 0.405 ' CZ ' ' HB2' ' B' ' 6' ' ' LYS . 54.9 m-85 -127.42 158.58 36.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.302 0.572 . . . . 7.84 112.063 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.533 ' SG ' ' HB1' ' B' ' 60' ' ' ALA . 24.0 p -145.22 145.78 31.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.023 -0.99 . . . . 4.73 110.581 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -101.76 137.15 40.45 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.824 0.345 . . . . 4.43 110.555 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -76.87 126.0 30.24 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.106 -0.497 . . . . 2.72 111.467 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 39.0 mt -88.73 -20.87 24.24 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.86 0.319 . . . . 3.78 111.86 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -147.37 156.73 45.97 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 121.052 -0.259 . . . . 4.88 111.399 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 138.47 29.24 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.48 2.12 . . . . 3.11 112.378 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' B' ' 25' ' ' PHE . 69.2 t80 -136.74 130.55 32.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.489 -0.778 . . . . 4.0 110.801 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.469 ' HA ' HG23 ' B' ' 24' ' ' THR . 34.2 m -111.83 119.56 38.99 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.884 0.373 . . . . 3.82 111.034 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.72 142.28 48.2 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.816 -0.629 . . . . 3.22 112.319 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.666 HG21 HD12 ' A' ' 44' ' ' ILE . 73.9 p -111.14 -22.24 11.53 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.95 0.405 . . . . 4.64 111.534 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.42 ' HB3' HD21 ' A' ' 73' ' ' LEU . 93.3 m-20 -117.45 160.56 20.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.698 -0.683 . . . . 4.05 110.206 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.38 -33.46 75.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 4.26 111.652 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -84.77 -4.26 58.97 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.834 0.35 . . . . 4.22 110.952 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -81.74 153.88 26.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.068 -0.515 . . . . 3.77 110.557 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' B' ' 48' ' ' LEU . 0.5 OUTLIER -104.43 144.05 32.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.961 -0.755 . . . . 3.13 108.961 178.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.469 HG23 ' HA ' ' B' ' 16' ' ' THR . 99.8 m -114.81 121.94 44.82 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.767 -0.651 . . . . 2.46 110.172 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' B' ' 15' ' ' TYR . 31.9 p90 -138.57 153.41 48.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.833 0.679 . . . . 2.49 112.833 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -109.52 -179.59 3.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.839 -0.43 . . . . 6.21 109.839 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.5 135.45 35.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.114 0.483 . . . . 3.87 109.842 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.03 31.97 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.524 -1.03 . . . . 4.23 110.524 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -96.79 178.69 5.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.793 0.806 . . . . 4.19 113.001 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.7 mm -135.76 114.16 15.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 113.763 -1.562 . . . . 5.23 111.245 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.07 139.58 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 4.64 110.861 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' B' ' 32' ' ' HIS . 7.2 m170 -91.68 128.81 37.65 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.456 -0.572 . . . . 7.14 109.456 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.443 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.9 tt -72.08 98.7 2.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 6.33 110.58 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 38.3 mm -79.54 -63.11 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 6.97 111.125 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.0 t -157.97 110.13 2.33 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.824 0.676 . . . . 7.03 112.824 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.438 ' O ' HG23 ' B' ' 38' ' ' THR . 58.6 mtmt -56.29 -69.81 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.999 -0.741 . . . . 7.52 108.999 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.51 98.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.426 -0.352 . . . . 8.93 111.394 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 36' ' ' LYS . 23.7 p -111.37 -5.3 14.65 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.34 -0.391 . . . . 7.05 111.104 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.27 -8.36 72.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.81 -0.71 . . . . 8.42 111.649 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.24 120.43 31.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.812 0.339 . . . . 7.96 110.656 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.31 55.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.496 . . . . 8.2 111.35 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 -0.7 83.72 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.807 -0.633 . . . . 6.68 112.675 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -121.63 127.37 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.333 0.566 . . . . 5.83 112.088 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' TRP . . . . . 0.57 ' HB2' ' CE2' ' B' ' 55' ' ' PHE . 23.2 m0 -113.88 162.15 16.72 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.285 -0.871 . . . . 5.87 109.201 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -114.19 131.25 56.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.086 0.469 . . . . 5.33 110.89 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.83 174.73 22.22 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.454 -0.794 . . . . 4.14 112.073 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.26 132.81 52.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.143 0.497 . . . . 6.02 110.272 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 50' ' ' GLY . 19.8 tp -129.81 170.28 14.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.192 -0.913 . . . . 4.21 109.755 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.471 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 67.7 m-20 -17.7 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.33 1.604 . . . . 5.39 115.33 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 84.4 -12.57 54.94 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 114.545 0.578 . . . . 5.53 114.545 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -119.5 134.36 55.25 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.461 0.63 . . . . 5.33 111.105 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.46 146.5 31.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.07 -0.514 . . . . 5.79 110.18 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.47 -177.48 41.93 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.541 -0.838 . . . . 3.35 112.55 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.98 160.99 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 112.126 0.417 . . . . 4.3 112.126 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' B' ' 44' ' ' TRP . 2.7 p90 -124.79 149.55 62.97 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.665 -0.698 . . . . 3.72 111.106 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.69 122.4 5.45 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.828 2.352 . . . . 3.97 115.171 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 51.26 43.76 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 114.171 1.174 . . . . 5.85 114.171 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.48 92.26 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.166 1.172 . . . . 5.67 114.166 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -102.84 17.52 23.72 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.425 -0.954 . . . . 3.89 108.425 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.533 ' HB1' ' SG ' ' B' ' 9' ' ' CYS . . . -146.26 138.2 24.96 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.591 0.219 . . . . 3.89 111.591 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 p -109.11 121.59 62.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.498 -0.319 . . . . 4.64 111.336 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.45 155.93 3.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.82 0.343 . . . . 6.72 110.594 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.87 -51.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 6.54 110.639 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.301 -0.856 . . . . 7.43 110.714 -179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.724 0.297 . . . . 16.5 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -84.58 148.03 26.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 13.22 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.4 pt -139.52 154.77 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.632 . . . . 12.19 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.87 134.57 53.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.023 -0.535 . . . . 11.64 110.376 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.8 t -118.16 100.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.376 -0.601 . . . . 6.66 109.376 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 14.5 tmtt? -88.82 131.2 35.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 6.86 112.155 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -106.08 163.17 12.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.252 -0.885 . . . . 3.79 110.841 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.74 -21.97 66.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.275 -0.421 . . . . 5.48 111.348 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 t -81.23 -8.51 59.76 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.382 -0.372 . . . . 7.65 111.18 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.1 54.99 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.179 -0.534 . . . . 7.08 112.965 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -97.0 108.58 21.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 6.58 111.337 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.0 p -99.93 124.33 45.15 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.928 -0.578 . . . . 6.95 110.261 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.57 143.85 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.368 . . . . 5.97 111.185 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.1 m -98.13 135.66 39.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.865 -0.607 . . . . 8.28 110.786 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.89 152.95 52.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 10.02 110.985 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.48 121.01 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 12.19 109.753 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.444 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.5 m -140.12 -178.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.086 0.469 . . . . 14.73 111.446 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 38.8 tt0 -145.63 146.28 28.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.49 -0.777 . . . . 18.57 109.873 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 72.2 Cg_exo -50.47 -26.4 16.3 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 19.89 112.91 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 m -85.64 -23.85 27.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.323 -0.399 . . . . 21.46 111.28 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.6 148.96 8.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.381 . . . . 18.56 111.392 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 m -95.85 144.19 26.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.904 -0.589 . . . . 20.15 111.139 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.603 HD12 HD23 ' A' ' 50' ' ' LEU . 24.0 mm -51.86 -44.58 37.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.132 -0.485 . . . . 16.47 111.433 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.18 -38.06 67.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.853 0.359 . . . . 19.99 110.329 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -68.07 -38.84 82.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.556 . . . . 16.38 110.087 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -58.99 -48.57 86.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 116.144 -0.48 . . . . 13.8 110.416 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.75 -32.67 71.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.05 -0.523 . . . . 13.67 110.885 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.19 78.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.147 -0.479 . . . . 14.55 110.351 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' A' ' 17' ' ' VAL . 36.9 mtmm -70.09 -42.75 72.31 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 13.7 110.228 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.615 ' CG2' HD11 ' A' ' 36' ' ' ILE . 86.3 mt -61.05 -41.46 89.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.093 0.473 . . . . 9.57 109.985 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -32.87 74.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.819 -0.628 . . . . 15.04 110.989 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -66.12 -35.91 81.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 12.47 111.402 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -92.32 -59.25 2.13 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.399 0.518 . . . . 9.23 112.399 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.451 ' OE2' HD13 ' A' ' 36' ' ' ILE . 32.1 tt0 -81.66 -11.41 59.09 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.999 0.74 . . . . 9.6 112.999 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.83 -21.11 4.91 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.636 -0.792 . . . . 12.2 114.454 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.615 HD11 ' CG2' ' A' ' 30' ' ' ILE . 13.8 pt -54.54 135.49 62.92 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 117.469 0.634 . . . . 11.27 111.92 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 89.9 Cg_endo -78.98 135.41 12.4 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.819 2.346 . . . . 14.23 112.468 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.3 Cg_exo -54.33 -27.16 46.95 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.799 2.333 . . . . 14.34 112.965 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.51 -24.11 67.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.427 -0.351 . . . . 16.96 111.339 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -110.79 -5.16 15.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 14.45 111.363 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -80.93 128.09 33.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 10.91 111.495 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 42' ' ' ARG . 27.9 ttt-85 -125.18 114.21 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.18 -0.674 . . . . 9.32 109.18 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -101.94 126.54 48.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 10.56 110.858 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.85 134.39 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 9.75 110.893 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CB ' HD11 ' A' ' 50' ' ' LEU . 83.0 t80 -151.53 123.14 7.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.585 -0.734 . . . . 15.27 110.187 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 69.35 18.55 7.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.803 -0.635 . . . . 14.76 111.614 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.55 -12.07 70.63 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.704 -0.76 . . . . 12.99 112.678 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -107.72 148.49 29.36 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.05 0.452 . . . . 17.08 111.442 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -82.45 129.26 34.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.727 -0.669 . . . . 14.97 110.096 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.603 HD23 HD12 ' A' ' 23' ' ' ILE . 6.8 mp -67.97 130.87 44.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 14.81 111.225 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HB2' ' CG ' ' A' ' 54' ' ' ARG . 11.5 mm-40 -86.74 128.54 35.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.904 -0.589 . . . . 21.0 110.41 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.9 m-20 -52.03 -31.48 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.747 -0.66 . . . . 18.5 112.759 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.53 3.76 85.17 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.736 -0.745 . . . . 21.79 113.867 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' CG ' ' HB2' ' A' ' 51' ' ' GLU . 34.6 mmt180 -103.15 177.44 4.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.992 0.396 . . . . 24.16 110.829 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -123.16 160.5 26.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.364 . . . . 21.36 111.087 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -51.91 -31.01 26.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 18.41 111.753 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 p -71.04 -25.85 62.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.735 0.272 . . . . 21.76 111.735 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.81 -37.52 87.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.647 0.26 . . . . 23.14 111.059 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.91 7.46 46.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 19.37 111.829 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 61.97 36.27 15.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.864 0.364 . . . . 22.24 111.54 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -78.65 107.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 17.93 111.272 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -95.21 -179.14 4.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.224 -0.444 . . . . 21.49 111.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.06 155.34 24.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.108 -0.496 . . . . 19.19 111.936 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 58.48 31.11 20.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.686 -0.688 . . . . 16.92 111.455 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -86.19 158.26 19.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 14.92 110.631 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 t -114.26 125.33 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 11.29 110.728 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -115.09 122.59 46.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.902 -0.59 . . . . 10.94 110.229 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -85.69 111.66 20.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.904 0.383 . . . . 8.09 111.611 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -92.34 115.0 27.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.032 -0.531 . . . . 6.7 109.807 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.5 -161.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.271 0.471 . . . . 7.13 112.271 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 tp -125.81 121.28 32.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.511 -0.768 . . . . 8.31 110.065 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -43.11 -70.77 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.083 -0.508 . . . . 14.22 111.909 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.7 tp -140.05 137.67 34.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.561 -0.291 . . . . 13.68 110.343 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? 179.8 -58.98 0.01 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.91 0.386 . . . . 20.03 110.403 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.17 35.94 0.36 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.042 -0.599 . . . . 17.34 112.413 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.377 -1.235 . . . . 17.6 112.417 179.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.496 0.188 . . . . 9.15 111.142 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -109.24 175.31 5.5 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.253 0.549 . . . . 10.58 110.954 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.59 132.39 49.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.27 -0.877 . . . . 7.56 109.444 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.9 160.05 33.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.327 0.584 . . . . 7.84 112.056 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.524 ' SG ' ' HA ' ' B' ' 62' ' ' GLN . 32.5 m -141.49 146.93 37.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.982 -1.008 . . . . 4.73 110.201 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -102.04 143.79 31.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.829 0.347 . . . . 4.43 111.078 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.5 m -82.01 123.64 29.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.999 -0.546 . . . . 2.72 111.515 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.37 -20.68 22.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.923 0.342 . . . . 3.78 111.923 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' B' ' 14' ' ' PRO . 30.6 t80 -154.94 144.64 15.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 117.921 0.328 . . . . 4.88 111.02 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' B' ' 13' ' ' PHE . 32.3 Cg_exo -59.45 138.46 84.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.416 2.077 . . . . 3.11 112.608 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.567 ' CZ ' ' HD3' ' B' ' 56' ' ' PRO . 29.2 t80 -133.72 131.1 39.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.687 -0.688 . . . . 4.0 110.839 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.614 ' HA ' HG23 ' B' ' 24' ' ' THR . 54.5 m -111.89 117.92 34.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.989 0.423 . . . . 3.82 111.049 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.45 138.01 47.19 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.973 -0.632 . . . . 3.22 112.366 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 15.7 m -104.51 -21.44 13.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.352 0.596 . . . . 4.64 110.241 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -118.46 156.06 29.69 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.948 -1.024 . . . . 4.05 109.861 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -64.72 -38.62 91.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 4.26 111.186 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.8 -3.21 33.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.809 0.338 . . . . 4.22 110.963 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -88.65 160.98 17.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 3.77 110.919 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' B' ' 48' ' ' LEU . 0.6 OUTLIER -103.87 140.66 37.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.542 -0.54 . . . . 3.13 109.542 178.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.614 HG23 ' HA ' ' B' ' 16' ' ' THR . 56.0 m -116.07 121.73 43.05 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.297 -0.865 . . . . 2.46 109.992 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.587 ' HB3' HD22 ' B' ' 48' ' ' LEU . 17.8 p90 -140.23 159.06 43.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.913 0.709 . . . . 2.49 112.913 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.558 ' H ' ' HG3' ' B' ' 29' ' ' GLU . 81.4 mtt-85 -109.74 179.36 4.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.328 -0.249 . . . . 6.21 110.328 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -82.23 140.53 33.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.051 0.453 . . . . 3.87 110.048 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.61 21.87 49.23 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.602 -0.999 . . . . 4.23 110.602 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.558 ' HG3' ' H ' ' B' ' 26' ' ' ARG . 5.3 mm-40 -97.96 179.45 4.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.471 0.915 . . . . 4.19 113.471 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -130.5 123.56 55.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.821 -1.536 . . . . 5.23 111.417 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -122.07 135.67 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.725 -0.671 . . . . 4.64 111.191 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.48 132.72 42.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.703 -0.481 . . . . 7.14 109.703 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.459 ' C ' HD23 ' B' ' 33' ' ' LEU . 3.3 tt -72.98 100.46 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 6.33 110.798 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.18 -62.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.554 -0.748 . . . . 6.97 110.824 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 68.5 m -158.37 110.11 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.647 0.61 . . . . 7.03 112.647 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.712 ' O ' HG23 ' B' ' 38' ' ' THR . 35.0 mtmt -57.91 -71.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.383 -0.599 . . . . 7.52 109.383 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -45.72 94.43 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.325 -0.398 . . . . 8.93 111.502 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.712 HG23 ' O ' ' B' ' 36' ' ' LYS . 68.6 p -106.58 -9.02 16.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.241 -0.436 . . . . 7.05 111.051 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.29 -5.0 62.68 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.909 -0.662 . . . . 8.42 112.345 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -129.98 120.79 25.34 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.873 0.368 . . . . 7.96 110.554 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 133.3 55.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.945 -0.57 . . . . 8.2 111.61 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 -0.64 85.48 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.586 -0.734 . . . . 6.68 112.699 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.412 ' CH2' ' HB3' ' B' ' 56' ' ' PRO . 79.6 m95 -121.86 123.6 42.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.324 0.562 . . . . 5.83 111.799 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' TRP . . . . . 0.558 ' HB2' ' CE1' ' B' ' 55' ' ' PHE . 21.8 m0 -110.32 172.11 7.06 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.504 -0.771 . . . . 5.87 109.322 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -125.39 130.61 52.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 5.33 110.905 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.2 176.31 21.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.488 -0.778 . . . . 4.14 111.77 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -124.7 133.79 53.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.303 0.573 . . . . 6.02 110.207 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.677 ' O ' ' N ' ' B' ' 50' ' ' GLY . 27.3 tp -129.56 170.1 14.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.098 -0.955 . . . . 4.21 109.778 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.507 ' H ' ' HG ' ' B' ' 48' ' ' LEU . 31.5 p-10 -17.58 63.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.126 1.528 . . . . 5.39 115.126 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' B' ' 48' ' ' LEU . . . 83.61 -12.37 52.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 114.429 0.532 . . . . 5.53 114.429 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.32 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.545 0.672 . . . . 5.33 111.068 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' B' ' 52' ' ' GLU . 0.0 OUTLIER -112.27 146.18 38.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.07 -0.514 . . . . 5.79 110.506 179.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . 0.431 ' N ' ' HG ' ' B' ' 23' ' ' LEU . . . -174.74 -176.06 42.75 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.666 -0.778 . . . . 3.35 113.017 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 31.4 m -113.5 160.47 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 112.51 0.559 . . . . 4.3 112.51 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 44' ' ' TRP . 6.2 p90 -125.19 148.49 60.79 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.563 -0.744 . . . . 3.72 110.976 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.567 ' HD3' ' CZ ' ' B' ' 15' ' ' TYR . 89.2 Cg_endo -79.05 123.24 5.59 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.035 2.49 . . . . 3.97 115.369 -177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 52.32 43.55 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.553 1.316 . . . . 5.85 114.553 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ASN . . . . . 0.613 HD22 ' N ' ' B' ' 58' ' ' ASN . 0.8 OUTLIER 60.52 93.55 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.692 1.367 . . . . 5.67 114.692 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.27 12.8 35.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.748 -0.834 . . . . 3.89 108.748 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.42 138.6 29.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.497 -0.32 . . . . 3.89 111.622 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.46 126.99 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.501 -0.318 . . . . 4.64 111.823 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.524 ' HA ' ' SG ' ' B' ' 9' ' ' CYS . 53.6 tt0 -59.37 140.69 55.87 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 110.167 -0.309 . . . . 6.72 110.167 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 56.3 mt -101.63 -60.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 6.54 110.705 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.149 -0.929 . . . . 7.43 110.76 179.734 . . . . . . . . 0 0 . 1 stop_ save_